id,label,effectiveTime,active,moduleId,definitionStatusId
224961000,Ability to sleep (observable entity),20020131,1,9E+17,9E+17
224992003,Mental defense mechanisms (observable entity),20020131,1,9E+17,9E+17
224433004,Availability of workplace drinking water (observable entity),20020131,1,9E+17,9E+17
224437003,Availability of workplace welfare facility (observable entity),20020131,1,9E+17,9E+17
224441004,Availability of workplace rest area facilities (observable entity),20020131,1,9E+17,9E+17
224429006,Availability of workplace vending machine facilities (observable entity),20020131,1,9E+17,9E+17
224412008,Availability of facilities in workplace (observable entity),20020131,1,9E+17,9E+17
224413003,Availability of workplace toilet facilities (observable entity),20020131,1,9E+17,9E+17
224417002,Availability of workplace handwashing facilities (observable entity),20020131,1,9E+17,9E+17
224421009,Availability of workplace shower facilities (observable entity),20020131,1,9E+17,9E+17
224425000,Availability of workplace canteen facilities (observable entity),20020131,1,9E+17,9E+17
224475003,Detail of care and support circumstances and networks (observable entity),20020131,1,9E+17,9E+17
224476002,Availability of help from lay caregiver (observable entity),20020131,1,9E+17,9E+17
224487005,Details of informal caregiver (observable entity),20020131,1,9E+17,9E+17
224488000,Willingness of caregiver to provide care (observable entity),20020131,1,9E+17,9E+17
224463008,Details relating to changes in job (observable entity),20020131,1,9E+17,9E+17
224469007,Prospects of promotion (observable entity),20020131,1,9E+17,9E+17
224409005,Time spent working away from home (observable entity),20020131,1,9E+17,9E+17
224348009,Enduring power of attorney (observable entity),20020131,1,9E+17,9E+17
224350001,Eligibility for criminal injuries compensation (observable entity),20020131,1,9E+17,9E+17
224359000,Duration of military service (observable entity),20020131,1,9E+17,9E+17
224360005,Number of previous jobs (observable entity),20020131,1,9E+17,9E+17
224361009,Type of job (observable entity),20020131,1,9E+17,9E+17
224362002,Employment status (observable entity),20020131,1,9E+17,9E+17
224326003,Qualifications achieved (observable entity),20020131,1,9E+17,9E+17
224329005,Legal affairs and legal constraints (observable entity),20020131,1,9E+17,9E+17
224391004,Acceptance of authority at work (observable entity),20020131,1,9E+17,9E+17
224394007,Acceptance of supervision at work (observable entity),20020131,1,9E+17,9E+17
224399002,Attendance at work (observable entity),20020131,1,9E+17,9E+17
224406003,Details relating to place of work and employer (observable entity),20020131,1,9E+17,9E+17
224388004,Awareness of safety at work (observable entity),20020131,1,9E+17,9E+17
224373009,Length of time in job (observable entity),20020131,1,9E+17,9E+17
224374003,Regularity of work (observable entity),20020131,1,9E+17,9E+17
224377005,Number of jobs at once (observable entity),20020131,1,9E+17,9E+17
224494008,Availability of informal caregiver (observable entity),20020131,1,9E+17,9E+17
224522000,Countries planned to visit (observable entity),20020131,1,9E+17,9E+17
224523005,Number of dependants (observable entity),20020131,1,9E+17,9E+17
224524004,Number of dependants in household (observable entity),20020131,1,9E+17,9E+17
224525003,Number in household (observable entity),20020131,1,9E+17,9E+17
224514007,Caregiver transport (observable entity),20020131,1,9E+17,9E+17
224497001,Proximity of informal caregiver (observable entity),20020131,1,9E+17,9E+17
224502004,Number of informal caregivers (observable entity),20020131,1,9E+17,9E+17
224503009,Quality of informal care (observable entity),20020131,1,9E+17,9E+17
224507005,Neighborhood care support (observable entity),20020131,1,9E+17,9E+17
224511004,Support for informal caregiver (observable entity),20020131,1,9E+17,9E+17
225597007,Ability to interact with others (observable entity),20020131,1,9E+17,9E+17
225598002,Interaction with others (observable entity),20020131,1,9E+17,9E+17
225567004,Appearance of cornea (observable entity),20020131,1,9E+17,9E+17
225568009,General appearance of eye (observable entity),20020131,1,9E+17,9E+17
225487001,Self-confidence (observable entity),20020131,1,9E+17,9E+17
225490007,Use of 'I' statements (observable entity),20020131,1,9E+17,9E+17
225464009,Attitude (observable entity),20020131,1,9E+17,9E+17
225467002,Volition (observable entity),20020131,1,9E+17,9E+17
225510008,Self-image (observable entity),20020131,1,9E+17,9E+17
225517006,Sexual partners (observable entity),20020131,1,9E+17,9E+17
225781004,Pain tolerance level (observable entity),20020131,1,9E+17,9E+17
225847002,Ability to talk about problems (observable entity),20020131,1,9E+17,9E+17
225810002,Vulnerability to exploitation (observable entity),20020131,1,9E+17,9E+17
224324000,Number of pupils in class (observable entity),20020131,1,9E+17,9E+17
225044005,General immune status (observable entity),20020131,1,9E+17,9E+17
224323006,Number of pupils in school (observable entity),20020131,1,9E+17,9E+17
225850004,Awareness of rules and boundaries (observable entity),20020131,1,9E+17,9E+17
224093006,Details of family (observable entity),20020131,1,9E+17,9E+17
224095004,Number of siblings (observable entity),20020131,1,9E+17,9E+17
224096003,Number of brothers (observable entity),20020131,1,9E+17,9E+17
224097007,Number of sisters (observable entity),20020131,1,9E+17,9E+17
224099005,Type of upbringing (observable entity),20020131,1,9E+17,9E+17
224098002,Place in family order (observable entity),20020131,1,9E+17,9E+17
224086007,Details of relatives (observable entity),20020131,1,9E+17,9E+17
224085006,Family details / household composition (observable entity),20020131,1,9E+17,9E+17
224084005,Number of previous marriages (observable entity),20020131,1,9E+17,9E+17
224075005,Mother tongue (observable entity),20020131,1,9E+17,9E+17
224076006,First language (observable entity),20020131,1,9E+17,9E+17
224077002,Second language (observable entity),20020131,1,9E+17,9E+17
224083004,Marital or partnership status (observable entity),20020131,1,9E+17,9E+17
224130005,Household composition (observable entity),20020131,1,9E+17,9E+17
224111005,Details of parents (observable entity),20020131,1,9E+17,9E+17
224112003,Age of parents (observable entity),20020131,1,9E+17,9E+17
224117009,Details of own children (observable entity),20020131,1,9E+17,9E+17
224118004,Number of offspring (observable entity),20020131,1,9E+17,9E+17
224119007,Age spread of children in family (observable entity),20020131,1,9E+17,9E+17
224150009,Pet ownership (observable entity),20020131,1,9E+17,9E+17
224261007,State of repair of house (observable entity),20020131,1,9E+17,9E+17
224263005,Adequacy of living space (observable entity),20020131,1,9E+17,9E+17
224265003,Personalization of home (observable entity),20020131,1,9E+17,9E+17
224268001,Cleanliness of home (observable entity),20020131,1,9E+17,9E+17
224272002,Tidiness of home (observable entity),20020131,1,9E+17,9E+17
224275000,Decoration of home (observable entity),20020131,1,9E+17,9E+17
224238005,Status of waiting list for accommodation (observable entity),20020131,1,9E+17,9E+17
224242008,Presence of communal areas in accommodation (observable entity),20020131,1,9E+17,9E+17
224245005,Opportunity for privacy in accommodation (observable entity),20020131,1,9E+17,9E+17
224249004,Characteristics of home environment (observable entity),20020131,1,9E+17,9E+17
224278003,Domestic facilities (observable entity),20020131,1,9E+17,9E+17
224303005,Education currently received (observable entity),20020131,1,9E+17,9E+17
224312007,Number of changes of school (observable entity),20020131,1,9E+17,9E+17
224314008,Degree of integration into mainstream education (observable entity),20020131,1,9E+17,9E+17
224279006,Details of telephone in the home (observable entity),20020131,1,9E+17,9E+17
224285004,Education and schooling detail (observable entity),20020131,1,9E+17,9E+17
224286003,Age at starting school (observable entity),20020131,1,9E+17,9E+17
224287007,Age at leaving school (observable entity),20020131,1,9E+17,9E+17
224288002,Duration of formal education (observable entity),20020131,1,9E+17,9E+17
224289005,Degree of interruption to education (observable entity),20020131,1,9E+17,9E+17
224293004,Education received in the past (observable entity),20020131,1,9E+17,9E+17
224235008,Eligibility for accommodation (observable entity),20020131,1,9E+17,9E+17
224178005,Frequency of payment of income (observable entity),20020131,1,9E+17,9E+17
224185009,Pattern of income (observable entity),20020131,1,9E+17,9E+17
224189003,Sufficiency of income for needs (observable entity),20020131,1,9E+17,9E+17
224173001,Individual income (observable entity),20020131,1,9E+17,9E+17
224153006,Local environment and neighborhood details (observable entity),20020131,1,9E+17,9E+17
224154000,Relationship with neighbors (observable entity),20020131,1,9E+17,9E+17
224155004,Details of local facilities and amenities (observable entity),20020131,1,9E+17,9E+17
224156003,State of public utilities and amenities (observable entity),20020131,1,9E+17,9E+17
224164009,Financial circumstances (observable entity),20020131,1,9E+17,9E+17
224167002,Income details (observable entity),20020131,1,9E+17,9E+17
224168007,Household income (observable entity),20020131,1,9E+17,9E+17
224192004,Benefit status (observable entity),20020131,1,9E+17,9E+17
224230003,Temporary shelter arrangements (observable entity),20020131,1,9E+17,9E+17
224193009,Entitlement to benefit status (observable entity),20020131,1,9E+17,9E+17
224200006,Management of financial affairs (observable entity),20020131,1,9E+17,9E+17
224203008,Use of banks and building societies (observable entity),20020131,1,9E+17,9E+17
224209007,Residence and accommodation circumstances (observable entity),20020131,1,9E+17,9E+17
224210002,Housing ownership and tenure (observable entity),20020131,1,9E+17,9E+17
228134009,School attendance (observable entity),20020131,1,9E+17,9E+17
228130000,Access to child (observable entity),20020131,1,9E+17,9E+17
228127007,Wardship (observable entity),20020131,1,9E+17,9E+17
228844008,Wedge filter angle (observable entity),20020131,1,9E+17,9E+17
228845009,Brachytherapy treatment parameters (observable entity),20020131,1,9E+17,9E+17
228846005,Brachytherapy radiation source strength (observable entity),20020131,1,9E+17,9E+17
228847001,Number of radioactive sources (observable entity),20020131,1,9E+17,9E+17
228848006,Brachytherapy radiation dose rate (observable entity),20020131,1,9E+17,9E+17
228849003,Brachytherapy radiation dose (observable entity),20020131,1,9E+17,9E+17
228850003,Total reference air kerma (observable entity),20020131,1,9E+17,9E+17
228851004,Reference point dose (observable entity),20020131,1,9E+17,9E+17
228852006,Nominal uterine body dose (observable entity),20020131,1,9E+17,9E+17
228853001,Radiation treating distance (observable entity),20020131,1,9E+17,9E+17
228854007,Radionuclide therapy parameters (observable entity),20020131,1,9E+17,9E+17
228855008,Radionuclide source activity (observable entity),20020131,1,9E+17,9E+17
228856009,Radionuclide dose (observable entity),20020131,1,9E+17,9E+17
228857000,Radionuclide uptake (observable entity),20020131,1,9E+17,9E+17
228858005,Pre-treatment uptake (observable entity),20020131,1,9E+17,9E+17
228859002,Radiation therapy observable (observable entity),20020131,1,9E+17,9E+17
228860007,Nominal standard dose (observable entity),20020131,1,9E+17,9E+17
228843002,Thickness of surface bolus (observable entity),20020131,1,9E+17,9E+17
228861006,Number of radiotherapy applications (observable entity),20020131,1,9E+17,9E+17
228842007,Thickness of cutout (observable entity),20020131,1,9E+17,9E+17
228840004,Radiotherapy beam modifier dimensions (observable entity),20020131,1,9E+17,9E+17
228823008,Reduced focus skin distance (observable entity),20020131,1,9E+17,9E+17
228824002,Source axis distance (observable entity),20020131,1,9E+17,9E+17
228825001,External beam radiation therapy pin height (observable entity),20020131,1,9E+17,9E+17
228826000,External beam radiation therapy height above couch (observable entity),20020131,1,9E+17,9E+17
228827009,Isocenter couch distance (observable entity),20020131,1,9E+17,9E+17
228828004,External beam radiation therapy setup angles (observable entity),20020131,1,9E+17,9E+17
228829007,Gantry angle (observable entity),20020131,1,9E+17,9E+17
228830002,Tilt angle (observable entity),20020131,1,9E+17,9E+17
228831003,Tangential angle (observable entity),20020131,1,9E+17,9E+17
228832005,Couch angle (observable entity),20020131,1,9E+17,9E+17
228833000,Jaw angle (observable entity),20020131,1,9E+17,9E+17
228834006,Beam angle (observable entity),20020131,1,9E+17,9E+17
228835007,Wedge angle (observable entity),20020131,1,9E+17,9E+17
228836008,Hinge angle (observable entity),20020131,1,9E+17,9E+17
228837004,Rotation external beam radiation therapy parameters (observable entity),20020131,1,9E+17,9E+17
228838009,Number of arcs (observable entity),20020131,1,9E+17,9E+17
228839001,Number of centers (observable entity),20020131,1,9E+17,9E+17
228841000,Thickness of block (observable entity),20020131,1,9E+17,9E+17
228822003,Extended focus skin distance (observable entity),20020131,1,9E+17,9E+17
228862004,Number of fractions (observable entity),20020131,1,9E+17,9E+17
228863009,Number of exposures (observable entity),20020131,1,9E+17,9E+17
228865002,Brachytherapy source activity (observable entity),20020131,1,9E+17,9E+17
228867005,High dose rate brachytherapy (observable entity),20020131,1,9E+17,9E+17
228868000,Low dose rate brachytherapy (observable entity),20020131,1,9E+17,9E+17
228821005,Standard focus skin distance (observable entity),20020131,1,9E+17,9E+17
228819000,External beam radiation therapy setup distances (observable entity),20020131,1,9E+17,9E+17
228820006,Source skin distance (observable entity),20020131,1,9E+17,9E+17
228779000,Radiotherapy parameter (observable entity),20020131,1,9E+17,9E+17
228802002,Length of external beam radiation therapy beam (observable entity),20020131,1,9E+17,9E+17
228803007,External beam radiation therapy dose parameters (observable entity),20020131,1,9E+17,9E+17
228804001,External beam radiation therapy radiation dose specification (observable entity),20020131,1,9E+17,9E+17
228805000,Maximum radiation target dose (observable entity),20020131,1,9E+17,9E+17
228807008,Minimum radiation target dose (observable entity),20020131,1,9E+17,9E+17
228808003,Modal radiation target dose (observable entity),20020131,1,9E+17,9E+17
228809006,Mean radiation target dose (observable entity),20020131,1,9E+17,9E+17
228810001,Maximum radiation tissue dose (observable entity),20020131,1,9E+17,9E+17
228811002,Target radiation absorbed dose (observable entity),20020131,1,9E+17,9E+17
228812009,Critical radiation tissue dose (observable entity),20020131,1,9E+17,9E+17
228813004,Intersection radiation dose (observable entity),20020131,1,9E+17,9E+17
228814005,Mid-plane radiation dose (observable entity),20020131,1,9E+17,9E+17
228815006,Incident radiation dose (observable entity),20020131,1,9E+17,9E+17
228816007,Percentage depth dose (observable entity),20020131,1,9E+17,9E+17
228817003,External beam radiation therapy monitor units (observable entity),20020131,1,9E+17,9E+17
228818008,External beam radiation therapy setup parameters (observable entity),20020131,1,9E+17,9E+17
228801009,Width of external beam radiation therapy beam (observable entity),20020131,1,9E+17,9E+17
228800005,Depth of external beam radiation therapy beam (observable entity),20020131,1,9E+17,9E+17
228798003,Diameter of irradiated volume (observable entity),20020131,1,9E+17,9E+17
228780002,External beam radiation therapy treatment parameters (observable entity),20020131,1,9E+17,9E+17
228781003,External beam radiation therapy beam energy (observable entity),20020131,1,9E+17,9E+17
228782005,Radiation half-value thickness (observable entity),20020131,1,9E+17,9E+17
228784006,External beam radiation therapy dose rate (observable entity),20020131,1,9E+17,9E+17
228788009,Field separation (observable entity),20020131,1,9E+17,9E+17
228789001,External beam radiation therapy volume parameters (observable entity),20020131,1,9E+17,9E+17
228790005,Irradiated volume (observable entity),20020131,1,9E+17,9E+17
228791009,Gross tumor volume (observable entity),20020131,1,9E+17,9E+17
228792002,Clinical target volume (observable entity),20020131,1,9E+17,9E+17
228793007,Planning target volume (observable entity),20020131,1,9E+17,9E+17
228794001,Irradiated volume dimensions (observable entity),20020131,1,9E+17,9E+17
228795000,Depth of irradiated volume (observable entity),20020131,1,9E+17,9E+17
228796004,Width of irradiated volume (observable entity),20020131,1,9E+17,9E+17
228797008,Length of irradiated volume (observable entity),20020131,1,9E+17,9E+17
228799006,External beam radiation therapy beam dimensions (observable entity),20020131,1,9E+17,9E+17
228272008,Health-related behavior (observable entity),20020131,1,9E+17,9E+17
228283004,Drinking environment (observable entity),20020131,1,9E+17,9E+17
228282009,Drinking habits (observable entity),20020131,1,9E+17,9E+17
228328008,Age at starting drinking (observable entity),20020131,1,9E+17,9E+17
228329000,Time since stopped drinking (observable entity),20020131,1,9E+17,9E+17
228330005,Total time drunk alcohol (observable entity),20020131,1,9E+17,9E+17
228331009,Priority of drink-related activities (observable entity),20020131,1,9E+17,9E+17
228296003,Company when drinking (observable entity),20020131,1,9E+17,9E+17
228308009,Pattern of drinking (observable entity),20020131,1,9E+17,9E+17
228309001,Pattern of drinking through day (observable entity),20020131,1,9E+17,9E+17
228311005,Pattern of alcohol consumption through week (observable entity),20020131,1,9E+17,9E+17
228163007,Receipt of benefit status (observable entity),20020131,1,9E+17,9E+17
228338003,Ability to control drinking (observable entity),20020131,1,9E+17,9E+17
228466005,Commitment to sexual relationship (observable entity),20020131,1,9E+17,9E+17
228470002,Orientation of sexual relationship (observable entity),20020131,1,9E+17,9E+17
228473000,Duration of sexual relationship (observable entity),20020131,1,9E+17,9E+17
228476008,Use of protection for sex (observable entity),20020131,1,9E+17,9E+17
228465009,Sexual relationship details (observable entity),20020131,1,9E+17,9E+17
228464008,Number of sexual partners in past 5 years (observable entity),20020131,1,9E+17,9E+17
228462007,Total number of sexual partners ever (observable entity),20020131,1,9E+17,9E+17
228449008,Frequency of exercise (observable entity),20020131,1,9E+17,9E+17
228450008,Time spent exercising (observable entity),20020131,1,9E+17,9E+17
228454004,Frequency of sex (observable entity),20020131,1,9E+17,9E+17
228455003,Time since stopped being sexually active (observable entity),20020131,1,9E+17,9E+17
228456002,Age became sexually active (observable entity),20020131,1,9E+17,9E+17
228457006,Total time sexually active (observable entity),20020131,1,9E+17,9E+17
228458001,Number of sexual partners (observable entity),20020131,1,9E+17,9E+17
228459009,Number of current sexual partners (observable entity),20020131,1,9E+17,9E+17
228463002,Number of sexual partners in past year (observable entity),20020131,1,9E+17,9E+17
228489002,Snuff use (observable entity),20020131,1,9E+17,9E+17
228519008,Frequency of chewing tobacco (observable entity),20020131,1,9E+17,9E+17
228520002,Time since stopped chewing tobacco (observable entity),20020131,1,9E+17,9E+17
228521003,Total time chewed tobacco (observable entity),20020131,1,9E+17,9E+17
228522005,Age at starting chewing tobacco (observable entity),20020131,1,9E+17,9E+17
228510007,Chewed tobacco consumption (observable entity),20020131,1,9E+17,9E+17
228508005,Age at starting moist tobacco use (observable entity),20020131,1,9E+17,9E+17
228490006,Snuff consumption (observable entity),20020131,1,9E+17,9E+17
228495001,Frequency of snuff use (observable entity),20020131,1,9E+17,9E+17
228496000,Time since stopped snuff use (observable entity),20020131,1,9E+17,9E+17
228497009,Total time snuff used (observable entity),20020131,1,9E+17,9E+17
228498004,Age at starting snuff use (observable entity),20020131,1,9E+17,9E+17
228500003,Moist tobacco consumption (observable entity),20020131,1,9E+17,9E+17
228505008,Frequency of moist tobacco use (observable entity),20020131,1,9E+17,9E+17
228506009,Time since stopped using moist tobacco (observable entity),20020131,1,9E+17,9E+17
228507000,Total time moist tobacco used (observable entity),20020131,1,9E+17,9E+17
228360000,Attitude to drinking (observable entity),20020131,1,9E+17,9E+17
228345003,Use of stratagems to control drinking (observable entity),20020131,1,9E+17,9E+17
228349009,Tolerance to alcohol (observable entity),20020131,1,9E+17,9E+17
228421001,Time devoted to drug-related activities (observable entity),20020131,1,9E+17,9E+17
228422008,Time spent obtaining drugs (observable entity),20020131,1,9E+17,9E+17
228423003,Time spent taking drugs (observable entity),20020131,1,9E+17,9E+17
228424009,Time spent recovering from drugs (observable entity),20020131,1,9E+17,9E+17
228425005,Routine of drug-related activities (observable entity),20020131,1,9E+17,9E+17
228429004,Drug-related rituals (observable entity),20020131,1,9E+17,9E+17
228432001,Drug tolerance (observable entity),20020131,1,9E+17,9E+17
228413007,Age at starting drug misuse (observable entity),20020131,1,9E+17,9E+17
228390007,Frequency of drug misuse (observable entity),20020131,1,9E+17,9E+17
228391006,Drug injection behavior (observable entity),20020131,1,9E+17,9E+17
228394003,Drug injecting equipment hygiene (observable entity),20020131,1,9E+17,9E+17
228401002,Cleaning of drug injection equipment (observable entity),20020131,1,9E+17,9E+17
228411009,Time since stopped drug misuse (observable entity),20020131,1,9E+17,9E+17
228412002,Total time drugs misused (observable entity),20020131,1,9E+17,9E+17
228415000,Priority of drug-related activities (observable entity),20020131,1,9E+17,9E+17
225972001,Ability to maintain self-esteem (observable entity),20020131,1,9E+17,9E+17
225898008,Position of artificial lens (observable entity),20020131,1,9E+17,9E+17
225900005,Ability to control behavior (observable entity),20020131,1,9E+17,9E+17
225854008,Adherence to rules and boundaries (observable entity),20020131,1,9E+17,9E+17
225904001,Ability to prevent undesirable behavior (observable entity),20020131,1,9E+17,9E+17
225908003,Pain score (observable entity),20020131,1,9E+17,9E+17
225918008,Conversation content (observable entity),20020131,1,9E+17,9E+17
185975009,Hospital reference number (observable entity),20020131,1,9E+17,9E+17
185980000,Date records held from (observable entity),20020131,1,9E+17,9E+17
186034007,Ethnicity / related nationality data (observable entity),20020131,1,9E+17,9E+17
186063005,Power of attorney observable (observable entity),20020131,1,9E+17,9E+17
240258008,Limb length discrepancy (observable entity),20020131,1,9E+17,9E+17
243814003,Interpretation of findings (observable entity),20020131,1,9E+17,9E+17
229646000,Type of post-laryngectomy voice (observable entity),20020131,1,9E+17,9E+17
229024009,Behavior accompanying sex (observable entity),20020131,1,9E+17,9E+17
229226003,Wheelchair sport (qualifier value),20020131,1,9E+17,9E+17
229238007,Moving between two positions (observable entity),20020131,1,9E+17,9E+17
229257003,Active wrist movements (observable entity),20020131,1,9E+17,9E+17
229819007,Tobacco use and exposure (observable entity),20020131,1,9E+17,9E+17
229767007,Tripod grip (observable entity),20020131,1,9E+17,9E+17
128442000,Femoral artery pressure waveform (observable entity),20020131,1,9E+17,9E+17
128443005,Pulmonary arterial waveform (observable entity),20020131,1,9E+17,9E+17
128446002,Intra-arterial waveform (observable entity),20020131,1,9E+17,9E+17
128449009,Pulmonary artery wedge pressure waveform (observable entity),20020131,1,9E+17,9E+17
128452001,Pulmonary valve pullback pressure waveform (observable entity),20020131,1,9E+17,9E+17
129087001,Atrial effective refractory period (observable entity),20020131,1,9E+17,9E+17
129088006,Ventricular effective refractory period (observable entity),20020131,1,9E+17,9E+17
125680007,Marital status (observable entity),20020131,1,9E+17,9E+17
115598002,Consistency of specimen (observable entity),20020131,1,9E+17,9E+17
116335008,"Cartilage formation, function (observable entity)",20020131,1,9E+17,9E+17
170967006,Prognosis/outlook (observable entity),20020131,1,9E+17,9E+17
184140000,Caregiver details (observable entity),20020131,1,9E+17,9E+17
184142008,Patient's next of kin (observable entity),20020131,1,9E+17,9E+17
184149004,Key Holder (observable entity),20020131,1,9E+17,9E+17
184107009,Patient hospital number (observable entity),20020131,1,9E+17,9E+17
184106000,Patient distance from office (observable entity),20020131,1,9E+17,9E+17
184104002,Patient occupation (observable entity),20020131,1,9E+17,9E+17
184103008,Patient telephone number (observable entity),20020131,1,9E+17,9E+17
184102003,Patient postal code (observable entity),20020131,1,9E+17,9E+17
184095009,Patient forename (observable entity),20020131,1,9E+17,9E+17
184096005,Patient surname (observable entity),20020131,1,9E+17,9E+17
184097001,Patient address (observable entity),20020131,1,9E+17,9E+17
184098006,Patient title (observable entity),20020131,1,9E+17,9E+17
184099003,Date of birth (observable entity),20020131,1,9E+17,9E+17
184100006,Patient sex (observable entity),20020131,1,9E+17,9E+17
183797002,Duration of inpatient stay (observable entity),20020131,1,9E+17,9E+17
182129007,"Histiocyte chemotaxis, function (observable entity)",20020131,1,9E+17,9E+17
181166003,"Monocyte chemotaxis, function (observable entity)",20020131,1,9E+17,9E+17
135852002,"Independent housing, lives alone (observable entity)",20020131,1,9E+17,9E+17
160238001,Depth of history (observable entity),20020131,1,9E+17,9E+17
134374006,Hearing test bilateral abnormality (finding),20020131,1,9E+17,9E+17
134375007,Hearing test left abnormality (finding),20020131,1,9E+17,9E+17
134376008,Hearing test right abnormality (finding),20020131,1,9E+17,9E+17
135793001,Moving away (finding),20020131,1,9E+17,9E+17
134418002,Level of interest - normal (finding),20020131,1,9E+17,9E+17
134432000,Recorded/predicted peak expiratory flow rate ratio (observable entity),20020131,1,9E+17,9E+17
134204007,Platelet clumps (finding),20020131,1,9E+17,9E+17
134274008,Reads Punjabi (finding),20020131,1,9E+17,9E+17
134275009,Reads Portuguese (finding),20020131,1,9E+17,9E+17
134276005,Reads Polish (finding),20020131,1,9E+17,9E+17
134277001,Reads Hindi (finding),20020131,1,9E+17,9E+17
134278006,Reads French (finding),20020131,1,9E+17,9E+17
134280000,Reads English (finding),20020131,1,9E+17,9E+17
134281001,Reads Czech (finding),20020131,1,9E+17,9E+17
134282008,Reads Chinese (finding),20020131,1,9E+17,9E+17
134284009,Reads Cantonese (finding),20020131,1,9E+17,9E+17
134285005,Reads Bengali (finding),20020131,1,9E+17,9E+17
134286006,Reads Arabic (finding),20020131,1,9E+17,9E+17
134273002,Reads Russian (finding),20020131,1,9E+17,9E+17
134271000,Reads Somali (finding),20020131,1,9E+17,9E+17
134269000,Reads Tamil (finding),20020131,1,9E+17,9E+17
134266007,Language read (observable entity),20020131,1,9E+17,9E+17
134267003,Reads Urdu (finding),20020131,1,9E+17,9E+17
134270004,Reads Spanish (finding),20020131,1,9E+17,9E+17
130951007,Bladder retention of urine (observable entity),20020131,1,9E+17,9E+17
130952000,Bladder voiding contraction (observable entity),20020131,1,9E+17,9E+17
168089007,Amniotic fluid appearance (observable entity),20020131,1,9E+17,9E+17
168149003,Fluid sample collection time (observable entity),20020131,1,9E+17,9E+17
167621006,Feces quantity (observable entity),20020131,1,9E+17,9E+17
167613000,Examination of feces consistency (observable entity),20020131,1,9E+17,9E+17
167599008,Odor of stool (observable entity),20020131,1,9E+17,9E+17
167604002,Color of stool (observable entity),20020131,1,9E+17,9E+17
167839000,Odor of vomit (observable entity),20020131,1,9E+17,9E+17
167879009,Synovial fluid appearance (observable entity),20020131,1,9E+17,9E+17
167886001,Synovial fluid viscosity (observable entity),20020131,1,9E+17,9E+17
168013002,Ascitic fluid appearance (observable entity),20020131,1,9E+17,9E+17
167950001,Pleural fluid appearance (observable entity),20020131,1,9E+17,9E+17
167706005,Cerebrospinal fluid appearance (observable entity),20020131,1,9E+17,9E+17
167807007,Sperm motility (observable entity),20020131,1,9E+17,9E+17
167816006,Semen sample age (observable entity),20020131,1,9E+17,9E+17
167826004,Vomit appearance (observable entity),20020131,1,9E+17,9E+17
167784005,Sperm motility at 6-8 hours (observable entity),20020131,1,9E+17,9E+17
169786001,Postnatal data (observable entity),20020131,1,9E+17,9E+17
169811007,Birth detail (observable entity),20020131,1,9E+17,9E+17
169812000,Place of birth (observable entity),20020131,1,9E+17,9E+17
169821004,Duration of first stage of labor (observable entity),20020131,1,9E+17,9E+17
169822006,Duration of second stage of labor (observable entity),20020131,1,9E+17,9E+17
169823001,Duration of third stage of labor (observable entity),20020131,1,9E+17,9E+17
169652001,Antenatal amniocentesis - normal (finding),20020131,1,9E+17,9E+17
169653006,Antenatal amniocentesis - abnormal (finding),20020131,1,9E+17,9E+17
169663003,Antenatal ultrasound scan normal and appropriate for dates (finding),20020131,1,9E+17,9E+17
169665005,Antenatal ultrasound scan abnormal (finding),20020131,1,9E+17,9E+17
170005003,Child weight centile (observable entity),20020131,1,9E+17,9E+17
170089007,Infant milestone (observable entity),20020131,1,9E+17,9E+17
170090003,Age when first smiled (observable entity),20020131,1,9E+17,9E+17
170091004,Age when first tooth appeared (observable entity),20020131,1,9E+17,9E+17
170092006,Age when first sat (observable entity),20020131,1,9E+17,9E+17
170093001,Age when first crawled (observable entity),20020131,1,9E+17,9E+17
170094007,Age when first stood (observable entity),20020131,1,9E+17,9E+17
170095008,Age when first walked (observable entity),20020131,1,9E+17,9E+17
170096009,Age when first talked (observable entity),20020131,1,9E+17,9E+17
169909004,Apgar score at 5 minutes (observable entity),20020131,1,9E+17,9E+17
169876006,Birth head circumference (observable entity),20020131,1,9E+17,9E+17
169886007,Birth length (observable entity),20020131,1,9E+17,9E+17
169895004,Apgar score at 1 minute (observable entity),20020131,1,9E+17,9E+17
169953009,Placenta weight (observable entity),20020131,1,9E+17,9E+17
169955002,Placental diameter (observable entity),20020131,1,9E+17,9E+17
169922007,Apgar score at 10 minutes (observable entity),20020131,1,9E+17,9E+17
169231003,Antenatal ultrasound result received (observable entity),20020131,1,9E+17,9E+17
169263009,Action potential measure (observable entity),20020131,1,9E+17,9E+17
169264003,Skeletal muscle action potential (observable entity),20020131,1,9E+17,9E+17
169265002,Peripheral nerve action potential (observable entity),20020131,1,9E+17,9E+17
161168008,Morbidity index (observable entity),20020131,1,9E+17,9E+17
161139007,Language spoken (observable entity),20020131,1,9E+17,9E+17
161732006,Gravida (observable entity),20020131,1,9E+17,9E+17
161714006,Estimated date of delivery (observable entity),20020131,1,9E+17,9E+17
161033005,Social history baseline (observable entity),20020131,1,9E+17,9E+17
161038001,Domiciliary service need (observable entity),20020131,1,9E+17,9E+17
161085007,Detail of history of foreign travel (observable entity),20020131,1,9E+17,9E+17
161086008,Recent countries visited (observable entity),20020131,1,9E+17,9E+17
161089001,Previous countries lived in (observable entity),20020131,1,9E+17,9E+17
161097008,Date of return from travel (observable entity),20020131,1,9E+17,9E+17
162088006,Feces/motions - symptoms (observable entity),20020131,1,9E+17,9E+17
162098000,Frequency of defecation (observable entity),20020131,1,9E+17,9E+17
160538000,Religious affiliation (observable entity),20020131,1,9E+17,9E+17
160503002,Parent of (observable entity),20020131,1,9E+17,9E+17
160476009,Social / personal history observable (observable entity),20020131,1,9E+17,9E+17
160481000,Social group (observable entity),20020131,1,9E+17,9E+17
160553008,Degree of religious observance (observable entity),20020131,1,9E+17,9E+17
160922003,Job details (observable entity),20020131,1,9E+17,9E+17
160928004,Amount of time off work (observable entity),20020131,1,9E+17,9E+17
160931003,Economic milestone (observable entity),20020131,1,9E+17,9E+17
160894005,Commencement of employment (observable entity),20020131,1,9E+17,9E+17
160852007,Family milestone (observable entity),20020131,1,9E+17,9E+17
160786009,Personal milestones (observable entity),20020131,1,9E+17,9E+17
165314000,Mental disability assessment score (observable entity),20020131,1,9E+17,9E+17
165315004,Mental disability admission score (observable entity),20020131,1,9E+17,9E+17
165316003,Mental disability in-patient score (observable entity),20020131,1,9E+17,9E+17
165317007,Mental disability discharge score (observable entity),20020131,1,9E+17,9E+17
165318002,Mental disability outpatient score (observable entity),20020131,1,9E+17,9E+17
165319005,Mental disability domiciliary visit score (observable entity),20020131,1,9E+17,9E+17
165477002,Red blood cell shape (observable entity),20020131,1,9E+17,9E+17
165263003,Walking distance (observable entity),20020131,1,9E+17,9E+17
165242000,Wheelchair mobility (observable entity),20020131,1,9E+17,9E+17
166345007,Thyroid hormone tests abnormal (finding),20020131,1,9E+17,9E+17
166484003,Pituitary function test abnormal (finding),20020131,1,9E+17,9E+17
166485002,Pituitary function test normal (finding),20020131,1,9E+17,9E+17
165084003,Exercise tolerance test abnormal (finding),20020131,1,9E+17,9E+17
162879003,Height and weight (observable entity),20020131,1,9E+17,9E+17
162564003,Awareness of diagnosis (observable entity),20020131,1,9E+17,9E+17
164750000,Audiogram bilateral abnormality (finding),20020131,1,9E+17,9E+17
164751001,Audiogram left abnormality (finding),20020131,1,9E+17,9E+17
164944000,PR interval feature (observable entity),20020131,1,9E+17,9E+17
164945004,Electrocardiogram: P-R interval normal (finding),20020131,1,9E+17,9E+17
164946003,Electrocardiographic P-R interval abnormal (finding),20020131,1,9E+17,9E+17
164949005,QRS complex feature (observable entity),20020131,1,9E+17,9E+17
164950005,Electrocardiogram: QRS complex normal (finding),20020131,1,9E+17,9E+17
164951009,Electrocardiographic QRS complex abnormal (finding),20020131,1,9E+17,9E+17
164956004,Electrocardiogram: Q-T interval abnormal (finding),20020131,1,9E+17,9E+17
164937009,Electrocardiographic U wave abnormal (finding),20020131,1,9E+17,9E+17
164936000,Electrocardiogram: U wave normal (finding),20020131,1,9E+17,9E+17
164933008,Electrocardiogram: T wave normal (finding),20020131,1,9E+17,9E+17
164912004,Electrocardiographic P wave abnormal (finding),20020131,1,9E+17,9E+17
164916001,Electrocardiogram: Q wave normal (finding),20020131,1,9E+17,9E+17
164917005,Electrocardiographic Q wave abnormal (finding),20020131,1,9E+17,9E+17
164920002,Electrocardiogram: R wave normal (finding),20020131,1,9E+17,9E+17
164921003,Electrocardiographic R wave abnormal (finding),20020131,1,9E+17,9E+17
164924006,Electrocardiogram: S wave normal (finding),20020131,1,9E+17,9E+17
164925007,Electrocardiographic S wave abnormal (finding),20020131,1,9E+17,9E+17
164928009,Electrocardiogram: ST interval (observable entity),20020131,1,9E+17,9E+17
164929001,Electrocardiogram: ST interval normal (finding),20020131,1,9E+17,9E+17
164930006,Electrocardiographic ST interval abnormal (finding),20020131,1,9E+17,9E+17
164931005,ST elevation (observable entity),20020131,1,9E+17,9E+17
164934002,Electrocardiographic T wave abnormal (finding),20020131,1,9E+17,9E+17
165041004,Forced expired volume (observable entity),20020131,1,9E+17,9E+17
165053000,Expected peak flow rate x 50 percent (observable entity),20020131,1,9E+17,9E+17
165054006,Optimal peak flow rate (observable entity),20020131,1,9E+17,9E+17
165055007,Expected peak flow rate x 30 percent (observable entity),20020131,1,9E+17,9E+17
165056008,Expected peak flow rate x 80 percent (observable entity),20020131,1,9E+17,9E+17
165075003,Cardiac function test normal (finding),20020131,1,9E+17,9E+17
165076002,Cardiac function test abnormal (finding),20020131,1,9E+17,9E+17
165078001,Circulatory time (observable entity),20020131,1,9E+17,9E+17
165033004,Respiratory flow rate (observable entity),20020131,1,9E+17,9E+17
164811005,Special female test normal (finding),20020131,1,9E+17,9E+17
164812003,Special female test abnormal (finding),20020131,1,9E+17,9E+17
164825006,Special male test normal (finding),20020131,1,9E+17,9E+17
164826007,Special male test abnormal (finding),20020131,1,9E+17,9E+17
164835000,Limb length (observable entity),20020131,1,9E+17,9E+17
164752008,Audiogram right abnormality (finding),20020131,1,9E+17,9E+17
164768002,"Special ear, nose and throat procedure normal (finding)",20020131,1,9E+17,9E+17
164769005,"Special ear, nose and throat procedure abnormal (finding)",20020131,1,9E+17,9E+17
164788003,Special gastrointestinal tract test normal (finding),20020131,1,9E+17,9E+17
164789006,Special gastrointestinal tract test abnormal (finding),20020131,1,9E+17,9E+17
164802005,Residual urine volume (observable entity),20020131,1,9E+17,9E+17
164836004,Musculoskeletal movement (observable entity),20020131,1,9E+17,9E+17
289962003,Tympanic membrane color (observable entity),20020131,1,9E+17,9E+17
289781003,Position of gravid cervix (observable entity),20020131,1,9E+17,9E+17
289825001,Diameter of cervical dilatation (observable entity),20020131,1,9E+17,9E+17
363958007,Ciliary body observable (observable entity),20020131,1,9E+17,9E+17
363957002,Appearance of iris (observable entity),20020131,1,9E+17,9E+17
363956006,Iris observable (observable entity),20020131,1,9E+17,9E+17
363955005,Equality of pupils (observable entity),20020131,1,9E+17,9E+17
363954009,Pupil shape (observable entity),20020131,1,9E+17,9E+17
363953003,Size of pupil (observable entity),20020131,1,9E+17,9E+17
363959004,Crystalline lens observable (observable entity),20020131,1,9E+17,9E+17
363952008,Appearance of pupil (observable entity),20020131,1,9E+17,9E+17
363950000,Measure of anterior chamber (observable entity),20020131,1,9E+17,9E+17
363949000,Observable of angle of anterior chamber (observable entity),20020131,1,9E+17,9E+17
363948008,Depth of anterior chamber (observable entity),20020131,1,9E+17,9E+17
363947003,Appearance of anterior chamber (observable entity),20020131,1,9E+17,9E+17
363946007,Anterior chamber observable (observable entity),20020131,1,9E+17,9E+17
363945006,Corneal epithelial staining feature (observable entity),20020131,1,9E+17,9E+17
363951001,Pupil observable (observable entity),20020131,1,9E+17,9E+17
363960009,Cataract feature (observable entity),20020131,1,9E+17,9E+17
363961008,Feature of lens capsule in pseudophakia (observable entity),20020131,1,9E+17,9E+17
363971005,Optic disc observable (observable entity),20020131,1,9E+17,9E+17
363970006,Retinal vein feature (observable entity),20020131,1,9E+17,9E+17
363969005,Retinal artery feature (observable entity),20020131,1,9E+17,9E+17
363968002,Retinal vessel feature (observable entity),20020131,1,9E+17,9E+17
363967007,Retina/choroid observable (observable entity),20020131,1,9E+17,9E+17
363966003,Feature of red reflex (observable entity),20020131,1,9E+17,9E+17
363965004,Vitreous cavity observable (observable entity),20020131,1,9E+17,9E+17
363964000,Anterior sclera feature (observable entity),20020131,1,9E+17,9E+17
363963006,Sclera and episclera observable (observable entity),20020131,1,9E+17,9E+17
363962001,Feature of artificial lens (observable entity),20020131,1,9E+17,9E+17
363944005,Corneal epithelium feature (observable entity),20020131,1,9E+17,9E+17
363943004,Corneal observable (observable entity),20020131,1,9E+17,9E+17
363942009,Palpebral conjunctival feature (observable entity),20020131,1,9E+17,9E+17
363922000,Characteristic of language (observable entity),20020131,1,9E+17,9E+17
363921007,Fluency of speech (observable entity),20020131,1,9E+17,9E+17
363920008,Intelligibility of articulation (observable entity),20020131,1,9E+17,9E+17
363919002,Quality of speech (observable entity),20020131,1,9E+17,9E+17
363918005,Speech observable (observable entity),20020131,1,9E+17,9E+17
363917000,Characteristic of type of voice production (observable entity),20020131,1,9E+17,9E+17
363916009,Characteristic of voice (observable entity),20020131,1,9E+17,9E+17
363915008,Speech and language observable (observable entity),20020131,1,9E+17,9E+17
363914007,Characteristic of vocal and verbal behavior (observable entity),20020131,1,9E+17,9E+17
363913001,Non-verbal communication observable (observable entity),20020131,1,9E+17,9E+17
363912006,Communication speech and language observable (observable entity),20020131,1,9E+17,9E+17
363911004,Rules and boundaries observables (observable entity),20020131,1,9E+17,9E+17
363910003,Characteristic of psychosocial functioning (observable entity),20020131,1,9E+17,9E+17
363909008,Aspect of behavior (observable entity),20020131,1,9E+17,9E+17
363923005,Details of use and content of language (observable entity),20020131,1,9E+17,9E+17
363924004,Self-expression observable (observable entity),20020131,1,9E+17,9E+17
363927006,General characteristic of eye (observable entity),20020131,1,9E+17,9E+17
363941002,Limbal conjunctiva feature (observable entity),20020131,1,9E+17,9E+17
363940001,Conjunctival observable (observable entity),20020131,1,9E+17,9E+17
363939003,Measure of globe (observable entity),20020131,1,9E+17,9E+17
363937001,Size of globe (observable entity),20020131,1,9E+17,9E+17
363936005,Appearance of eyeball (observable entity),20020131,1,9E+17,9E+17
363935009,Globe observable (observable entity),20020131,1,9E+17,9E+17
363934008,Measure of palpebral fissure (observable entity),20020131,1,9E+17,9E+17
363933002,Palpebral fissure observable (observable entity),20020131,1,9E+17,9E+17
363932007,Measure of eyelid (observable entity),20020131,1,9E+17,9E+17
363931000,Eye closing feature (observable entity),20020131,1,9E+17,9E+17
363930004,Appearance of eyelid (observable entity),20020131,1,9E+17,9E+17
363929009,Eyelid observable (observable entity),20020131,1,9E+17,9E+17
363928001,Moistness of eye (observable entity),20020131,1,9E+17,9E+17
363926002,Eye/vision observable (observable entity),20020131,1,9E+17,9E+17
363984001,Orthoptic observable (observable entity),20020131,1,9E+17,9E+17
364024007,Response to sound (observable entity),20020131,1,9E+17,9E+17
364023001,Ability to hear loud voice (observable entity),20020131,1,9E+17,9E+17
364022006,Ability to hear conversational voice (observable entity),20020131,1,9E+17,9E+17
364021004,Ability to hear whisper (observable entity),20020131,1,9E+17,9E+17
364020003,Ability to hear voice (observable entity),20020131,1,9E+17,9E+17
364030007,Nose feature (observable entity),20020131,1,9E+17,9E+17
364029002,Upper respiratory tract observable (observable entity),20020131,1,9E+17,9E+17
364028005,Stapedial feature (observable entity),20020131,1,9E+17,9E+17
364027000,Audiological test feature (observable entity),20020131,1,9E+17,9E+17
364026009,Conductivity of sound (observable entity),20020131,1,9E+17,9E+17
364025008,Auditory discrimination feature (observable entity),20020131,1,9E+17,9E+17
363908000,Details of drug misuse behavior (observable entity),20020131,1,9E+17,9E+17
364019009,Ability to hear (observable entity),20020131,1,9E+17,9E+17
364017006,Moistness of mastoid cavity (observable entity),20020131,1,9E+17,9E+17
363999001,Measure of pinna (observable entity),20020131,1,9E+17,9E+17
363998009,Color of pinna (observable entity),20020131,1,9E+17,9E+17
363996008,Form of pinna (observable entity),20020131,1,9E+17,9E+17
363995007,Pinna observable (observable entity),20020131,1,9E+17,9E+17
363994006,Odor of ear (observable entity),20020131,1,9E+17,9E+17
363993000,Appearance of ear (observable entity),20020131,1,9E+17,9E+17
363992005,External ear observable (observable entity),20020131,1,9E+17,9E+17
363991003,Ear observable (observable entity),20020131,1,9E+17,9E+17
363990002,Ear / auditory observable (observable entity),20020131,1,9E+17,9E+17
363989006,"Ear, nose / throat observable (observable entity)",20020131,1,9E+17,9E+17
363988003,Prosthesis of eyeball (observable entity),20020131,1,9E+17,9E+17
363987008,Device of eye observable (observable entity),20020131,1,9E+17,9E+17
363986004,Feature of ocular balance (observable entity),20020131,1,9E+17,9E+17
364000004,Ear canal feature (observable entity),20020131,1,9E+17,9E+17
364018001,Hearing observable (observable entity),20020131,1,9E+17,9E+17
364002007,Size of ear canal (observable entity),20020131,1,9E+17,9E+17
364016002,Mastoid cavity observable (observable entity),20020131,1,9E+17,9E+17
364015003,Mastoid observable (observable entity),20020131,1,9E+17,9E+17
364014004,Stapes mobility (observable entity),20020131,1,9E+17,9E+17
364013005,Stapes observable (observable entity),20020131,1,9E+17,9E+17
364012000,Incus mobility (observable entity),20020131,1,9E+17,9E+17
364011007,Incus observable (observable entity),20020131,1,9E+17,9E+17
364010008,Malleus mobility (observable entity),20020131,1,9E+17,9E+17
364009003,Malleus observable (observable entity),20020131,1,9E+17,9E+17
364008006,Ossicle observable (observable entity),20020131,1,9E+17,9E+17
364007001,Middle ear observable (observable entity),20020131,1,9E+17,9E+17
364006005,Feature of color of tympanic membrane (observable entity),20020131,1,9E+17,9E+17
364005009,Appearance of tympanic membrane (observable entity),20020131,1,9E+17,9E+17
364004008,Tympanic membrane observable (observable entity),20020131,1,9E+17,9E+17
364003002,Color of ear canal (observable entity),20020131,1,9E+17,9E+17
364001000,Appearance of ear canal (observable entity),20020131,1,9E+17,9E+17
363907005,Details of tobacco chewing (observable entity),20020131,1,9E+17,9E+17
363906001,Details of moist tobacco use (observable entity),20020131,1,9E+17,9E+17
363810004,Body composition measure (observable entity),20020131,1,9E+17,9E+17
363806002,Weight loss (amount) (observable entity),20020131,1,9E+17,9E+17
363805003,Weight gain (amount) (observable entity),20020131,1,9E+17,9E+17
363804004,Body weight characteristic (observable entity),20020131,1,9E+17,9E+17
363803005,Mobility (observable entity),20020131,1,9E+17,9E+17
363802000,Frequency of falls (observable entity),20020131,1,9E+17,9E+17
363801007,Observable feature of falls (observable entity),20020131,1,9E+17,9E+17
363799009,Characteristic of extremity (observable entity),20020131,1,9E+17,9E+17
363798001,Color of hand (observable entity),20020131,1,9E+17,9E+17
363797006,Appearance of hand (observable entity),20020131,1,9E+17,9E+17
363796002,Characteristic of the hand (observable entity),20020131,1,9E+17,9E+17
363794004,Facial characteristic (observable entity),20020131,1,9E+17,9E+17
363811000,Head circumference measure (observable entity),20020131,1,9E+17,9E+17
363812007,Head circumference (observable entity),20020131,1,9E+17,9E+17
363832008,Sensation observable (observable entity),20020131,1,9E+17,9E+17
363826003,Cerebrospinal fluid pressure observable (observable entity),20020131,1,9E+17,9E+17
363825004,Intracranial pressure observable (observable entity),20020131,1,9E+17,9E+17
363824000,Meningeal observable (observable entity),20020131,1,9E+17,9E+17
363823006,Cerebral dominance observable (observable entity),20020131,1,9E+17,9E+17
363822001,Brain observable (observable entity),20020131,1,9E+17,9E+17
363821008,Central nervous system observable (observable entity),20020131,1,9E+17,9E+17
363820009,Neurological observable (observable entity),20020131,1,9E+17,9E+17
363819003,Drug therapy observable (observable entity),20020131,1,9E+17,9E+17
363818006,General physical observable (observable entity),20020131,1,9E+17,9E+17
363817001,Sleep related observable (observable entity),20020131,1,9E+17,9E+17
363813002,Body odor (observable entity),20020131,1,9E+17,9E+17
363793005,Feature of loss of body fat (observable entity),20020131,1,9E+17,9E+17
363792000,Appearance relating to age (observable entity),20020131,1,9E+17,9E+17
363791007,General appearance of patient (observable entity),20020131,1,9E+17,9E+17
363790008,General characteristic of appearance (observable entity),20020131,1,9E+17,9E+17
363789004,General characteristic of patient (observable entity),20020131,1,9E+17,9E+17
363788007,Clinical history/examination observable (observable entity),20020131,1,9E+17,9E+17
363787002,Observable entity (observable entity),20020131,1,9E+17,9E+17
363833003,Observable of sensation of touch (observable entity),20020131,1,9E+17,9E+17
363835005,Pain tolerance (observable entity),20020131,1,9E+17,9E+17
363882003,Motivation (observable entity),20020131,1,9E+17,9E+17
363881005,Character trait (observable entity),20020131,1,9E+17,9E+17
363878000,Ability to think abstractly (observable entity),20020131,1,9E+17,9E+17
363877005,Thought content (observable entity),20020131,1,9E+17,9E+17
363876001,Characteristic of thought (observable entity),20020131,1,9E+17,9E+17
363871006,Mental state (observable entity),20020131,1,9E+17,9E+17
363870007,"Mental state, behavior / psychosocial function observable (observable entity)",20020131,1,9E+17,9E+17
363869006,Pattern electroretinography feature (observable entity),20020131,1,9E+17,9E+17
363905002,Details of alcohol drinking behavior (observable entity),20020131,1,9E+17,9E+17
363904003,Development of sexuality (observable entity),20020131,1,9E+17,9E+17
363903009,Sexual behavior (observable entity),20020131,1,9E+17,9E+17
363902004,Characteristic of sexual activity (observable entity),20020131,1,9E+17,9E+17
363901006,Detail of sexuality and sexual activity (observable entity),20020131,1,9E+17,9E+17
363900007,Characteristic of aggressive behavior (observable entity),20020131,1,9E+17,9E+17
363899002,Characteristic of complex / social behavior (observable entity),20020131,1,9E+17,9E+17
363898005,Habits (observable entity),20020131,1,9E+17,9E+17
363897000,Motor function behavior (observable entity),20020131,1,9E+17,9E+17
363896009,Behavior observable (observable entity),20020131,1,9E+17,9E+17
363895008,Psychotic symptom (observable entity),20020131,1,9E+17,9E+17
363894007,Characteristic of self-concept (observable entity),20020131,1,9E+17,9E+17
363893001,Component of Glasgow coma scale (observable entity),20020131,1,9E+17,9E+17
363892006,Psychodynamic features (observable entity),20020131,1,9E+17,9E+17
363834009,Measure of touch (observable entity),20020131,1,9E+17,9E+17
363867008,Ophthalmic electrodiagnostic feature (observable entity),20020131,1,9E+17,9E+17
363848009,Pattern of gross motor movement (observable entity),20020131,1,9E+17,9E+17
363847004,Movement observable (observable entity),20020131,1,9E+17,9E+17
363846008,Finger-nose test response (observable entity),20020131,1,9E+17,9E+17
363845007,Finger-finger test response (observable entity),20020131,1,9E+17,9E+17
363844006,Pattern of coordination (observable entity),20020131,1,9E+17,9E+17
363843000,Coordination observable (observable entity),20020131,1,9E+17,9E+17
363842005,Feature of turning balance when walking (observable entity),20020131,1,9E+17,9E+17
363841003,Feature of walking balance (observable entity),20020131,1,9E+17,9E+17
363840002,Feature of standing balance (observable entity),20020131,1,9E+17,9E+17
363839004,Feature of sitting balance (observable entity),20020131,1,9E+17,9E+17
363838007,Balance observable (observable entity),20020131,1,9E+17,9E+17
363837002,Measure of gait (observable entity),20020131,1,9E+17,9E+17
363836006,Gait observable (observable entity),20020131,1,9E+17,9E+17
363849001,Gross movement of limb (observable entity),20020131,1,9E+17,9E+17
363868003,Electroretinographic feature (observable entity),20020131,1,9E+17,9E+17
363850001,Motor response (observable entity),20020131,1,9E+17,9E+17
363852009,Characteristic of body control (observable entity),20020131,1,9E+17,9E+17
363866004,Somatosensory evoked potentials feature (observable entity),20020131,1,9E+17,9E+17
363865000,Visual evoked potential feature (observable entity),20020131,1,9E+17,9E+17
363864001,Evoked potential feature (observable entity),20020131,1,9E+17,9E+17
363863007,Reflex observable (observable entity),20020131,1,9E+17,9E+17
363862002,Single muscle fiber feature (observable entity),20020131,1,9E+17,9E+17
363861009,Electromyogram feature (observable entity),20020131,1,9E+17,9E+17
363860005,Peripheral neurophysiological feature (observable entity),20020131,1,9E+17,9E+17
363859000,Electroencephalogram feature (observable entity),20020131,1,9E+17,9E+17
363858008,Neuroelectrophysiology observable (observable entity),20020131,1,9E+17,9E+17
363857003,Measure of seizure (observable entity),20020131,1,9E+17,9E+17
363856007,Seizure observable (observable entity),20020131,1,9E+17,9E+17
363853004,Feature of body posture (observable entity),20020131,1,9E+17,9E+17
363851002,Feature of local motor movement (observable entity),20020131,1,9E+17,9E+17
364150009,Rectum feature (observable entity),20020131,1,9E+17,9E+17
364149009,Large intestine observable (observable entity),20020131,1,9E+17,9E+17
364148001,Measure of stomach (observable entity),20020131,1,9E+17,9E+17
364147006,Appearance of stomach (observable entity),20020131,1,9E+17,9E+17
364146002,Stomach observable (observable entity),20020131,1,9E+17,9E+17
364145003,Measure of esophagus (observable entity),20020131,1,9E+17,9E+17
364144004,Feature of esophageal function (observable entity),20020131,1,9E+17,9E+17
364151008,Appearance of rectum (observable entity),20020131,1,9E+17,9E+17
364152001,Contents of rectum (observable entity),20020131,1,9E+17,9E+17
364154000,Appearance of anus (observable entity),20020131,1,9E+17,9E+17
364153006,Anal feature (observable entity),20020131,1,9E+17,9E+17
364143005,Esophagus observable (observable entity),20020131,1,9E+17,9E+17
364142000,Digestive system observable (observable entity),20020131,1,9E+17,9E+17
364140008,Maxillofacial prosthesis feature (observable entity),20020131,1,9E+17,9E+17
364139006,Dental appliance feature (observable entity),20020131,1,9E+17,9E+17
364138003,Dental restoration feature (observable entity),20020131,1,9E+17,9E+17
364137008,Dental appliance or restoration observable (observable entity),20020131,1,9E+17,9E+17
364136004,Measure of salivary tract (observable entity),20020131,1,9E+17,9E+17
364135000,Salivary duct feature (observable entity),20020131,1,9E+17,9E+17
364134001,Salivary apparatus observable (observable entity),20020131,1,9E+17,9E+17
364133007,Measure of dentition (observable entity),20020131,1,9E+17,9E+17
364132002,Moistness of lip (observable entity),20020131,1,9E+17,9E+17
364131009,Color of lip (observable entity),20020131,1,9E+17,9E+17
364141007,Fit of maxillofacial prosthesis (observable entity),20020131,1,9E+17,9E+17
364155004,Anal mucosa appearance (observable entity),20020131,1,9E+17,9E+17
364173001,Quantity of defecation (observable entity),20020131,1,9E+17,9E+17
364172006,Speed of defecation (observable entity),20020131,1,9E+17,9E+17
364171004,Defecation observable (observable entity),20020131,1,9E+17,9E+17
364170003,Speed of swallowing (observable entity),20020131,1,9E+17,9E+17
364174007,Measure of defecation (observable entity),20020131,1,9E+17,9E+17
364180004,Kidney feature (observable entity),20020131,1,9E+17,9E+17
364179002,Urinary tract observable (observable entity),20020131,1,9E+17,9E+17
364178005,Urogenital observable (observable entity),20020131,1,9E+17,9E+17
364177000,Breath test feature (observable entity),20020131,1,9E+17,9E+17
364176009,Gastrointestinal tolerance feature (observable entity),20020131,1,9E+17,9E+17
364175008,Gastrointestinal test observable (observable entity),20020131,1,9E+17,9E+17
364169004,Swallowing feature (observable entity),20020131,1,9E+17,9E+17
364161001,Consistency of liver (observable entity),20020131,1,9E+17,9E+17
364160000,Appearance of liver (observable entity),20020131,1,9E+17,9E+17
364159005,Liver observable (observable entity),20020131,1,9E+17,9E+17
364157007,Anal sphincter feature (observable entity),20020131,1,9E+17,9E+17
364156003,Anal verge appearance (observable entity),20020131,1,9E+17,9E+17
364168007,Gastrointestinal tract gaseousness (observable entity),20020131,1,9E+17,9E+17
364162008,Measure of liver (observable entity),20020131,1,9E+17,9E+17
364167002,Functional characteristic of gastrointestinal tract (observable entity),20020131,1,9E+17,9E+17
364166006,Measure of gallbladder (observable entity),20020131,1,9E+17,9E+17
364165005,Appearance of gallbladder (observable entity),20020131,1,9E+17,9E+17
364164009,Gallbladder feature (observable entity),20020131,1,9E+17,9E+17
364163003,Biliary tract observable (observable entity),20020131,1,9E+17,9E+17
364130005,Arrangement of lip (observable entity),20020131,1,9E+17,9E+17
364129000,Size of lip (observable entity),20020131,1,9E+17,9E+17
364128008,Appearance of lip (observable entity),20020131,1,9E+17,9E+17
364033009,Nasopharynx feature (observable entity),20020131,1,9E+17,9E+17
364032004,Size of nose (observable entity),20020131,1,9E+17,9E+17
364034003,Feature of adenoids (observable entity),20020131,1,9E+17,9E+17
364035002,Nasal airway feature (observable entity),20020131,1,9E+17,9E+17
364051005,Feature of trachea (observable entity),20020131,1,9E+17,9E+17
364050006,Tracheobronchial features (observable entity),20020131,1,9E+17,9E+17
364049006,Lower respiratory tract observable (observable entity),20020131,1,9E+17,9E+17
364048003,Respiratory observable (observable entity),20020131,1,9E+17,9E+17
364047008,Size of tonsil (observable entity),20020131,1,9E+17,9E+17
364046004,Appearance of tonsil (observable entity),20020131,1,9E+17,9E+17
364045000,Tonsil observable (observable entity),20020131,1,9E+17,9E+17
364044001,Appearance of pharynx (observable entity),20020131,1,9E+17,9E+17
364043007,Pharyngeal observable (observable entity),20020131,1,9E+17,9E+17
364042002,Mobility of arytenoid (observable entity),20020131,1,9E+17,9E+17
364041009,Arytenoid observable (observable entity),20020131,1,9E+17,9E+17
364040005,Function of vocal cords (observable entity),20020131,1,9E+17,9E+17
364039008,Vocal cord feature (observable entity),20020131,1,9E+17,9E+17
364038000,Appearance of larynx (observable entity),20020131,1,9E+17,9E+17
364037005,Larynx feature (observable entity),20020131,1,9E+17,9E+17
364036001,Measure of nose (observable entity),20020131,1,9E+17,9E+17
364031006,Appearance of nose (observable entity),20020131,1,9E+17,9E+17
364052003,Lung observable (observable entity),20020131,1,9E+17,9E+17
364054002,Characteristic of cough (observable entity),20020131,1,9E+17,9E+17
364111005,Oral cavity observable (observable entity),20020131,1,9E+17,9E+17
364110006,"Oral cavity, dental / salivary observable (observable entity)",20020131,1,9E+17,9E+17
364107004,Lymph node / lymphatics observable (observable entity),20020131,1,9E+17,9E+17
364106008,Spleen observable (observable entity),20020131,1,9E+17,9E+17
364105007,"Blood, lymphatics/immune system observable (observable entity)",20020131,1,9E+17,9E+17
364112003,Tooth observable (observable entity),20020131,1,9E+17,9E+17
364113008,Eruption of tooth (observable entity),20020131,1,9E+17,9E+17
364115001,Dental center-line (observable entity),20020131,1,9E+17,9E+17
364127003,Lip feature (observable entity),20020131,1,9E+17,9E+17
364126007,Oral hygiene status (observable entity),20020131,1,9E+17,9E+17
364125006,Oral airway feature (observable entity),20020131,1,9E+17,9E+17
364124005,Appearance of gingivae (observable entity),20020131,1,9E+17,9E+17
364123004,Gingivae feature (observable entity),20020131,1,9E+17,9E+17
364122009,Moistness of tongue (observable entity),20020131,1,9E+17,9E+17
364121002,Surface appearance of tongue (observable entity),20020131,1,9E+17,9E+17
364120001,Symmetry of tongue (observable entity),20020131,1,9E+17,9E+17
364119007,Appearance of tongue (observable entity),20020131,1,9E+17,9E+17
364118004,Tongue feature (observable entity),20020131,1,9E+17,9E+17
364117009,Appearance of oral mucosa (observable entity),20020131,1,9E+17,9E+17
364116000,Oral mucosa feature (observable entity),20020131,1,9E+17,9E+17
364114002,Feature of tooth plaque (observable entity),20020131,1,9E+17,9E+17
364053008,Characteristic of respiratory tract function (observable entity),20020131,1,9E+17,9E+17
364069001,Cardiac conduction system feature (observable entity),20020131,1,9E+17,9E+17
364068009,Electrocardiographic feature (observable entity),20020131,1,9E+17,9E+17
364067004,Cardiac investigative observable (observable entity),20020131,1,9E+17,9E+17
364066008,Cardiovascular observable (observable entity),20020131,1,9E+17,9E+17
364065007,Distribution of ventilation:perfusion (observable entity),20020131,1,9E+17,9E+17
364062005,Respiration observable (observable entity),20020131,1,9E+17,9E+17
364061003,Vocal fremitus (observable entity),20020131,1,9E+17,9E+17
364060002,Chest auscultation feature (observable entity),20020131,1,9E+17,9E+17
364059007,Cardiac dullness to percussion (observable entity),20020131,1,9E+17,9E+17
364058004,Chest percussion (observable entity),20020131,1,9E+17,9E+17
364057009,Characteristic of respiratory effort (observable entity),20020131,1,9E+17,9E+17
364056000,Respiratory movement feature (observable entity),20020131,1,9E+17,9E+17
364055001,Respiratory characteristics of chest (observable entity),20020131,1,9E+17,9E+17
289462007,Anterior posterior diameter of sacral outlet (observable entity),20020131,1,9E+17,9E+17
289436003,Date fetal movements first detected (observable entity),20020131,1,9E+17,9E+17
289107006,Ability to cough (observable entity),20020131,1,9E+17,9E+17
289274009,Odor of placenta (observable entity),20020131,1,9E+17,9E+17
289251005,Time rupture of membranes detected (observable entity),20020131,1,9E+17,9E+17
289248003,Duration of labor (observable entity),20020131,1,9E+17,9E+17
289249006,Time contractions became regular (observable entity),20020131,1,9E+17,9E+17
289250006,Time vaginal show detected (observable entity),20020131,1,9E+17,9E+17
289206005,Estimated date of delivery from last period (observable entity),20020131,1,9E+17,9E+17
361063004,Lack of education (finding),20020131,1,9E+17,9E+17
364181000,Appearance of kidney (observable entity),20020131,1,9E+17,9E+17
364182007,Size of kidney (observable entity),20020131,1,9E+17,9E+17
282716004,Gross motor functions (observable entity),20020131,1,9E+17,9E+17
282309002,Ability to balance when standing (observable entity),20020131,1,9E+17,9E+17
282316001,Ability to stand alone (observable entity),20020131,1,9E+17,9E+17
282303001,Ability to balance when sitting (observable entity),20020131,1,9E+17,9E+17
282288009,Microbiology interpretation (observable entity),20020131,1,9E+17,9E+17
282290005,Imaging interpretation (observable entity),20020131,1,9E+17,9E+17
282291009,Diagnosis interpretation (observable entity),20020131,1,9E+17,9E+17
282292002,Uncertain diagnosis (observable entity),20020131,1,9E+17,9E+17
282295000,Ability to balance (observable entity),20020131,1,9E+17,9E+17
282322005,Ability to stand on one leg (observable entity),20020131,1,9E+17,9E+17
282465005,Physiological functions and activities (navigational concept),20020131,1,9E+17,9E+17
284089007,Presence of orthopedic joint implant (observable entity),20020131,1,9E+17,9E+17
284363000,Fine motor functions (observable entity),20020131,1,9E+17,9E+17
284364006,Hand functions (observable entity),20020131,1,9E+17,9E+17
284386007,Ability to balance when bending (observable entity),20020131,1,9E+17,9E+17
284388008,Ability to balance when reaching (observable entity),20020131,1,9E+17,9E+17
281004000,Visual function (observable entity),20020131,1,9E+17,9E+17
281053000,Sex of baby at delivery (observable entity),20020131,1,9E+17,9E+17
281054006,Baby length centile (observable entity),20020131,1,9E+17,9E+17
281271004,Date sample received in laboratory (observable entity),20020131,1,9E+17,9E+17
281133001,Amount of thought (observable entity),20020131,1,9E+17,9E+17
281826003,Angle of deformity (observable entity),20020131,1,9E+17,9E+17
281395000,Glasgow Coma Score eye opening subscore (observable entity),20020131,1,9E+17,9E+17
281396004,Glasgow Coma Scale motor response subscore (observable entity),20020131,1,9E+17,9E+17
281397008,Glasgow Coma Scale verbal response subscore (observable entity),20020131,1,9E+17,9E+17
281384006,Simplified acute physiology score (observable entity),20020131,1,9E+17,9E+17
281688001,Biparietal diameter (observable entity),20020131,1,9E+17,9E+17
281559009,Number of days off work (observable entity),20020131,1,9E+17,9E+17
364426004,Form of lumbar spine (observable entity),20020131,1,9E+17,9E+17
364425000,Lumbar spine observable (observable entity),20020131,1,9E+17,9E+17
364423007,Stability of thoracic spine (observable entity),20020131,1,9E+17,9E+17
364422002,Movement of thoracic spine (observable entity),20020131,1,9E+17,9E+17
364421009,Form of thoracic spine (observable entity),20020131,1,9E+17,9E+17
364420005,Thoracic spine observable (observable entity),20020131,1,9E+17,9E+17
364427008,Movement of lumbar spine (observable entity),20020131,1,9E+17,9E+17
364418007,Stability of neck (observable entity),20020131,1,9E+17,9E+17
364416006,Feature of cervical spine (observable entity),20020131,1,9E+17,9E+17
364415005,Spinal region observable (observable entity),20020131,1,9E+17,9E+17
364414009,Trunk structure observable (observable entity),20020131,1,9E+17,9E+17
364413003,Size of neck (observable entity),20020131,1,9E+17,9E+17
364412008,Measure of neck (observable entity),20020131,1,9E+17,9E+17
364417002,Movement of neck (observable entity),20020131,1,9E+17,9E+17
364428003,Stability of lumbar spine (observable entity),20020131,1,9E+17,9E+17
364430001,Measure of lumbar spine (observable entity),20020131,1,9E+17,9E+17
364444007,Movement of ribs (observable entity),20020131,1,9E+17,9E+17
364443001,Arrangement of ribs (observable entity),20020131,1,9E+17,9E+17
364442006,Size of rib (observable entity),20020131,1,9E+17,9E+17
364441004,Feature of rib structure (observable entity),20020131,1,9E+17,9E+17
364440003,Size of sternum (observable entity),20020131,1,9E+17,9E+17
364439000,Feature of sternum structure (observable entity),20020131,1,9E+17,9E+17
364438008,Feature of bone of thorax (observable entity),20020131,1,9E+17,9E+17
364437003,Measure of thorax (observable entity),20020131,1,9E+17,9E+17
364436007,Proportion of thorax (observable entity),20020131,1,9E+17,9E+17
364435006,Size of thorax (observable entity),20020131,1,9E+17,9E+17
364434005,Appearance of thorax (observable entity),20020131,1,9E+17,9E+17
364433004,Feature of region of thorax (observable entity),20020131,1,9E+17,9E+17
364432009,Measure of spine (observable entity),20020131,1,9E+17,9E+17
364431002,Bragard test response (observable entity),20020131,1,9E+17,9E+17
364411001,Neck region observable (observable entity),20020131,1,9E+17,9E+17
364410000,Temporomandibular joint feature (observable entity),20020131,1,9E+17,9E+17
364409005,Facial bone feature (observable entity),20020131,1,9E+17,9E+17
364408002,Fontanelle feature (observable entity),20020131,1,9E+17,9E+17
364385001,Measure of lactation (observable entity),20020131,1,9E+17,9E+17
364384002,Flow of breast milk (observable entity),20020131,1,9E+17,9E+17
364383008,Quantity of lactation (observable entity),20020131,1,9E+17,9E+17
364382003,Pattern of breast function (observable entity),20020131,1,9E+17,9E+17
364381005,Lactation observable (observable entity),20020131,1,9E+17,9E+17
364380006,Color of nipple (observable entity),20020131,1,9E+17,9E+17
364379008,Proportion of nipple (observable entity),20020131,1,9E+17,9E+17
364378000,Form of nipple (observable entity),20020131,1,9E+17,9E+17
364377005,Appearance of nipple (observable entity),20020131,1,9E+17,9E+17
364376001,Nipple observable (observable entity),20020131,1,9E+17,9E+17
364375002,Development of the breasts (observable entity),20020131,1,9E+17,9E+17
364374003,Color of breast (observable entity),20020131,1,9E+17,9E+17
364445008,Mediastinal feature (observable entity),20020131,1,9E+17,9E+17
364407007,Appearance of head (observable entity),20020131,1,9E+17,9E+17
364406003,Skull feature (observable entity),20020131,1,9E+17,9E+17
364405004,Skull structure observable (observable entity),20020131,1,9E+17,9E+17
364404000,Head region observable (observable entity),20020131,1,9E+17,9E+17
364403006,Head and neck region observable (observable entity),20020131,1,9E+17,9E+17
364402001,Body region observable (observable entity),20020131,1,9E+17,9E+17
364446009,General characteristics of abdomen (observable entity),20020131,1,9E+17,9E+17
364447000,Feature of abdominal appearance (observable entity),20020131,1,9E+17,9E+17
364448005,Appearance of skin of abdominal wall (observable entity),20020131,1,9E+17,9E+17
364503009,Thomas test response (observable entity),20020131,1,9E+17,9E+17
364502004,Ortolani's test response (observable entity),20020131,1,9E+17,9E+17
364501006,Hip joint feature (observable entity),20020131,1,9E+17,9E+17
364500007,Feature of hip region (observable entity),20020131,1,9E+17,9E+17
364499003,Measure of lower limb (observable entity),20020131,1,9E+17,9E+17
364498006,Proportion of lower limb (observable entity),20020131,1,9E+17,9E+17
364497001,Feature of lower limb (observable entity),20020131,1,9E+17,9E+17
364496005,Feature of musculoskeletal structure of digit of hand (observable entity),20020131,1,9E+17,9E+17
364494008,Feature of finger joint (observable entity),20020131,1,9E+17,9E+17
364493002,Feature of musculoskeletal structure of finger (observable entity),20020131,1,9E+17,9E+17
364492007,Feature of finger (observable entity),20020131,1,9E+17,9E+17
364490004,Feature of joint of thumb (observable entity),20020131,1,9E+17,9E+17
364489008,Feature of musculoskeletal structure of thumb (observable entity),20020131,1,9E+17,9E+17
364488000,Feature of thumb (observable entity),20020131,1,9E+17,9E+17
364504003,Feature of knee region (observable entity),20020131,1,9E+17,9E+17
364487005,Feature of digit of hand (observable entity),20020131,1,9E+17,9E+17
364505002,Knee joint feature (observable entity),20020131,1,9E+17,9E+17
364524004,Feature of joint of toe (observable entity),20020131,1,9E+17,9E+17
364523005,Feature of musculoskeletal structure of toe (observable entity),20020131,1,9E+17,9E+17
364522000,Feature of subtalar joint (observable entity),20020131,1,9E+17,9E+17
364520008,Feature of foot joint (observable entity),20020131,1,9E+17,9E+17
364519002,Measure of foot (observable entity),20020131,1,9E+17,9E+17
364517000,Mobility of foot (observable entity),20020131,1,9E+17,9E+17
364516009,Movement of foot (observable entity),20020131,1,9E+17,9E+17
364515008,Color of foot (observable entity),20020131,1,9E+17,9E+17
364514007,Proportion of foot (observable entity),20020131,1,9E+17,9E+17
364513001,Size of foot (observable entity),20020131,1,9E+17,9E+17
364512006,Feature of foot region (observable entity),20020131,1,9E+17,9E+17
364510003,Feature of ankle joint (observable entity),20020131,1,9E+17,9E+17
364509008,Feature of ankle region (observable entity),20020131,1,9E+17,9E+17
364508000,Apprehension test response (observable entity),20020131,1,9E+17,9E+17
364507005,Stroke test response (observable entity),20020131,1,9E+17,9E+17
364486001,Measure of hand (observable entity),20020131,1,9E+17,9E+17
364464002,Feature of upper limb (observable entity),20020131,1,9E+17,9E+17
364463008,Limb structure observable (observable entity),20020131,1,9E+17,9E+17
364462003,Proportion of pelvic structure (observable entity),20020131,1,9E+17,9E+17
364461005,Arrangement of pelvis (observable entity),20020131,1,9E+17,9E+17
364460006,Size of pelvis (observable entity),20020131,1,9E+17,9E+17
364459001,Measure of abdomen (observable entity),20020131,1,9E+17,9E+17
364458009,Characteristic of bowel sounds (observable entity),20020131,1,9E+17,9E+17
364457004,Characteristic of auscultation of abdomen (observable entity),20020131,1,9E+17,9E+17
364455007,Characteristic of localized abdominal dullness to percussion (observable entity),20020131,1,9E+17,9E+17
364454006,Feature of abdominal dullness (observable entity),20020131,1,9E+17,9E+17
364453000,Sensation of abdomen (observable entity),20020131,1,9E+17,9E+17
364452005,Tone of abdomen (observable entity),20020131,1,9E+17,9E+17
364451003,Movement of abdomen (observable entity),20020131,1,9E+17,9E+17
364450002,Contour of abdomen (observable entity),20020131,1,9E+17,9E+17
364449002,Consistency of abdomen (observable entity),20020131,1,9E+17,9E+17
364465001,Size of upper limb (observable entity),20020131,1,9E+17,9E+17
364485002,Feature of function of hand (observable entity),20020131,1,9E+17,9E+17
364466000,Proportion of upper limb (observable entity),20020131,1,9E+17,9E+17
364484003,Proportion of hand (observable entity),20020131,1,9E+17,9E+17
364483009,Feature of hand region (observable entity),20020131,1,9E+17,9E+17
364481006,Feature of wrist joint (observable entity),20020131,1,9E+17,9E+17
364480007,Feature of wrist region (observable entity),20020131,1,9E+17,9E+17
364478001,Feature of elbow joint (observable entity),20020131,1,9E+17,9E+17
364477006,Feature of elbow region (observable entity),20020131,1,9E+17,9E+17
364475003,Feature of shoulder joint (observable entity),20020131,1,9E+17,9E+17
364474004,Feature of shoulder region (observable entity),20020131,1,9E+17,9E+17
364473005,Arrangement of clavicle (observable entity),20020131,1,9E+17,9E+17
364472000,Size of clavicle (observable entity),20020131,1,9E+17,9E+17
364471007,Feature of clavicle structure (observable entity),20020131,1,9E+17,9E+17
364470008,Size of scapula (observable entity),20020131,1,9E+17,9E+17
364469007,Feature of scapular structure (observable entity),20020131,1,9E+17,9E+17
364468004,Feature of bone of upper limb (observable entity),20020131,1,9E+17,9E+17
364467009,Measure of upper limb (observable entity),20020131,1,9E+17,9E+17
364373009,Consistency of breast (observable entity),20020131,1,9E+17,9E+17
364372004,Form of breast (observable entity),20020131,1,9E+17,9E+17
364371006,Appearance of breast (observable entity),20020131,1,9E+17,9E+17
364315009,Sexual function observable (observable entity),20020131,1,9E+17,9E+17
364321008,Position of pregnancy (observable entity),20020131,1,9E+17,9E+17
364320009,Pregnancy observable (observable entity),20020131,1,9E+17,9E+17
364319003,"Pregnancy, childbirth / puerperium observable (observable entity)",20020131,1,9E+17,9E+17
364318006,Genitourinary test reaction (observable entity),20020131,1,9E+17,9E+17
364317001,Characteristic of orgasm (observable entity),20020131,1,9E+17,9E+17
364316005,Sexual intercourse observable (observable entity),20020131,1,9E+17,9E+17
364322001,Pattern of pregnancy (observable entity),20020131,1,9E+17,9E+17
286692009,Level of extraversion (observable entity),20020131,1,9E+17,9E+17
286693004,Level of neuroticism (observable entity),20020131,1,9E+17,9E+17
286699000,Level of psychoticism (observable entity),20020131,1,9E+17,9E+17
364526002,Regional structure observable (observable entity),20020131,1,9E+17,9E+17
364323006,Quantity of pregnancy (observable entity),20020131,1,9E+17,9E+17
364325004,Parity (observable entity),20020131,1,9E+17,9E+17
364353004,Measure of amniotic membranes (observable entity),20020131,1,9E+17,9E+17
364352009,Number of amniotic membranes (observable entity),20020131,1,9E+17,9E+17
364351002,Completeness of membranes (observable entity),20020131,1,9E+17,9E+17
364350001,Form of amniotic membrane (observable entity),20020131,1,9E+17,9E+17
364349001,Amniotic membrane feature (observable entity),20020131,1,9E+17,9E+17
364348009,Uterine membrane feature (observable entity),20020131,1,9E+17,9E+17
364346008,Measure of placenta (observable entity),20020131,1,9E+17,9E+17
364345007,Color of placenta (observable entity),20020131,1,9E+17,9E+17
364344006,Consistency of placenta (observable entity),20020131,1,9E+17,9E+17
364343000,Completeness of placenta (observable entity),20020131,1,9E+17,9E+17
364342005,Form of placenta (observable entity),20020131,1,9E+17,9E+17
364341003,Placental feature (observable entity),20020131,1,9E+17,9E+17
364340002,Structures of conception observable (observable entity),20020131,1,9E+17,9E+17
364339004,Characteristic of third stage of labor (observable entity),20020131,1,9E+17,9E+17
364338007,Characteristic of delivery push in labor (observable entity),20020131,1,9E+17,9E+17
364354005,Quantity of liquor (observable entity),20020131,1,9E+17,9E+17
364356007,Form of umbilical cord (observable entity),20020131,1,9E+17,9E+17
364370007,Breast observable (observable entity),20020131,1,9E+17,9E+17
364369006,Measure of female pelvis (observable entity),20020131,1,9E+17,9E+17
364368003,Proportion of female pelvis (observable entity),20020131,1,9E+17,9E+17
364367008,Arrangement of female pelvis (observable entity),20020131,1,9E+17,9E+17
364366004,Size of female pelvis (observable entity),20020131,1,9E+17,9E+17
364365000,Obstetric pelvic observable (observable entity),20020131,1,9E+17,9E+17
364364001,Characteristic of fetal heart deceleration (observable entity),20020131,1,9E+17,9E+17
364363007,Cardiotochogram feature (observable entity),20020131,1,9E+17,9E+17
364362002,Obstetric investigative observable (observable entity),20020131,1,9E+17,9E+17
364361009,Measure of umbilical cord (observable entity),20020131,1,9E+17,9E+17
364360005,Arrangement of umbilical cord (observable entity),20020131,1,9E+17,9E+17
364359000,Pulsation of prolapsed cord (observable entity),20020131,1,9E+17,9E+17
364358008,Pulsation of cord through intact membranes (observable entity),20020131,1,9E+17,9E+17
364357003,Pulsation of cord (observable entity),20020131,1,9E+17,9E+17
364355006,Umbilical cord feature (observable entity),20020131,1,9E+17,9E+17
364324000,Measure of pregnancy (observable entity),20020131,1,9E+17,9E+17
364330000,Pattern of labor (observable entity),20020131,1,9E+17,9E+17
364329005,Characteristic of first stage of labor (observable entity),20020131,1,9E+17,9E+17
364328002,Labor observable (observable entity),20020131,1,9E+17,9E+17
364327007,Viability of pregnancy (observable entity),20020131,1,9E+17,9E+17
364332008,Blood loss in labor (observable entity),20020131,1,9E+17,9E+17
286546002,Depth of periodontal pocket (observable entity),20020131,1,9E+17,9E+17
364337002,Characteristic of second stage of labor (observable entity),20020131,1,9E+17,9E+17
364336006,Pattern of delivery (observable entity),20020131,1,9E+17,9E+17
364335005,Speed of delivery (observable entity),20020131,1,9E+17,9E+17
364334009,Aspect of delivery (observable entity),20020131,1,9E+17,9E+17
364333003,Measure of labor (observable entity),20020131,1,9E+17,9E+17
364713004,Temporal observable (observable entity),20020131,1,9E+17,9E+17
364712009,Laboratory test observable (observable entity),20020131,1,9E+17,9E+17
364711002,Specific test feature (observable entity),20020131,1,9E+17,9E+17
364710001,Red blood cell morphology (observable entity),20020131,1,9E+17,9E+17
364709006,Hematology observable (observable entity),20020131,1,9E+17,9E+17
364684009,Body product observable (observable entity),20020131,1,9E+17,9E+17
364683003,TU interval feature (observable entity),20020131,1,9E+17,9E+17
364681001,Waveform observable (observable entity),20020131,1,9E+17,9E+17
364680000,Tourniquet detail (observable entity),20020131,1,9E+17,9E+17
364678006,Neuromuscular blockade observable (observable entity),20020131,1,9E+17,9E+17
364676005,Anesthetic observable (observable entity),20020131,1,9E+17,9E+17
364675009,Feature of infant milestones (observable entity),20020131,1,9E+17,9E+17
364674008,Child developmental detail (observable entity),20020131,1,9E+17,9E+17
364673002,General physiological development observable (observable entity),20020131,1,9E+17,9E+17
364686006,Feature of sperm (observable entity),20020131,1,9E+17,9E+17
364688007,Odor of urine (observable entity),20020131,1,9E+17,9E+17
364708003,Specimen observable (observable entity),20020131,1,9E+17,9E+17
364706004,Life event observable (observable entity),20020131,1,9E+17,9E+17
364705000,Management of own financial affairs (observable entity),20020131,1,9E+17,9E+17
364704001,Performance at work (observable entity),20020131,1,9E+17,9E+17
364703007,Employment detail (observable entity),20020131,1,9E+17,9E+17
364702002,Details of awaiting housing or re-housing (observable entity),20020131,1,9E+17,9E+17
364701009,Feature of homelessness (observable entity),20020131,1,9E+17,9E+17
364700005,Details of special educational needs (observable entity),20020131,1,9E+17,9E+17
364699009,Ethnic group (observable entity),20020131,1,9E+17,9E+17
364698001,Ventilator observable (observable entity),20020131,1,9E+17,9E+17
364697006,Equipment observable (observable entity),20020131,1,9E+17,9E+17
364696002,Odor of sputum (observable entity),20020131,1,9E+17,9E+17
364694004,Measure of vomit (observable entity),20020131,1,9E+17,9E+17
364691007,Measure of stool (observable entity),20020131,1,9E+17,9E+17
364690008,Appearance of stool (observable entity),20020131,1,9E+17,9E+17
364577009,Movement of bone (observable entity),20020131,1,9E+17,9E+17
364576000,Form of bone (observable entity),20020131,1,9E+17,9E+17
364575001,Bone observable (observable entity),20020131,1,9E+17,9E+17
364574002,Measure of skeletal muscle (observable entity),20020131,1,9E+17,9E+17
364573008,Extension lag (observable entity),20020131,1,9E+17,9E+17
364572003,Characteristic of power of skeletal muscle (observable entity),20020131,1,9E+17,9E+17
364571005,Arrangement of skeletal muscle (observable entity),20020131,1,9E+17,9E+17
364570006,Size of skeletal muscle (observable entity),20020131,1,9E+17,9E+17
364569005,Appearance of skeletal muscle (observable entity),20020131,1,9E+17,9E+17
364568002,Muscle observable (observable entity),20020131,1,9E+17,9E+17
364567007,Tendon observable (observable entity),20020131,1,9E+17,9E+17
364566003,Measure of joint (observable entity),20020131,1,9E+17,9E+17
364565004,Joint stress test response (observable entity),20020131,1,9E+17,9E+17
364564000,Range of joint movement (observable entity),20020131,1,9E+17,9E+17
364563006,Joint movement (observable entity),20020131,1,9E+17,9E+17
364579007,Weight-bearing ability (observable entity),20020131,1,9E+17,9E+17
364596008,Color of umbilical stump (observable entity),20020131,1,9E+17,9E+17
364595007,Appearance of umbilical stump (observable entity),20020131,1,9E+17,9E+17
364594006,Umbilical stump observable (observable entity),20020131,1,9E+17,9E+17
364592005,Component of Apgar score (observable entity),20020131,1,9E+17,9E+17
364591003,Feature of birth length (observable entity),20020131,1,9E+17,9E+17
364589006,Birth weight (observable entity),20020131,1,9E+17,9E+17
364588003,Feature of sex of baby (observable entity),20020131,1,9E+17,9E+17
364587008,Birth outcome (observable entity),20020131,1,9E+17,9E+17
364586004,State at birth (observable entity),20020131,1,9E+17,9E+17
364585000,Neonate observable (observable entity),20020131,1,9E+17,9E+17
364584001,Perinatal observable (observable entity),20020131,1,9E+17,9E+17
364582002,Footwear feature (observable entity),20020131,1,9E+17,9E+17
364581009,Musculoskeletal device observable (observable entity),20020131,1,9E+17,9E+17
364580005,Musculoskeletal measure (observable entity),20020131,1,9E+17,9E+17
364578004,Observable feature of walking (observable entity),20020131,1,9E+17,9E+17
364597004,Moistness of umbilical stump (observable entity),20020131,1,9E+17,9E+17
364562001,Joint observable (observable entity),20020131,1,9E+17,9E+17
364561008,Musculoskeletal observable (observable entity),20020131,1,9E+17,9E+17
364598009,Odor of umbilical cord stump (observable entity),20020131,1,9E+17,9E+17
364600003,Form of fetus (observable entity),20020131,1,9E+17,9E+17
364642001,Swelling feature (observable entity),20020131,1,9E+17,9E+17
364641008,Movement of mass with respiration (observable entity),20020131,1,9E+17,9E+17
364640009,Cough impulse of lump (observable entity),20020131,1,9E+17,9E+17
364639007,Feature of a mass (observable entity),20020131,1,9E+17,9E+17
364638004,Swelling / lump observable (observable entity),20020131,1,9E+17,9E+17
364637009,Lesion feature (observable entity),20020131,1,9E+17,9E+17
364636000,Lesion observable (observable entity),20020131,1,9E+17,9E+17
364635001,Feature of present pain intensity (observable entity),20020131,1,9E+17,9E+17
364634002,Affective dimension of pain (observable entity),20020131,1,9E+17,9E+17
364599001,Fetal observable (observable entity),20020131,1,9E+17,9E+17
364632003,Pain character (observable entity),20020131,1,9E+17,9E+17
364614003,Sagittal suture palpable vaginally (observable entity),20020131,1,9E+17,9E+17
364613009,Presenting part visible vaginally (observable entity),20020131,1,9E+17,9E+17
364612004,Presenting part palpable vaginally (observable entity),20020131,1,9E+17,9E+17
364611006,Fetal descent in relation to ischial spines (observable entity),20020131,1,9E+17,9E+17
364610007,Engagement of presenting part (observable entity),20020131,1,9E+17,9E+17
364609002,Feature of malposition of fetus (observable entity),20020131,1,9E+17,9E+17
364608005,Position of vertex presentation (observable entity),20020131,1,9E+17,9E+17
364607000,Position of fetus (observable entity),20020131,1,9E+17,9E+17
364606009,Presentation of fontanelles (observable entity),20020131,1,9E+17,9E+17
364605008,Attitude of fetus (observable entity),20020131,1,9E+17,9E+17
364604007,Arrangement of fetus (observable entity),20020131,1,9E+17,9E+17
364603001,Ballottement of fetal parts (observable entity),20020131,1,9E+17,9E+17
364602006,Fetal parts observable (observable entity),20020131,1,9E+17,9E+17
364601004,Feature of fetal head molding (observable entity),20020131,1,9E+17,9E+17
364615002,Advancement of presenting part (observable entity),20020131,1,9E+17,9E+17
364633008,Sensory dimension of pain (observable entity),20020131,1,9E+17,9E+17
364617005,Fetal movement feature (observable entity),20020131,1,9E+17,9E+17
364631005,Pattern of pain (observable entity),20020131,1,9E+17,9E+17
364630006,Abdominal pain characteristic (observable entity),20020131,1,9E+17,9E+17
364629001,Characteristics of pain of truncal structure (observable entity),20020131,1,9E+17,9E+17
364627004,Characteristics of pain of head and neck region (observable entity),20020131,1,9E+17,9E+17
364626008,Characteristic of pain at anatomical site (observable entity),20020131,1,9E+17,9E+17
364625007,Characteristic of pain (observable entity),20020131,1,9E+17,9E+17
364624006,Pain / sensation observable (observable entity),20020131,1,9E+17,9E+17
364623000,Feature of fetal heart sounds (observable entity),20020131,1,9E+17,9E+17
364622005,Feature of baseline fetal heart rate (observable entity),20020131,1,9E+17,9E+17
364621003,Feature of fetal heart rate (observable entity),20020131,1,9E+17,9E+17
364620002,Fetal heart feature (observable entity),20020131,1,9E+17,9E+17
364619008,Measure of fetal movement (observable entity),20020131,1,9E+17,9E+17
364618000,Pattern of fetal movement (observable entity),20020131,1,9E+17,9E+17
364616001,Measure of fetus (observable entity),20020131,1,9E+17,9E+17
364236009,Color of vaginal discharge (observable entity),20020131,1,9E+17,9E+17
364239002,Lochia feature (observable entity),20020131,1,9E+17,9E+17
364238005,Odor of vaginal discharge (observable entity),20020131,1,9E+17,9E+17
364237000,Quantity of vaginal discharge (observable entity),20020131,1,9E+17,9E+17
364229008,Size of clitoris (observable entity),20020131,1,9E+17,9E+17
364228000,Clitoris observable (observable entity),20020131,1,9E+17,9E+17
364230003,Vagina feature (observable entity),20020131,1,9E+17,9E+17
364235008,Consistency of vaginal discharge (observable entity),20020131,1,9E+17,9E+17
364234007,Vaginal discharge feature (observable entity),20020131,1,9E+17,9E+17
364233001,Arrangement of vagina (observable entity),20020131,1,9E+17,9E+17
364232006,Form of vagina (observable entity),20020131,1,9E+17,9E+17
364231004,Size of vagina (observable entity),20020131,1,9E+17,9E+17
364243003,Sensation of vagina (observable entity),20020131,1,9E+17,9E+17
364242008,Tone of vagina (observable entity),20020131,1,9E+17,9E+17
364241001,Contents of vagina (observable entity),20020131,1,9E+17,9E+17
364227005,Color of vulva (observable entity),20020131,1,9E+17,9E+17
364240000,Consistency of lochia (observable entity),20020131,1,9E+17,9E+17
364196001,Micturition feature (observable entity),20020131,1,9E+17,9E+17
364195002,Measure of urethra (observable entity),20020131,1,9E+17,9E+17
364194003,Appearance of urethra (observable entity),20020131,1,9E+17,9E+17
364193009,Urethral feature (observable entity),20020131,1,9E+17,9E+17
364192004,Bladder test feature (observable entity),20020131,1,9E+17,9E+17
364198000,Frequency of urination (observable entity),20020131,1,9E+17,9E+17
364200006,Measure of urination (observable entity),20020131,1,9E+17,9E+17
364199008,Characteristic of desire for urination (observable entity),20020131,1,9E+17,9E+17
364197005,Pattern of urination (observable entity),20020131,1,9E+17,9E+17
364201005,Urine output observable (observable entity),20020131,1,9E+17,9E+17
364186005,Bladder feature (observable entity),20020131,1,9E+17,9E+17
364185009,Appearance of ureter (observable entity),20020131,1,9E+17,9E+17
364184008,Ureter observable (observable entity),20020131,1,9E+17,9E+17
364183002,Measure of kidney (observable entity),20020131,1,9E+17,9E+17
364191006,Measure of bladder (observable entity),20020131,1,9E+17,9E+17
364190007,Bladder neck competence (observable entity),20020131,1,9E+17,9E+17
364189003,Sensation of bladder (observable entity),20020131,1,9E+17,9E+17
364188006,Tone of bladder (observable entity),20020131,1,9E+17,9E+17
364187001,Size of bladder (observable entity),20020131,1,9E+17,9E+17
364202003,Measure of urine output (observable entity),20020131,1,9E+17,9E+17
364219001,Prostate feature (observable entity),20020131,1,9E+17,9E+17
364218009,Characteristic of erection (observable entity),20020131,1,9E+17,9E+17
364217004,Foreskin feature (observable entity),20020131,1,9E+17,9E+17
364216008,Glans penis feature (observable entity),20020131,1,9E+17,9E+17
364215007,Appearance of penis (observable entity),20020131,1,9E+17,9E+17
364214006,Penis feature (observable entity),20020131,1,9E+17,9E+17
364220007,Prostate surface feature (observable entity),20020131,1,9E+17,9E+17
364221006,Smegma feature (observable entity),20020131,1,9E+17,9E+17
364226001,Sensation of vulva (observable entity),20020131,1,9E+17,9E+17
364225002,Form of vulva (observable entity),20020131,1,9E+17,9E+17
364224003,Size of vulval structure (observable entity),20020131,1,9E+17,9E+17
364223009,Vulva observable (observable entity),20020131,1,9E+17,9E+17
364222004,Female genitalia feature (observable entity),20020131,1,9E+17,9E+17
364207009,Testicular feature (observable entity),20020131,1,9E+17,9E+17
364206000,Scrotum feature (observable entity),20020131,1,9E+17,9E+17
364205001,Male genitalia feature (observable entity),20020131,1,9E+17,9E+17
364204002,Genital observable (observable entity),20020131,1,9E+17,9E+17
364203008,Urological test feature (observable entity),20020131,1,9E+17,9E+17
364208004,Appearance of testes (observable entity),20020131,1,9E+17,9E+17
364213000,Appearance of epididymis (observable entity),20020131,1,9E+17,9E+17
364210002,Consistency of testes (observable entity),20020131,1,9E+17,9E+17
364211003,Measure of testes (observable entity),20020131,1,9E+17,9E+17
364212005,Epididymis observable (observable entity),20020131,1,9E+17,9E+17
286747008,Level of egocentricity (observable entity),20020131,1,9E+17,9E+17
364254008,Form of uterus (observable entity),20020131,1,9E+17,9E+17
364253002,Fundal height of uterus (observable entity),20020131,1,9E+17,9E+17
364252007,Uterus feature (observable entity),20020131,1,9E+17,9E+17
364251000,Arrangement of hymen (observable entity),20020131,1,9E+17,9E+17
364250004,Shape of hymen (observable entity),20020131,1,9E+17,9E+17
364249004,Size of hymen (observable entity),20020131,1,9E+17,9E+17
364261007,Movement of uterus (observable entity),20020131,1,9E+17,9E+17
364260008,Contents of uterus (observable entity),20020131,1,9E+17,9E+17
364259003,Measure of uterus (observable entity),20020131,1,9E+17,9E+17
364258006,Proportion of uterus (observable entity),20020131,1,9E+17,9E+17
364257001,Displacement of uterus (observable entity),20020131,1,9E+17,9E+17
364256005,Arrangement of uterus (observable entity),20020131,1,9E+17,9E+17
364255009,Consistency of uterus (observable entity),20020131,1,9E+17,9E+17
364262000,Sensation of uterus (observable entity),20020131,1,9E+17,9E+17
364248007,Vaginal hymen feature (observable entity),20020131,1,9E+17,9E+17
364247002,Measure of vagina (observable entity),20020131,1,9E+17,9E+17
364245005,Pulsation of vagina (observable entity),20020131,1,9E+17,9E+17
364244009,Moistness of vagina (observable entity),20020131,1,9E+17,9E+17
364263005,Feature of gravid uterus (observable entity),20020131,1,9E+17,9E+17
364300008,Moistness of female perineum (observable entity),20020131,1,9E+17,9E+17
364299000,Female perineal hygiene (observable entity),20020131,1,9E+17,9E+17
364298008,Form of female perineum (observable entity),20020131,1,9E+17,9E+17
364297003,Female perineum observable (observable entity),20020131,1,9E+17,9E+17
364296007,Feature of ovulation (observable entity),20020131,1,9E+17,9E+17
364295006,Measure of ovary (observable entity),20020131,1,9E+17,9E+17
364294005,Arrangement of ovary (observable entity),20020131,1,9E+17,9E+17
364293004,Ovary feature (observable entity),20020131,1,9E+17,9E+17
364292009,Measure of cervix (observable entity),20020131,1,9E+17,9E+17
364291002,Color of cervix (observable entity),20020131,1,9E+17,9E+17
364290001,Characteristic of sensation of cervix (observable entity),20020131,1,9E+17,9E+17
364289005,Feature of ferning of cervical mucous (observable entity),20020131,1,9E+17,9E+17
364288002,Feature of cellularity of cervical mucous (observable entity),20020131,1,9E+17,9E+17
364287007,Feature of consistency of cervical mucous (observable entity),20020131,1,9E+17,9E+17
364301007,Tone of female perineum (observable entity),20020131,1,9E+17,9E+17
364302000,Color of female perineum (observable entity),20020131,1,9E+17,9E+17
364264004,Size of gravid uterus (observable entity),20020131,1,9E+17,9E+17
364286003,Cervical mucus feature (observable entity),20020131,1,9E+17,9E+17
364270005,Frequency of uterine contraction (observable entity),20020131,1,9E+17,9E+17
364269009,Pattern of uterine contractions (observable entity),20020131,1,9E+17,9E+17
364268001,Feature of uterine contractions (observable entity),20020131,1,9E+17,9E+17
364267006,Arrangement of gravid uterus (observable entity),20020131,1,9E+17,9E+17
364266002,Shape of pregnant abdomen (observable entity),20020131,1,9E+17,9E+17
364265003,Height of gravid uterus (observable entity),20020131,1,9E+17,9E+17
364271009,Regularity of uterine contraction (observable entity),20020131,1,9E+17,9E+17
364272002,Quantity of uterine contraction (observable entity),20020131,1,9E+17,9E+17
364275000,Effectiveness of uterine contraction (observable entity),20020131,1,9E+17,9E+17
364285004,Contents of cervix (observable entity),20020131,1,9E+17,9E+17
364284000,Direction of cervix (observable entity),20020131,1,9E+17,9E+17
364283006,Arrangement of uterine cervix (observable entity),20020131,1,9E+17,9E+17
364282001,Consistency of uterine cervix (observable entity),20020131,1,9E+17,9E+17
364281008,Thickness of cervix (observable entity),20020131,1,9E+17,9E+17
364280009,Form of uterine cervix (observable entity),20020131,1,9E+17,9E+17
364279006,Uterine cervix feature (observable entity),20020131,1,9E+17,9E+17
364278003,Measure of gravid uterus (observable entity),20020131,1,9E+17,9E+17
364277008,Contraction state of uterus (observable entity),20020131,1,9E+17,9E+17
364276004,Measure of uterine contractions (observable entity),20020131,1,9E+17,9E+17
364274001,Duration of uterine contraction (observable entity),20020131,1,9E+17,9E+17
285132003,Habits involving hair (observable entity),20020131,1,9E+17,9E+17
285060003,Enjoyment of sex (observable entity),20020131,1,9E+17,9E+17
284536002,Communication and body language functions (observable entity),20020131,1,9E+17,9E+17
284608002,Ability to control aggression (observable entity),20020131,1,9E+17,9E+17
284594001,Shouting (observable entity),20020131,1,9E+17,9E+17
284471000,Mid arm muscle circumference (observable entity),20020131,1,9E+17,9E+17
284472007,Hip circumference (observable entity),20020131,1,9E+17,9E+17
284473002,Mid upper arm circumference (observable entity),20020131,1,9E+17,9E+17
284474008,Self-control (observable entity),20020131,1,9E+17,9E+17
284478006,Biochemistry interpretation 1 (observable entity),20020131,1,9E+17,9E+17
284507002,Predictability of behavior (observable entity),20020131,1,9E+17,9E+17
284479003,Biochemistry interpretation 2 (observable entity),20020131,1,9E+17,9E+17
285285000,Cobb angle (observable entity),20020131,1,9E+17,9E+17
285231000,Mental function (observable entity),20020131,1,9E+17,9E+17
285233002,Oral motor functions (observable entity),20020131,1,9E+17,9E+17
285284001,Rib vertebra angle (observable entity),20020131,1,9E+17,9E+17
285258007,Ability to resist thoughts (observable entity),20020131,1,9E+17,9E+17
285244005,Cognitive style (observable entity),20020131,1,9E+17,9E+17
285250000,Ability to resist dangerous thoughts (observable entity),20020131,1,9E+17,9E+17
285259004,Ability to resist obsessional thoughts (observable entity),20020131,1,9E+17,9E+17
285414005,Width of cervix (observable entity),20020131,1,9E+17,9E+17
306751006,Duration of individual radiotherapy treatment (observable entity),20020131,1,9E+17,9E+17
306779000,Ability to cough voluntarily (observable entity),20020131,1,9E+17,9E+17
306956008,Position of vocal cords on respiration (observable entity),20020131,1,9E+17,9E+17
307117005,Place of origin (observable entity),20020131,1,9E+17,9E+17
307119008,Legal history relating to appointment of power of attorney (observable entity),20020131,1,9E+17,9E+17
304698007,Penis circumference (observable entity),20020131,1,9E+17,9E+17
304599007,Endocrine test finding (observable entity),20020131,1,9E+17,9E+17
304602002,Antenatal ultrasound finding (observable entity),20020131,1,9E+17,9E+17
310360002,Expected forced expiratory volume in one second/Forced vital capacity ratio (observable entity),20020131,1,9E+17,9E+17
310521000,Expected forced vital capacity (observable entity),20020131,1,9E+17,9E+17
310520004,Expected forced expired volume in 1 second (observable entity),20020131,1,9E+17,9E+17
310506006,Reason for termination of pregnancy (observable entity),20020131,1,9E+17,9E+17
310467003,Years of menstruating life (observable entity),20020131,1,9E+17,9E+17
312262004,External beam radiation therapy beam parameters (observable entity),20020131,1,9E+17,9E+17
311718005,"Cognitive discrimination, function (observable entity)",20020131,1,9E+17,9E+17
311841007,"Intelligibility, function (observable entity)",20020131,1,9E+17,9E+17
312009002,Cognitive function: initiation (observable entity),20020131,1,9E+17,9E+17
312010007,Cognitive function: goal setting (observable entity),20020131,1,9E+17,9E+17
312011006,Cognitive function: planning (observable entity),20020131,1,9E+17,9E+17
312016001,"Metacognition, function (observable entity)",20020131,1,9E+17,9E+17
312018000,Sensorimotor functions (observable entity),20020131,1,9E+17,9E+17
312019008,"Visuo-motor organization, function (observable entity)",20020131,1,9E+17,9E+17
312020002,"Recognition, function (observable entity)",20020131,1,9E+17,9E+17
312021003,"Route recognition, function (observable entity)",20020131,1,9E+17,9E+17
312024006,"Oculomotor control, function (observable entity)",20020131,1,9E+17,9E+17
310883007,Sperm forward progression (observable entity),20020131,1,9E+17,9E+17
310611001,Cardiovascular measure (observable entity),20020131,1,9E+17,9E+17
310612008,Cardiac measure (observable entity),20020131,1,9E+17,9E+17
311544007,"Information processing, function (observable entity)",20020131,1,9E+17,9E+17
311551003,"Spatial orientation good, function (observable entity)",20020131,1,9E+17,9E+17
311552005,"Spatial orientation, function (observable entity)",20020131,1,9E+17,9E+17
311553000,"Episodic memory, function (observable entity)",20020131,1,9E+17,9E+17
311554006,"Prospective memory, function (observable entity)",20020131,1,9E+17,9E+17
311534005,"Conceptualization, function (observable entity)",20020131,1,9E+17,9E+17
311463005,Standing tolerance (observable entity),20020131,1,9E+17,9E+17
311465003,Cognitive functions (observable entity),20020131,1,9E+17,9E+17
311505004,"Visual processing, function (observable entity)",20020131,1,9E+17,9E+17
311507007,Executive cognitive functions (observable entity),20020131,1,9E+17,9E+17
308063003,Total number of sick days in last year (observable entity),20020131,1,9E+17,9E+17
312370006,Doppler studies abnormal (finding),20020131,1,9E+17,9E+17
314981002,Spirometry reversibility positive (finding),20020131,1,9E+17,9E+17
314980001,Spirometry reversibility negative (finding),20020131,1,9E+17,9E+17
314979004,Spirometry reversibility test (procedure),20020131,1,9E+17,9E+17
299980005,Controlling position (observable entity),20020131,1,9E+17,9E+17
299981009,"Changing position, function (observable entity)",20020131,1,9E+17,9E+17
299944005,Ability to recognize writing on skin (observable entity),20020131,1,9E+17,9E+17
299931000,Two point discrimination distance (observable entity),20020131,1,9E+17,9E+17
299420003,Ankle joint - range of movement (observable entity),20020131,1,9E+17,9E+17
299421004,Range of ankle flexion (observable entity),20020131,1,9E+17,9E+17
299422006,Active range of ankle flexion (observable entity),20020131,1,9E+17,9E+17
299428005,Passive range of ankle flexion (observable entity),20020131,1,9E+17,9E+17
299433009,Range of ankle extension (observable entity),20020131,1,9E+17,9E+17
299434003,Active range of ankle extension (observable entity),20020131,1,9E+17,9E+17
299439008,Passive range of ankle extension (observable entity),20020131,1,9E+17,9E+17
299444001,Stability of ankle (observable entity),20020131,1,9E+17,9E+17
299451005,Ankle joint color (observable entity),20020131,1,9E+17,9E+17
299332000,Knee joint - range of movement (observable entity),20020131,1,9E+17,9E+17
299333005,Range of knee flexion (observable entity),20020131,1,9E+17,9E+17
299284008,Range of hip internal rotation (observable entity),20020131,1,9E+17,9E+17
299285009,Active range of hip internal rotation (observable entity),20020131,1,9E+17,9E+17
299290007,Passive range of hip internal rotation (observable entity),20020131,1,9E+17,9E+17
299295002,Range of hip external rotation (observable entity),20020131,1,9E+17,9E+17
299296001,Active range of hip external rotation (observable entity),20020131,1,9E+17,9E+17
299301001,Passive range of hip external rotation (observable entity),20020131,1,9E+17,9E+17
299334004,Active range of knee flexion (observable entity),20020131,1,9E+17,9E+17
299344002,Range of knee extension (observable entity),20020131,1,9E+17,9E+17
315228009,Excessive ultra violet ray exposure (observable entity),20020131,1,9E+17,9E+17
315227004,Excessive sun exposure (observable entity),20020131,1,9E+17,9E+17
299381003,Knee joint color (observable entity),20020131,1,9E+17,9E+17
299339009,Passive range of knee flexion (observable entity),20020131,1,9E+17,9E+17
315244000,Change in behavior (observable entity),20020131,1,9E+17,9E+17
299362006,Passive range of knee external rotation (observable entity),20020131,1,9E+17,9E+17
299345001,Active range of knee extension (observable entity),20020131,1,9E+17,9E+17
299350007,Passive range of knee extension (observable entity),20020131,1,9E+17,9E+17
299355002,Range of knee internal rotation (observable entity),20020131,1,9E+17,9E+17
299356001,Passive range of knee internal rotation (observable entity),20020131,1,9E+17,9E+17
299361004,Range of knee external rotation (observable entity),20020131,1,9E+17,9E+17
299600005,Passive range of toe extension (observable entity),20020131,1,9E+17,9E+17
299605000,Range of toe abduction (observable entity),20020131,1,9E+17,9E+17
299606004,Active range of toe abduction (observable entity),20020131,1,9E+17,9E+17
299611002,Passive range of toe abduction (observable entity),20020131,1,9E+17,9E+17
299595001,Active range of toe extension (observable entity),20020131,1,9E+17,9E+17
299582006,Toe joint - range of movement (observable entity),20020131,1,9E+17,9E+17
299583001,Range of toe flexion (observable entity),20020131,1,9E+17,9E+17
299584007,Active range of toe flexion (observable entity),20020131,1,9E+17,9E+17
299589002,Passive range of toe flexion (observable entity),20020131,1,9E+17,9E+17
299594002,Range of toe extension (observable entity),20020131,1,9E+17,9E+17
299617003,Active range of toe adduction (observable entity),20020131,1,9E+17,9E+17
299616007,Range of toe adduction (observable entity),20020131,1,9E+17,9E+17
299622003,Passive range of toe adduction (observable entity),20020131,1,9E+17,9E+17
299629007,Toe joint stability (observable entity),20020131,1,9E+17,9E+17
299637004,Toe joint color (observable entity),20020131,1,9E+17,9E+17
299503004,Passive range of midtarsal supination (observable entity),20020131,1,9E+17,9E+17
299517008,Foot joint color (observable entity),20020131,1,9E+17,9E+17
299498002,Active range of midtarsal supination (observable entity),20020131,1,9E+17,9E+17
299485006,Foot joint - range of movement (observable entity),20020131,1,9E+17,9E+17
299486007,Range of midtarsal pronation (observable entity),20020131,1,9E+17,9E+17
299487003,Active range of midtarsal pronation (observable entity),20020131,1,9E+17,9E+17
299492001,Passive range of midtarsal pronation (observable entity),20020131,1,9E+17,9E+17
299497007,Range of midtarsal supination (observable entity),20020131,1,9E+17,9E+17
299550008,Subtalar joint stability (observable entity),20020131,1,9E+17,9E+17
299545002,Active range of subtalar joint eversion (observable entity),20020131,1,9E+17,9E+17
299527002,Subtalar joint - range of movement (observable entity),20020131,1,9E+17,9E+17
299528007,Range of inversion of subtalar joint (observable entity),20020131,1,9E+17,9E+17
299529004,Passive range of subtalar joint inversion (observable entity),20020131,1,9E+17,9E+17
299534000,Active range of subtalar joint inversion (observable entity),20020131,1,9E+17,9E+17
299539005,Range eversion of subtalar joint (observable entity),20020131,1,9E+17,9E+17
299540007,Passive range of subtalar joint eversion (observable entity),20020131,1,9E+17,9E+17
300579006,Total number of lesions (observable entity),20020131,1,9E+17,9E+17
300555009,Day of ovulation (observable entity),20020131,1,9E+17,9E+17
300556005,Date of ovulation (observable entity),20020131,1,9E+17,9E+17
300547002,Ability to have sexual intercourse (observable entity),20020131,1,9E+17,9E+17
314756007,Child height = 0.4th centile (observable entity),20020131,1,9E+17,9E+17
300524003,Ability to get an erection (observable entity),20020131,1,9E+17,9E+17
314541000,Physiological nystagmus (observable entity),20020131,1,9E+17,9E+17
300809003,Ability to undertake voluntary work (observable entity),20020131,1,9E+17,9E+17
299279002,Passive range of hip adduction (observable entity),20020131,1,9E+17,9E+17
300118003,Pinna length (observable entity),20020131,1,9E+17,9E+17
300119006,Pinna breadth (observable entity),20020131,1,9E+17,9E+17
300374002,Ability to defecate (observable entity),20020131,1,9E+17,9E+17
300368002,Vomit volume (observable entity),20020131,1,9E+17,9E+17
298317001,Heel-shin test response (observable entity),20020131,1,9E+17,9E+17
298299000,Quadriceps circumference (observable entity),20020131,1,9E+17,9E+17
298370007,Temporomandibular joint stability (observable entity),20020131,1,9E+17,9E+17
298348009,Number of falls (observable entity),20020131,1,9E+17,9E+17
298338007,Motor function of jaw (observable entity),20020131,1,9E+17,9E+17
298342005,Truncal posture (observable entity),20020131,1,9E+17,9E+17
298263005,Beginning of range of joint movement (observable entity),20020131,1,9E+17,9E+17
298264004,End of range of joint movement (observable entity),20020131,1,9E+17,9E+17
298505002,Thoracic spine - range of movement (observable entity),20020131,1,9E+17,9E+17
298506001,Range of thoracic spine flexion (observable entity),20020131,1,9E+17,9E+17
298507005,Active range of thoracic spine flexion (observable entity),20020131,1,9E+17,9E+17
298512006,Passive range of thoracic spine flexion (observable entity),20020131,1,9E+17,9E+17
298517000,Range of thoracic spine extension (observable entity),20020131,1,9E+17,9E+17
298541002,Active range of thoracic spine left lateral flexion (observable entity),20020131,1,9E+17,9E+17
298546007,Passive range of thoracic spine left lateral flexion (observable entity),20020131,1,9E+17,9E+17
298551001,Range of thoracic spine right rotation (observable entity),20020131,1,9E+17,9E+17
298552008,Active range of thoracic spine right rotation (observable entity),20020131,1,9E+17,9E+17
298557002,Passive range of thoracic spine right rotation (observable entity),20020131,1,9E+17,9E+17
298540001,Range of thoracic spine left lateral flexion (observable entity),20020131,1,9E+17,9E+17
298518005,Active range of thoracic spine extension (observable entity),20020131,1,9E+17,9E+17
298524004,Passive range of thoracic spine extension (observable entity),20020131,1,9E+17,9E+17
298529009,Range of thoracic spine right lateral flexion (observable entity),20020131,1,9E+17,9E+17
298530004,Active range of thoracic spine right lateral flexion (observable entity),20020131,1,9E+17,9E+17
298535009,Passive range of thoracic spine right lateral flexion (observable entity),20020131,1,9E+17,9E+17
298410000,Passive range of cervical spine flexion (observable entity),20020131,1,9E+17,9E+17
298415005,Range of extension of cervical spine (observable entity),20020131,1,9E+17,9E+17
298416006,Active range of cervical spine extension (observable entity),20020131,1,9E+17,9E+17
298421009,Passive range of cervical spine extension (observable entity),20020131,1,9E+17,9E+17
298405004,Active range of cervical spine flexion (observable entity),20020131,1,9E+17,9E+17
298403006,Cervical spine - range of movement (observable entity),20020131,1,9E+17,9E+17
298404000,Range of flexion of cervical spine (observable entity),20020131,1,9E+17,9E+17
298467009,Passive range of cervical spine left rotation (observable entity),20020131,1,9E+17,9E+17
298427008,Range of cervical spine right lateral flexion (observable entity),20020131,1,9E+17,9E+17
298449002,Range of cervical spine right rotation (observable entity),20020131,1,9E+17,9E+17
298450002,Active range of cervical spine right rotation (observable entity),20020131,1,9E+17,9E+17
298455007,Passive range of cervical spine right rotation (observable entity),20020131,1,9E+17,9E+17
298460006,Range of cervical spine left rotation (observable entity),20020131,1,9E+17,9E+17
298461005,Active range of cervical spine left rotation (observable entity),20020131,1,9E+17,9E+17
298428003,Active range of cervical spine right lateral flexion (observable entity),20020131,1,9E+17,9E+17
298433004,Passive range of cervical spine right lateral flexion (observable entity),20020131,1,9E+17,9E+17
298438008,Range of cervical spine left lateral flexion (observable entity),20020131,1,9E+17,9E+17
298439000,Active range of cervical spine left lateral flexion (observable entity),20020131,1,9E+17,9E+17
298444007,Passive range of cervical spine left lateral flexion (observable entity),20020131,1,9E+17,9E+17
298060002,Number of admissions (observable entity),20020131,1,9E+17,9E+17
298059007,Date of onset (observable entity),20020131,1,9E+17,9E+17
298057009,Number of appointments attended (observable entity),20020131,1,9E+17,9E+17
298058004,Number of appointments missed (observable entity),20020131,1,9E+17,9E+17
298562001,Range of thoracic spine left rotation (observable entity),20020131,1,9E+17,9E+17
299031002,Hand size (observable entity),20020131,1,9E+17,9E+17
315485007,Born in Namibia (finding),20020131,1,9E+17,9E+17
315484006,Born in Mozambique (finding),20020131,1,9E+17,9E+17
315486008,Born in Nauru (finding),20020131,1,9E+17,9E+17
299045008,Palmar grip (observable entity),20020131,1,9E+17,9E+17
299046009,Scissor grip (observable entity),20020131,1,9E+17,9E+17
315487004,Born in Nepal (finding),20020131,1,9E+17,9E+17
315488009,Born in New Zealand (finding),20020131,1,9E+17,9E+17
315489001,Born in Nicaragua (finding),20020131,1,9E+17,9E+17
299008002,Passive range of wrist pronation (observable entity),20020131,1,9E+17,9E+17
315501003,Born in Peru (finding),20020131,1,9E+17,9E+17
315500002,Born in Paraguay (finding),20020131,1,9E+17,9E+17
315499006,Born in Papua New Guinea (finding),20020131,1,9E+17,9E+17
315498003,Born in Panama (finding),20020131,1,9E+17,9E+17
299014009,Wrist joint stability (observable entity),20020131,1,9E+17,9E+17
315497008,Born in Palestine (finding),20020131,1,9E+17,9E+17
315496004,Born in Pakistan (finding),20020131,1,9E+17,9E+17
315495000,Born in Oman (finding),20020131,1,9E+17,9E+17
315494001,Born in Norway (finding),20020131,1,9E+17,9E+17
315493007,Born in Northern Ireland (finding),20020131,1,9E+17,9E+17
315492002,Born in North Korea (finding),20020131,1,9E+17,9E+17
315491009,Born in Nigeria (finding),20020131,1,9E+17,9E+17
299022002,Wrist joint color (observable entity),20020131,1,9E+17,9E+17
315490005,Born in Niger (finding),20020131,1,9E+17,9E+17
315483000,Born in Morocco (finding),20020131,1,9E+17,9E+17
315482005,Born in Mongolia (finding),20020131,1,9E+17,9E+17
315468005,Born in Lithuania (finding),20020131,1,9E+17,9E+17
315467000,Born in Liechtenstein (finding),20020131,1,9E+17,9E+17
299080007,Passive range of finger extension (observable entity),20020131,1,9E+17,9E+17
315466009,Born in Libya (finding),20020131,1,9E+17,9E+17
315465008,Born in Liberia (finding),20020131,1,9E+17,9E+17
315464007,Born in Lesotho (finding),20020131,1,9E+17,9E+17
315463001,Born in Lebanon (finding),20020131,1,9E+17,9E+17
299085002,Range of finger abduction (observable entity),20020131,1,9E+17,9E+17
299086001,Active range of finger abduction (observable entity),20020131,1,9E+17,9E+17
315462006,Born in Latvia (finding),20020131,1,9E+17,9E+17
315461004,Born in Laos (finding),20020131,1,9E+17,9E+17
315460003,Born in Kyrgyzstan (finding),20020131,1,9E+17,9E+17
315459008,Born in Kuwait (finding),20020131,1,9E+17,9E+17
299091000,Passive range of finger abduction (observable entity),20020131,1,9E+17,9E+17
315458000,Born in Kosovo (finding),20020131,1,9E+17,9E+17
315457005,Born in Kiribati (finding),20020131,1,9E+17,9E+17
315456001,Born in Kenya (finding),20020131,1,9E+17,9E+17
315469002,Born in Luxembourg (finding),20020131,1,9E+17,9E+17
315502005,Born in Philippines (finding),20020131,1,9E+17,9E+17
315470001,Born in Madagascar (finding),20020131,1,9E+17,9E+17
299074004,Range of finger extension (observable entity),20020131,1,9E+17,9E+17
315481003,Born in Monaco (finding),20020131,1,9E+17,9E+17
315480002,Born in Moldavia (finding),20020131,1,9E+17,9E+17
299057004,Finger size (observable entity),20020131,1,9E+17,9E+17
299059001,Form of finger (observable entity),20020131,1,9E+17,9E+17
315479000,Born in Mexico (finding),20020131,1,9E+17,9E+17
299062003,Finger joint - range of movement (observable entity),20020131,1,9E+17,9E+17
299063008,Range of finger flexion (observable entity),20020131,1,9E+17,9E+17
299064002,Active range of finger flexion (observable entity),20020131,1,9E+17,9E+17
315478008,Born in Mauritius (finding),20020131,1,9E+17,9E+17
315477003,Born in Mauritania (finding),20020131,1,9E+17,9E+17
315476007,Born in Malta (finding),20020131,1,9E+17,9E+17
315475006,Born in Mali (finding),20020131,1,9E+17,9E+17
299069007,Passive range of finger flexion (observable entity),20020131,1,9E+17,9E+17
315474005,Born in Maldives (finding),20020131,1,9E+17,9E+17
315473004,Born in Malaysia (finding),20020131,1,9E+17,9E+17
315471002,Born in Malawi (finding),20020131,1,9E+17,9E+17
299075003,Active range of finger extension (observable entity),20020131,1,9E+17,9E+17
315503000,Born in Poland (finding),20020131,1,9E+17,9E+17
315504006,Born in Portugal (finding),20020131,1,9E+17,9E+17
315505007,Born in Puerto Rico (finding),20020131,1,9E+17,9E+17
315547006,Born in Turkey (finding),20020131,1,9E+17,9E+17
298946001,Wrist joint - range of movement (observable entity),20020131,1,9E+17,9E+17
298947005,Range of wrist flexion (observable entity),20020131,1,9E+17,9E+17
298948000,Active range of wrist flexion (observable entity),20020131,1,9E+17,9E+17
315546002,Born in Tunisia (finding),20020131,1,9E+17,9E+17
315545003,Born in Trinidad and Tobago (finding),20020131,1,9E+17,9E+17
315544004,Born in Tonga (finding),20020131,1,9E+17,9E+17
315543005,Born in Togo (finding),20020131,1,9E+17,9E+17
298953005,Passive range of wrist flexion (observable entity),20020131,1,9E+17,9E+17
315542000,Born in The Netherlands (finding),20020131,1,9E+17,9E+17
315540008,Born in Thailand (finding),20020131,1,9E+17,9E+17
315539006,Born in Tanzania (finding),20020131,1,9E+17,9E+17
315538003,Born in Tajikistan (finding),20020131,1,9E+17,9E+17
298958001,Range of wrist extension (observable entity),20020131,1,9E+17,9E+17
298959009,Active range of wrist extension (observable entity),20020131,1,9E+17,9E+17
315537008,Born in Taiwan (finding),20020131,1,9E+17,9E+17
315536004,Born in Syria (finding),20020131,1,9E+17,9E+17
315548001,Born in Turkmenistan (finding),20020131,1,9E+17,9E+17
315535000,Born in Switzerland (finding),20020131,1,9E+17,9E+17
315549009,Born in Tuvalu (finding),20020131,1,9E+17,9E+17
298923003,Elbow joint stability (observable entity),20020131,1,9E+17,9E+17
315561001,Born in Western Samoa (finding),20020131,1,9E+17,9E+17
315560000,Born in Wales (finding),20020131,1,9E+17,9E+17
315559005,Born in Vietnam (finding),20020131,1,9E+17,9E+17
315558002,Born in Venezuela (finding),20020131,1,9E+17,9E+17
315557007,Born in Vatican City (finding),20020131,1,9E+17,9E+17
315556003,Born in Vanuatu (finding),20020131,1,9E+17,9E+17
315555004,Born in Uzbekistan (finding),20020131,1,9E+17,9E+17
298933006,Elbow joint color (observable entity),20020131,1,9E+17,9E+17
315554000,Born in Uruguay (finding),20020131,1,9E+17,9E+17
315553006,Born in United Arab Emirates (finding),20020131,1,9E+17,9E+17
315552001,Born in Ukraine (finding),20020131,1,9E+17,9E+17
315551008,Born in Uganda (finding),20020131,1,9E+17,9E+17
315550009,Born in United States of America (finding),20020131,1,9E+17,9E+17
315455002,Born in Kazakhstan (finding),20020131,1,9E+17,9E+17
315534001,Born in Sweden (finding),20020131,1,9E+17,9E+17
315533007,Born in Swaziland (finding),20020131,1,9E+17,9E+17
315517009,Born in Seychelles (finding),20020131,1,9E+17,9E+17
315516000,Born in Senegal (finding),20020131,1,9E+17,9E+17
315515001,Born in Scotland (finding),20020131,1,9E+17,9E+17
315514002,Born in Saudi Arabia (finding),20020131,1,9E+17,9E+17
298991005,Range of wrist supination (observable entity),20020131,1,9E+17,9E+17
298992003,Active range of wrist supination (observable entity),20020131,1,9E+17,9E+17
315513008,Born in Sao Tome and Principe (finding),20020131,1,9E+17,9E+17
315512003,Born in San Marino (finding),20020131,1,9E+17,9E+17
315511005,Born in Rwanda (finding),20020131,1,9E+17,9E+17
315510006,Born in Russia (finding),20020131,1,9E+17,9E+17
298997009,Passive range of wrist supination (observable entity),20020131,1,9E+17,9E+17
315509001,Born in Romania (finding),20020131,1,9E+17,9E+17
315508009,Born in Republic of Korea (finding),20020131,1,9E+17,9E+17
315507004,Born in Republic of Ireland (finding),20020131,1,9E+17,9E+17
315506008,Born in Qatar (finding),20020131,1,9E+17,9E+17
299002001,Range of wrist pronation (observable entity),20020131,1,9E+17,9E+17
299003006,Active range of wrist pronation (observable entity),20020131,1,9E+17,9E+17
298986009,Passive range of wrist adduction (observable entity),20020131,1,9E+17,9E+17
298964008,Passive range of wrist extension (observable entity),20020131,1,9E+17,9E+17
315518004,Born in Sierra Leone (finding),20020131,1,9E+17,9E+17
315520001,Born in Slovakia (finding),20020131,1,9E+17,9E+17
315532002,Born in Suriname (finding),20020131,1,9E+17,9E+17
315531009,Born in Sudan (finding),20020131,1,9E+17,9E+17
315530005,Born in St. Vincent (finding),20020131,1,9E+17,9E+17
298969003,Range of wrist abduction (observable entity),20020131,1,9E+17,9E+17
298970002,Active range of wrist abduction (observable entity),20020131,1,9E+17,9E+17
315529000,Born in St. Lucia (finding),20020131,1,9E+17,9E+17
315528008,Born in St. Kitts and Nevis (finding),20020131,1,9E+17,9E+17
315527003,Born in Sri Lanka (finding),20020131,1,9E+17,9E+17
315526007,Born in Spain (finding),20020131,1,9E+17,9E+17
298975007,Passive range of wrist abduction (observable entity),20020131,1,9E+17,9E+17
315525006,Born in South Korea (finding),20020131,1,9E+17,9E+17
315524005,Born in South Africa (finding),20020131,1,9E+17,9E+17
315523004,Born in Somalia (finding),20020131,1,9E+17,9E+17
315522009,Born in Solomon Islands (finding),20020131,1,9E+17,9E+17
298980003,Range of wrist adduction (observable entity),20020131,1,9E+17,9E+17
298981004,Active range of wrist adduction (observable entity),20020131,1,9E+17,9E+17
315521002,Born in Slovenia (finding),20020131,1,9E+17,9E+17
315519007,Born in Singapore (finding),20020131,1,9E+17,9E+17
299096005,Range of finger adduction (observable entity),20020131,1,9E+17,9E+17
299097001,Active range of finger adduction (observable entity),20020131,1,9E+17,9E+17
315454003,Born in Jordan (finding),20020131,1,9E+17,9E+17
315380003,Born in Barbados (finding),20020131,1,9E+17,9E+17
315379001,Born in Bangladesh (finding),20020131,1,9E+17,9E+17
315378009,Born in Bahrain (finding),20020131,1,9E+17,9E+17
315377004,Born in Bahamas (finding),20020131,1,9E+17,9E+17
299220001,Leg size (observable entity),20020131,1,9E+17,9E+17
315381004,Born in Belgium (finding),20020131,1,9E+17,9E+17
315382006,Born in Belize (finding),20020131,1,9E+17,9E+17
299203000,Thumb joint color (observable entity),20020131,1,9E+17,9E+17
315396000,Born in Cambodia (finding),20020131,1,9E+17,9E+17
315395001,Born in Burundi (finding),20020131,1,9E+17,9E+17
315394002,Born in Burma (finding),20020131,1,9E+17,9E+17
299189005,Passive range of thumb opposition (observable entity),20020131,1,9E+17,9E+17
315393008,Born in Burkina Faso (finding),20020131,1,9E+17,9E+17
315392003,Born in Bulgaria (finding),20020131,1,9E+17,9E+17
315391005,Born in Brunei (finding),20020131,1,9E+17,9E+17
315390006,Born in British Guyana (finding),20020131,1,9E+17,9E+17
299194005,Thumb joint stability (observable entity),20020131,1,9E+17,9E+17
315389002,Born in Brazil (finding),20020131,1,9E+17,9E+17
315388005,Born in Botswana (finding),20020131,1,9E+17,9E+17
315387000,Born in Bosnia - Herzegovnia (finding),20020131,1,9E+17,9E+17
315386009,Born in Bolivia (finding),20020131,1,9E+17,9E+17
315385008,Born in Bhutan (finding),20020131,1,9E+17,9E+17
315384007,Born in Benin (finding),20020131,1,9E+17,9E+17
315383001,Born in Belorussia (finding),20020131,1,9E+17,9E+17
315397009,Born in Cameroon (finding),20020131,1,9E+17,9E+17
315376008,Born in Azerbaijan (finding),20020131,1,9E+17,9E+17
299256003,Passive range of hip extension (observable entity),20020131,1,9E+17,9E+17
315360004,Country of birth - Atlantic (finding),20020131,1,9E+17,9E+17
315359009,Country of birth - Australasian (finding),20020131,1,9E+17,9E+17
315358001,Country of birth - African (finding),20020131,1,9E+17,9E+17
315357006,Country of birth - American continent (finding),20020131,1,9E+17,9E+17
299261001,Range of hip abduction (observable entity),20020131,1,9E+17,9E+17
299262008,Active range of hip abduction (observable entity),20020131,1,9E+17,9E+17
315356002,Country of birth - Asian (finding),20020131,1,9E+17,9E+17
315355003,Country of birth - European (finding),20020131,1,9E+17,9E+17
315354004,Country of birth (observable entity),20020131,1,9E+17,9E+17
299267002,Passive range of hip abduction (observable entity),20020131,1,9E+17,9E+17
299272006,Range of hip adduction (observable entity),20020131,1,9E+17,9E+17
299273001,Active range of hip adduction (observable entity),20020131,1,9E+17,9E+17
315361000,Country of birth - Pacific (finding),20020131,1,9E+17,9E+17
315365009,Born in Afghanistan (finding),20020131,1,9E+17,9E+17
315375007,Born in Austria (finding),20020131,1,9E+17,9E+17
315374006,Born in Australia (finding),20020131,1,9E+17,9E+17
299238003,Hip joint - range of movement (observable entity),20020131,1,9E+17,9E+17
299239006,Range of hip flexion (observable entity),20020131,1,9E+17,9E+17
299240008,Active range of hip flexion (observable entity),20020131,1,9E+17,9E+17
315373000,Born in Armenia (finding),20020131,1,9E+17,9E+17
315372005,Born in Argentina (finding),20020131,1,9E+17,9E+17
315370002,Born in Antigua and Barbuda (finding),20020131,1,9E+17,9E+17
299245003,Passive range of hip flexion (observable entity),20020131,1,9E+17,9E+17
315369003,Born in Angola (finding),20020131,1,9E+17,9E+17
315368006,Born in Andorra (finding),20020131,1,9E+17,9E+17
315367001,Born in Algeria (finding),20020131,1,9E+17,9E+17
315366005,Born in Albania (finding),20020131,1,9E+17,9E+17
299250009,Range of hip extension (observable entity),20020131,1,9E+17,9E+17
299251008,Active range of hip extension (observable entity),20020131,1,9E+17,9E+17
315562008,Born in Yugoslavia (finding),20020131,1,9E+17,9E+17
299184000,Active range of thumb opposition (observable entity),20020131,1,9E+17,9E+17
315398004,Born in Canada (finding),20020131,1,9E+17,9E+17
315437006,Born in Guinea Republic (finding),20020131,1,9E+17,9E+17
315436002,Born in Guinea Bissau (finding),20020131,1,9E+17,9E+17
315435003,Born in Guatemala (finding),20020131,1,9E+17,9E+17
315434004,Born in Grenada (finding),20020131,1,9E+17,9E+17
315433005,Born in Greece (finding),20020131,1,9E+17,9E+17
299129008,Form of thumb (observable entity),20020131,1,9E+17,9E+17
315432000,Born in Ghana (finding),20020131,1,9E+17,9E+17
315431007,Born in Germany (finding),20020131,1,9E+17,9E+17
299138005,Thumb joint - range of movement (observable entity),20020131,1,9E+17,9E+17
299139002,Range of thumb flexion (observable entity),20020131,1,9E+17,9E+17
315438001,Born in Guyana (finding),20020131,1,9E+17,9E+17
299140000,Active range of thumb flexion (observable entity),20020131,1,9E+17,9E+17
315439009,Born in Haiti (finding),20020131,1,9E+17,9E+17
299116008,Finger joint color (observable entity),20020131,1,9E+17,9E+17
315453009,Born in Japan (finding),20020131,1,9E+17,9E+17
315452004,Born in Jamaica (finding),20020131,1,9E+17,9E+17
315451006,Born in Ivory Coast (finding),20020131,1,9E+17,9E+17
299102003,Passive range of finger adduction (observable entity),20020131,1,9E+17,9E+17
315450007,Born in Italy (finding),20020131,1,9E+17,9E+17
315449007,Born in Israel (finding),20020131,1,9E+17,9E+17
315448004,Born in Ireland (finding),20020131,1,9E+17,9E+17
315447009,Born in Iraq (finding),20020131,1,9E+17,9E+17
299107009,Finger joint stability (observable entity),20020131,1,9E+17,9E+17
315446000,Born in Iran (finding),20020131,1,9E+17,9E+17
315445001,Born in Indonesia (finding),20020131,1,9E+17,9E+17
315444002,Born in India (finding),20020131,1,9E+17,9E+17
315443008,Born in Iceland (finding),20020131,1,9E+17,9E+17
315442003,Born in Hungary (finding),20020131,1,9E+17,9E+17
315441005,Born in Hong Kong (finding),20020131,1,9E+17,9E+17
315440006,Born in Honduras (finding),20020131,1,9E+17,9E+17
299183006,Range of thumb opposition (observable entity),20020131,1,9E+17,9E+17
315430008,Born in Georgia (finding),20020131,1,9E+17,9E+17
315428006,Born in Gabon (finding),20020131,1,9E+17,9E+17
315412001,Born in Czech Republic (finding),20020131,1,9E+17,9E+17
315411008,Born in Cyprus (finding),20020131,1,9E+17,9E+17
299167006,Passive range of thumb abduction (observable entity),20020131,1,9E+17,9E+17
315410009,Born in Cuba (finding),20020131,1,9E+17,9E+17
315409004,Born in Croatia (finding),20020131,1,9E+17,9E+17
315408007,Born in Costa Rica (finding),20020131,1,9E+17,9E+17
315407002,Born in Congo (finding),20020131,1,9E+17,9E+17
299172002,Range of thumb adduction (observable entity),20020131,1,9E+17,9E+17
299173007,Active range of thumb adduction (observable entity),20020131,1,9E+17,9E+17
315406006,Born in Comoros Islands (finding),20020131,1,9E+17,9E+17
315405005,Born in Colombia (finding),20020131,1,9E+17,9E+17
315404009,Born in China (finding),20020131,1,9E+17,9E+17
315403003,Born in Chile (finding),20020131,1,9E+17,9E+17
299178003,Passive range of thumb adduction (observable entity),20020131,1,9E+17,9E+17
315402008,Born in Chechnya (finding),20020131,1,9E+17,9E+17
315401001,Born in Chad (finding),20020131,1,9E+17,9E+17
315400000,Born in Central African Republic (finding),20020131,1,9E+17,9E+17
315413006,Born in Democratic People's Republic of Korea (finding),20020131,1,9E+17,9E+17
315429003,Born in Gambia (finding),20020131,1,9E+17,9E+17
315414000,Born in Denmark (finding),20020131,1,9E+17,9E+17
299161007,Range of thumb abduction (observable entity),20020131,1,9E+17,9E+17
315427001,Born in France (finding),20020131,1,9E+17,9E+17
299145005,Passive range of thumb flexion (observable entity),20020131,1,9E+17,9E+17
315426005,Born in Finland (finding),20020131,1,9E+17,9E+17
315425009,Born in Fiji (finding),20020131,1,9E+17,9E+17
315424008,Born in Ethiopia (finding),20020131,1,9E+17,9E+17
315423002,Born in Estonia (finding),20020131,1,9E+17,9E+17
299150004,Range of thumb extension (observable entity),20020131,1,9E+17,9E+17
299151000,Active range of thumb extension (observable entity),20020131,1,9E+17,9E+17
315422007,Born in Equatorial Guinea (finding),20020131,1,9E+17,9E+17
315421000,Born in England (finding),20020131,1,9E+17,9E+17
315420004,Born in El Salvador (finding),20020131,1,9E+17,9E+17
315419005,Born in Egypt (finding),20020131,1,9E+17,9E+17
299156005,Passive range of thumb extension (observable entity),20020131,1,9E+17,9E+17
315418002,Born in Ecuador (finding),20020131,1,9E+17,9E+17
315417007,Born in East Timor (finding),20020131,1,9E+17,9E+17
315416003,Born in Dominican Republic (finding),20020131,1,9E+17,9E+17
315415004,Born in Djibouti (finding),20020131,1,9E+17,9E+17
299162000,Active range of thumb abduction (observable entity),20020131,1,9E+17,9E+17
315563003,Born in Zaire (finding),20020131,1,9E+17,9E+17
315565005,Born in Zimbabwe (finding),20020131,1,9E+17,9E+17
298651009,Passive range of lumbar spine right rotation (observable entity),20020131,1,9E+17,9E+17
298656004,Range of lumbar spine left rotation (observable entity),20020131,1,9E+17,9E+17
298657008,Active range of lumbar spine left rotation (observable entity),20020131,1,9E+17,9E+17
298662009,Passive range of lumbar spine left rotation (observable entity),20020131,1,9E+17,9E+17
298718008,Chest circumference - inspiration (observable entity),20020131,1,9E+17,9E+17
298719000,Chest circumference - expiration (observable entity),20020131,1,9E+17,9E+17
298691007,Lasgue test response (observable entity),20020131,1,9E+17,9E+17
298646003,Active range of lumbar spine right rotation (observable entity),20020131,1,9E+17,9E+17
298599001,Lumbar spine - range of movement (observable entity),20020131,1,9E+17,9E+17
298600003,Range of flexion of lumbar spine (observable entity),20020131,1,9E+17,9E+17
298601004,Active range of lumbar spine flexion (observable entity),20020131,1,9E+17,9E+17
298563006,Active range of thoracic spine left rotation (observable entity),20020131,1,9E+17,9E+17
298568002,Passive range of thoracic spine left rotation (observable entity),20020131,1,9E+17,9E+17
298606009,Passive range of lumbar spine flexion (observable entity),20020131,1,9E+17,9E+17
298629001,Passive range of lumbar spine right lateral flexion (observable entity),20020131,1,9E+17,9E+17
298634002,Range of lumbar spine left lateral flexion (observable entity),20020131,1,9E+17,9E+17
298635001,Active range of lumbar spine left lateral flexion (observable entity),20020131,1,9E+17,9E+17
298640009,Passive range of lumbar spine left lateral flexion (observable entity),20020131,1,9E+17,9E+17
298645004,Range of lumbar spine right rotation (observable entity),20020131,1,9E+17,9E+17
298611006,Range of lumbar spine extension (observable entity),20020131,1,9E+17,9E+17
298612004,Active range of lumbar spine extension (observable entity),20020131,1,9E+17,9E+17
298617005,Passive range of lumbar spine extension (observable entity),20020131,1,9E+17,9E+17
298622005,Range of lumbar spine right lateral flexion (observable entity),20020131,1,9E+17,9E+17
298624006,Active range of lumbar spine right lateral flexion (observable entity),20020131,1,9E+17,9E+17
298862006,Shoulder joint color (observable entity),20020131,1,9E+17,9E+17
298837006,Passive range of shoulder external rotation (observable entity),20020131,1,9E+17,9E+17
298842003,Range of shoulder circumduction (observable entity),20020131,1,9E+17,9E+17
298843008,Active range of shoulder circumduction (observable entity),20020131,1,9E+17,9E+17
298848004,Passive range of shoulder circumduction (observable entity),20020131,1,9E+17,9E+17
298853009,Shoulder joint stability (observable entity),20020131,1,9E+17,9E+17
298878008,Elbow joint - range of movement (observable entity),20020131,1,9E+17,9E+17
298880002,Active range of elbow flexion (observable entity),20020131,1,9E+17,9E+17
298902009,Active range of elbow supination (observable entity),20020131,1,9E+17,9E+17
315577000,Main spoken language Kutchi (finding),20020131,1,9E+17,9E+17
315576009,Main spoken language Iba (finding),20020131,1,9E+17,9E+17
315575008,Main spoken language Hindi (finding),20020131,1,9E+17,9E+17
315574007,Main spoken language Hausa (finding),20020131,1,9E+17,9E+17
298907003,Passive range of elbow supination (observable entity),20020131,1,9E+17,9E+17
315572006,Main spoken language Gujerati (finding),20020131,1,9E+17,9E+17
315571004,Main spoken language French (finding),20020131,1,9E+17,9E+17
315570003,Main spoken language English (finding),20020131,1,9E+17,9E+17
298912002,Range of elbow pronation (observable entity),20020131,1,9E+17,9E+17
298913007,Active range of elbow pronation (observable entity),20020131,1,9E+17,9E+17
315569004,Main spoken language Czech (finding),20020131,1,9E+17,9E+17
315568007,Main spoken language Cantonese (finding),20020131,1,9E+17,9E+17
315567002,Main spoken language Bengali (finding),20020131,1,9E+17,9E+17
315566006,Main spoken language Arabic (finding),20020131,1,9E+17,9E+17
298918003,Passive range of elbow pronation (observable entity),20020131,1,9E+17,9E+17
298901002,Range of elbow supination (observable entity),20020131,1,9E+17,9E+17
298879000,Range of elbow flexion (observable entity),20020131,1,9E+17,9E+17
315578005,Main spoken language Mandarin (finding),20020131,1,9E+17,9E+17
315580004,Main spoken language Portuguese (finding),20020131,1,9E+17,9E+17
315590007,Born in Yemen (finding),20020131,1,9E+17,9E+17
298885007,Passive range of elbow flexion (observable entity),20020131,1,9E+17,9E+17
315589003,Main spoken language Yoruba (finding),20020131,1,9E+17,9E+17
315588006,Main spoken language Urdu (finding),20020131,1,9E+17,9E+17
315587001,Main spoken language Tamil (finding),20020131,1,9E+17,9E+17
315586005,Main spoken language Sylheti (finding),20020131,1,9E+17,9E+17
298890005,Range of elbow extension (observable entity),20020131,1,9E+17,9E+17
298891009,Active range of elbow extension (observable entity),20020131,1,9E+17,9E+17
315585009,Main spoken language Swahili (finding),20020131,1,9E+17,9E+17
315584008,Main spoken language Spanish (finding),20020131,1,9E+17,9E+17
315583002,Main spoken language Somali (finding),20020131,1,9E+17,9E+17
315582007,Main spoken language Russian (finding),20020131,1,9E+17,9E+17
298896004,Passive range of elbow extension (observable entity),20020131,1,9E+17,9E+17
315581000,Main spoken language Punjabi (finding),20020131,1,9E+17,9E+17
315579002,Main spoken language Polish (finding),20020131,1,9E+17,9E+17
315564009,Born in Zambia (finding),20020131,1,9E+17,9E+17
298832000,Active range of shoulder external rotation (observable entity),20020131,1,9E+17,9E+17
298773006,Shoulder joint - range of movement (observable entity),20020131,1,9E+17,9E+17
298774000,Range of shoulder flexion (observable entity),20020131,1,9E+17,9E+17
298775004,Active range of shoulder flexion (observable entity),20020131,1,9E+17,9E+17
298780008,Passive range of shoulder flexion (observable entity),20020131,1,9E+17,9E+17
298785003,Range of shoulder extension (observable entity),20020131,1,9E+17,9E+17
298786002,Active range of shoulder extension (observable entity),20020131,1,9E+17,9E+17
298755008,Carrying angle of forearm (observable entity),20020131,1,9E+17,9E+17
298831007,Range of shoulder external rotation (observable entity),20020131,1,9E+17,9E+17
298814000,Passive range of shoulder adduction (observable entity),20020131,1,9E+17,9E+17
298819005,Range of shoulder internal rotation (observable entity),20020131,1,9E+17,9E+17
298820004,Active range of shoulder internal rotation (observable entity),20020131,1,9E+17,9E+17
298826005,Passive range of shoulder internal rotation (observable entity),20020131,1,9E+17,9E+17
298808007,Range of shoulder adduction (observable entity),20020131,1,9E+17,9E+17
298791001,Passive range of shoulder extension (observable entity),20020131,1,9E+17,9E+17
298796006,Range of shoulder abduction (observable entity),20020131,1,9E+17,9E+17
298797002,Active range of shoulder abduction (observable entity),20020131,1,9E+17,9E+17
298803003,Passive range of shoulder abduction (observable entity),20020131,1,9E+17,9E+17
298809004,Active range of shoulder adduction (observable entity),20020131,1,9E+17,9E+17
313384009,Place of death (observable entity),20020131,1,9E+17,9E+17
313232000,Peak expiratory flow rate after bronchodilation (observable entity),20020131,1,9E+17,9E+17
313222007,Forced expiratory volume in one second/Forced vital capacity percent (observable entity),20020131,1,9E+17,9E+17
313221000,Respiratory percentage (observable entity),20020131,1,9E+17,9E+17
313223002,Percent predicted forced expired volume in one second (observable entity),20020131,1,9E+17,9E+17
313292002,Route of breathing (observable entity),20020131,1,9E+17,9E+17
313289001,Duration of seizure (observable entity),20020131,1,9E+17,9E+17
313276007,Peak expiratory flow rate before bronchodilation (observable entity),20020131,1,9E+17,9E+17
303527006,Range of cervical spine retraction (observable entity),20020131,1,9E+17,9E+17
303528001,Range of cervical spine protraction (observable entity),20020131,1,9E+17,9E+17
303535009,Active range of cervical spine retraction (observable entity),20020131,1,9E+17,9E+17
303540001,Active range of cervical spine protraction (observable entity),20020131,1,9E+17,9E+17
302782007,Red blood cell color (observable entity),20020131,1,9E+17,9E+17
303116000,Memory function (observable entity),20020131,1,9E+17,9E+17
303186005,Legal status of patient (observable entity),20020131,1,9E+17,9E+17
304289003,Cytomegalovirus status (observable entity),20020131,1,9E+17,9E+17
304251008,Resuscitation status (observable entity),20020131,1,9E+17,9E+17
313131002,Number of membranes present (observable entity),20020131,1,9E+17,9E+17
313088003,Ocular muscle balance (observable entity),20020131,1,9E+17,9E+17
304189005,Range of shoulder horizontal flexion (observable entity),20020131,1,9E+17,9E+17
304190001,Range of shoulder horizontal extension (observable entity),20020131,1,9E+17,9E+17
304191002,Active range of shoulder horizontal flexion (observable entity),20020131,1,9E+17,9E+17
304192009,Passive range of shoulder horizontal flexion (observable entity),20020131,1,9E+17,9E+17
304203000,Passive range of shoulder horizontal extension (observable entity),20020131,1,9E+17,9E+17
304202005,Active range of shoulder horizontal extension (observable entity),20020131,1,9E+17,9E+17
313203003,Hearing test abnormal (finding),20020131,1,9E+17,9E+17
313199003,Antenatal screening finding (observable entity),20020131,1,9E+17,9E+17
313193002,Peak flow rate (respiratory) (observable entity),20020131,1,9E+17,9E+17
313192007,Expected peak expiratory flow rate (observable entity),20020131,1,9E+17,9E+17
313198006,Child examination interpretation (observable entity),20020131,1,9E+17,9E+17
301334000,Birth weight centile (observable entity),20020131,1,9E+17,9E+17
314037008,Serum appearance (observable entity),20020131,1,9E+17,9E+17
301062004,Cervical mucus ferning score (observable entity),20020131,1,9E+17,9E+17
301244000,Ability to cough up sputum (observable entity),20020131,1,9E+17,9E+17
301259006,Appearance of chest movement (observable entity),20020131,1,9E+17,9E+17
301116009,ST segment duration (observable entity),20020131,1,9E+17,9E+17
301117000,QT interval duration (observable entity),20020131,1,9E+17,9E+17
302286009,Arterial diameter (observable entity),20020131,1,9E+17,9E+17
302287000,Aortic diameter (observable entity),20020131,1,9E+17,9E+17
302180008,Prison record and criminal activity details (observable entity),20020131,1,9E+17,9E+17
302181007,Legal history relating to child (observable entity),20020131,1,9E+17,9E+17
302147001,Demographic history detail (observable entity),20020131,1,9E+17,9E+17
302148006,"Legal, financial, employment and socioeconomic history detail (observable entity)",20020131,1,9E+17,9E+17
302149003,"Housing, local environment and transport detail (observable entity)",20020131,1,9E+17,9E+17
302150003,Requirement for domiciliary service (observable entity),20020131,1,9E+17,9E+17
302160007,"Household, family and support network detail (observable entity)",20020131,1,9E+17,9E+17
302249008,Urogenital function (observable entity),20020131,1,9E+17,9E+17
302252000,Musculoskeletal functions and activities (navigational concept),20020131,1,9E+17,9E+17
313611000,Sweat volume (observable entity),20020131,1,9E+17,9E+17
301831002,Extracranial cerebrospinal fluid pressure (observable entity),20020131,1,9E+17,9E+17
301898006,Body surface area (observable entity),20020131,1,9E+17,9E+17
302119000,Fitness for work (observable entity),20020131,1,9E+17,9E+17
302121005,History relating to military service (observable entity),20020131,1,9E+17,9E+17
302132005,American Society of Anesthesiologists physical status class (observable entity),20020131,1,9E+17,9E+17
302138009,Willingness to be a donor (observable entity),20020131,1,9E+17,9E+17
302142007,School / class size (observable entity),20020131,1,9E+17,9E+17
302033003,Bone age corrected height centile (observable entity),20020131,1,9E+17,9E+17
301992006,Ability to close eyes (observable entity),20020131,1,9E+17,9E+17
255211006,Shuttle number (observable entity),20020131,1,9E+17,9E+17
255324009,Movement (observable entity),20020131,1,9E+17,9E+17
260952005,Number of diverticula (observable entity),20020131,1,9E+17,9E+17
258158006,"Sleep, function (observable entity)",20020131,1,9E+17,9E+17
258153002,Target heart rate achieved (observable entity),20020131,1,9E+17,9E+17
258152007,Treadmill level achieved (observable entity),20020131,1,9E+17,9E+17
257736002,Flying (qualifier value),20020131,1,9E+17,9E+17
257737006,Mountaineering (qualifier value),20020131,1,9E+17,9E+17
257752004,Joint angulation (observable entity),20020131,1,9E+17,9E+17
257733005,Activity (observable entity),20020131,1,9E+17,9E+17
258088000,Bicycle test level achieved (observable entity),20020131,1,9E+17,9E+17
258140000,Level achieved (observable entity),20020131,1,9E+17,9E+17
258145005,Stairs climbed (observable entity),20020131,1,9E+17,9E+17
258148007,Standing up (observable entity),20020131,1,9E+17,9E+17
258151000,Protocol stage achieved (observable entity),20020131,1,9E+17,9E+17
248571006,Posture for breathing (observable entity),20020131,1,9E+17,9E+17
248582003,Rhythm of respiration (observable entity),20020131,1,9E+17,9E+17
248565000,Respiratory effort (observable entity),20020131,1,9E+17,9E+17
248546008,Ease of respiration (observable entity),20020131,1,9E+17,9E+17
248557003,Chest movement (observable entity),20020131,1,9E+17,9E+17
248558008,Symmetry of chest movement (observable entity),20020131,1,9E+17,9E+17
248612000,Diaphragmatic dullness to percussion (observable entity),20020131,1,9E+17,9E+17
248610008,Hepatic dullness to percussion in chest (observable entity),20020131,1,9E+17,9E+17
248592006,Character of cough (observable entity),20020131,1,9E+17,9E+17
248598005,Sputum volume (observable entity),20020131,1,9E+17,9E+17
248603002,Consistency of sputum (observable entity),20020131,1,9E+17,9E+17
248606005,Characteristic of movement of trachea (observable entity),20020131,1,9E+17,9E+17
248609003,Chest resonance to percussion (observable entity),20020131,1,9E+17,9E+17
248535005,Lump volume (observable entity),20020131,1,9E+17,9E+17
248525004,Distance of rectal mass above anal margin (observable entity),20020131,1,9E+17,9E+17
248526003,Number of lumps (observable entity),20020131,1,9E+17,9E+17
248529005,Lump size (observable entity),20020131,1,9E+17,9E+17
248530000,Diameter of lump (observable entity),20020131,1,9E+17,9E+17
248531001,Circumference of lump (observable entity),20020131,1,9E+17,9E+17
248532008,Length of lump (observable entity),20020131,1,9E+17,9E+17
248533003,Width of lump (observable entity),20020131,1,9E+17,9E+17
248472001,Body color (observable entity),20020131,1,9E+17,9E+17
248492008,Joint circumference (observable entity),20020131,1,9E+17,9E+17
248808008,Breast size (observable entity),20020131,1,9E+17,9E+17
248815000,Surface characteristics of breast (observable entity),20020131,1,9E+17,9E+17
248821001,Position of nipple (observable entity),20020131,1,9E+17,9E+17
248823003,Nipple size (observable entity),20020131,1,9E+17,9E+17
248789005,Quality of orgasm (observable entity),20020131,1,9E+17,9E+17
248805006,Symmetry of breasts (observable entity),20020131,1,9E+17,9E+17
248698002,Exocardial sounds (observable entity),20020131,1,9E+17,9E+17
248412009,Color of extremity (observable entity),20020131,1,9E+17,9E+17
248140009,Oral habits (observable entity),20020131,1,9E+17,9E+17
248148002,Facial expression (observable entity),20020131,1,9E+17,9E+17
248178006,Lip competence (observable entity),20020131,1,9E+17,9E+17
248175009,Upper lip size (observable entity),20020131,1,9E+17,9E+17
248155000,Degree of personal cleanliness (observable entity),20020131,1,9E+17,9E+17
248159006,State of dress (observable entity),20020131,1,9E+17,9E+17
248167003,Facial appearance (observable entity),20020131,1,9E+17,9E+17
248168008,Facial profile (observable entity),20020131,1,9E+17,9E+17
248092002,Eroticism (observable entity),20020131,1,9E+17,9E+17
248093007,Erotic interest (observable entity),20020131,1,9E+17,9E+17
248095000,Libido (observable entity),20020131,1,9E+17,9E+17
248336007,Pubis to ground height (observable entity),20020131,1,9E+17,9E+17
248337003,Height from demispan (observable entity),20020131,1,9E+17,9E+17
248338008,Height centile (observable entity),20020131,1,9E+17,9E+17
248339000,Trend in height centile (observable entity),20020131,1,9E+17,9E+17
248340003,Growth velocity centile (observable entity),20020131,1,9E+17,9E+17
248343001,Weight trend (observable entity),20020131,1,9E+17,9E+17
248346009,Weight change (observable entity),20020131,1,9E+17,9E+17
248347000,Percentage change in weight (observable entity),20020131,1,9E+17,9E+17
248348005,Percentage weight gain (observable entity),20020131,1,9E+17,9E+17
248349002,Percentage weight loss (observable entity),20020131,1,9E+17,9E+17
248353000,Percentage of reference weight (observable entity),20020131,1,9E+17,9E+17
248354006,Percentage overweight (observable entity),20020131,1,9E+17,9E+17
248355007,Percentage underweight (observable entity),20020131,1,9E+17,9E+17
248335006,Sitting height (observable entity),20020131,1,9E+17,9E+17
248356008,Weight centile (observable entity),20020131,1,9E+17,9E+17
248317002,Distribution of body fat loss (observable entity),20020131,1,9E+17,9E+17
248326004,Body measure (observable entity),20020131,1,9E+17,9E+17
248357004,Trend in weight centile (observable entity),20020131,1,9E+17,9E+17
248361005,Total body fat (observable entity),20020131,1,9E+17,9E+17
248396005,Head circumference with caput (observable entity),20020131,1,9E+17,9E+17
248400005,Jaw size (observable entity),20020131,1,9E+17,9E+17
248383009,Fontanelle size (observable entity),20020131,1,9E+17,9E+17
248362003,Lean body mass (observable entity),20020131,1,9E+17,9E+17
248363008,Fat-free mass (observable entity),20020131,1,9E+17,9E+17
248365001,Circumference measure (observable entity),20020131,1,9E+17,9E+17
248366000,Chest circumference (observable entity),20020131,1,9E+17,9E+17
248367009,Waist/hip ratio (observable entity),20020131,1,9E+17,9E+17
248368004,Elbow breadth (observable entity),20020131,1,9E+17,9E+17
248370008,Head size (observable entity),20020131,1,9E+17,9E+17
248371007,Symmetry of skull (observable entity),20020131,1,9E+17,9E+17
248373005,Width of skull (observable entity),20020131,1,9E+17,9E+17
248378001,Height of skull (observable entity),20020131,1,9E+17,9E+17
248384003,Level of fontanelle (observable entity),20020131,1,9E+17,9E+17
248233002,Mental alertness (observable entity),20020131,1,9E+17,9E+17
248237001,Response to stimulus (observable entity),20020131,1,9E+17,9E+17
248238006,Response to conversation (observable entity),20020131,1,9E+17,9E+17
248239003,Response to commands (observable entity),20020131,1,9E+17,9E+17
248240001,Response to pain (observable entity),20020131,1,9E+17,9E+17
248241002,Glasgow coma score (observable entity),20020131,1,9E+17,9E+17
248210003,Complexion (observable entity),20020131,1,9E+17,9E+17
248215008,Use of make-up (observable entity),20020131,1,9E+17,9E+17
248217000,State of consciousness and awareness (observable entity),20020131,1,9E+17,9E+17
248250000,Tendency to bleed (observable entity),20020131,1,9E+17,9E+17
248288003,General development (observable entity),20020131,1,9E+17,9E+17
248291003,Facial skeletal pattern (observable entity),20020131,1,9E+17,9E+17
248295007,Physique type (observable entity),20020131,1,9E+17,9E+17
248300009,Body fat observable (observable entity),20020131,1,9E+17,9E+17
248303006,Distribution of body fat (observable entity),20020131,1,9E+17,9E+17
248263006,Duration of sleep (observable entity),20020131,1,9E+17,9E+17
249482005,Swallowing pattern (observable entity),20020131,1,9E+17,9E+17
249447009,Position of vocal cord at rest (observable entity),20020131,1,9E+17,9E+17
249484006,Ease of swallowing (observable entity),20020131,1,9E+17,9E+17
249521002,Frequency of bowel action (observable entity),20020131,1,9E+17,9E+17
249522009,Awareness of bowel function (observable entity),20020131,1,9E+17,9E+17
249532002,Color of abdominal wall (observable entity),20020131,1,9E+17,9E+17
249412001,Color of gingivae (observable entity),20020131,1,9E+17,9E+17
249320000,Form of bridge of nose (observable entity),20020131,1,9E+17,9E+17
249325005,Form of tip of nose (observable entity),20020131,1,9E+17,9E+17
249335004,Form of nostril (observable entity),20020131,1,9E+17,9E+17
249312002,Ethnic form of nose (observable entity),20020131,1,9E+17,9E+17
249292000,Form of stream of urine (observable entity),20020131,1,9E+17,9E+17
249293005,Strength of stream of urine (observable entity),20020131,1,9E+17,9E+17
249298001,Consistency of urine (observable entity),20020131,1,9E+17,9E+17
249299009,Contents of urine (observable entity),20020131,1,9E+17,9E+17
249309000,Form of nose (observable entity),20020131,1,9E+17,9E+17
249401001,Moistness of oral mucosa (observable entity),20020131,1,9E+17,9E+17
249402008,Color of oral mucosa (observable entity),20020131,1,9E+17,9E+17
249350008,Contents of anterior nasal cavity (observable entity),20020131,1,9E+17,9E+17
249363002,Adenoids size (observable entity),20020131,1,9E+17,9E+17
249379001,Tongue size (observable entity),20020131,1,9E+17,9E+17
249542000,Abdominal muscle tone (observable entity),20020131,1,9E+17,9E+17
249691002,Form of sternum (observable entity),20020131,1,9E+17,9E+17
249694005,Form of ribs (observable entity),20020131,1,9E+17,9E+17
249707001,Form of spine (observable entity),20020131,1,9E+17,9E+17
249666002,Form of neck (observable entity),20020131,1,9E+17,9E+17
249668001,Form of thorax (observable entity),20020131,1,9E+17,9E+17
249669009,General structure of thorax (observable entity),20020131,1,9E+17,9E+17
249676004,Anteroposterior diameter of chest (observable entity),20020131,1,9E+17,9E+17
249677008,Form of clavicle (observable entity),20020131,1,9E+17,9E+17
249748003,Arm length (observable entity),20020131,1,9E+17,9E+17
249749006,Form of hand (observable entity),20020131,1,9E+17,9E+17
249753008,Glove size (observable entity),20020131,1,9E+17,9E+17
249719009,Effect of movement on spine deformity (observable entity),20020131,1,9E+17,9E+17
249725008,Form of scapula (observable entity),20020131,1,9E+17,9E+17
249730007,Form of pelvis and buttocks (observable entity),20020131,1,9E+17,9E+17
249735002,Form of limbs (observable entity),20020131,1,9E+17,9E+17
249736001,Form of arm (observable entity),20020131,1,9E+17,9E+17
249283003,Awareness of bladder function (observable entity),20020131,1,9E+17,9E+17
249583002,Position of kidney (observable entity),20020131,1,9E+17,9E+17
249587001,Sounds in abdomen (observable entity),20020131,1,9E+17,9E+17
249566006,Liver size (observable entity),20020131,1,9E+17,9E+17
249551008,Abdominal percussion note feature (observable entity),20020131,1,9E+17,9E+17
249555004,Percussion dullness below costal margin (observable entity),20020131,1,9E+17,9E+17
249556003,Percussion dullness above pubis (observable entity),20020131,1,9E+17,9E+17
249634007,Patency of anus (observable entity),20020131,1,9E+17,9E+17
249636009,Appearance of anal orifice (observable entity),20020131,1,9E+17,9E+17
249640000,Integrity of anal sphincter (observable entity),20020131,1,9E+17,9E+17
249606000,Prostate size (observable entity),20020131,1,9E+17,9E+17
249609007,Consistency of prostate (observable entity),20020131,1,9E+17,9E+17
249617004,Stool size (observable entity),20020131,1,9E+17,9E+17
249618009,Consistency of stool (observable entity),20020131,1,9E+17,9E+17
249622004,Contents of stool (observable entity),20020131,1,9E+17,9E+17
249282008,Frequency of incontinence (observable entity),20020131,1,9E+17,9E+17
248995002,General shape of pelvis (observable entity),20020131,1,9E+17,9E+17
248998000,Distance between ischial tuberosities (observable entity),20020131,1,9E+17,9E+17
248999008,Position of ischial spines (observable entity),20020131,1,9E+17,9E+17
249000005,Distance between ischial spines (observable entity),20020131,1,9E+17,9E+17
249001009,Shape of sacral curve (observable entity),20020131,1,9E+17,9E+17
249002002,Shape of sacrosciatic notch (observable entity),20020131,1,9E+17,9E+17
249008003,Angle of subpubic arch (observable entity),20020131,1,9E+17,9E+17
249009006,Width of subpubic arch (observable entity),20020131,1,9E+17,9E+17
249010001,Anteroposterior diameter of pelvic outlet (observable entity),20020131,1,9E+17,9E+17
249011002,Diagonal conjugate of pelvis (observable entity),20020131,1,9E+17,9E+17
249003007,Width of sacrosciatic notch (observable entity),20020131,1,9E+17,9E+17
248991006,Number of live deliveries (observable entity),20020131,1,9E+17,9E+17
248990007,Duration of pregnancy at time of previous miscarriage (observable entity),20020131,1,9E+17,9E+17
248989003,Number of miscarriages (observable entity),20020131,1,9E+17,9E+17
248958002,Menstrual loss data (observable entity),20020131,1,9E+17,9E+17
248959005,Period - menstrual-data (observable entity),20020131,1,9E+17,9E+17
248960000,Cycle -menstrual - data (observable entity),20020131,1,9E+17,9E+17
248983002,Obstetric history (observable entity),20020131,1,9E+17,9E+17
248986005,Estimated date of conception (observable entity),20020131,1,9E+17,9E+17
248987001,Date symptom of pregnancy first noted (observable entity),20020131,1,9E+17,9E+17
249012009,Obstetric conjugate of pelvis (observable entity),20020131,1,9E+17,9E+17
249015006,Girth of pregnant abdomen (observable entity),20020131,1,9E+17,9E+17
249041000,Fetal movement strength (observable entity),20020131,1,9E+17,9E+17
249044008,Fetal heart rhythm (observable entity),20020131,1,9E+17,9E+17
249046005,Number of fetal hearts heard (observable entity),20020131,1,9E+17,9E+17
249049003,Volume of fetal heart sounds (observable entity),20020131,1,9E+17,9E+17
249050003,Fetus size (observable entity),20020131,1,9E+17,9E+17
249053001,Relation of fetal size to dates (observable entity),20020131,1,9E+17,9E+17
249062004,Lie of fetus (observable entity),20020131,1,9E+17,9E+17
249040004,Fetal movement activity (observable entity),20020131,1,9E+17,9E+17
249016007,Height of uterine fundus (observable entity),20020131,1,9E+17,9E+17
249021005,Effacement of cervix (observable entity),20020131,1,9E+17,9E+17
249022003,Percentage effacement of cervix (observable entity),20020131,1,9E+17,9E+17
249023008,Bishop's score of cervix (observable entity),20020131,1,9E+17,9E+17
249027009,Application of cervix to presenting part (observable entity),20020131,1,9E+17,9E+17
248956003,Diameter of ovary (observable entity),20020131,1,9E+17,9E+17
248955004,Ovary size (observable entity),20020131,1,9E+17,9E+17
248872005,Patency of vaginal introitus (observable entity),20020131,1,9E+17,9E+17
248886009,Number of openings of vaginal fistula (observable entity),20020131,1,9E+17,9E+17
248940008,Cervical excitation (observable entity),20020131,1,9E+17,9E+17
248944004,Uterus size (observable entity),20020131,1,9E+17,9E+17
248946002,Position of uterus (observable entity),20020131,1,9E+17,9E+17
248948001,Version of uterus (observable entity),20020131,1,9E+17,9E+17
248949009,Flexion of uterus (observable entity),20020131,1,9E+17,9E+17
248951008,Mobility of uterus (observable entity),20020131,1,9E+17,9E+17
248926007,Parity of cervical os (observable entity),20020131,1,9E+17,9E+17
248908009,Pelvic muscle tone around vagina (observable entity),20020131,1,9E+17,9E+17
248913008,Uterine cervix size (observable entity),20020131,1,9E+17,9E+17
248918004,Length of uterine cervix (observable entity),20020131,1,9E+17,9E+17
248920001,Position of uterine cervix (observable entity),20020131,1,9E+17,9E+17
248924005,Patency of cervical os uteri (observable entity),20020131,1,9E+17,9E+17
249197004,Maternal condition during puerperium (observable entity),20020131,1,9E+17,9E+17
249198009,Condition and involution of uterus after childbirth (observable entity),20020131,1,9E+17,9E+17
249199001,Form of uterus after childbirth (observable entity),20020131,1,9E+17,9E+17
249204007,Internal condition of uterus after childbirth (observable entity),20020131,1,9E+17,9E+17
249209002,Rate of involution of uterus (observable entity),20020131,1,9E+17,9E+17
249212004,Quantity of lochia (observable entity),20020131,1,9E+17,9E+17
249214003,Color of lochia (observable entity),20020131,1,9E+17,9E+17
249194006,Length of umbilical cord (observable entity),20020131,1,9E+17,9E+17
249192005,Number of umbilical arteries (observable entity),20020131,1,9E+17,9E+17
249171005,Placenta size (observable entity),20020131,1,9E+17,9E+17
249178004,Diameter of retroplacental clot (observable entity),20020131,1,9E+17,9E+17
249183007,Number of amnions in membranes (observable entity),20020131,1,9E+17,9E+17
249184001,Number of chorions in membranes (observable entity),20020131,1,9E+17,9E+17
249191003,Number of blood vessels in umbilical cord (observable entity),20020131,1,9E+17,9E+17
249193000,Number of umbilical veins (observable entity),20020131,1,9E+17,9E+17
249169005,Speed of delivery of placenta (observable entity),20020131,1,9E+17,9E+17
249222005,Neonatal condition (observable entity),20020131,1,9E+17,9E+17
249268008,Odor of smegma (observable entity),20020131,1,9E+17,9E+17
249270004,Quantity of smegma (observable entity),20020131,1,9E+17,9E+17
249278006,Ability to pass urine (observable entity),20020131,1,9E+17,9E+17
249260001,Retraction of foreskin (observable entity),20020131,1,9E+17,9E+17
249235001,Scrotum size (observable entity),20020131,1,9E+17,9E+17
249237009,Position of testicle (observable entity),20020131,1,9E+17,9E+17
249241008,Testicle size (observable entity),20020131,1,9E+17,9E+17
249245004,Penis size (observable entity),20020131,1,9E+17,9E+17
249246003,Shape of penis (observable entity),20020131,1,9E+17,9E+17
249251009,Glans penis size (observable entity),20020131,1,9E+17,9E+17
249164000,Ability to push in labor (observable entity),20020131,1,9E+17,9E+17
249101006,Positions of breech presentation (observable entity),20020131,1,9E+17,9E+17
249111004,Engagement of head (observable entity),20020131,1,9E+17,9E+17
249119002,Date false contractions first detected (observable entity),20020131,1,9E+17,9E+17
249076003,Molding score (observable entity),20020131,1,9E+17,9E+17
249077007,Molding grade (observable entity),20020131,1,9E+17,9E+17
249165004,Progress of second stage of labor (observable entity),20020131,1,9E+17,9E+17
249120008,Onset of labor first stage (observable entity),20020131,1,9E+17,9E+17
249152008,Shortest interval between contractions (observable entity),20020131,1,9E+17,9E+17
249153003,Longest interval between contractions (observable entity),20020131,1,9E+17,9E+17
249156006,Level of presenting part in relation to ischial spines (observable entity),20020131,1,9E+17,9E+17
249160009,Onset of second stage of labor (observable entity),20020131,1,9E+17,9E+17
249163006,Onset of pushing (in labor) (observable entity),20020131,1,9E+17,9E+17
249121007,Relation of onset of labor to due date (observable entity),20020131,1,9E+17,9E+17
249123005,Onset of contractions (observable entity),20020131,1,9E+17,9E+17
249129009,Condition of amniotic fluid (observable entity),20020131,1,9E+17,9E+17
249133002,Consistency of liquor (observable entity),20020131,1,9E+17,9E+17
249140001,Progress of first stage of labor (observable entity),20020131,1,9E+17,9E+17
246847004,Movement of eyelid (observable entity),20020131,1,9E+17,9E+17
246795003,Degree of levator lift (observable entity),20020131,1,9E+17,9E+17
246796002,Eye meridian (observable entity),20020131,1,9E+17,9E+17
246797006,Eye meridian start point (observable entity),20020131,1,9E+17,9E+17
246820009,Position of eyelid (observable entity),20020131,1,9E+17,9E+17
246900007,General appearance of palpebral conjunctiva (observable entity),20020131,1,9E+17,9E+17
246917000,Position of eyeball (observable entity),20020131,1,9E+17,9E+17
246794004,Height of palpebral fissure (observable entity),20020131,1,9E+17,9E+17
246889007,General appearance of limbal conjunctiva (observable entity),20020131,1,9E+17,9E+17
246793005,Height of upper lid above pupil center (observable entity),20020131,1,9E+17,9E+17
246792000,Eye measure (observable entity),20020131,1,9E+17,9E+17
246724006,Position of pupil light reflex (observable entity),20020131,1,9E+17,9E+17
246716001,Ocular divergence (observable entity),20020131,1,9E+17,9E+17
246704007,Eye movement with one eye open (observable entity),20020131,1,9E+17,9E+17
246705008,Range of movement of one eye open (observable entity),20020131,1,9E+17,9E+17
246706009,Ocular convergence (observable entity),20020131,1,9E+17,9E+17
246707000,Convergence on approaching object (observable entity),20020131,1,9E+17,9E+17
246710007,Convergence near point (observable entity),20020131,1,9E+17,9E+17
246776005,Reflex eye movement (observable entity),20020131,1,9E+17,9E+17
246777001,Horizontal doll's head reflex (observable entity),20020131,1,9E+17,9E+17
246778006,Vertical doll's head reflex (observable entity),20020131,1,9E+17,9E+17
246785005,Associated movements on eye movement (observable entity),20020131,1,9E+17,9E+17
246786006,Movement of globe on eye movement (observable entity),20020131,1,9E+17,9E+17
246787002,Movement of lids on eye movement (observable entity),20020131,1,9E+17,9E+17
246788007,Movement of head on eye movement (observable entity),20020131,1,9E+17,9E+17
246790008,Sounds associated with eye movement (observable entity),20020131,1,9E+17,9E+17
246760001,Micronystagmus (observable entity),20020131,1,9E+17,9E+17
246765006,Patterns of eye movement (observable entity),20020131,1,9E+17,9E+17
247088007,Vitreous morphology (observable entity),20020131,1,9E+17,9E+17
247073002,Lens capsule clarity in pseudophakia (observable entity),20020131,1,9E+17,9E+17
247046003,Position of ciliary body (observable entity),20020131,1,9E+17,9E+17
247050005,Position of lens (observable entity),20020131,1,9E+17,9E+17
247053007,Cataract form (observable entity),20020131,1,9E+17,9E+17
247063004,Cataract maturity (observable entity),20020131,1,9E+17,9E+17
247166005,Status of macula in subtotal retinal detachment (observable entity),20020131,1,9E+17,9E+17
247104005,General appearance of retina (observable entity),20020131,1,9E+17,9E+17
247110005,Retinal artery appearance (observable entity),20020131,1,9E+17,9E+17
247116004,Retinal vein appearance (observable entity),20020131,1,9E+17,9E+17
246974002,Color of sclera (observable entity),20020131,1,9E+17,9E+17
246979007,Scleral vascularity (observable entity),20020131,1,9E+17,9E+17
246933002,Corneal epithelial staining pattern (observable entity),20020131,1,9E+17,9E+17
247026008,Position of iris (observable entity),20020131,1,9E+17,9E+17
247029001,Iris pigmentation (observable entity),20020131,1,9E+17,9E+17
247030006,Color of iris (observable entity),20020131,1,9E+17,9E+17
246692008,Eye movement with both eyes open (observable entity),20020131,1,9E+17,9E+17
246206008,Number of lesions (observable entity),20020131,1,9E+17,9E+17
246207004,Number of plaques (observable entity),20020131,1,9E+17,9E+17
246208009,Number of granulomas (observable entity),20020131,1,9E+17,9E+17
246209001,Number of abscesses (observable entity),20020131,1,9E+17,9E+17
246210006,Number of fetal deaths (observable entity),20020131,1,9E+17,9E+17
246211005,Number of previous pregnancies (observable entity),20020131,1,9E+17,9E+17
246212003,Number of foreign bodies (observable entity),20020131,1,9E+17,9E+17
246213008,Number of joints involved (observable entity),20020131,1,9E+17,9E+17
246214002,Number of tumors (observable entity),20020131,1,9E+17,9E+17
246109007,Stimulus current (observable entity),20020131,1,9E+17,9E+17
246116008,Lesion size (observable entity),20020131,1,9E+17,9E+17
246117004,Stone size (observable entity),20020131,1,9E+17,9E+17
246118009,Calculus size (observable entity),20020131,1,9E+17,9E+17
246120007,Nodule size (observable entity),20020131,1,9E+17,9E+17
246600005,Flip response (observable entity),20020131,1,9E+17,9E+17
246603007,Simulated rotation response (observable entity),20020131,1,9E+17,9E+17
246683005,Ocular head posture (observable entity),20020131,1,9E+17,9E+17
246693003,Range of movement of both eyes open (observable entity),20020131,1,9E+17,9E+17
246511009,Sensory threshold (observable entity),20020131,1,9E+17,9E+17
246518003,Stimulus voltage (observable entity),20020131,1,9E+17,9E+17
246466008,Detrusor function (observable entity),20020131,1,9E+17,9E+17
246435002,Number of fetuses (observable entity),20020131,1,9E+17,9E+17
246436001,Number of fetuses started with (observable entity),20020131,1,9E+17,9E+17
246437005,Number of fetuses reduced to (observable entity),20020131,1,9E+17,9E+17
246464006,Function (observable entity),20020131,1,9E+17,9E+17
246467004,Urethral function (observable entity),20020131,1,9E+17,9E+17
246569003,Function of specific cranial nerves (observable entity),20020131,1,9E+17,9E+17
246558001,Cerebral dominance (observable entity),20020131,1,9E+17,9E+17
246559009,Hand preference (observable entity),20020131,1,9E+17,9E+17
246560004,Foot preference (observable entity),20020131,1,9E+17,9E+17
246561000,Eye dominance (observable entity),20020131,1,9E+17,9E+17
247750002,Drive (observable entity),20020131,1,9E+17,9E+17
247751003,Sense of purpose (observable entity),20020131,1,9E+17,9E+17
247752005,Level of interest (observable entity),20020131,1,9E+17,9E+17
247756008,Initiative (observable entity),20020131,1,9E+17,9E+17
247659005,Use of imagination (observable entity),20020131,1,9E+17,9E+17
247660000,Independence of thought (observable entity),20020131,1,9E+17,9E+17
247888008,Awareness of self (observable entity),20020131,1,9E+17,9E+17
247889000,Sense of identity (observable entity),20020131,1,9E+17,9E+17
247891008,Self-esteem (observable entity),20020131,1,9E+17,9E+17
247331000,Ear sensations (observable entity),20020131,1,9E+17,9E+17
247291001,Attention to direct verbal communication (observable entity),20020131,1,9E+17,9E+17
247292008,Response to high frequency sounds (observable entity),20020131,1,9E+17,9E+17
247293003,Response to low frequency sounds (observable entity),20020131,1,9E+17,9E+17
247297002,Localization of sound source (observable entity),20020131,1,9E+17,9E+17
247298007,Localization of voice (observable entity),20020131,1,9E+17,9E+17
247310003,Lateralization of sound (observable entity),20020131,1,9E+17,9E+17
247376000,Beginning of painful arc (observable entity),20020131,1,9E+17,9E+17
247374002,Range of painful joint movement (observable entity),20020131,1,9E+17,9E+17
247375001,Arc of pain in joint (observable entity),20020131,1,9E+17,9E+17
247377009,End of painful arc (observable entity),20020131,1,9E+17,9E+17
247222003,Optic disc cup (observable entity),20020131,1,9E+17,9E+17
247225001,Optic cup/disc ratio (observable entity),20020131,1,9E+17,9E+17
247259002,Light reflex of tympanic membrane (observable entity),20020131,1,9E+17,9E+17
247239001,Auricle size (observable entity),20020131,1,9E+17,9E+17
247250003,Contents of ear canal (observable entity),20020131,1,9E+17,9E+17
247571009,General mental state (observable entity),20020131,1,9E+17,9E+17
247572002,"Intellect, function (observable entity)",20020131,1,9E+17,9E+17
247625006,Flow of thought (observable entity),20020131,1,9E+17,9E+17
247626007,Speed of thought (observable entity),20020131,1,9E+17,9E+17
247639006,Clarity of thought (observable entity),20020131,1,9E+17,9E+17
247642000,Thought process (observable entity),20020131,1,9E+17,9E+17
249770000,Ring size (observable entity),20020131,1,9E+17,9E+17
252105006,Number of metastases (observable entity),20020131,1,9E+17,9E+17
252106007,Number of chancres (observable entity),20020131,1,9E+17,9E+17
252108008,Number of stenoses (observable entity),20020131,1,9E+17,9E+17
252111009,Number of lost pregnancies (observable entity),20020131,1,9E+17,9E+17
252112002,Number of stillbirths (observable entity),20020131,1,9E+17,9E+17
252113007,Number of abortions (observable entity),20020131,1,9E+17,9E+17
252114001,Number of induced abortions (observable entity),20020131,1,9E+17,9E+17
252115000,Number of cesarean sections (observable entity),20020131,1,9E+17,9E+17
252116004,Observation parameter (observable entity),20020131,1,9E+17,9E+17
252075009,Venous velocity (observable entity),20020131,1,9E+17,9E+17
252079003,Venous ambulatory pressure (observable entity),20020131,1,9E+17,9E+17
252081001,Venous flow (observable entity),20020131,1,9E+17,9E+17
252082008,Venous mean flow (observable entity),20020131,1,9E+17,9E+17
252083003,Venous reflux flow (observable entity),20020131,1,9E+17,9E+17
252084009,Tissue perfusion measure (observable entity),20020131,1,9E+17,9E+17
252085005,Tissue perfusion isotope clearance (observable entity),20020131,1,9E+17,9E+17
252087002,Tissue perfusion red cell flux (observable entity),20020131,1,9E+17,9E+17
252088007,Tissue perfusion red cell velocity (observable entity),20020131,1,9E+17,9E+17
252089004,Tissue perfusion temperature (observable entity),20020131,1,9E+17,9E+17
252090008,Rewarming time (tissue perfusion) (observable entity),20020131,1,9E+17,9E+17
252094004,Claudication distance (observable entity),20020131,1,9E+17,9E+17
252095003,Maximum distance walked (observable entity),20020131,1,9E+17,9E+17
252096002,Surface foot pressure (observable entity),20020131,1,9E+17,9E+17
252117008,Strength of test substance (observable entity),20020131,1,9E+17,9E+17
252118003,Strength of tuberculin test substance (observable entity),20020131,1,9E+17,9E+17
252119006,Strength of coccidioidin test substance (observable entity),20020131,1,9E+17,9E+17
252120000,Allergen concentration (observable entity),20020131,1,9E+17,9E+17
252141006,Treadmill speed achieved (observable entity),20020131,1,9E+17,9E+17
252074008,Venous measure (observable entity),20020131,1,9E+17,9E+17
252140007,Treadmill gradient achieved (observable entity),20020131,1,9E+17,9E+17
252138002,Scandinavian protocol stage achieved (observable entity),20020131,1,9E+17,9E+17
252121001,Acetic acid concentration (observable entity),20020131,1,9E+17,9E+17
252122008,Perfusion rate of medium (observable entity),20020131,1,9E+17,9E+17
252123003,Temperature of medium (observable entity),20020131,1,9E+17,9E+17
252124009,Test distance (observable entity),20020131,1,9E+17,9E+17
252125005,Ocular test distance (observable entity),20020131,1,9E+17,9E+17
252126006,Pin distance (observable entity),20020131,1,9E+17,9E+17
252127002,Test time (observable entity),20020131,1,9E+17,9E+17
252128007,Time since loading dose (observable entity),20020131,1,9E+17,9E+17
252129004,Test duration (observable entity),20020131,1,9E+17,9E+17
252130009,Total exercise time (observable entity),20020131,1,9E+17,9E+17
252131008,Time from start of test (observable entity),20020131,1,9E+17,9E+17
252132001,Measurement period (observable entity),20020131,1,9E+17,9E+17
252133006,Apgar measurement period (observable entity),20020131,1,9E+17,9E+17
252134000,Bruce protocol stage achieved (observable entity),20020131,1,9E+17,9E+17
252135004,Balke protocol stage achieved (observable entity),20020131,1,9E+17,9E+17
252136003,Master protocol stage achieved (observable entity),20020131,1,9E+17,9E+17
252137007,Modified Bruce protocol stage achieved (observable entity),20020131,1,9E+17,9E+17
252139005,Wingate protocol stage achieved (observable entity),20020131,1,9E+17,9E+17
252073002,Arterial impedance (observable entity),20020131,1,9E+17,9E+17
252072007,Upstroke time of arterial pressure (observable entity),20020131,1,9E+17,9E+17
252071000,Arterial pressure index (observable entity),20020131,1,9E+17,9E+17
252000003,Bladder neck function (observable entity),20020131,1,9E+17,9E+17
252003001,Bladder appearance (observable entity),20020131,1,9E+17,9E+17
252009002,Bladder capacity (observable entity),20020131,1,9E+17,9E+17
252010007,Functional bladder capacity (observable entity),20020131,1,9E+17,9E+17
252011006,Maximum anesthetic bladder capacity (observable entity),20020131,1,9E+17,9E+17
252012004,Maximum cystometric capacity (observable entity),20020131,1,9E+17,9E+17
252013009,Bladder compliance (observable entity),20020131,1,9E+17,9E+17
252015002,Profile length of urethra (observable entity),20020131,1,9E+17,9E+17
252016001,Functional profile length of urethra (observable entity),20020131,1,9E+17,9E+17
252017005,Functional profile length of urethra - resting (observable entity),20020131,1,9E+17,9E+17
252018000,Functional profile length of urethra - stressed (observable entity),20020131,1,9E+17,9E+17
252019008,Total profile length of urethra (observable entity),20020131,1,9E+17,9E+17
252022005,Urethral sphincter function (observable entity),20020131,1,9E+17,9E+17
251996002,Bladder neck position (observable entity),20020131,1,9E+17,9E+17
251980000,Urinary times (observable entity),20020131,1,9E+17,9E+17
251981001,Opening time of bladder neck (observable entity),20020131,1,9E+17,9E+17
251982008,Urinary voiding total flow time (observable entity),20020131,1,9E+17,9E+17
251983003,Time to maximum urinary flow (observable entity),20020131,1,9E+17,9E+17
251984009,Urinary flow rate (observable entity),20020131,1,9E+17,9E+17
251985005,Maximal urinary flow rate (observable entity),20020131,1,9E+17,9E+17
251986006,Average urinary flow rate (observable entity),20020131,1,9E+17,9E+17
251987002,Rate of bladder filling (observable entity),20020131,1,9E+17,9E+17
251993005,Vesicoureteric function (observable entity),20020131,1,9E+17,9E+17
251997006,Bladder neck descent (observable entity),20020131,1,9E+17,9E+17
252023000,Urethral opening mechanism (observable entity),20020131,1,9E+17,9E+17
252059006,Vascular measure (observable entity),20020131,1,9E+17,9E+17
252060001,Arterial measure (observable entity),20020131,1,9E+17,9E+17
252061002,Arterial flow (observable entity),20020131,1,9E+17,9E+17
252062009,Peak arterial flow (observable entity),20020131,1,9E+17,9E+17
252063004,Mean arterial flow (observable entity),20020131,1,9E+17,9E+17
252064005,Arterial velocity (observable entity),20020131,1,9E+17,9E+17
252065006,Peak arterial velocity (observable entity),20020131,1,9E+17,9E+17
252066007,Mean arterial velocity (observable entity),20020131,1,9E+17,9E+17
252067003,Arterial velocity waveform (observable entity),20020131,1,9E+17,9E+17
252068008,"Pulsatility index, arterial velocity waveform (observable entity)",20020131,1,9E+17,9E+17
252069000,Laplace transform damping factor for arterial velocity waveform (observable entity),20020131,1,9E+17,9E+17
252070004,Principal component analysis of arterial velocity waveform (observable entity),20020131,1,9E+17,9E+17
252024006,Urethral closure mechanism (observable entity),20020131,1,9E+17,9E+17
252027004,Vesicourethral function (observable entity),20020131,1,9E+17,9E+17
252031005,Penis measure (observable entity),20020131,1,9E+17,9E+17
252032003,Erection duration (observable entity),20020131,1,9E+17,9E+17
252033008,Erection size (observable entity),20020131,1,9E+17,9E+17
252034002,Erection frequency (observable entity),20020131,1,9E+17,9E+17
252035001,Penile vascular function (observable entity),20020131,1,9E+17,9E+17
252038004,Penile brachial index (observable entity),20020131,1,9E+17,9E+17
252040009,Voiding measure (observable entity),20020131,1,9E+17,9E+17
252042001,Duration of micturition (observable entity),20020131,1,9E+17,9E+17
252043006,Maximal bladder flow rate (observable entity),20020131,1,9E+17,9E+17
252044000,Average bladder flow rate (observable entity),20020131,1,9E+17,9E+17
251974008,Bladder volume at strong desire to void (observable entity),20020131,1,9E+17,9E+17
251972007,Bladder volume at first desire to void (observable entity),20020131,1,9E+17,9E+17
251721007,Angle patency (observable entity),20020131,1,9E+17,9E+17
251727006,Angle appearance (observable entity),20020131,1,9E+17,9E+17
251720008,Central retinal artery pressure (observable entity),20020131,1,9E+17,9E+17
251717000,Intraocular lens determination (observable entity),20020131,1,9E+17,9E+17
251709008,Corneal measure (observable entity),20020131,1,9E+17,9E+17
251710003,Corneal curvature radius (observable entity),20020131,1,9E+17,9E+17
251711004,Corneal curvature meridian (observable entity),20020131,1,9E+17,9E+17
251712006,Corneal diameter (observable entity),20020131,1,9E+17,9E+17
251713001,Horizontal corneal diameter (observable entity),20020131,1,9E+17,9E+17
251714007,Vertical corneal diameter (observable entity),20020131,1,9E+17,9E+17
251716009,Corneal endothelial cell density (observable entity),20020131,1,9E+17,9E+17
251751001,Binocular single vision (observable entity),20020131,1,9E+17,9E+17
251781009,Ocular accommodation convergence/accommodation ratio (observable entity),20020131,1,9E+17,9E+17
251783007,Visual suppression density (observable entity),20020131,1,9E+17,9E+17
251784001,Ocular fixation observable (observable entity),20020131,1,9E+17,9E+17
251787008,Ocular fixation preference (observable entity),20020131,1,9E+17,9E+17
251788003,Ocular fixation projection (observable entity),20020131,1,9E+17,9E+17
251772003,Optical axis deviation (observable entity),20020131,1,9E+17,9E+17
251760009,Optical fusion (observable entity),20020131,1,9E+17,9E+17
251761008,Prism fusion range (observable entity),20020131,1,9E+17,9E+17
251762001,Prism strength (observable entity),20020131,1,9E+17,9E+17
251763006,Stereoscopic vision (observable entity),20020131,1,9E+17,9E+17
251765004,Stereoscopic discrimination (observable entity),20020131,1,9E+17,9E+17
251771005,Optical axis alignment (observable entity),20020131,1,9E+17,9E+17
251646000,Cervical mucus volume (observable entity),20020131,1,9E+17,9E+17
251647009,Cervical mucus consistency (observable entity),20020131,1,9E+17,9E+17
251629003,Dermatomal somatosensory evoked potential amplitude (observable entity),20020131,1,9E+17,9E+17
251628006,Dermatomal somatosensory evoked potential latency (observable entity),20020131,1,9E+17,9E+17
251626005,Somatosensory evoked potential central conduction time (observable entity),20020131,1,9E+17,9E+17
251607002,Flash visual evoked potential amplitude (observable entity),20020131,1,9E+17,9E+17
251624008,Somatosensory evoked potential conduction time (observable entity),20020131,1,9E+17,9E+17
251625009,Cortical somatosensory evoked potential latency (observable entity),20020131,1,9E+17,9E+17
251649007,Cervical mucus spinnbarkeit score (observable entity),20020131,1,9E+17,9E+17
251651006,Cervical mucus pH (observable entity),20020131,1,9E+17,9E+17
251677003,Uterine activity (observable entity),20020131,1,9E+17,9E+17
251680002,Uterine contraction intensity (observable entity),20020131,1,9E+17,9E+17
251681003,Interval between uterine contractions (observable entity),20020131,1,9E+17,9E+17
251682005,Fetal kick count (observable entity),20020131,1,9E+17,9E+17
251683000,Uterine pressure (observable entity),20020131,1,9E+17,9E+17
251685007,Photostress recovery time (observable entity),20020131,1,9E+17,9E+17
251686008,Contrast sensitivity (observable entity),20020131,1,9E+17,9E+17
251687004,Monochrome contrast sensitivity (observable entity),20020131,1,9E+17,9E+17
251688009,Color contrast sensitivity (observable entity),20020131,1,9E+17,9E+17
251691009,Corneal thickness (observable entity),20020131,1,9E+17,9E+17
251692002,Ocular axial length (observable entity),20020131,1,9E+17,9E+17
251672009,Fetal heart baseline pattern (observable entity),20020131,1,9E+17,9E+17
251650007,Cervical mucus cellularity score (observable entity),20020131,1,9E+17,9E+17
251671002,Fetal heart rate variability (observable entity),20020131,1,9E+17,9E+17
251653009,Postcoital time (observable entity),20020131,1,9E+17,9E+17
251657005,Postcoital cervical mucus sperm motility (observable entity),20020131,1,9E+17,9E+17
251661004,Luteal phase function (observable entity),20020131,1,9E+17,9E+17
251662006,Ovulation status (observable entity),20020131,1,9E+17,9E+17
251667000,Cardiotochogram reactivity (observable entity),20020131,1,9E+17,9E+17
251670001,Baseline fetal heart rate (observable entity),20020131,1,9E+17,9E+17
251909002,Dynamic lung volume (observable entity),20020131,1,9E+17,9E+17
251910007,Forced expired volume in 0.75 seconds (observable entity),20020131,1,9E+17,9E+17
251911006,Forced inspired volume (observable entity),20020131,1,9E+17,9E+17
251912004,Forced inspired volume in 1 second (observable entity),20020131,1,9E+17,9E+17
251913009,Inspiratory vital capacity (observable entity),20020131,1,9E+17,9E+17
251914003,Expiratory vital capacity (observable entity),20020131,1,9E+17,9E+17
251915002,Static lung volume (observable entity),20020131,1,9E+17,9E+17
251916001,Respiratory dead space (observable entity),20020131,1,9E+17,9E+17
251917005,Flow volume loop flow rate (observable entity),20020131,1,9E+17,9E+17
251918000,Maximum expiratory flow rate (observable entity),20020131,1,9E+17,9E+17
251919008,Maximum expiratory flow rate at 25 percent of vital capacity (observable entity),20020131,1,9E+17,9E+17
251920002,Maximum expiratory flow rate at 50 percent of vital capacity (observable entity),20020131,1,9E+17,9E+17
251921003,Maximum expiratory flow rate at 75 percent of vital capacity (observable entity),20020131,1,9E+17,9E+17
251922005,Maximum mid-expiratory flow rate (observable entity),20020131,1,9E+17,9E+17
251923000,Maximum inspiratory flow rate (observable entity),20020131,1,9E+17,9E+17
251924006,Maximum inspiratory flow rate at 25 percent of vital capacity (observable entity),20020131,1,9E+17,9E+17
251926008,Maximum inspiratory flow rate at 50 percent of vital capacity (observable entity),20020131,1,9E+17,9E+17
251908005,Respiratory volume (observable entity),20020131,1,9E+17,9E+17
251927004,Maximum inspiratory flow rate at 75 percent of vital capacity (observable entity),20020131,1,9E+17,9E+17
251907000,Respiratory pressure (observable entity),20020131,1,9E+17,9E+17
251905008,Closing volume (nitrogen washout) (observable entity),20020131,1,9E+17,9E+17
251888006,Specific compliance (lung) (observable entity),20020131,1,9E+17,9E+17
251889003,Total thoracic compliance (observable entity),20020131,1,9E+17,9E+17
251890007,Alveolar-arterial oxygen tension difference (observable entity),20020131,1,9E+17,9E+17
251891006,Respiratory shunt (observable entity),20020131,1,9E+17,9E+17
251899008,Expired gas concentration (observable entity),20020131,1,9E+17,9E+17
251900003,Expired carbon monoxide concentration (observable entity),20020131,1,9E+17,9E+17
251901004,Maximum voluntary ventilation (observable entity),20020131,1,9E+17,9E+17
251902006,Nitrogen washout measure (observable entity),20020131,1,9E+17,9E+17
251903001,Time to 2 percent N2 (nitrogen washout) (observable entity),20020131,1,9E+17,9E+17
251904007,Number of breaths (nitrogen washout) (observable entity),20020131,1,9E+17,9E+17
251906009,Nitrogen index (nitrogen washout) (observable entity),20020131,1,9E+17,9E+17
251886005,Static lung compliance (observable entity),20020131,1,9E+17,9E+17
251928009,Maximum expiratory flow rate/max inspiratory flow rate ratio (observable entity),20020131,1,9E+17,9E+17
251931005,Forced mid-expiratory flow rate (observable entity),20020131,1,9E+17,9E+17
251955000,Alveolar-capillary membrane conductance (observable entity),20020131,1,9E+17,9E+17
251957008,Urinary tract pressure (observable entity),20020131,1,9E+17,9E+17
251958003,Urethral pressure (observable entity),20020131,1,9E+17,9E+17
251959006,Maximum urethral pressure (observable entity),20020131,1,9E+17,9E+17
251960001,Maximum urethral closure pressure (observable entity),20020131,1,9E+17,9E+17
251961002,Premicturition intravesical pressure (observable entity),20020131,1,9E+17,9E+17
251962009,Opening intravesical pressure (observable entity),20020131,1,9E+17,9E+17
251963004,Maximum intravesical pressure (observable entity),20020131,1,9E+17,9E+17
251964005,Intravesical pressure at maximum flow (observable entity),20020131,1,9E+17,9E+17
251965006,Intravesical contraction pressure at maximum flow (observable entity),20020131,1,9E+17,9E+17
251967003,Detrusor pressure (observable entity),20020131,1,9E+17,9E+17
251968008,Kidney/bladder pressure differential (observable entity),20020131,1,9E+17,9E+17
251969000,Renal pelvis pressure (observable entity),20020131,1,9E+17,9E+17
251970004,Pressure transmission ratio (observable entity),20020131,1,9E+17,9E+17
251971000,Bladder volume (observable entity),20020131,1,9E+17,9E+17
251954001,Pulmonary capillary blood volume (observable entity),20020131,1,9E+17,9E+17
251930006,Forced expiratory flow rate (observable entity),20020131,1,9E+17,9E+17
251953007,Alveolar volume (observable entity),20020131,1,9E+17,9E+17
251951009,Oxygen transfer factor (observable entity),20020131,1,9E+17,9E+17
251932003,Forced expiratory flow rate between 25 to 75 percent of vital capacity (observable entity),20020131,1,9E+17,9E+17
251936000,Best ever peak expiratory flow rate (observable entity),20020131,1,9E+17,9E+17
251939007,Single peak expiratory flow rate (observable entity),20020131,1,9E+17,9E+17
251940009,Serial peak expiratory flow rate (observable entity),20020131,1,9E+17,9E+17
251941008,Peak inspiratory flow rate (observable entity),20020131,1,9E+17,9E+17
251942001,Respiratory ratio (observable entity),20020131,1,9E+17,9E+17
251943006,Forced expired volume in one second/vital capacity ratio (observable entity),20020131,1,9E+17,9E+17
251944000,Forced expired volume in one second/forced vital capacity ratio (observable entity),20020131,1,9E+17,9E+17
251945004,Empey index (observable entity),20020131,1,9E+17,9E+17
251946003,Dead space/tidal volume ratio (observable entity),20020131,1,9E+17,9E+17
251947007,Anatomical dead space/tidal volume ratio (observable entity),20020131,1,9E+17,9E+17
251948002,Physiological dead space/tidal volume ratio (observable entity),20020131,1,9E+17,9E+17
251949005,Transfer factor (respiratory measure) (observable entity),20020131,1,9E+17,9E+17
251950005,Carbon monoxide transfer factor (observable entity),20020131,1,9E+17,9E+17
251952002,Transfer coefficient (respiratory measure) (observable entity),20020131,1,9E+17,9E+17
251885009,Dynamic compliance (observable entity),20020131,1,9E+17,9E+17
251883002,Thoracic compliance (observable entity),20020131,1,9E+17,9E+17
251824005,Tanner axillary hair stage (observable entity),20020131,1,9E+17,9E+17
251828008,Testicular volume (observable entity),20020131,1,9E+17,9E+17
251804006,Puberty stage (observable entity),20020131,1,9E+17,9E+17
251805007,Tanner boys genital development stage (observable entity),20020131,1,9E+17,9E+17
251811005,Tanner girls breast development stage (observable entity),20020131,1,9E+17,9E+17
251817009,Pubic hair stage (observable entity),20020131,1,9E+17,9E+17
251884008,Chest wall compliance (observable entity),20020131,1,9E+17,9E+17
251880004,Respiratory measure (observable entity),20020131,1,9E+17,9E+17
251882007,Airway conductance (observable entity),20020131,1,9E+17,9E+17
252558006,Nasal mucociliary clearance measure (observable entity),20020131,1,9E+17,9E+17
252693009,Slump test response (observable entity),20020131,1,9E+17,9E+17
252694003,Cervical spine stress test response (observable entity),20020131,1,9E+17,9E+17
252701008,Anterior drawer test response (observable entity),20020131,1,9E+17,9E+17
252702001,Reverse pivot shift test response (observable entity),20020131,1,9E+17,9E+17
252703006,Flexion-rotation drawer test response (observable entity),20020131,1,9E+17,9E+17
252705004,Patellar compression test response (observable entity),20020131,1,9E+17,9E+17
252744007,Motor terminal latency (observable entity),20020131,1,9E+17,9E+17
252704000,Dynamic extension test response (observable entity),20020131,1,9E+17,9E+17
252706003,Knee squat test response (observable entity),20020131,1,9E+17,9E+17
250431005,Color of fluid (observable entity),20020131,1,9E+17,9E+17
250432003,Color of tissue (observable entity),20020131,1,9E+17,9E+17
250433008,Turbidity of fluid (observable entity),20020131,1,9E+17,9E+17
250434002,Odor of specimen (observable entity),20020131,1,9E+17,9E+17
250430006,Color of specimen (observable entity),20020131,1,9E+17,9E+17
250410007,Test temperature (observable entity),20020131,1,9E+17,9E+17
250500000,Sperm morphology (observable entity),20020131,1,9E+17,9E+17
250272005,White blood cell morphology (observable entity),20020131,1,9E+17,9E+17
250290006,White blood cell granularity (observable entity),20020131,1,9E+17,9E+17
250315003,Platelet morphology (observable entity),20020131,1,9E+17,9E+17
250772006,Oxygen concentration (observable entity),20020131,1,9E+17,9E+17
250773001,Respired oxygen concentration (observable entity),20020131,1,9E+17,9E+17
250774007,Inspired oxygen concentration (observable entity),20020131,1,9E+17,9E+17
250775008,Expired oxygen concentration (observable entity),20020131,1,9E+17,9E+17
250777000,Mixed expired oxygen concentration (observable entity),20020131,1,9E+17,9E+17
250778005,End tidal oxygen concentration (observable entity),20020131,1,9E+17,9E+17
250779002,Oxygen concentration in equipment (observable entity),20020131,1,9E+17,9E+17
250780004,Carbon dioxide concentration (observable entity),20020131,1,9E+17,9E+17
250781000,Respired carbon dioxide concentration (observable entity),20020131,1,9E+17,9E+17
250782007,Inspired carbon dioxide concentration (observable entity),20020131,1,9E+17,9E+17
250783002,Mixed expired carbon dioxide concentration (observable entity),20020131,1,9E+17,9E+17
250784008,End tidal carbon dioxide concentration (observable entity),20020131,1,9E+17,9E+17
250785009,Carbon dioxide concentration in equipment (observable entity),20020131,1,9E+17,9E+17
250786005,Respired carbon dioxide tension (observable entity),20020131,1,9E+17,9E+17
250787001,Inspired carbon dioxide tension (observable entity),20020131,1,9E+17,9E+17
250788006,Expired carbon dioxide tension (observable entity),20020131,1,9E+17,9E+17
250789003,Mixed expired carbon dioxide tension (observable entity),20020131,1,9E+17,9E+17
250790007,End tidal carbon dioxide tension (observable entity),20020131,1,9E+17,9E+17
250792004,Inspired nitrogen concentration (observable entity),20020131,1,9E+17,9E+17
250816009,Spontaneous tidal volume (observable entity),20020131,1,9E+17,9E+17
250817000,Mandatory tidal volume (observable entity),20020131,1,9E+17,9E+17
250825003,Ambient temperature (observable entity),20020131,1,9E+17,9E+17
250826002,Inspired gas temperature (observable entity),20020131,1,9E+17,9E+17
250827006,Humidity of gas (observable entity),20020131,1,9E+17,9E+17
250828001,Absolute humidity (observable entity),20020131,1,9E+17,9E+17
250829009,Relative humidity (observable entity),20020131,1,9E+17,9E+17
250831000,Train of four ratio (observable entity),20020131,1,9E+17,9E+17
250791006,Respired nitrogen concentration (observable entity),20020131,1,9E+17,9E+17
250793009,Expired nitrogen concentration (observable entity),20020131,1,9E+17,9E+17
250794003,End tidal nitrogen concentration (observable entity),20020131,1,9E+17,9E+17
250795002,Nitrogen concentration in equipment (observable entity),20020131,1,9E+17,9E+17
250796001,Nitrous oxide concentration (observable entity),20020131,1,9E+17,9E+17
250797005,Respired nitrous oxide concentration (observable entity),20020131,1,9E+17,9E+17
250798000,Inspired nitrous oxide concentration (observable entity),20020131,1,9E+17,9E+17
250799008,Expired nitrous oxide concentration (observable entity),20020131,1,9E+17,9E+17
250800007,End tidal nitrous oxide concentration (observable entity),20020131,1,9E+17,9E+17
250801006,Nitrous oxide concentration in equipment (observable entity),20020131,1,9E+17,9E+17
250802004,Anesthetic agent concentration (observable entity),20020131,1,9E+17,9E+17
250803009,Respired anesthetic agent concentration (observable entity),20020131,1,9E+17,9E+17
250804003,Inspired anesthetic agent concentration (observable entity),20020131,1,9E+17,9E+17
250805002,Expired anesthetic agent concentration (observable entity),20020131,1,9E+17,9E+17
250806001,End tidal anesthetic agent concentration (observable entity),20020131,1,9E+17,9E+17
250807005,Anesthetic agent concentration in equipment (observable entity),20020131,1,9E+17,9E+17
250808000,Arteriovenous difference (observable entity),20020131,1,9E+17,9E+17
250532000,Crystal birefringence (observable entity),20020131,1,9E+17,9E+17
250533005,Synovial fluid composition (observable entity),20020131,1,9E+17,9E+17
250832007,Train of four count (observable entity),20020131,1,9E+17,9E+17
249927007,Movement of shoulder (observable entity),20020131,1,9E+17,9E+17
249882004,Motor function of palate (observable entity),20020131,1,9E+17,9E+17
249893002,Gross movement of body and limbs (observable entity),20020131,1,9E+17,9E+17
249971006,Patterning of movement (observable entity),20020131,1,9E+17,9E+17
249948009,Grade of muscle power (observable entity),20020131,1,9E+17,9E+17
249952009,Movement with assistance of gravity (observable entity),20020131,1,9E+17,9E+17
249953004,Movement with gravity eliminated (finding),20020131,1,9E+17,9E+17
249954005,Movement against gravity (finding),20020131,1,9E+17,9E+17
249955006,Movement against resistance (finding),20020131,1,9E+17,9E+17
249956007,Medical Research Council grade - muscle power (observable entity),20020131,1,9E+17,9E+17
249957003,Oxford scale - muscle power (observable entity),20020131,1,9E+17,9E+17
249958008,Pinch grip (observable entity),20020131,1,9E+17,9E+17
249959000,"Opposition of thumb, function (observable entity)",20020131,1,9E+17,9E+17
249960005,Control of movement (observable entity),20020131,1,9E+17,9E+17
249872000,Protrusion of tongue (observable entity),20020131,1,9E+17,9E+17
249815005,Foot length (observable entity),20020131,1,9E+17,9E+17
249816006,Foot width (observable entity),20020131,1,9E+17,9E+17
249817002,Shoe size (observable entity),20020131,1,9E+17,9E+17
249819004,Form of toes (observable entity),20020131,1,9E+17,9E+17
249774009,Form of leg (observable entity),20020131,1,9E+17,9E+17
249793006,Form of foot (observable entity),20020131,1,9E+17,9E+17
249871007,Motor function of tongue (observable entity),20020131,1,9E+17,9E+17
249853000,Trunk control (observable entity),20020131,1,9E+17,9E+17
249832009,Circumference of muscle (observable entity),20020131,1,9E+17,9E+17
249834005,Wall to tragus distance (observable entity),20020131,1,9E+17,9E+17
249835006,Wall to occiput distance (observable entity),20020131,1,9E+17,9E+17
249836007,Finger to floor distance (observable entity),20020131,1,9E+17,9E+17
249837003,Fingertip to palm distance (observable entity),20020131,1,9E+17,9E+17
249838008,Intermalleoli distance (observable entity),20020131,1,9E+17,9E+17
249839000,Leg length (observable entity),20020131,1,9E+17,9E+17
249840003,Apparent leg length (observable entity),20020131,1,9E+17,9E+17
249841004,True leg length (observable entity),20020131,1,9E+17,9E+17
249842006,Divided leg length (observable entity),20020131,1,9E+17,9E+17
249843001,Site of leg length deficiency (observable entity),20020131,1,9E+17,9E+17
249844007,Awareness of posture (observable entity),20020131,1,9E+17,9E+17
250139001,General fit of footwear (observable entity),20020131,1,9E+17,9E+17
250146005,Heel of footwear (observable entity),20020131,1,9E+17,9E+17
250154007,Depth of toe box of footwear (observable entity),20020131,1,9E+17,9E+17
250106004,Anteroposterior stability of knee (observable entity),20020131,1,9E+17,9E+17
250109006,Stability of meniscus (observable entity),20020131,1,9E+17,9E+17
250113004,Foot joint stability (observable entity),20020131,1,9E+17,9E+17
250101009,Knee joint stability (observable entity),20020131,1,9E+17,9E+17
250157000,Fit of insole of footwear (observable entity),20020131,1,9E+17,9E+17
250159002,Fastening of footwear (observable entity),20020131,1,9E+17,9E+17
250161006,Weight of footwear (observable entity),20020131,1,9E+17,9E+17
250163009,Quality of construction of footwear (observable entity),20020131,1,9E+17,9E+17
250166001,Compliance with footwear (observable entity),20020131,1,9E+17,9E+17
250168000,Wear of footwear (observable entity),20020131,1,9E+17,9E+17
250100005,Hip joint stability (observable entity),20020131,1,9E+17,9E+17
250000008,Step length (observable entity),20020131,1,9E+17,9E+17
250001007,Step height (observable entity),20020131,1,9E+17,9E+17
250078000,Quadriceps lag (observable entity),20020131,1,9E+17,9E+17
250085001,Form of joint (observable entity),20020131,1,9E+17,9E+17
250091004,Form of hip (observable entity),20020131,1,9E+17,9E+17
251604009,Pattern visual evoked potentials amplitude (observable entity),20020131,1,9E+17,9E+17
250835009,Post-tetanic count (observable entity),20020131,1,9E+17,9E+17
251361006,Speech discrimination score (observable entity),20020131,1,9E+17,9E+17
251362004,Nasal air flow (observable entity),20020131,1,9E+17,9E+17
251363009,Nasal peak air flow (observable entity),20020131,1,9E+17,9E+17
251364003,Nasal peak inspiratory air flow (observable entity),20020131,1,9E+17,9E+17
251365002,Nasal pressure (observable entity),20020131,1,9E+17,9E+17
251341000,Submandibular saliva flow rate (observable entity),20020131,1,9E+17,9E+17
251323008,Peer assessment rating (orthodontic index) (observable entity),20020131,1,9E+17,9E+17
251324002,Index of orthodontic treatment need (observable entity),20020131,1,9E+17,9E+17
251325001,Index of orthodontic treatment need - dental health component (observable entity),20020131,1,9E+17,9E+17
251326000,Index of orthodontic treatment need - esthetic component (observable entity),20020131,1,9E+17,9E+17
251329007,Dental caries activity (observable entity),20020131,1,9E+17,9E+17
251335007,Dental restoration or prosthesis shade (observable entity),20020131,1,9E+17,9E+17
251336008,Salivary duct patency (observable entity),20020131,1,9E+17,9E+17
251337004,Salivary duct texture (observable entity),20020131,1,9E+17,9E+17
251338009,Salivary flow rate (observable entity),20020131,1,9E+17,9E+17
251339001,Whole saliva flow rate (observable entity),20020131,1,9E+17,9E+17
251340004,Parotid saliva flow rate (observable entity),20020131,1,9E+17,9E+17
251366001,Transnasal pressure (observable entity),20020131,1,9E+17,9E+17
251367005,Nasal resistance (observable entity),20020131,1,9E+17,9E+17
251368000,Nasal saccharin transit time (observable entity),20020131,1,9E+17,9E+17
251369008,Nasal ciliary beat frequency (observable entity),20020131,1,9E+17,9E+17
251395005,Urinary D Xylose output (observable entity),20020131,1,9E+17,9E+17
251396006,Urinary glucose output (observable entity),20020131,1,9E+17,9E+17
251400006,D-Xylose tolerance (observable entity),20020131,1,9E+17,9E+17
251402003,Small intestine glucose tolerance (observable entity),20020131,1,9E+17,9E+17
251404002,Small intestine permeability (observable entity),20020131,1,9E+17,9E+17
251407009,Hydrogen output (observable entity),20020131,1,9E+17,9E+17
251408004,Carbon dioxide output (observable entity),20020131,1,9E+17,9E+17
251411003,Time since previous micturition (observable entity),20020131,1,9E+17,9E+17
251412005,First glass appearance (observable entity),20020131,1,9E+17,9E+17
251417004,Second glass appearance (observable entity),20020131,1,9E+17,9E+17
251422004,Acetic acid test reaction (observable entity),20020131,1,9E+17,9E+17
251424003,Amine test reaction (observable entity),20020131,1,9E+17,9E+17
251394009,Urinary lactose output (observable entity),20020131,1,9E+17,9E+17
251322003,Orthodontic index (observable entity),20020131,1,9E+17,9E+17
251393003,Urinary sucrose output (observable entity),20020131,1,9E+17,9E+17
251371008,Nasal airway patency (observable entity),20020131,1,9E+17,9E+17
251374000,Gastrointestinal pressure (observable entity),20020131,1,9E+17,9E+17
251375004,Gastric pressure (observable entity),20020131,1,9E+17,9E+17
251376003,Anal sphincter pressure (observable entity),20020131,1,9E+17,9E+17
251377007,Abdominal pressure (observable entity),20020131,1,9E+17,9E+17
251378002,Gastrointestinal sensation (observable entity),20020131,1,9E+17,9E+17
251382000,Gastroesophageal reflux status (observable entity),20020131,1,9E+17,9E+17
251383005,Acid reflux status (observable entity),20020131,1,9E+17,9E+17
251384004,Bile reflux status (observable entity),20020131,1,9E+17,9E+17
251386002,Gastrin output (observable entity),20020131,1,9E+17,9E+17
251392008,Urinary sugar output (observable entity),20020131,1,9E+17,9E+17
251321005,Present tooth count (observable entity),20020131,1,9E+17,9E+17
251320006,Sound tooth count (observable entity),20020131,1,9E+17,9E+17
251319000,Decayed tooth count (observable entity),20020131,1,9E+17,9E+17
251265000,Cardiac pacemaker electrocardiographic pattern (observable entity),20020131,1,9E+17,9E+17
251271006,Vascular resistance (observable entity),20020131,1,9E+17,9E+17
251272004,Cardiac muscle thickness (observable entity),20020131,1,9E+17,9E+17
251254005,U wave shape (observable entity),20020131,1,9E+17,9E+17
251239004,U wave height (observable entity),20020131,1,9E+17,9E+17
251243000,Segment deviation (electrocardiogram) (observable entity),20020131,1,9E+17,9E+17
251246008,Electrocardiographic complex shape (observable entity),20020131,1,9E+17,9E+17
251247004,P wave shape (observable entity),20020131,1,9E+17,9E+17
251249001,Q wave shape (observable entity),20020131,1,9E+17,9E+17
251250001,R wave shape (observable entity),20020131,1,9E+17,9E+17
251251002,S wave shape (observable entity),20020131,1,9E+17,9E+17
251252009,QRS complex shape (observable entity),20020131,1,9E+17,9E+17
251253004,T wave shape (observable entity),20020131,1,9E+17,9E+17
251425002,Vaginal pH (observable entity),20020131,1,9E+17,9E+17
251303007,"Present, sound and crowned tooth count (observable entity)",20020131,1,9E+17,9E+17
251304001,Root canal length (observable entity),20020131,1,9E+17,9E+17
251305000,Pulp vital response (observable entity),20020131,1,9E+17,9E+17
251306004,Index of periodontal condition (observable entity),20020131,1,9E+17,9E+17
251307008,Plaque index of Sillness and Loe (observable entity),20020131,1,9E+17,9E+17
251308003,Gingival index of Sillness and Loe (observable entity),20020131,1,9E+17,9E+17
251309006,Community periodontal index of treatment need (observable entity),20020131,1,9E+17,9E+17
251310001,Gingival bleeding index (observable entity),20020131,1,9E+17,9E+17
251311002,Dental plaque score (observable entity),20020131,1,9E+17,9E+17
251312009,Gingival bleeding score (observable entity),20020131,1,9E+17,9E+17
251313004,Dental caries experience index (observable entity),20020131,1,9E+17,9E+17
251314005,"Decayed, missing and filled tooth count (observable entity)",20020131,1,9E+17,9E+17
251315006,"Ratio of decayed to decayed, missing and filled teeth (observable entity)",20020131,1,9E+17,9E+17
251316007,Ratio of decayed to decayed and filled teeth (observable entity),20020131,1,9E+17,9E+17
251317003,Missing tooth count (observable entity),20020131,1,9E+17,9E+17
251318008,Filled tooth count (observable entity),20020131,1,9E+17,9E+17
251301009,Occlusal vertical dimension (observable entity),20020131,1,9E+17,9E+17
251300005,Ratio of upper to lower face height (observable entity),20020131,1,9E+17,9E+17
251298005,Nasolabial angle (observable entity),20020131,1,9E+17,9E+17
251291004,Dental measure (observable entity),20020131,1,9E+17,9E+17
251292006,Overjet (observable entity),20020131,1,9E+17,9E+17
251293001,Overbite (observable entity),20020131,1,9E+17,9E+17
251294007,Width of tooth (observable entity),20020131,1,9E+17,9E+17
251295008,Ratio of upper incisor tooth width to lower incisor tooth width (observable entity),20020131,1,9E+17,9E+17
251296009,Dental crowding measure (observable entity),20020131,1,9E+17,9E+17
251297000,Dental arch width (observable entity),20020131,1,9E+17,9E+17
251299002,Facial proportion (observable entity),20020131,1,9E+17,9E+17
251427005,Muscle compartment pressure (observable entity),20020131,1,9E+17,9E+17
251428000,Intrinsic compartment pressure (observable entity),20020131,1,9E+17,9E+17
251429008,First dorsal extensor compartment pressure (observable entity),20020131,1,9E+17,9E+17
251543001,Motor unit stability (observable entity),20020131,1,9E+17,9E+17
251545008,Motor unit firing rate (observable entity),20020131,1,9E+17,9E+17
251546009,Macro electromyography amplitude/area (observable entity),20020131,1,9E+17,9E+17
251550002,Single muscle fiber density (observable entity),20020131,1,9E+17,9E+17
251551003,Single muscle fiber mean interspike interval (observable entity),20020131,1,9E+17,9E+17
251552005,Single muscle fiber action potential propagation velocity (observable entity),20020131,1,9E+17,9E+17
251532009,Motor unit characteristic (observable entity),20020131,1,9E+17,9E+17
251533004,Motor unit duration (observable entity),20020131,1,9E+17,9E+17
251534005,Motor unit amplitude (observable entity),20020131,1,9E+17,9E+17
251535006,Motor unit potentials (observable entity),20020131,1,9E+17,9E+17
251536007,Motor unit number (observable entity),20020131,1,9E+17,9E+17
251537003,Motor unit morphology (observable entity),20020131,1,9E+17,9E+17
251518007,Turns/amplitude ratio (observable entity),20020131,1,9E+17,9E+17
251560006,H-reflex (observable entity),20020131,1,9E+17,9E+17
251585002,Vibration threshold (observable entity),20020131,1,9E+17,9E+17
251586001,Pain threshold (observable entity),20020131,1,9E+17,9E+17
251587005,Tactile threshold (observable entity),20020131,1,9E+17,9E+17
251591000,Pattern electroretinography P50 (observable entity),20020131,1,9E+17,9E+17
251592007,P50 latency (observable entity),20020131,1,9E+17,9E+17
251593002,P50 amplitude (observable entity),20020131,1,9E+17,9E+17
251594008,Pattern electroretinography N95 (observable entity),20020131,1,9E+17,9E+17
251595009,N95 amplitude (observable entity),20020131,1,9E+17,9E+17
251596005,N95/P50 ratio (observable entity),20020131,1,9E+17,9E+17
251598006,Electro-oculogram pattern (observable entity),20020131,1,9E+17,9E+17
251601001,Pattern visual evoked potential P 100 component (observable entity),20020131,1,9E+17,9E+17
251602008,Pattern visual evoked potential P 100 component amplitude (observable entity),20020131,1,9E+17,9E+17
251584003,Electrical threshold (observable entity),20020131,1,9E+17,9E+17
251583009,Thermal threshold (observable entity),20020131,1,9E+17,9E+17
251581006,Symmetry of blink reflex (observable entity),20020131,1,9E+17,9E+17
251565001,Nerve conduction pattern (observable entity),20020131,1,9E+17,9E+17
251568004,Nerve conduction velocity (observable entity),20020131,1,9E+17,9E+17
251569007,Nerve action potential amplitude (observable entity),20020131,1,9E+17,9E+17
251570008,Nerve refractory period (observable entity),20020131,1,9E+17,9E+17
251571007,Reaction to repetitive stimulation (observable entity),20020131,1,9E+17,9E+17
251577006,Blink reflex component (observable entity),20020131,1,9E+17,9E+17
251578001,Latency of blink reflex (observable entity),20020131,1,9E+17,9E+17
251579009,R1 latency of blink reflex (observable entity),20020131,1,9E+17,9E+17
251580007,R2 latency of blink reflex (observable entity),20020131,1,9E+17,9E+17
251582004,Recovery cycle of reflex (observable entity),20020131,1,9E+17,9E+17
251236006,T wave height (observable entity),20020131,1,9E+17,9E+17
251517002,Electromyography interference pattern (observable entity),20020131,1,9E+17,9E+17
251430003,Flexor compartment of forearm pressure (observable entity),20020131,1,9E+17,9E+17
251431004,Extensor compartment of forearm pressure (observable entity),20020131,1,9E+17,9E+17
251432006,Grip/pinch (observable entity),20020131,1,9E+17,9E+17
251433001,Grip strength (observable entity),20020131,1,9E+17,9E+17
251434007,Key pinch (observable entity),20020131,1,9E+17,9E+17
251435008,Tip pinch (observable entity),20020131,1,9E+17,9E+17
251441001,Generalized electroencephalogram pattern (observable entity),20020131,1,9E+17,9E+17
251445005,Dominant electroencephalogram frequency (observable entity),20020131,1,9E+17,9E+17
251516006,Electromyography amplitude (observable entity),20020131,1,9E+17,9E+17
251507007,Electroencephalogram symmetry (observable entity),20020131,1,9E+17,9E+17
251484000,Focal electroencephalogram pattern (observable entity),20020131,1,9E+17,9E+17
251233003,QRS complex height (observable entity),20020131,1,9E+17,9E+17
250858007,Duration of tourniquet inflation (observable entity),20020131,1,9E+17,9E+17
250859004,Tourniquet inflation pressure (observable entity),20020131,1,9E+17,9E+17
250862001,Systemic arterial waveform (observable entity),20020131,1,9E+17,9E+17
250863006,Capnograph waveform (observable entity),20020131,1,9E+17,9E+17
250864000,Plethysmograph waveform (observable entity),20020131,1,9E+17,9E+17
250865004,Electrocardiographic waveform (observable entity),20020131,1,9E+17,9E+17
250866003,Airway pressure waveform (observable entity),20020131,1,9E+17,9E+17
250867007,Flow volume loop (observable entity),20020131,1,9E+17,9E+17
250868002,Pressure volume loop (observable entity),20020131,1,9E+17,9E+17
250871005,Ventilator generated pressure (observable entity),20020131,1,9E+17,9E+17
250872003,Ventilator flow output (observable entity),20020131,1,9E+17,9E+17
250873008,Ventilator volume output (observable entity),20020131,1,9E+17,9E+17
250874002,Ventilator delivered tidal volume (observable entity),20020131,1,9E+17,9E+17
250875001,Ventilator delivered minute volume (observable entity),20020131,1,9E+17,9E+17
250876000,Ventilator rate (observable entity),20020131,1,9E+17,9E+17
250877009,Mandatory breath rate (observable entity),20020131,1,9E+17,9E+17
250856006,Airway device cuff pressure (observable entity),20020131,1,9E+17,9E+17
250854009,Positive end expiratory pressure (observable entity),20020131,1,9E+17,9E+17
250836005,Double burst count (observable entity),20020131,1,9E+17,9E+17
250837001,Double burst ratio (observable entity),20020131,1,9E+17,9E+17
250838006,Tetanic fade (observable entity),20020131,1,9E+17,9E+17
250839003,Tetanic fade ratio (observable entity),20020131,1,9E+17,9E+17
250840001,Depth of anesthesia (observable entity),20020131,1,9E+17,9E+17
250841002,Electroencephalogram spectral edge frequency (observable entity),20020131,1,9E+17,9E+17
250842009,Median electroencephalogram frequency (observable entity),20020131,1,9E+17,9E+17
250843004,Central nervous system pressure (observable entity),20020131,1,9E+17,9E+17
250844005,Intracranial pressure (observable entity),20020131,1,9E+17,9E+17
250848008,Gas flow (observable entity),20020131,1,9E+17,9E+17
250849000,Fresh gas flow (observable entity),20020131,1,9E+17,9E+17
250850000,Gas pressure (observable entity),20020131,1,9E+17,9E+17
250851001,Pressure in the breathing system (observable entity),20020131,1,9E+17,9E+17
250852008,Airway pressure (observable entity),20020131,1,9E+17,9E+17
250853003,End-expiratory pressure (observable entity),20020131,1,9E+17,9E+17
250855005,Negative end expiratory pressure (observable entity),20020131,1,9E+17,9E+17
250878004,Triggered breath rate (observable entity),20020131,1,9E+17,9E+17
250880005,Gas cylinder pressure (observable entity),20020131,1,9E+17,9E+17
250905001,Optokinetic response (observable entity),20020131,1,9E+17,9E+17
250903008,Cochlear function (observable entity),20020131,1,9E+17,9E+17
250879007,Gas pipeline pressure (observable entity),20020131,1,9E+17,9E+17
250900006,Stapedial reflex threshold (observable entity),20020131,1,9E+17,9E+17
250881009,Equipment temperature (observable entity),20020131,1,9E+17,9E+17
250882002,Intravenous fluid warmer temperature (observable entity),20020131,1,9E+17,9E+17
250883007,Warming-cooling mattress temperature (observable entity),20020131,1,9E+17,9E+17
250884001,Radiant heater temperature (observable entity),20020131,1,9E+17,9E+17
250885000,Heat exchanger temperature (observable entity),20020131,1,9E+17,9E+17
250886004,Anesthetic vaporizer temperature (observable entity),20020131,1,9E+17,9E+17
250888003,Sound level (observable entity),20020131,1,9E+17,9E+17
250889006,Hearing level (observable entity),20020131,1,9E+17,9E+17
250891003,Listening level (observable entity),20020131,1,9E+17,9E+17
250892005,Most comfortable listening level (observable entity),20020131,1,9E+17,9E+17
250893000,Uncomfortable loudness level (observable entity),20020131,1,9E+17,9E+17
250894006,Masking level (observable entity),20020131,1,9E+17,9E+17
250897004,Frequency selectivity (observable entity),20020131,1,9E+17,9E+17
250898009,Temporal resolution (observable entity),20020131,1,9E+17,9E+17
250901005,Stapedial reflex latency (observable entity),20020131,1,9E+17,9E+17
251145000,Electrocardiographic voltage (observable entity),20020131,1,9E+17,9E+17
251191008,Cardiac axis (observable entity),20020131,1,9E+17,9E+17
251216005,U wave duration (observable entity),20020131,1,9E+17,9E+17
251219003,Electrocardiographic complex height (observable entity),20020131,1,9E+17,9E+17
251220009,P wave height (observable entity),20020131,1,9E+17,9E+17
251224000,Q wave height (observable entity),20020131,1,9E+17,9E+17
251227007,R wave height (observable entity),20020131,1,9E+17,9E+17
251230000,S wave height (observable entity),20020131,1,9E+17,9E+17
251192001,P wave axis (observable entity),20020131,1,9E+17,9E+17
251196003,QRS Axis (observable entity),20020131,1,9E+17,9E+17
251202000,Electrocardiographic complex characteristic (observable entity),20020131,1,9E+17,9E+17
251203005,Electrocardiographic complex duration (observable entity),20020131,1,9E+17,9E+17
251204004,P wave duration (observable entity),20020131,1,9E+17,9E+17
251207006,PR interval duration (observable entity),20020131,1,9E+17,9E+17
251208001,QRS complex duration (observable entity),20020131,1,9E+17,9E+17
251210004,T wave duration (observable entity),20020131,1,9E+17,9E+17
251213002,TU interval duration (observable entity),20020131,1,9E+17,9E+17
251067001,Cardiovascular pressure (observable entity),20020131,1,9E+17,9E+17
251081004,Cardiovascular pressure gradient (observable entity),20020131,1,9E+17,9E+17
251082006,Atrioventricular gradient (observable entity),20020131,1,9E+17,9E+17
251085008,Ventriculoarterial gradient (observable entity),20020131,1,9E+17,9E+17
251089002,Cardiac conduction (observable entity),20020131,1,9E+17,9E+17
251090006,Nodal function (observable entity),20020131,1,9E+17,9E+17
251091005,Sinus node function (observable entity),20020131,1,9E+17,9E+17
251095001,Atrioventricular nodal function (observable entity),20020131,1,9E+17,9E+17
251048000,Cardiac ratio (observable entity),20020131,1,9E+17,9E+17
251049008,Left to right ventricular stroke volume ratio (observable entity),20020131,1,9E+17,9E+17
251050008,Pulmonary to systemic flow ratio (observable entity),20020131,1,9E+17,9E+17
251099007,Cardiac conduction pathway (observable entity),20020131,1,9E+17,9E+17
251127000,Effective refractory period (cardiac conduction) (observable entity),20020131,1,9E+17,9E+17
251128005,Atrioventricular nodal effective refractory period (observable entity),20020131,1,9E+17,9E+17
251129002,Atrioventricular nodal slow pathway effective refractory period (observable entity),20020131,1,9E+17,9E+17
251130007,Atrioventricular accessory pathway effective refractory period (observable entity),20020131,1,9E+17,9E+17
251131006,AH interval (cardiac conduction) (observable entity),20020131,1,9E+17,9E+17
251132004,HV interval (cardiac conduction) (observable entity),20020131,1,9E+17,9E+17
251133009,Wenckebach cycle length (observable entity),20020131,1,9E+17,9E+17
251134003,General electrocardiographic appearance (observable entity),20020131,1,9E+17,9E+17
251100004,Intra-atrial conduction (observable entity),20020131,1,9E+17,9E+17
251101000,His-Purkinje conduction (observable entity),20020131,1,9E+17,9E+17
251109003,Areas of slow cardiac conduction (observable entity),20020131,1,9E+17,9E+17
251110008,Areas of ventricular slow conduction (observable entity),20020131,1,9E+17,9E+17
251111007,Areas of atrial slow conduction (observable entity),20020131,1,9E+17,9E+17
251112000,Cardiac conduction pattern (observable entity),20020131,1,9E+17,9E+17
251113005,Atrioventricular conduction pattern (observable entity),20020131,1,9E+17,9E+17
276205001,Country of origin (observable entity),20020131,1,9E+17,9E+17
276250004,Overall electromyography pattern (observable entity),20020131,1,9E+17,9E+17
276450002,Tooth plaque disclosure (observable entity),20020131,1,9E+17,9E+17
276350001,Subischial leg length (observable entity),20020131,1,9E+17,9E+17
276354005,Weight velocity (observable entity),20020131,1,9E+17,9E+17
276355006,Weight centile velocity (observable entity),20020131,1,9E+17,9E+17
275727004,Hearing test normal (finding),20020131,1,9E+17,9E+17
275728009,Audiogram normal (finding),20020131,1,9E+17,9E+17
275729001,Audiogram abnormal (finding),20020131,1,9E+17,9E+17
276031006,Details of education (observable entity),20020131,1,9E+17,9E+17
276056000,Job milestones (observable entity),20020131,1,9E+17,9E+17
276057009,Retirement milestones (observable entity),20020131,1,9E+17,9E+17
276058004,Employment circumstances (observable entity),20020131,1,9E+17,9E+17
275924004,"Result, lab.- general (observable entity)",20020131,1,9E+17,9E+17
277124004,Flash visual evoked potentials latency (observable entity),20020131,1,9E+17,9E+17
277128001,Cortical somatosensory evoked potential amplitude (observable entity),20020131,1,9E+17,9E+17
277177009,Tympanic membrane mobility (observable entity),20020131,1,9E+17,9E+17
277030002,Post-activation response (observable entity),20020131,1,9E+17,9E+17
277034006,Test interpretation (observable entity),20020131,1,9E+17,9E+17
277387000,Cormack and Lehane grade (observable entity),20020131,1,9E+17,9E+17
277388005,Mallampati grade (observable entity),20020131,1,9E+17,9E+17
277235001,Number of bleeding points (observable entity),20020131,1,9E+17,9E+17
276774000,Right ventricular end-diastolic pressure (observable entity),20020131,1,9E+17,9E+17
276781007,Left ventricular end-diastolic pressure (observable entity),20020131,1,9E+17,9E+17
276771008,Aortic pressure (observable entity),20020131,1,9E+17,9E+17
277009006,Pattern electroretinogram response (observable entity),20020131,1,9E+17,9E+17
276997009,Flash visual evoked potential component (observable entity),20020131,1,9E+17,9E+17
276996000,Visual evoked potential symmetry (observable entity),20020131,1,9E+17,9E+17
276994002,Pattern visual evoked potential component (observable entity),20020131,1,9E+17,9E+17
276900001,Systemic vascular resistance index (observable entity),20020131,1,9E+17,9E+17
276901002,Pulmonary vascular resistance (observable entity),20020131,1,9E+17,9E+17
276902009,Pulmonary vascular resistance index (observable entity),20020131,1,9E+17,9E+17
276863001,Nitrogen concentration (observable entity),20020131,1,9E+17,9E+17
276864007,Arteriovenous difference - oxygen (observable entity),20020131,1,9E+17,9E+17
276865008,Arteriovenous difference - carbon dioxide (observable entity),20020131,1,9E+17,9E+17
274895002,Additional biochemistry interpretations (observable entity),20020131,1,9E+17,9E+17
275256003,"Testicular growth, function (observable entity)",20020131,1,9E+17,9E+17
275257007,"Penis growth, function (observable entity)",20020131,1,9E+17,9E+17
275301001,Diameter of testicle (observable entity),20020131,1,9E+17,9E+17
274519004,"Abnormal result, function study of peripheral nervous system / special senses (finding)",20020131,1,9E+17,9E+17
274520005,Abnormal results function studies of central nervous system (finding),20020131,1,9E+17,9E+17
274524001,Electroretinogram abnormal (finding),20020131,1,9E+17,9E+17
274525000,Abnormal results of cardiovascular function studies (finding),20020131,1,9E+17,9E+17
277923006,Pulse oximetry waveform (observable entity),20020131,1,9E+17,9E+17
277901007,Sputum appearance (observable entity),20020131,1,9E+17,9E+17
277896005,Color of sputum (observable entity),20020131,1,9E+17,9E+17
278221001,Continuous electroencephalogram measure (observable entity),20020131,1,9E+17,9E+17
278223003,Sensory nerve conduction velocity (observable entity),20020131,1,9E+17,9E+17
278224009,Motor nerve conduction velocity (observable entity),20020131,1,9E+17,9E+17
278225005,Sensory nerve action potential amplitude (observable entity),20020131,1,9E+17,9E+17
278226006,Muscle action potential amplitude (observable entity),20020131,1,9E+17,9E+17
278082003,Amplitude of deceleration (fetal heart rate) (observable entity),20020131,1,9E+17,9E+17
278083008,Duration of deceleration (fetal heart rate) (observable entity),20020131,1,9E+17,9E+17
278089007,Length of cervix in labor (observable entity),20020131,1,9E+17,9E+17
278071006,Retroplacental clot volume (observable entity),20020131,1,9E+17,9E+17
278067008,Proportion of fetal head above pelvic brim (observable entity),20020131,1,9E+17,9E+17
277677008,Room temperature medium (observable entity),20020131,1,9E+17,9E+17
277679006,Body temperature medium (observable entity),20020131,1,9E+17,9E+17
277680009,Cold medium (observable entity),20020131,1,9E+17,9E+17
278652005,Tooth presence (observable entity),20020131,1,9E+17,9E+17
278653000,Tooth angulation (observable entity),20020131,1,9E+17,9E+17
278654006,Tooth color (observable entity),20020131,1,9E+17,9E+17
278663008,Incisor tooth inclination (observable entity),20020131,1,9E+17,9E+17
278664002,Incisor tooth angulation (observable entity),20020131,1,9E+17,9E+17
278665001,Canine tooth angulation (observable entity),20020131,1,9E+17,9E+17
278666000,Buccal tooth inclination (observable entity),20020131,1,9E+17,9E+17
278667009,Interincisal teeth angle (observable entity),20020131,1,9E+17,9E+17
278967006,Rubella status (observable entity),20020131,1,9E+17,9E+17
278969009,Hepatitis B status (observable entity),20020131,1,9E+17,9E+17
278970005,Hepatitis A status (observable entity),20020131,1,9E+17,9E+17
278973007,Hepatitis C status (observable entity),20020131,1,9E+17,9E+17
278977008,Human immunodeficiency virus status (observable entity),20020131,1,9E+17,9E+17
278996007,Medium dose rate brachytherapy (observable entity),20020131,1,9E+17,9E+17
278869005,Illness behavior (observable entity),20020131,1,9E+17,9E+17
278844005,General clinical state (observable entity),20020131,1,9E+17,9E+17
278907009,Respiratory pattern (observable entity),20020131,1,9E+17,9E+17
278268006,Stimulus frequency (observable entity),20020131,1,9E+17,9E+17
278249008,Mixed nerve action potential amplitude (observable entity),20020131,1,9E+17,9E+17
278231008,Motor nerve conduction pattern (observable entity),20020131,1,9E+17,9E+17
278233006,Sensory nerve conduction pattern (observable entity),20020131,1,9E+17,9E+17
278234000,Mixed nerve conduction pattern (observable entity),20020131,1,9E+17,9E+17
278248000,Mixed nerve conduction velocity (observable entity),20020131,1,9E+17,9E+17
278250008,Reflex latency (observable entity),20020131,1,9E+17,9E+17
278299007,Acute physiology and chronic health evaluation risk of hospital death score (observable entity),20020131,1,9E+17,9E+17
278301000,Daily therapeutic intervention scoring system score (observable entity),20020131,1,9E+17,9E+17
278302007,Total therapeutic intervention scoring system score (observable entity),20020131,1,9E+17,9E+17
278566009,Appearance of dental veneer (observable entity),20020131,1,9E+17,9E+17
278567000,Appearance of dental bridge (observable entity),20020131,1,9E+17,9E+17
278565008,Appearance of dental crown (observable entity),20020131,1,9E+17,9E+17
278611001,Maxillofacial prosthesis function (observable entity),20020131,1,9E+17,9E+17
278614009,Appearance of denture (observable entity),20020131,1,9E+17,9E+17
278564007,Appearance of dental filling (observable entity),20020131,1,9E+17,9E+17
278459006,Eustachian tube function (observable entity),20020131,1,9E+17,9E+17
278460001,Middle ear function (observable entity),20020131,1,9E+17,9E+17
278461002,Middle ear compliance (observable entity),20020131,1,9E+17,9E+17
278462009,Middle ear pressure (observable entity),20020131,1,9E+17,9E+17
278464005,Middle ear conductance (observable entity),20020131,1,9E+17,9E+17
278547009,Appearance of dental restoration (observable entity),20020131,1,9E+17,9E+17
264919007,Rib hump angle (observable entity),20020131,1,9E+17,9E+17
264922009,Goiter size (observable entity),20020131,1,9E+17,9E+17
264924005,Wart size (observable entity),20020131,1,9E+17,9E+17
264888005,Number of breaks (observable entity),20020131,1,9E+17,9E+17
264889002,Number of cysts (observable entity),20020131,1,9E+17,9E+17
264890006,Number of papilloma (observable entity),20020131,1,9E+17,9E+17
264891005,Number of phlycten (observable entity),20020131,1,9E+17,9E+17
264892003,Number of pressure ulcers (observable entity),20020131,1,9E+17,9E+17
264893008,Number of ulcers (observable entity),20020131,1,9E+17,9E+17
264894002,Number of ureteric calculi (observable entity),20020131,1,9E+17,9E+17
264895001,Number of warts (observable entity),20020131,1,9E+17,9E+17
264899007,Oral air flow (observable entity),20020131,1,9E+17,9E+17
264783006,Aceto-white reaction (observable entity),20020131,1,9E+17,9E+17
264825005,Chest respiratory movements (observable entity),20020131,1,9E+17,9E+17
261955003,"Moving jaw, function (observable entity)",20020131,1,9E+17,9E+17
263495000,Gender (observable entity),20020131,1,9E+17,9E+17
263612005,Number of adhesions (observable entity),20020131,1,9E+17,9E+17
263617004,Number of parathyroid tumors (observable entity),20020131,1,9E+17,9E+17
262285001,Weight decreased (finding),20020131,1,9E+17,9E+17
262286000,Weight increased (finding),20020131,1,9E+17,9E+17
272385004,Outdoor pursuit (qualifier value),20020131,1,9E+17,9E+17
271810005,Color of face (observable entity),20020131,1,9E+17,9E+17
271925006,Cardiovascular test finding (observable entity),20020131,1,9E+17,9E+17
271926007,Abdominal test finding (observable entity),20020131,1,9E+17,9E+17
271927003,Genitourinary test finding (observable entity),20020131,1,9E+17,9E+17
271928008,"Ear, nose and throat test finding (observable entity)",20020131,1,9E+17,9E+17
271929000,Locomotor test interpretation (observable entity),20020131,1,9E+17,9E+17
271930005,Dermatological test interpretation (observable entity),20020131,1,9E+17,9E+17
271931009,Metabolic test finding (observable entity),20020131,1,9E+17,9E+17
271932002,Hematology interpretation (observable entity),20020131,1,9E+17,9E+17
271933007,Immunology interpretation (observable entity),20020131,1,9E+17,9E+17
271934001,Biochemistry test interpretation (observable entity),20020131,1,9E+17,9E+17
271935000,Biopsy interpretation (observable entity),20020131,1,9E+17,9E+17
271936004,Endoscopy finding (observable entity),20020131,1,9E+17,9E+17
271937008,Screening interpretation (observable entity),20020131,1,9E+17,9E+17
271924005,Neurological test finding (observable entity),20020131,1,9E+17,9E+17
271923004,Respiratory function interpretation (observable entity),20020131,1,9E+17,9E+17
271921002,Electrocardiogram finding (observable entity),20020131,1,9E+17,9E+17
271905007,History interpretation (observable entity),20020131,1,9E+17,9E+17
271906008,Examination finding (observable entity),20020131,1,9E+17,9E+17
271907004,General examination finding (observable entity),20020131,1,9E+17,9E+17
271908009,Respiratory examination finding (observable entity),20020131,1,9E+17,9E+17
271909001,Neurology examination finding (observable entity),20020131,1,9E+17,9E+17
271910006,Cardiovascular examination finding (observable entity),20020131,1,9E+17,9E+17
271911005,Abdominal examination finding (observable entity),20020131,1,9E+17,9E+17
271912003,Genitourinary examination finding (observable entity),20020131,1,9E+17,9E+17
271913008,Eye examination interpretation (observable entity),20020131,1,9E+17,9E+17
271914002,"Ear, nose and throat examination finding (observable entity)",20020131,1,9E+17,9E+17
271915001,Orodental examination interpretation (observable entity),20020131,1,9E+17,9E+17
271916000,Locomotor examination finding (observable entity),20020131,1,9E+17,9E+17
271917009,Interpretation of behavior (observable entity),20020131,1,9E+17,9E+17
271918004,Specific test interpretations (observable entity),20020131,1,9E+17,9E+17
271919007,Body substance analysis interpretation (observable entity),20020131,1,9E+17,9E+17
271920001,Histopathology interpretation (observable entity),20020131,1,9E+17,9E+17
271922009,Visual test interpretation (observable entity),20020131,1,9E+17,9E+17
271731004,Regularity of pupil (observable entity),20020131,1,9E+17,9E+17
271736009,Movement of uvula (observable entity),20020131,1,9E+17,9E+17
271705001,Gait type (observable entity),20020131,1,9E+17,9E+17
271773007,Straight leg raise test response (observable entity),20020131,1,9E+17,9E+17
369715008,Breslow measurement - Invasion > 1.5mm from deep border of granular layer (finding),20020131,1,9E+17,9E+17
369714007,Breslow measurement - Invasion 0.76 to 1.5mm from deep border of granular layer (finding),20020131,1,9E+17,9E+17
272051008,Memory assessment (observable entity),20020131,1,9E+17,9E+17
268362009,Auditory/vestibular test normal (finding),20020131,1,9E+17,9E+17
268363004,Auditory/vestibular test abnormal (finding),20020131,1,9E+17,9E+17
268607006,Hypertension risk level (observable entity),20020131,1,9E+17,9E+17
268926000,Respiratory system examined - no abnormality detected (observable entity),20020131,1,9E+17,9E+17
268469004,Antenatal data (observable entity),20020131,1,9E+17,9E+17
268379003,Vital capacity (observable entity),20020131,1,9E+17,9E+17
268384009,Total blood volume (observable entity),20020131,1,9E+17,9E+17
268391007,Disability assessment - mental (observable entity),20020131,1,9E+17,9E+17
268475008,Outcome of delivery (observable entity),20020131,1,9E+17,9E+17
268476009,Sex of baby (observable entity),20020131,1,9E+17,9E+17
268482007,Child height centile (observable entity),20020131,1,9E+17,9E+17
266980002,Self-help group membership (observable entity),20020131,1,9E+17,9E+17
266981003,Schooling (observable entity),20020131,1,9E+17,9E+17
267011001,Gynecological history (observable entity),20020131,1,9E+17,9E+17
266941005,Provision of domiciliary services (observable entity),20020131,1,9E+17,9E+17
266955002,Employment milestones (observable entity),20020131,1,9E+17,9E+17
267065001,Urine appearance (observable entity),20020131,1,9E+17,9E+17
267013003,Past pregnancy outcome (observable entity),20020131,1,9E+17,9E+17
267050002,Site of gastrointestinal tract pain (observable entity),20020131,1,9E+17,9E+17
266930008,Exercise history (observable entity),20020131,1,9E+17,9E+17
271306003,Best ever peak flow rate (respiratory) (observable entity),20020131,1,9E+17,9E+17
271391000,Provision of home help (observable entity),20020131,1,9E+17,9E+17
271397001,Menstrual data (observable entity),20020131,1,9E+17,9E+17
271624007,Method of breathing (observable entity),20020131,1,9E+17,9E+17
271626009,Depth of respiration (observable entity),20020131,1,9E+17,9E+17
271628005,Position of trachea (observable entity),20020131,1,9E+17,9E+17
271600004,Body form (observable entity),20020131,1,9E+17,9E+17
271603002,Height / growth measure (observable entity),20020131,1,9E+17,9E+17
271605009,Position of body and posture (observable entity),20020131,1,9E+17,9E+17
271619009,Quality of personal care shown by appearance (observable entity),20020131,1,9E+17,9E+17
271692001,Presentation of fetus (observable entity),20020131,1,9E+17,9E+17
271671001,Smell of breath (observable entity),20020131,1,9E+17,9E+17
271507006,Peak flow rate after bronchodilation (observable entity),20020131,1,9E+17,9E+17
271508001,Expected peak flow rate (respiratory) (observable entity),20020131,1,9E+17,9E+17
271562002,Total duration of labor (observable entity),20020131,1,9E+17,9E+17
271529005,Peak flow rate before bronchodilation (observable entity),20020131,1,9E+17,9E+17
269823000,Hemoglobin A1C - diabetic control interpretation (observable entity),20020131,1,9E+17,9E+17
269902007,Feces foreign constituent (observable entity),20020131,1,9E+17,9E+17
269903002,Feces pancreatic effects (observable entity),20020131,1,9E+17,9E+17
270477000,Type of gastrointestinal tract pain (observable entity),20020131,1,9E+17,9E+17
43260008,Hose diving (qualifier value),20020131,1,9E+17,9E+17
43224003,Pleural pressure (observable entity),20020131,1,9E+17,9E+17
43068009,Motherhood (observable entity),20020131,1,9E+17,9E+17
44432004,"Muscle tensile strength, function (observable entity)",20020131,1,9E+17,9E+17
44815009,Breslow measurement - greater than 1.75 mm (finding),20020131,1,9E+17,9E+17
44098006,Archery (qualifier value),20020131,1,9E+17,9E+17
41633001,Intraocular pressure (observable entity),20020131,1,9E+17,9E+17
41701000,Dark adaptation (observable entity),20020131,1,9E+17,9E+17
40909004,Regional lung volume (observable entity),20020131,1,9E+17,9E+17
41011002,T wave feature (observable entity),20020131,1,9E+17,9E+17
42457008,Residual respiratory volume (observable entity),20020131,1,9E+17,9E+17
42233006,"Muscle motor unit potential, function (observable entity)",20020131,1,9E+17,9E+17
42111002,Bladder function (observable entity),20020131,1,9E+17,9E+17
48761009,Motor behavior (observable entity),20020131,1,9E+17,9E+17
45500009,"Muscle innervation ratio, function (observable entity)",20020131,1,9E+17,9E+17
46470002,Barlow test response (observable entity),20020131,1,9E+17,9E+17
46649000,Close circuit scuba diving (qualifier value),20020131,1,9E+17,9E+17
35544009,Apley compression test response (observable entity),20020131,1,9E+17,9E+17
35706003,Isovolume pressure-flow curve (observable entity),20020131,1,9E+17,9E+17
35877002,S wave feature (observable entity),20020131,1,9E+17,9E+17
35897007,Active movement (observable entity),20020131,1,9E+17,9E+17
33405001,P wave feature (observable entity),20020131,1,9E+17,9E+17
34205009,Ejection (qualifier value),20020131,1,9E+17,9E+17
33957008,Personal dead space volume (observable entity),20020131,1,9E+17,9E+17
39211005,Bowel action (observable entity),20020131,1,9E+17,9E+17
39438000,U wave feature (observable entity),20020131,1,9E+17,9E+17
39599007,Snorkel diving (qualifier value),20020131,1,9E+17,9E+17
39146006,"Stress tolerance, function (observable entity)",20020131,1,9E+17,9E+17
40137007,Pupil light reflex (observable entity),20020131,1,9E+17,9E+17
38080001,"Reciprocal innervation, function (observable entity)",20020131,1,9E+17,9E+17
59328004,Forced expired volume in 1 second (observable entity),20020131,1,9E+17,9E+17
60747006,Doll's head reflex (observable entity),20020131,1,9E+17,9E+17
60984000,"Non-rapid eye movement sleep, function (observable entity)",20020131,1,9E+17,9E+17
61017008,Lung relaxation pressure (observable entity),20020131,1,9E+17,9E+17
60534004,"Muscle isometric contraction, function (observable entity)",20020131,1,9E+17,9E+17
57605004,Modified Dukes stage D (finding),20020131,1,9E+17,9E+17
57566009,Total lung capacity (observable entity),20020131,1,9E+17,9E+17
57206007,Singing (observable entity),20020131,1,9E+17,9E+17
57036006,Fetal gestational age (observable entity),20020131,1,9E+17,9E+17
57427004,Handedness (observable entity),20020131,1,9E+17,9E+17
57306005,Modified Dukes stage C2 (finding),20020131,1,9E+17,9E+17
58608000,Upper esophageal sphincter pressure (observable entity),20020131,1,9E+17,9E+17
58915005,Immune status (observable entity),20020131,1,9E+17,9E+17
58516001,"Antagonist muscle action, function (observable entity)",20020131,1,9E+17,9E+17
63498000,Diving (qualifier value),20020131,1,9E+17,9E+17
65077007,Disjunctive ocular movement (observable entity),20020131,1,9E+17,9E+17
64607003,Coordinated eye movement (observable entity),20020131,1,9E+17,9E+17
61931005,Postvaccination state (observable entity),20020131,1,9E+17,9E+17
61428000,"Muscle isotonic contraction, function (observable entity)",20020131,1,9E+17,9E+17
62262004,Minimum volume (observable entity),20020131,1,9E+17,9E+17
51478000,Maximal gastric acid secretory capacity (observable entity),20020131,1,9E+17,9E+17
51717002,Expired carbon dioxide concentration (observable entity),20020131,1,9E+17,9E+17
51104005,Pitch (observable entity),20020131,1,9E+17,9E+17
52653008,Respiratory sounds (observable entity),20020131,1,9E+17,9E+17
49169007,Head compression response (observable entity),20020131,1,9E+17,9E+17
50542000,Clark melanoma level 2 (finding),20020131,1,9E+17,9E+17
50834005,Forced vital capacity (observable entity),20020131,1,9E+17,9E+17
50373000,Body height measure (observable entity),20020131,1,9E+17,9E+17
49950003,Meal-stimulated gastric acid secretion (observable entity),20020131,1,9E+17,9E+17
55591008,Conjunctive eye movement (observable entity),20020131,1,9E+17,9E+17
55562005,Inspiratory reserve volume (observable entity),20020131,1,9E+17,9E+17
55532004,Expiratory reserve volume (observable entity),20020131,1,9E+17,9E+17
56769006,Modified Dukes stage A (finding),20020131,1,9E+17,9E+17
53173007,Modified Dukes stage B2 (finding),20020131,1,9E+17,9E+17
54498006,Modified Dukes stage C1 (finding),20020131,1,9E+17,9E+17
10947000,"Synergist muscle action, function (observable entity)",20020131,1,9E+17,9E+17
12140005,"Muscle contraction, function (observable entity)",20020131,1,9E+17,9E+17
11977004,"Muscle relaxation, function (observable entity)",20020131,1,9E+17,9E+17
8625004,Legal status (observable entity),20020131,1,9E+17,9E+17
8690003,Diaphragmatic excursion (observable entity),20020131,1,9E+17,9E+17
9576003,Esophageal pressure (observable entity),20020131,1,9E+17,9E+17
14951008,Fatherhood (observable entity),20020131,1,9E+17,9E+17
14468000,Sports activity (observable entity),20020131,1,9E+17,9E+17
15876000,McMurray test response (observable entity),20020131,1,9E+17,9E+17
16162007,Total airway resistance (observable entity),20020131,1,9E+17,9E+17
16034002,Clark melanoma level 5 (finding),20020131,1,9E+17,9E+17
14075006,Static-line parachuting (qualifier value),20020131,1,9E+17,9E+17
13621006,Tidal volume (observable entity),20020131,1,9E+17,9E+17
2548005,Peak gastric acid output (observable entity),20020131,1,9E+17,9E+17
2767007,Dysergia (observable entity),20020131,1,9E+17,9E+17
3863008,Lung compliance (observable entity),20020131,1,9E+17,9E+17
3030002,ST segment (observable entity),20020131,1,9E+17,9E+17
1556006,Clark melanoma level 4 (finding),20020131,1,9E+17,9E+17
6942003,Level of consciousness (observable entity),20020131,1,9E+17,9E+17
6918002,Muscle tone (observable entity),20020131,1,9E+17,9E+17
6427007,Chest expansion (observable entity),20020131,1,9E+17,9E+17
6304003,Airway resistance (observable entity),20020131,1,9E+17,9E+17
7542004,Personal status (observable entity),20020131,1,9E+17,9E+17
4683004,Living condition (observable entity),20020131,1,9E+17,9E+17
4751000,Leisure physical activity (observable entity),20020131,1,9E+17,9E+17
4065008,Affect function (observable entity),20020131,1,9E+17,9E+17
4051006,Finkelsteins test response (observable entity),20020131,1,9E+17,9E+17
5222008,Pressure difference between alveoli and mouth (observable entity),20020131,1,9E+17,9E+17
28239005,Two point static discrimination response (observable entity),20020131,1,9E+17,9E+17
27625002,Wakefulness (observable entity),20020131,1,9E+17,9E+17
27556003,Lachman test response (observable entity),20020131,1,9E+17,9E+17
27913002,Maximum inspiratory pressure (observable entity),20020131,1,9E+17,9E+17
24607002,Q wave feature (observable entity),20020131,1,9E+17,9E+17
31261004,"Agonist muscle action, function (observable entity)",20020131,1,9E+17,9E+17
31498000,Cephalic-vagal gastric acid secretion (observable entity),20020131,1,9E+17,9E+17
31346003,"Muscle property, function (observable entity)",20020131,1,9E+17,9E+17
32198009,Parachuting (qualifier value),20020131,1,9E+17,9E+17
31763002,Ocular motility observable (observable entity),20020131,1,9E+17,9E+17
31747005,Modified Dukes stage B1 (finding),20020131,1,9E+17,9E+17
28895007,Sky-diving (qualifier value),20020131,1,9E+17,9E+17
30367009,Lung clearance index (observable entity),20020131,1,9E+17,9E+17
29533001,Inspiratory capacity (observable entity),20020131,1,9E+17,9E+17
19166009,Stapedial reflex (observable entity),20020131,1,9E+17,9E+17
18491006,Peak expiratory flow rate (observable entity),20020131,1,9E+17,9E+17
19982009,Dead space gas volume (observable entity),20020131,1,9E+17,9E+17
17202005,Maximum expiratory pressure (observable entity),20020131,1,9E+17,9E+17
17456000,Breslow measurement - depth from 0.76 to 1.75 mm (finding),20020131,1,9E+17,9E+17
17328006,Flow of urine (observable entity),20020131,1,9E+17,9E+17
22751002,"Contraction of external anal sphincter, function (observable entity)",20020131,1,9E+17,9E+17
22690006,Nerve conduction (observable entity),20020131,1,9E+17,9E+17
23980007,Apley test response (observable entity),20020131,1,9E+17,9E+17
20910001,Pivot shift test response (observable entity),20020131,1,9E+17,9E+17
21122005,Femoral nerve stretch response (observable entity),20020131,1,9E+17,9E+17
21165006,Clark melanoma level 3 (finding),20020131,1,9E+17,9E+17
20426007,Volume history of lung (observable entity),20020131,1,9E+17,9E+17
20733006,Living place (observable entity),20020131,1,9E+17,9E+17
20635005,Semi-open circuit scuba diving (qualifier value),20020131,1,9E+17,9E+17
77219005,Saccadic eye movement (observable entity),20020131,1,9E+17,9E+17
91444001,Smooth pursuit movement (observable entity),20020131,1,9E+17,9E+17
78513008,Fusion binocular vision (observable entity),20020131,1,9E+17,9E+17
89919001,Transmural pressure (observable entity),20020131,1,9E+17,9E+17
79010009,Parenthood (observable entity),20020131,1,9E+17,9E+17
90062008,Gastric tonus (observable entity),20020131,1,9E+17,9E+17
78718001,Muscle function (observable entity),20020131,1,9E+17,9E+17
91343008,Lower esophageal sphincter pressure (observable entity),20020131,1,9E+17,9E+17
75098008,Flow history (observable entity),20020131,1,9E+17,9E+17
75335000,Scuba diving (qualifier value),20020131,1,9E+17,9E+17
83204003,Free diving (qualifier value),20020131,1,9E+17,9E+17
83284001,Clark melanoma level 1 (finding),20020131,1,9E+17,9E+17
82984001,Posterior drawer test response (observable entity),20020131,1,9E+17,9E+17
83411002,Slow vital capacity (observable entity),20020131,1,9E+17,9E+17
82187007,Gastric acid secretion (observable entity),20020131,1,9E+17,9E+17
87042004,Bowel sounds (observable entity),20020131,1,9E+17,9E+17
85662007,Intravesical pressure (observable entity),20020131,1,9E+17,9E+17
84917001,Indirect light pupillary reflex (observable entity),20020131,1,9E+17,9E+17
84747008,Apley distraction test response (observable entity),20020131,1,9E+17,9E+17
85275003,Compressed air hose diving (qualifier value),20020131,1,9E+17,9E+17
86189008,Cerebrospinal fluid pressure (observable entity),20020131,1,9E+17,9E+17
86069005,Breslow measurement - depth less than 0.76 mm (finding),20020131,1,9E+17,9E+17
89129007,"Rapid eye movement sleep, function (observable entity)",20020131,1,9E+17,9E+17
88676009,Gross diagnosis (observable entity),20020131,1,9E+17,9E+17
79412009,Specific airway conductance (observable entity),20020131,1,9E+17,9E+17
89624001,Partial expiratory flow-static recoil curve (observable entity),20020131,1,9E+17,9E+17
79063001,Gas flow rate (v) (observable entity),20020131,1,9E+17,9E+17
89315003,Anatomical dead space (observable entity),20020131,1,9E+17,9E+17
89365007,"Muscle latency relaxation, function (observable entity)",20020131,1,9E+17,9E+17
81435004,QT interval feature (observable entity),20020131,1,9E+17,9E+17
88343004,Expiratory residual volume (observable entity),20020131,1,9E+17,9E+17
88345006,Carbon dioxide response curve measurement (observable entity),20020131,1,9E+17,9E+17
80633008,Suppression (observable entity),20020131,1,9E+17,9E+17
81184002,R wave feature (observable entity),20020131,1,9E+17,9E+17
88265002,Physiological dead space (observable entity),20020131,1,9E+17,9E+17
105717002,Condition AND/OR status of human remains (observable entity),20020131,1,9E+17,9E+17
105575000,Religiousness (observable entity),20020131,1,9E+17,9E+17
105576004,Religious commitment (observable entity),20020131,1,9E+17,9E+17
70017002,"Muscle elasticity, function (observable entity)",20020131,1,9E+17,9E+17
71172009,Volume of expired gas (observable entity),20020131,1,9E+17,9E+17
66621004,Sexual orientation (observable entity),20020131,1,9E+17,9E+17
110343009,Tongue thrust (observable entity),20020131,1,9E+17,9E+17
105417001,Disappearance of partner (finding),20020131,1,9E+17,9E+17
105421008,Educational achievement (observable entity),20020131,1,9E+17,9E+17
105422001,Poor education (finding),20020131,1,9E+17,9E+17
105423006,Good education (finding),20020131,1,9E+17,9E+17
70464006,Laryngeal airflow resistance (observable entity),20020131,1,9E+17,9E+17
70778006,Gas transport time peak following bronchodilator (observable entity),20020131,1,9E+17,9E+17
68362006,Binocular vision observable (observable entity),20020131,1,9E+17,9E+17
68545002,Gastric secretion (observable entity),20020131,1,9E+17,9E+17
68592003,Body composition (observable entity),20020131,1,9E+17,9E+17
108331001,Parental state (observable entity),20020131,1,9E+17,9E+17
68130003,Physical activity (observable entity),20020131,1,9E+17,9E+17
67461000,Alveolar pressure (observable entity),20020131,1,9E+17,9E+17
65825000,Functional residual capacity (observable entity),20020131,1,9E+17,9E+17
74397004,Living quarters (observable entity),20020131,1,9E+17,9E+17
111965008,Glottal airflow resistance (observable entity),20020131,1,9E+17,9E+17
111964007,Regional vital capacity (observable entity),20020131,1,9E+17,9E+17
111969002,Diaphragmatic movement (observable entity),20020131,1,9E+17,9E+17
65751005,Mixed gas hose diving (qualifier value),20020131,1,9E+17,9E+17
74024006,Dental caries susceptibility (observable entity),20020131,1,9E+17,9E+17
65453009,"Chalasia, function (observable entity)",20020131,1,9E+17,9E+17
102474005,Unexpected therapeutic effect (observable entity),20020131,1,9E+17,9E+17
102545003,"Lengthening muscle contraction, function (observable entity)",20020131,1,9E+17,9E+17
102546002,"Paradoxical muscle contraction, function (observable entity)",20020131,1,9E+17,9E+17
102547006,"Muscle action potential, function (observable entity)",20020131,1,9E+17,9E+17
65401001,"Psychomotor development, function (observable entity)",20020131,1,9E+17,9E+17
102544004,"Shortening muscle contraction, function (observable entity)",20020131,1,9E+17,9E+17
102542000,"Involuntary muscle contraction, function (observable entity)",20020131,1,9E+17,9E+17
66332009,"Muscle innervation, function (observable entity)",20020131,1,9E+17,9E+17
72066008,Basal gastric acid secretion (observable entity),20020131,1,9E+17,9E+17
103579009,Race (observable entity),20020131,1,9E+17,9E+17
103420007,Modified Dukes stage (observable entity),20020131,1,9E+17,9E+17
72947005,Maximum expiratory flow-static recoil curve (observable entity),20020131,1,9E+17,9E+17
71750001,Airborne lead (Pb) concentration (observable entity),20020131,1,9E+17,9E+17
370980007,"Fine motor coordination, function (observable entity)",20020731,1,9E+17,9E+17
370993002,Auditory acuity (observable entity),20020731,1,9E+17,9E+17
370962003,Orbit observable (observable entity),20020731,1,9E+17,9E+17
370959001,Lens thickness (observable entity),20020731,1,9E+17,9E+17
370955007,Corneal sensation (observable entity),20020731,1,9E+17,9E+17
370954006,Corneal curvature refracting power (observable entity),20020731,1,9E+17,9E+17
370938008,Horizontal cup disc ratio (observable entity),20020731,1,9E+17,9E+17
370937003,Vertical cup disc ratio (observable entity),20020731,1,9E+17,9E+17
370973005,Academic progress (observable entity),20020731,1,9E+17,9E+17
373063009,Substance observable (observable entity),20020731,1,9E+17,9E+17
373064003,Drug observable (observable entity),20020731,1,9E+17,9E+17
373197004,"Polyp size, largest dimension (observable entity)",20020731,1,9E+17,9E+17
373860006,Afterloaded brachytherapy source (observable entity),20020731,1,9E+17,9E+17
373861005,Manually afterloaded brachytherapy source (observable entity),20020731,1,9E+17,9E+17
373862003,Remotely afterloaded brachytherapy source (observable entity),20020731,1,9E+17,9E+17
373859001,Brachytherapy source loading method (observable entity),20020731,1,9E+17,9E+17
373642008,Extraocular eye movement (observable entity),20020731,1,9E+17,9E+17
373719009,Continuity of fetal heart sounds (observable entity),20020731,1,9E+17,9E+17
373720003,Site of loudest fetal heart sounds (observable entity),20020731,1,9E+17,9E+17
373848005,External beam radiation therapy geometry parameters (observable entity),20020731,1,9E+17,9E+17
373849002,Fixed field external beam radiation therapy parameters (observable entity),20020731,1,9E+17,9E+17
373850002,Single field external beam radiation therapy (observable entity),20020731,1,9E+17,9E+17
373851003,Two field external beam radiation therapy (observable entity),20020731,1,9E+17,9E+17
373852005,Three field external beam radiation therapy (observable entity),20020731,1,9E+17,9E+17
373853000,Four field external beam radiation therapy (observable entity),20020731,1,9E+17,9E+17
371846000,Pulmonary valve flow (observable entity),20020731,1,9E+17,9E+17
371847009,Tricuspid diastolic filling period (observable entity),20020731,1,9E+17,9E+17
371849007,Mitral diastolic filling period (observable entity),20020731,1,9E+17,9E+17
371848004,Pulmonary systolic ejection period (observable entity),20020731,1,9E+17,9E+17
371850007,Aortic systolic ejection period (observable entity),20020731,1,9E+17,9E+17
371839009,"Derived flow, non-valve (observable entity)",20020731,1,9E+17,9E+17
371840006,Tricuspid valve flow (observable entity),20020731,1,9E+17,9E+17
371841005,Fractional flow reserve using intravenous infusion (observable entity),20020731,1,9E+17,9E+17
371842003,Fractional flow reserve (observable entity),20020731,1,9E+17,9E+17
371845001,Aortic valve flow (observable entity),20020731,1,9E+17,9E+17
371844002,"Derived flow, nonvalve (observable entity)",20020731,1,9E+17,9E+17
371851006,Angioplasty inflation pressure (observable entity),20020731,1,9E+17,9E+17
371892002,Delivered radiation dose (observable entity),20020731,1,9E+17,9E+17
371852004,Angioplasty inflation duration (observable entity),20020731,1,9E+17,9E+17
371853009,"Derived period, non-valve (observable entity)",20020731,1,9E+17,9E+17
371854003,Rotational atherectomy speed (observable entity),20020731,1,9E+17,9E+17
371493002,Status of venous (large vessel) invasion by tumor (observable entity),20020731,1,9E+17,9E+17
371491000,Closest surgical margin to neoplasm in excised specimen (observable entity),20020731,1,9E+17,9E+17
371489008,Distance of neoplasm from closest surgical margin in excised specimen (observable entity),20020731,1,9E+17,9E+17
371484003,Patient name (observable entity),20020731,1,9E+17,9E+17
371482004,Surgical pathology identifier (observable entity),20020731,1,9E+17,9E+17
371479009,"Tumor size, largest dimension (observable entity)",20020731,1,9E+17,9E+17
371478001,"Specimen size, dimension 3 (observable entity)",20020731,1,9E+17,9E+17
371477006,"Specimen size, dimension 2 (observable entity)",20020731,1,9E+17,9E+17
371476002,"Specimen size, dimension 1 (observable entity)",20020731,1,9E+17,9E+17
371475003,Specimen size (observable entity),20020731,1,9E+17,9E+17
371494008,pN category (observable entity),20020731,1,9E+17,9E+17
371495009,Stage of tumor involvement of non-regional lymph nodes (observable entity),20020731,1,9E+17,9E+17
371497001,pM category (observable entity),20020731,1,9E+17,9E+17
371500007,Tumor configuration (observable entity),20020731,1,9E+17,9E+17
371498006,Additional pathologic finding in tumor specimen (observable entity),20020731,1,9E+17,9E+17
371473005,"Mitotic count score, 25x objective (observable entity)",20020731,1,9E+17,9E+17
371472000,Mitotic count score (observable entity),20020731,1,9E+17,9E+17
371471007,Nuclear pleomorphism score (observable entity),20020731,1,9E+17,9E+17
371470008,Tubule formation score (observable entity),20020731,1,9E+17,9E+17
371474004,"Mitotic count score, 40x objective (observable entity)",20020731,1,9E+17,9E+17
371440003,Cancer protocol observable (observable entity),20020731,1,9E+17,9E+17
371439000,Specimen type (observable entity),20020731,1,9E+17,9E+17
371835003,Fractional flow reserve using intracoronary bolus (observable entity),20020731,1,9E+17,9E+17
371826005,Total pulmonary resistance index (observable entity),20020731,1,9E+17,9E+17
371836002,Cardiac valve flow (observable entity),20020731,1,9E+17,9E+17
371837006,Mitral valve flow (observable entity),20020731,1,9E+17,9E+17
371509008,Status of peritumoral lymphocyte response (observable entity),20020731,1,9E+17,9E+17
371508000,Tumor stage (observable entity),20020731,1,9E+17,9E+17
371507005,Adequacy of specimen (observable entity),20020731,1,9E+17,9E+17
371506001,Specimen weight (observable entity),20020731,1,9E+17,9E+17
371502004,Tumor border configuration (observable entity),20020731,1,9E+17,9E+17
371501006,Polyp configuration (observable entity),20020731,1,9E+17,9E+17
371511004,Tumor immunophenotyping status (observable entity),20020731,1,9E+17,9E+17
371767005,Length of procedure (observable entity),20020731,1,9E+17,9E+17
372438005,Presence of neoplasm at deep (radial) surgical margin of excised specimen (observable entity),20020731,1,9E+17,9E+17
372303007,Ratio of blocks with prostate tumor to total number of blocks obtained (observable entity),20020731,1,9E+17,9E+17
372289007,Status of periprostatic fat invasion by tumor (observable entity),20020731,1,9E+17,9E+17
372264001,Status of small vessel invasion by tumor (observable entity),20020731,1,9E+17,9E+17
372261009,"Polyp size, dimension 3 (observable entity)",20020731,1,9E+17,9E+17
372260005,"Polyp size, dimension 2 (observable entity)",20020731,1,9E+17,9E+17
372259000,"Polyp size, dimension 1 (observable entity)",20020731,1,9E+17,9E+17
372258008,Polyp size (observable entity),20020731,1,9E+17,9E+17
372282003,Number of positive prostatic tissue chips obtained by resection (observable entity),20020731,1,9E+17,9E+17
372280006,Ratio of number of prostatic tissue cores positive for carcinoma to total number of cores obtained by needle biopsy (observable entity),20020731,1,9E+17,9E+17
372279008,Percentage of prostatic tissue involved by carcinoma (observable entity),20020731,1,9E+17,9E+17
372275002,Cytology sample identification number (observable entity),20020731,1,9E+17,9E+17
372274003,Sample identification number (observable entity),20020731,1,9E+17,9E+17
395715009,Status of lymphatic (small vessel) invasion by tumor (observable entity),20030131,1,9E+17,9E+17
395558005,Number of pieces in fragmented specimen (observable entity),20030131,1,9E+17,9E+17
395527009,Microscopic specimen observable (observable entity),20030131,1,9E+17,9E+17
395526000,Macroscopic specimen observable (observable entity),20030131,1,9E+17,9E+17
395511002,Polyp stalk length (observable entity),20030131,1,9E+17,9E+17
395509006,"Polyp size, additional dimension (observable entity)",20030131,1,9E+17,9E+17
385398005,"Tumor size, dominant nodule, greatest dimension (observable entity)",20030131,1,9E+17,9E+17
385397000,"Percentage of prostatic tissue, obtained by transurethral prostatic resection, involved by carcinoma (observable entity)",20030131,1,9E+17,9E+17
385396009,"Percentage of prostatic tissue, obtained by needle biopsy, involved by carcinoma (observable entity)",20030131,1,9E+17,9E+17
385393001,Distance of malignant neoplasm from closest lateral margin in excised specimen (observable entity),20030131,1,9E+17,9E+17
385400009,"Percentage of prostatic tissue, obtained by radical prostatectomy, involved by carcinoma (observable entity)",20030131,1,9E+17,9E+17
385401008,"Percentage of prostatic tissue, obtained by prostatic enucleation, involved by carcinoma (observable entity)",20030131,1,9E+17,9E+17
385375002,International Federation of Gynecology and Obstetrics stage for endometrial carcinoma (observable entity),20030131,1,9E+17,9E+17
385373009,International Federation of Gynecology and Obstetrics uterine tumor stage (observable entity),20030131,1,9E+17,9E+17
385371006,International Federation of Gynecology and Obstetrics stage for vulvar melanoma (observable entity),20030131,1,9E+17,9E+17
385369006,International Federation of Gynecology and Obstetrics stage for vulvar carcinoma (observable entity),20030131,1,9E+17,9E+17
385367008,International Federation of Gynecology and Obstetrics stage for cervical carcinoma (observable entity),20030131,1,9E+17,9E+17
385365000,International Federation of Gynecology and Obstetrics stage for epithelial tumor of ovary (observable entity),20030131,1,9E+17,9E+17
385363007,International Federation of Gynecology and Obstetrics ovarian tumor stage (observable entity),20030131,1,9E+17,9E+17
385391004,Status of venous (large vessel)/lymphatic (small vessel) invasion by tumor (observable entity),20030131,1,9E+17,9E+17
385388004,Lymphoma stage (observable entity),20030131,1,9E+17,9E+17
385361009,International Federation of Gynecology and Obstetrics stage for gynecological malignancy (observable entity),20030131,1,9E+17,9E+17
385352009,Human immunodeficiency virus World Health Organization class (observable entity),20030131,1,9E+17,9E+17
385351002,Human immunodeficiency virus Centers for Disease Control and Prevention category (observable entity),20030131,1,9E+17,9E+17
385349001,Clinical stage (observable entity),20030131,1,9E+17,9E+17
385357003,Dukes stage (observable entity),20030131,1,9E+17,9E+17
395091006,Preferred place of death (observable entity),20030131,1,9E+17,9E+17
395111008,Substance level in breath (observable entity),20030131,1,9E+17,9E+17
385274001,Distance of neoplasm from closest lateral surgical margin in excised specimen (observable entity),20030131,1,9E+17,9E+17
395177003,Smoking free weeks (observable entity),20030131,1,9E+17,9E+17
395060000,24 hour urine output (observable entity),20030131,1,9E+17,9E+17
386132006,Ablation frequency (observable entity),20030131,1,9E+17,9E+17
386131004,Ablation power (observable entity),20030131,1,9E+17,9E+17
386726008,"Thermoregulation, function (observable entity)",20030131,1,9E+17,9E+17
386530009,Systemic vascular resistance (observable entity),20030131,1,9E+17,9E+17
390792008,Target international normalized ratio (observable entity),20030131,1,9E+17,9E+17
384606002,Length of specimen (observable entity),20030131,1,9E+17,9E+17
384604004,Status of intratumoral/peritumoral lymphocyte response (observable entity),20030131,1,9E+17,9E+17
384631001,"Tumor size, invasive component, greatest dimension (observable entity)",20030131,1,9E+17,9E+17
384627007,"Specimen size, largest dimension (observable entity)",20030131,1,9E+17,9E+17
384626003,"Specimen size, additional dimension (observable entity)",20030131,1,9E+17,9E+17
384625004,pT category (observable entity),20030131,1,9E+17,9E+17
384669006,Status of microcalcifications in specimen (observable entity),20030131,1,9E+17,9E+17
392162000,Neuroretinal rim slope (observable entity),20030131,1,9E+17,9E+17
392161007,Neuroretinal rim width (observable entity),20030131,1,9E+17,9E+17
392160008,Neuroretinal rim color (observable entity),20030131,1,9E+17,9E+17
392159003,Neuroretinal rim observable (observable entity),20030131,1,9E+17,9E+17
392158006,Vertical diameter of optic disc (observable entity),20030131,1,9E+17,9E+17
392145005,Horizontal diameter of optic disc (observable entity),20030131,1,9E+17,9E+17
391400001,Virus isolation report (observable entity),20030131,1,9E+17,9E+17
391002003,Number of falls in last year (observable entity),20030131,1,9E+17,9E+17
390900001,Smoking cessation milestones (observable entity),20030131,1,9E+17,9E+17
390901002,Negotiated date for cessation of smoking (observable entity),20030131,1,9E+17,9E+17
390902009,Smoking status at 4 weeks (observable entity),20030131,1,9E+17,9E+17
390903004,Smoking status between 4 and 52 weeks (observable entity),20030131,1,9E+17,9E+17
390904005,Smoking status at 52 weeks (observable entity),20030131,1,9E+17,9E+17
390929004,Worst peak flow rate (observable entity),20030131,1,9E+17,9E+17
391105003,Target physical activity (observable entity),20030131,1,9E+17,9E+17
384995005,Secondary Gleason pattern (observable entity),20030131,1,9E+17,9E+17
385002007,Tertiary Gleason pattern (observable entity),20030131,1,9E+17,9E+17
384994009,Primary Gleason pattern (observable entity),20030131,1,9E+17,9E+17
384961006,Surgical attached tissue margin site involved by malignant neoplasm (observable entity),20030131,1,9E+17,9E+17
384727002,Specimen laterality (observable entity),20030131,1,9E+17,9E+17
384739005,Grading system used (observable entity),20030131,1,9E+17,9E+17
384891002,Distance of malignant neoplasm from closest surgical margin in excised specimen (observable entity),20030131,1,9E+17,9E+17
396551005,Femur length (observable entity),20030731,1,9E+17,9E+17
396552003,Abdominal circumference (observable entity),20030731,1,9E+17,9E+17
396694007,"Tumor size, non-dominant nodule, greatest dimension (observable entity)",20030731,1,9E+17,9E+17
396716004,Serum marker status (observable entity),20030731,1,9E+17,9E+17
396660005,Adequacy of specimen for determining T category (observable entity),20030731,1,9E+17,9E+17
396645007,Status of extension by tumor (observable entity),20030731,1,9E+17,9E+17
396663007,Histologic type of tumor-associated epithelial lesion (observable entity),20030731,1,9E+17,9E+17
396985003,Tumor location after sectioning (observable entity),20030731,1,9E+17,9E+17
396973006,Site of neovascularization (observable entity),20030731,1,9E+17,9E+17
396976003,Extent of optic nerve invasion by tumor (observable entity),20030731,1,9E+17,9E+17
401049002,Communication skills (observable entity),20030731,1,9E+17,9E+17
396975004,"Mitotic count score, 40x objective with a field area of 0.152 mm2 (observable entity)",20030731,1,9E+17,9E+17
396991001,Biopsy site (observable entity),20030731,1,9E+17,9E+17
397006007,World Health Organization tumor classification cannot be determined (observable entity),20030731,1,9E+17,9E+17
396995005,Aspirate site (observable entity),20030731,1,9E+17,9E+17
397005006,World Health Organization tumor classification (observable entity),20030731,1,9E+17,9E+17
397002009,Type of immunophenotypic analysis performed (observable entity),20030731,1,9E+17,9E+17
397003004,Immunophenotypic analysis result (observable entity),20030731,1,9E+17,9E+17
396935007,Size of specimen obtained by exenteration (observable entity),20030731,1,9E+17,9E+17
396783001,Number of nodal groups present in specimen (observable entity),20030731,1,9E+17,9E+17
396934006,Diameter of optic nerve in specimen (observable entity),20030731,1,9E+17,9E+17
396786009,Status of tumor metastasis to non-regional lymph nodes (observable entity),20030731,1,9E+17,9E+17
396790006,"Tumor size, largest metastasis, greatest dimension (observable entity)",20030731,1,9E+17,9E+17
396793008,Tumor viability (observable entity),20030731,1,9E+17,9E+17
396893004,Functional status of pancreatic endocrine tumor (observable entity),20030731,1,9E+17,9E+17
396926000,Type of study performed on tumor specimen (observable entity),20030731,1,9E+17,9E+17
396929007,Size of specimen obtained by enucleation (observable entity),20030731,1,9E+17,9E+17
396930002,Anteroposterior diameter of specimen (observable entity),20030731,1,9E+17,9E+17
396931003,Horizontal diameter of specimen (observable entity),20030731,1,9E+17,9E+17
396932005,Vertical diameter of specimen (observable entity),20030731,1,9E+17,9E+17
396933000,Length of optic nerve in specimen (observable entity),20030731,1,9E+17,9E+17
396920006,World Health Organization grade for central nervous system tumor (observable entity),20030731,1,9E+17,9E+17
401296001,Percentage reticulated platelet count (procedure),20030731,1,9E+17,9E+17
401320004,Hospital Anxiety and Depression scale: depression score (observable entity),20030731,1,9E+17,9E+17
401319005,Hospital Anxiety and Depression scale: anxiety score (observable entity),20030731,1,9E+17,9E+17
396327004,Type of lymph node submitted (observable entity),20030731,1,9E+17,9E+17
396361002,"Lesion size, largest dimension (observable entity)",20030731,1,9E+17,9E+17
396362009,"Lesion size, additional dimension (observable entity)",20030731,1,9E+17,9E+17
396402005,"Tumor extent of invasion, macroscopic (observable entity)",20030731,1,9E+17,9E+17
396406008,Status of specimen involvement by satellite nodule(s) (observable entity),20030731,1,9E+17,9E+17
396410006,Tumor pigmentation (observable entity),20030731,1,9E+17,9E+17
396367003,Status of tumor involvement by ulceration (observable entity),20030731,1,9E+17,9E+17
396395003,Status of tumor infiltration by lymphocytes (observable entity),20030731,1,9E+17,9E+17
396310007,Thickness of myometrium (observable entity),20030731,1,9E+17,9E+17
396252004,Grade of intraepithelial neoplasia involving exocervical margin (observable entity),20030731,1,9E+17,9E+17
396254003,Grade of intraepithelial neoplasia involving endocervical margin (observable entity),20030731,1,9E+17,9E+17
396277003,Fluid observable (observable entity),20030731,1,9E+17,9E+17
396278008,Identification number (observable entity),20030731,1,9E+17,9E+17
396276007,Fluid appearance (observable entity),20030731,1,9E+17,9E+17
396274005,Organ present in surgical specimen (observable entity),20030731,1,9E+17,9E+17
396272009,Grade of intraepithelial neoplasia involving deep margin (observable entity),20030731,1,9E+17,9E+17
396415001,Status of specimen involvement by matted nodes (observable entity),20030731,1,9E+17,9E+17
396510008,Distance of in situ carcinoma from closest lateral surgical margin in excised specimen (observable entity),20030731,1,9E+17,9E+17
396511007,Distance of in situ melanoma from closest lateral surgical margin in excised specimen of skin (observable entity),20030731,1,9E+17,9E+17
396515003,Distance of malignant melanoma from closest lateral margin (observable entity),20030731,1,9E+17,9E+17
396432002,Status of regression of tumor (observable entity),20030731,1,9E+17,9E+17
396475008,Distance of malignant neoplasm from closest parenchymal margin (observable entity),20030731,1,9E+17,9E+17
401163005,Percentage of best ever peak expiratory flow rate (observable entity),20030731,1,9E+17,9E+17
401159003,Reason for restarting smoking (observable entity),20030731,1,9E+17,9E+17
401160008,Smoking cessation program start date (observable entity),20030731,1,9E+17,9E+17
401199000,Percentage of peak expiratory flow rate variability (observable entity),20030731,1,9E+17,9E+17
401115007,Forced expired volume in 1 second pre steroids (observable entity),20030731,1,9E+17,9E+17
396191000,Fuhrman nuclear grade (observable entity),20030731,1,9E+17,9E+17
396210009,Status of adrenal gland involvement by tumor (observable entity),20030731,1,9E+17,9E+17
398300007,Systolic blood pressure validity range (observable entity),20030731,1,9E+17,9E+17
398299004,Time of death (observable entity),20030731,1,9E+17,9E+17
399299007,Treatment-determining electrocardiogram finding (observable entity),20030731,1,9E+17,9E+17
399301000,Regurgitant fraction (observable entity),20030731,1,9E+17,9E+17
399274006,Actual brachytherapy dose (observable entity),20030731,1,9E+17,9E+17
399276008,Actual fractions - external beam radiation therapy (observable entity),20030731,1,9E+17,9E+17
398095003,Guarantor address (observable entity),20030731,1,9E+17,9E+17
398099009,Street address (observable entity),20030731,1,9E+17,9E+17
398093005,Social security number (observable entity),20030731,1,9E+17,9E+17
398069000,Secondary Insurer (observable entity),20030731,1,9E+17,9E+17
399057003,Prescribed dose of brachytherapy (observable entity),20030731,1,9E+17,9E+17
398059006,Awareness under anesthesia (observable entity),20030731,1,9E+17,9E+17
398079003,Guarantor name (observable entity),20030731,1,9E+17,9E+17
399264008,Image mode (observable entity),20030731,1,9E+17,9E+17
398122008,Tourniquet on (observable entity),20030731,1,9E+17,9E+17
399337005,Actual external beam radiation therapy dose (observable entity),20030731,1,9E+17,9E+17
397443003,Site of largest single mass (observable entity),20030731,1,9E+17,9E+17
397447002,Lymphoma extent of involvement (observable entity),20030731,1,9E+17,9E+17
397978006,Secondary Insurer identification number (observable entity),20030731,1,9E+17,9E+17
399084002,Type of anesthetic (observable entity),20030731,1,9E+17,9E+17
397924006,Maternal satisfaction with anesthesia (observable entity),20030731,1,9E+17,9E+17
397413000,Vessel lumen diameter (observable entity),20030731,1,9E+17,9E+17
397414006,Vessel outside diameter (observable entity),20030731,1,9E+17,9E+17
397415007,Vessel lumen cross-sectional area (observable entity),20030731,1,9E+17,9E+17
397417004,Regurgitant flow (observable entity),20030731,1,9E+17,9E+17
397935001,Maternal satisfaction with delivery analgesia (observable entity),20030731,1,9E+17,9E+17
399077005,Prescribed external beam radiation therapy dose (observable entity),20030731,1,9E+17,9E+17
399060005,Imaging observable (observable entity),20030731,1,9E+17,9E+17
399186002,Actual duration - brachytherapy (observable entity),20030731,1,9E+17,9E+17
397995003,Relationship of consenting agent to patient (observable entity),20030731,1,9E+17,9E+17
397586001,Reproductive observable (observable entity),20030731,1,9E+17,9E+17
398014003,Decision to perform date (observable entity),20030731,1,9E+17,9E+17
397477008,Presence of fetal tissue in specimen (observable entity),20030731,1,9E+17,9E+17
398017005,Maternal satisfaction with labor analgesia (observable entity),20030731,1,9E+17,9E+17
399716000,"pT category, nasopharynx (observable entity)",20030731,1,9E+17,9E+17
398225001,Medical record number (observable entity),20030731,1,9E+17,9E+17
399722009,"pT category, nasal cavity and ethmoid sinus (observable entity)",20030731,1,9E+17,9E+17
399668004,Status of ovarian tumor omental implants (observable entity),20030731,1,9E+17,9E+17
399667009,"Organ AND/OR tissue, other than fallopian tube, microscopically involved by tumor (observable entity)",20030731,1,9E+17,9E+17
399482008,Total number of tissue cores (observable entity),20030731,1,9E+17,9E+17
399483003,Organ AND/OR tissue involved by tumor (observable entity),20030731,1,9E+17,9E+17
399703000,Integrated TNM category (observable entity),20030731,1,9E+17,9E+17
399698006,"pN category, nasopharynx (observable entity)",20030731,1,9E+17,9E+17
398198004,Guarantor phone number (observable entity),20030731,1,9E+17,9E+17
399450005,"pT category, iris (observable entity)",20030731,1,9E+17,9E+17
399737008,Date of pathology report (observable entity),20030731,1,9E+17,9E+17
399462009,Secondary tumor site (observable entity),20030731,1,9E+17,9E+17
399725006,Location of tumor within eye (observable entity),20030731,1,9E+17,9E+17
399753006,Date of death (observable entity),20030731,1,9E+17,9E+17
399743005,"pT category, hypopharynx (observable entity)",20030731,1,9E+17,9E+17
399539009,"pT category, subglottis (observable entity)",20030731,1,9E+17,9E+17
399574005,Degree of pigmentation of tumor (observable entity),20030731,1,9E+17,9E+17
397504000,Organ AND/OR tissue microscopically involved by tumor (observable entity),20030731,1,9E+17,9E+17
399537006,Clinical TNM stage grouping (observable entity),20030731,1,9E+17,9E+17
399583000,"pT category, ciliary body and choroid (observable entity)",20030731,1,9E+17,9E+17
399535003,"pT category, glottis (observable entity)",20030731,1,9E+17,9E+17
399549007,"pT category, lip and oral cavity (observable entity)",20030731,1,9E+17,9E+17
397512008,Site of non-invasive (desmoplastic) ovarian tumor omental implant (observable entity),20030731,1,9E+17,9E+17
397510000,Site of non-invasive (epithelial) ovarian tumor omental implant (observable entity),20030731,1,9E+17,9E+17
397511001,Status of non-invasive (desmoplastic) ovarian tumor omental implants (observable entity),20030731,1,9E+17,9E+17
397505004,Status of non-invasive (epithelial) ovarian tumor omental implants (observable entity),20030731,1,9E+17,9E+17
399566009,Tumor-node-metastasis (TNM) category (observable entity),20030731,1,9E+17,9E+17
399565008,Organ AND/OR tissue macroscopically involved by tumor (observable entity),20030731,1,9E+17,9E+17
399639000,Number of non-regional lymph nodes present in specimen (observable entity),20030731,1,9E+17,9E+17
399638008,Number of non-regional lymph nodes examined (observable entity),20030731,1,9E+17,9E+17
399637003,Histologic grade of intraepithelial neoplasia (observable entity),20030731,1,9E+17,9E+17
399656008,Status of tumor metastasis to regional lymph nodes (observable entity),20030731,1,9E+17,9E+17
399489004,Status of specimen involvement by macroscopic tumor (observable entity),20030731,1,9E+17,9E+17
399653000,Percentage of sarcomatoid element in tumor (observable entity),20030731,1,9E+17,9E+17
399651003,Date of report (observable entity),20030731,1,9E+17,9E+17
399496002,Distance of ductal carcinoma in situ of breast from closest surgical margin in excised breast specimen (observable entity),20030731,1,9E+17,9E+17
399631002,Tumor-node-metastasis (TNM) tumor observable (observable entity),20030731,1,9E+17,9E+17
399598003,Length of core in specimen obtained by needle biopsy (observable entity),20030731,1,9E+17,9E+17
399588009,Pathologic TNM stage grouping (observable entity),20030731,1,9E+17,9E+17
399628003,"pT category, oropharynx (observable entity)",20030731,1,9E+17,9E+17
399513006,"pT category, maxillary sinus (observable entity)",20030731,1,9E+17,9E+17
399613003,Site of invasive ovarian tumor omental implant (observable entity),20030731,1,9E+17,9E+17
399608002,Status of distant metastasis (observable entity),20030731,1,9E+17,9E+17
399023006,Right ventricular peak systolic pressure (observable entity),20030731,1,9E+17,9E+17
399423000,Date of admission (observable entity),20030731,1,9E+17,9E+17
399424006,Serum tumor marker category (observable entity),20030731,1,9E+17,9E+17
398269008,Best positive end expiratory pressure (observable entity),20030731,1,9E+17,9E+17
399428009,Status of invasive ovarian tumor omental implants (observable entity),20030731,1,9E+17,9E+17
399376006,"pT category, supraglottis (observable entity)",20030731,1,9E+17,9E+17
399390009,Tumor-node-metastasis (TNM) stage grouping (observable entity),20030731,1,9E+17,9E+17
398990005,Prescribed duration - brachytherapy (observable entity),20030731,1,9E+17,9E+17
399392001,Distance of in situ carcinoma from closest margin in excised specimen (observable entity),20030731,1,9E+17,9E+17
399435001,Specimen measurable (observable entity),20030731,1,9E+17,9E+17
398179001,Expiratory concentration (observable entity),20030731,1,9E+17,9E+17
399441008,Total number of tissue chips (observable entity),20030731,1,9E+17,9E+17
398184007,Duration tourniquet in place (observable entity),20030731,1,9E+17,9E+17
399445004,Specimen collection date (observable entity),20030731,1,9E+17,9E+17
399437009,Integrated M category (observable entity),20030731,1,9E+17,9E+17
398174006,Primary insurer (observable entity),20030731,1,9E+17,9E+17
398168006,Generally clean appearance (finding),20030731,1,9E+17,9E+17
399429001,Region of fallopian tube involved by tumor (observable entity),20030731,1,9E+17,9E+17
398159009,All critical points (observable entity),20030731,1,9E+17,9E+17
398153005,Transesophageal echocardiographic monitoring features (observable entity),20030731,1,9E+17,9E+17
399147001,Prescribed fractions - brachytherapy (observable entity),20030731,1,9E+17,9E+17
397647009,Ability to conceive (observable entity),20030731,1,9E+17,9E+17
397260005,Overall diameter of intraocular lens (observable entity),20030731,1,9E+17,9E+17
397652004,Ability to identify odor (observable entity),20030731,1,9E+17,9E+17
397870003,Primary Insurer Identification Number (observable entity),20030731,1,9E+17,9E+17
397259000,Monocular pupillary distance (observable entity),20030731,1,9E+17,9E+17
397853006,Vascular pressure monitoring features (observable entity),20030731,1,9E+17,9E+17
397678008,Surname (observable entity),20030731,1,9E+17,9E+17
397256007,Fitting point position (observable entity),20030731,1,9E+17,9E+17
400967004,Baseline weight (observable entity),20030731,1,9E+17,9E+17
397257003,Fitting point height (observable entity),20030731,1,9E+17,9E+17
397258008,Interpupillary distance (observable entity),20030731,1,9E+17,9E+17
397672009,Ability to sense temperature (observable entity),20030731,1,9E+17,9E+17
397623002,Ability to sense pressure (observable entity),20030731,1,9E+17,9E+17
397263007,A-constant of intraocular lens (observable entity),20030731,1,9E+17,9E+17
397266004,Intraocular lens haptic material (observable entity),20030731,1,9E+17,9E+17
397267008,Intraocular lens haptic angulation (observable entity),20030731,1,9E+17,9E+17
397268003,Intraocular lens design (observable entity),20030731,1,9E+17,9E+17
397269006,Intraocular lens optic edge design (observable entity),20030731,1,9E+17,9E+17
397621000,"Allergen specific antibody interpretation, semi-quantitative (observable entity)",20030731,1,9E+17,9E+17
397264001,Refractive index of intraocular lens (observable entity),20030731,1,9E+17,9E+17
397265000,Intraocular lens optic material (observable entity),20030731,1,9E+17,9E+17
397616003,Ability to be consciously aware of viscera (observable entity),20030731,1,9E+17,9E+17
397635003,Address (observable entity),20030731,1,9E+17,9E+17
397643008,Ability to sense sharp point (observable entity),20030731,1,9E+17,9E+17
397262002,Intraocular lens model (observable entity),20030731,1,9E+17,9E+17
397634004,Ability to sense heat (observable entity),20030731,1,9E+17,9E+17
397261009,Optic diameter of intraocular lens (observable entity),20030731,1,9E+17,9E+17
397155001,Body position (observable entity),20030731,1,9E+17,9E+17
401003006,Weight loss from baseline weight (observable entity),20030731,1,9E+17,9E+17
397727006,Ability to sense position and movement (observable entity),20030731,1,9E+17,9E+17
397720008,Ability to sense cold (observable entity),20030731,1,9E+17,9E+17
400989000,Carer Strain Index Score (observable entity),20030731,1,9E+17,9E+17
400987003,Asthma trigger (observable entity),20030731,1,9E+17,9E+17
397726002,Ability to smell (observable entity),20030731,1,9E+17,9E+17
397814002,Mode of ventilation monitoring (observable entity),20030731,1,9E+17,9E+17
401012008,Forced expired volume in 1 second before bronchodilation (observable entity),20030731,1,9E+17,9E+17
397793000,Monitoring features (observable entity),20030731,1,9E+17,9E+17
401013003,Forced expired volume in 1 second after bronchodilation (observable entity),20030731,1,9E+17,9E+17
397742009,Patient middle initial (observable entity),20030731,1,9E+17,9E+17
401014009,Peak expiratory flow rate pre steroids (observable entity),20030731,1,9E+17,9E+17
401015005,Peak expiratory flow rate post steroids (observable entity),20030731,1,9E+17,9E+17
397799001,Tourniquet off (observable entity),20030731,1,9E+17,9E+17
401019004,Trigger factor for seizure (observable entity),20030731,1,9E+17,9E+17
401016006,Forced expired volume in 1 second post steroids (observable entity),20030731,1,9E+17,9E+17
397270007,Intraocular lens form (observable entity),20030731,1,9E+17,9E+17
397836004,Time of delivery (observable entity),20030731,1,9E+17,9E+17
397705002,Ability to be consciously aware of the body (observable entity),20030731,1,9E+17,9E+17
397694001,Ability to sense vibration (observable entity),20030731,1,9E+17,9E+17
397252009,Eye glasses observable (observable entity),20030731,1,9E+17,9E+17
397253004,Pantascopic angle (observable entity),20030731,1,9E+17,9E+17
397254005,Optical center distance (observable entity),20030731,1,9E+17,9E+17
397255006,Centration distance (observable entity),20030731,1,9E+17,9E+17
397689001,Ability to sense tickle (observable entity),20030731,1,9E+17,9E+17
397191008,Specimen integrity (observable entity),20030731,1,9E+17,9E+17
397717000,"Allergen specific antibody interpretation, quantitative (observable entity)",20030731,1,9E+17,9E+17
397716009,Allergen specific antibody interpretation (observable entity),20030731,1,9E+17,9E+17
397208001,Status of arterial (large vessel) invasion by tumor (observable entity),20030731,1,9E+17,9E+17
397714007,Ability to sense pain (observable entity),20030731,1,9E+17,9E+17
397595009,"Allergen specific antibody interpretation, qualitative (observable entity)",20030731,1,9E+17,9E+17
397327009,Patency of fimbriated end of right fallopian tube (observable entity),20030731,1,9E+17,9E+17
397328004,Patency of fimbriated end of left fallopian tube (observable entity),20030731,1,9E+17,9E+17
397886005,Respiratory monitoring parameter features (observable entity),20030731,1,9E+17,9E+17
397330002,Relationship of right fallopian tube to right ovary (observable entity),20030731,1,9E+17,9E+17
397599003,Ability to sense touch (observable entity),20030731,1,9E+17,9E+17
397331003,Relationship of left fallopian tube to left ovary (observable entity),20030731,1,9E+17,9E+17
397329007,Fallopian tube observable (observable entity),20030731,1,9E+17,9E+17
397311002,Intraocular lens manufacturer (observable entity),20030731,1,9E+17,9E+17
397312009,Intraocular lens anterior chamber depth (observable entity),20030731,1,9E+17,9E+17
397310001,Contact lens tint (observable entity),20030731,1,9E+17,9E+17
398700009,Age at menarche (observable entity),20030731,1,9E+17,9E+17
399111002,Prescribed duration - external beam radiation therapy (observable entity),20030731,1,9E+17,9E+17
397910007,Awareness under general anesthesia (observable entity),20030731,1,9E+17,9E+17
397907000,Maternal satisfaction with analgesia post cesarean section (observable entity),20030731,1,9E+17,9E+17
399115006,Actual fractions - brachytherapy (observable entity),20030731,1,9E+17,9E+17
397592007,Ability to detect odor (observable entity),20030731,1,9E+17,9E+17
399116007,Prescribed fractions - external beam radiation therapy (observable entity),20030731,1,9E+17,9E+17
397309006,Contact lens addition power (observable entity),20030731,1,9E+17,9E+17
397292006,Contact lens manufacturer (observable entity),20030731,1,9E+17,9E+17
397293001,Contact lens model (observable entity),20030731,1,9E+17,9E+17
397294007,Contact lens fitting parameter (observable entity),20030731,1,9E+17,9E+17
397295008,Contact lens base curve (observable entity),20030731,1,9E+17,9E+17
397296009,Contact lens power curve (observable entity),20030731,1,9E+17,9E+17
397306004,Contact lens external optical zone (observable entity),20030731,1,9E+17,9E+17
397297000,Contact lens diameter (observable entity),20030731,1,9E+17,9E+17
397298005,Contact lens power (observable entity),20030731,1,9E+17,9E+17
397291004,Contact lens type (observable entity),20030731,1,9E+17,9E+17
397274003,Exophthalmometry measurement (observable entity),20030731,1,9E+17,9E+17
397273009,General appearance of bulbar conjunctiva (observable entity),20030731,1,9E+17,9E+17
397289007,Spectacle lens material (observable entity),20030731,1,9E+17,9E+17
397307008,Contact lens cylinder power (observable entity),20030731,1,9E+17,9E+17
397290003,Contact lens observable (observable entity),20030731,1,9E+17,9E+17
397288004,Feature of spectacle lens (observable entity),20030731,1,9E+17,9E+17
397300005,Contact lens material (observable entity),20030731,1,9E+17,9E+17
397304001,Contact lens posterior vertex power (observable entity),20030731,1,9E+17,9E+17
397610009,Ability to taste (observable entity),20030731,1,9E+17,9E+17
397281005,Front vertex power (observable entity),20030731,1,9E+17,9E+17
397280006,Back vertex power (observable entity),20030731,1,9E+17,9E+17
397305000,Contact lens internal optical zone (observable entity),20030731,1,9E+17,9E+17
397282003,Reading addition power (observable entity),20030731,1,9E+17,9E+17
397877000,Inspiratory concentration (observable entity),20030731,1,9E+17,9E+17
397302002,Contact lens optic zone (observable entity),20030731,1,9E+17,9E+17
397303007,Contact lens chord diameter (observable entity),20030731,1,9E+17,9E+17
397301009,Contact lens center thickness (observable entity),20030731,1,9E+17,9E+17
397880004,Respired nitric oxide concentration (observable entity),20030731,1,9E+17,9E+17
397308003,Contact lens cylinder axis (observable entity),20030731,1,9E+17,9E+17
398598008,Motility (observable entity),20030731,1,9E+17,9E+17
397272004,Bulbar conjunctiva feature (observable entity),20030731,1,9E+17,9E+17
397271006,Clarity of anterior chamber (observable entity),20030731,1,9E+17,9E+17
408588000,Service user's alias (observable entity),20040131,1,9E+17,9E+17
407708003,Sample appearance (observable entity),20040131,1,9E+17,9E+17
406126002,Type of polyp from which malignant neoplasm originated (observable entity),20040131,1,9E+17,9E+17
406086002,Type of nephrogenic rest present in specimen (observable entity),20040131,1,9E+17,9E+17
406093003,Organ AND/OR tissue involved by lymphoma (observable entity),20040131,1,9E+17,9E+17
406094009,Number of mitoses per 10 high power fields (observable entity),20040131,1,9E+17,9E+17
406127006,Pain intensity (observable entity),20040131,1,9E+17,9E+17
406646006,Incubation period (observable entity),20040131,1,9E+17,9E+17
406643003,World Health Organization Antiretroviral therapy guidelines (observable entity),20040131,1,9E+17,9E+17
408582004,Legal guardian details (observable entity),20040131,1,9E+17,9E+17
408587005,Legal guardian email address (observable entity),20040131,1,9E+17,9E+17
408584003,Legal guardian - home telephone number (observable entity),20040131,1,9E+17,9E+17
408585002,Legal guardian - mobile telephone number (observable entity),20040131,1,9E+17,9E+17
408586001,Legal guardian - work telephone number (observable entity),20040131,1,9E+17,9E+17
408576002,Caregiver email address (observable entity),20040131,1,9E+17,9E+17
405155000,Physical fitness behavior (observable entity),20040131,1,9E+17,9E+17
405154001,Level of suffering (observable entity),20040131,1,9E+17,9E+17
405260009,Mode of ventilation monitoring features (observable entity),20040131,1,9E+17,9E+17
405203009,Family normalization capacity (observable entity),20040131,1,9E+17,9E+17
405204003,Family involvement behavior: health care (observable entity),20040131,1,9E+17,9E+17
405205002,Family health status (observable entity),20040131,1,9E+17,9E+17
405206001,Family resiliency capacity (observable entity),20040131,1,9E+17,9E+17
405207005,Family support during treatment (observable entity),20040131,1,9E+17,9E+17
405208000,Community competence capacity (observable entity),20040131,1,9E+17,9E+17
405209008,Community health status (observable entity),20040131,1,9E+17,9E+17
405210003,Community health status: violence (observable entity),20040131,1,9E+17,9E+17
405211004,Community health status: immunity (observable entity),20040131,1,9E+17,9E+17
405215008,Community disaster readiness status (observable entity),20040131,1,9E+17,9E+17
405217000,Parenting behavior: infant/toddler safety (observable entity),20040131,1,9E+17,9E+17
405218005,Parenting behavior: early/middle childhood safety (observable entity),20040131,1,9E+17,9E+17
405219002,Parenting behavior: adolescent safety (observable entity),20040131,1,9E+17,9E+17
405156004,Student health status (observable entity),20040131,1,9E+17,9E+17
405150005,Risk control behavior: cancer (observable entity),20040131,1,9E+17,9E+17
405151009,Aspiration prevention behavior (observable entity),20040131,1,9E+17,9E+17
405202004,Family integrity (observable entity),20040131,1,9E+17,9E+17
405138004,Risk control behavior: drug use (observable entity),20040131,1,9E+17,9E+17
405137009,Risk control behavior: alcohol use (observable entity),20040131,1,9E+17,9E+17
405136000,Risk control behavior (observable entity),20040131,1,9E+17,9E+17
405135001,Parenting behavior: psychosocial safety (observable entity),20040131,1,9E+17,9E+17
405134002,Immunization behavior (observable entity),20040131,1,9E+17,9E+17
405622006,Patient middle name (observable entity),20040131,1,9E+17,9E+17
405610008,Operating room identifier (observable entity),20040131,1,9E+17,9E+17
405142001,Risk detection behavior (observable entity),20040131,1,9E+17,9E+17
405141008,Risk control behavior: unintended pregnancy (observable entity),20040131,1,9E+17,9E+17
405140009,Risk control behavior: tobacco use (observable entity),20040131,1,9E+17,9E+17
405139007,Risk control behavior: sexually transmitted disease (observable entity),20040131,1,9E+17,9E+17
405652003,Equipment serial number (observable entity),20040131,1,9E+17,9E+17
405653008,Anesthesia machine identifier (observable entity),20040131,1,9E+17,9E+17
405103001,Health orientation (observable entity),20040131,1,9E+17,9E+17
405102006,Health belief: perceived threat (observable entity),20040131,1,9E+17,9E+17
405636001,Total number of syphilis cases - primary and secondary (observable entity),20040131,1,9E+17,9E+17
405637005,"Total number of syphilis cases - primary, secondary and tertiary (observable entity)",20040131,1,9E+17,9E+17
405643007,Anesthesia procedure milestone (observable entity),20040131,1,9E+17,9E+17
405149005,Risk control behavior: visual impairment (observable entity),20040131,1,9E+17,9E+17
405148002,Risk control behavior: hearing impairment (observable entity),20040131,1,9E+17,9E+17
405145004,Personal safety behavior (observable entity),20040131,1,9E+17,9E+17
405144000,Home environment safety status (observable entity),20040131,1,9E+17,9E+17
405143006,Fall prevention behavior (observable entity),20040131,1,9E+17,9E+17
405146003,Physical injury status (observable entity),20040131,1,9E+17,9E+17
405534009,Adverse incident contributing factor (observable entity),20040131,1,9E+17,9E+17
405147007,Risk control behavior: cardiovascular health (observable entity),20040131,1,9E+17,9E+17
405201006,Family functioning capacity (observable entity),20040131,1,9E+17,9E+17
405200007,Family social climate (observable entity),20040131,1,9E+17,9E+17
405160001,Pain level: disruptive effects (observable entity),20040131,1,9E+17,9E+17
405161002,Pain level (observable entity),20040131,1,9E+17,9E+17
406534001,Out of hours contact details (observable entity),20040131,1,9E+17,9E+17
405162009,Symptom severity level (observable entity),20040131,1,9E+17,9E+17
405163004,Symptom severity level: perimenopause (observable entity),20040131,1,9E+17,9E+17
405164005,Symptom severity level: premenstrual syndrome (observable entity),20040131,1,9E+17,9E+17
408400006,Caregiver home telephone number (observable entity),20040131,1,9E+17,9E+17
408401005,Caregiver work telephone number (observable entity),20040131,1,9E+17,9E+17
408402003,Caregiver mobile telephone number (observable entity),20040131,1,9E+17,9E+17
404231008,Timed urine volume (observable entity),20040131,1,9E+17,9E+17
404230009,Specimen volume (observable entity),20040131,1,9E+17,9E+17
404264008,"Antimicrobial activity, function (observable entity)",20040131,1,9E+17,9E+17
404265009,Bactericidal activity (observable entity),20040131,1,9E+17,9E+17
404266005,Fungicidal activity (observable entity),20040131,1,9E+17,9E+17
404267001,Viricidal activity (observable entity),20040131,1,9E+17,9E+17
404268006,Parasiticidal activity (observable entity),20040131,1,9E+17,9E+17
404269003,Rickettsiostatic activity (observable entity),20040131,1,9E+17,9E+17
405165006,Nausea and vomiting status: disruptive effects (observable entity),20040131,1,9E+17,9E+17
406548001,Emergency contact details (observable entity),20040131,1,9E+17,9E+17
405187002,Abuse recovery status: emotional (observable entity),20040131,1,9E+17,9E+17
405195003,Intrapartum maternal status (observable entity),20040131,1,9E+17,9E+17
405196002,Neglect recovery status (observable entity),20040131,1,9E+17,9E+17
405197006,Neglect cessation status (observable entity),20040131,1,9E+17,9E+17
405198001,Abuse recovery status (observable entity),20040131,1,9E+17,9E+17
405199009,Family coping behavior (observable entity),20040131,1,9E+17,9E+17
405188007,Abuse recovery status: financial (observable entity),20040131,1,9E+17,9E+17
405189004,Abuse recovery status: physical (observable entity),20040131,1,9E+17,9E+17
405190008,Abuse recovery status: sexual (observable entity),20040131,1,9E+17,9E+17
405192000,Caregiver physical health status (observable entity),20040131,1,9E+17,9E+17
405186006,Abuse protection behavior (observable entity),20040131,1,9E+17,9E+17
405194004,Antepartum maternal status (observable entity),20040131,1,9E+17,9E+17
406544004,Time of visit (observable entity),20040131,1,9E+17,9E+17
405185005,Abuse cessation status (observable entity),20040131,1,9E+17,9E+17
405172007,Caregiver behavior: indirect care (observable entity),20040131,1,9E+17,9E+17
405157008,Personal health status (observable entity),20040131,1,9E+17,9E+17
405175009,Parenting behavior (observable entity),20040131,1,9E+17,9E+17
405176005,Blood glucose status (observable entity),20040131,1,9E+17,9E+17
405166007,Nausea and vomiting status (observable entity),20040131,1,9E+17,9E+17
405167003,Caregiver adaptative behavior: patient institutionalization (observable entity),20040131,1,9E+17,9E+17
405177001,Medication response (observable entity),20040131,1,9E+17,9E+17
405168008,Caregiver behavior: home care readiness (observable entity),20040131,1,9E+17,9E+17
405169000,Caregiver lifestyle disruption status (observable entity),20040131,1,9E+17,9E+17
405170004,Caregiver patient relationship (observable entity),20040131,1,9E+17,9E+17
405171000,Caregiver behavior: direct care (observable entity),20040131,1,9E+17,9E+17
405101004,Health belief: perceived resources (observable entity),20040131,1,9E+17,9E+17
405180000,Sensory function status: hearing (observable entity),20040131,1,9E+17,9E+17
405181001,Sensory function status: proprioception (observable entity),20040131,1,9E+17,9E+17
405182008,Sensory function status: taste and smell (observable entity),20040131,1,9E+17,9E+17
405183003,Sensory function status: vision (observable entity),20040131,1,9E+17,9E+17
405184009,Sensory function status (observable entity),20040131,1,9E+17,9E+17
406543005,Date of visit (observable entity),20040131,1,9E+17,9E+17
405178006,Postprocedural recovery status (observable entity),20040131,1,9E+17,9E+17
404963005,Growth pattern (observable entity),20040131,1,9E+17,9E+17
404924003,Knee height (observable entity),20040131,1,9E+17,9E+17
406217005,Bowel continence status (observable entity),20040131,1,9E+17,9E+17
404942008,Transverse movement (observable entity),20040131,1,9E+17,9E+17
404935008,Functional reach (observable entity),20040131,1,9E+17,9E+17
405915001,Distance of sarcoma from closest surgical margin in excised specimen (observable entity),20040131,1,9E+17,9E+17
405916000,Intergroup rhabdomyosarcoma study post-surgical clinical group (observable entity),20040131,1,9E+17,9E+17
405923004,"Kidney size, dimension 1 (observable entity)",20040131,1,9E+17,9E+17
405924005,"Kidney size, dimension 2 (observable entity)",20040131,1,9E+17,9E+17
405925006,"Kidney size, dimension 3 (observable entity)",20040131,1,9E+17,9E+17
405926007,Status of renal sinus involvement by tumor (observable entity),20040131,1,9E+17,9E+17
405920001,"Mitotic count score per 10 high power fields, 40x objective (observable entity)",20040131,1,9E+17,9E+17
405909001,Status of tumor involvement by necrosis (observable entity),20040131,1,9E+17,9E+17
405908009,Status of tumor involvement by anaplasia (observable entity),20040131,1,9E+17,9E+17
404943003,Posterior-anterior movement (observable entity),20040131,1,9E+17,9E+17
404973007,Infant milestone: 1 month (observable entity),20040131,1,9E+17,9E+17
404972002,Sexual functioning status (observable entity),20040131,1,9E+17,9E+17
404971009,Adaptive behavior: newborn (observable entity),20040131,1,9E+17,9E+17
404970005,Preterm infant status: 24-37 weeks gestation (observable entity),20040131,1,9E+17,9E+17
404969009,Play behavior (observable entity),20040131,1,9E+17,9E+17
404968001,Male physical maturation status (observable entity),20040131,1,9E+17,9E+17
404967006,Female physical maturation status (observable entity),20040131,1,9E+17,9E+17
404966002,Physical aging status (observable entity),20040131,1,9E+17,9E+17
404965003,Intrapartum fetal status (observable entity),20040131,1,9E+17,9E+17
404964004,Antepartum fetal status (observable entity),20040131,1,9E+17,9E+17
404974001,Impaired mobility: physiological status (observable entity),20040131,1,9E+17,9E+17
404980009,Spine - range of movement (observable entity),20040131,1,9E+17,9E+17
404979006,Neck joint - range of movement (observable entity),20040131,1,9E+17,9E+17
404977008,Skeletal functioning status (observable entity),20040131,1,9E+17,9E+17
404976004,Range of passive joint movement (observable entity),20040131,1,9E+17,9E+17
404975000,Impaired mobility: psycho-cognitive status (observable entity),20040131,1,9E+17,9E+17
404953002,Infant milestone: 2 months (observable entity),20040131,1,9E+17,9E+17
404950004,Sleep behavior (observable entity),20040131,1,9E+17,9E+17
404949004,Rest pattern (observable entity),20040131,1,9E+17,9E+17
404954008,Infant milestone: 4 months (observable entity),20040131,1,9E+17,9E+17
404962000,Adolescent development (observable entity),20040131,1,9E+17,9E+17
404961007,Child development: middle childhood (observable entity),20040131,1,9E+17,9E+17
404960008,Child development: 5 years (observable entity),20040131,1,9E+17,9E+17
404959003,Child development: 4 years (observable entity),20040131,1,9E+17,9E+17
404958006,Child development: 3 years (observable entity),20040131,1,9E+17,9E+17
404957001,Child development: 2 years (observable entity),20040131,1,9E+17,9E+17
404956005,Infant milestone: 12 months (observable entity),20040131,1,9E+17,9E+17
404955009,Infant milestone: 6 months (observable entity),20040131,1,9E+17,9E+17
404944009,Longitudinal movement (observable entity),20040131,1,9E+17,9E+17
405976009,National Wilms Tumor Study Group Stage for right kidney (observable entity),20040131,1,9E+17,9E+17
405977000,National Wilms Tumor Study Group Stage for left kidney (observable entity),20040131,1,9E+17,9E+17
405978005,Pathologic stage (observable entity),20040131,1,9E+17,9E+17
406197004,Belief pattern (observable entity),20040131,1,9E+17,9E+17
407576000,Forced vital capacity/expected forced vital capacity percent (observable entity),20040131,1,9E+17,9E+17
406198009,Personal belief pattern (observable entity),20040131,1,9E+17,9E+17
405979002,Pathologic TNM stage (observable entity),20040131,1,9E+17,9E+17
406013004,Location of tumor in relation to closest lateral margin (observable entity),20040131,1,9E+17,9E+17
406195007,Community details (observable entity),20040131,1,9E+17,9E+17
406215002,Self-control behavior (observable entity),20040131,1,9E+17,9E+17
406196008,Family behavior (observable entity),20040131,1,9E+17,9E+17
406199001,Maternal status (observable entity),20040131,1,9E+17,9E+17
406206009,Infant development by age (observable entity),20040131,1,9E+17,9E+17
406204007,Rest related observable (observable entity),20040131,1,9E+17,9E+17
405989003,"Specimen integrity, right ovary (observable entity)",20040131,1,9E+17,9E+17
405990007,"Specimen integrity, left ovary (observable entity)",20040131,1,9E+17,9E+17
406205008,Readiness (observable entity),20040131,1,9E+17,9E+17
406207000,Child development by age (observable entity),20040131,1,9E+17,9E+17
406201004,Safety behavior (observable entity),20040131,1,9E+17,9E+17
406000005,Type of fetal anomaly present in specimen (observable entity),20040131,1,9E+17,9E+17
406212004,Immune hypersensitivity response status (observable entity),20040131,1,9E+17,9E+17
406211006,Personal health management behavior (observable entity),20040131,1,9E+17,9E+17
406210007,Readiness for discharge (observable entity),20040131,1,9E+17,9E+17
405996001,Presence of fetal anomaly in specimen (observable entity),20040131,1,9E+17,9E+17
406209002,Effect of impaired mobility (observable entity),20040131,1,9E+17,9E+17
406208005,Adaptation behavior (observable entity),20040131,1,9E+17,9E+17
405995002,Type of fetal tissue present in specimen (observable entity),20040131,1,9E+17,9E+17
406190002,Detail of abuse (observable entity),20040131,1,9E+17,9E+17
406192005,Caregiver behavior (observable entity),20040131,1,9E+17,9E+17
406189006,Pain observable (observable entity),20040131,1,9E+17,9E+17
407561008,Forced vital capacity after bronchodilation (observable entity),20040131,1,9E+17,9E+17
405931009,National Wilms Tumor Study Group Stage (observable entity),20040131,1,9E+17,9E+17
406014005,Location of tumor within lateral margin (observable entity),20040131,1,9E+17,9E+17
405084006,Prenatal health behavior (observable entity),20040131,1,9E+17,9E+17
405043008,Bone healing status (observable entity),20040131,1,9E+17,9E+17
405038001,Swallowing status: pharyngeal phase (observable entity),20040131,1,9E+17,9E+17
405037006,Swallowing status: oral phase (observable entity),20040131,1,9E+17,9E+17
405036002,Swallowing status: esophageal phase (observable entity),20040131,1,9E+17,9E+17
405035003,Swallowing status (observable entity),20040131,1,9E+17,9E+17
405040006,Tissue integrity status (observable entity),20040131,1,9E+17,9E+17
405081003,Leisure behavior (observable entity),20040131,1,9E+17,9E+17
405082005,Pain control behavior (observable entity),20040131,1,9E+17,9E+17
407603001,Forced expiratory volume in one second/forced vital capacity ratio after bronchodilator (observable entity),20040131,1,9E+17,9E+17
405045001,Body image (observable entity),20040131,1,9E+17,9E+17
407602006,Forced expiratory volume in one second/Forced vital capacity ratio before bronchodilator (observable entity),20040131,1,9E+17,9E+17
405087004,Hearing compensation behavior (observable entity),20040131,1,9E+17,9E+17
405025009,Neurological status: spinal function (observable entity),20040131,1,9E+17,9E+17
407599001,Forced expiratory volume in one second/Forced vital capacity ratio pre steroids (observable entity),20040131,1,9E+17,9E+17
405088009,Vision compensation behavior (observable entity),20040131,1,9E+17,9E+17
405085007,Symptom control behavior (observable entity),20040131,1,9E+17,9E+17
405086008,Treatment behavior: illness and injury (observable entity),20040131,1,9E+17,9E+17
405089001,Weight control behavior (observable entity),20040131,1,9E+17,9E+17
405067000,Self-control: impulsive behavior (observable entity),20040131,1,9E+17,9E+17
405066009,Self-control behavior: fear (observable entity),20040131,1,9E+17,9E+17
405068005,Self-control behavior: self-mutilation (observable entity),20040131,1,9E+17,9E+17
405065008,Self-control behavior: distorted thought (observable entity),20040131,1,9E+17,9E+17
405064007,Self-control behavior: anxiety (observable entity),20040131,1,9E+17,9E+17
405063001,Self-control behavior: aggression (observable entity),20040131,1,9E+17,9E+17
405062006,Self-control behavior: abuse (observable entity),20040131,1,9E+17,9E+17
405061004,Adaptive behavior: physical disability (observable entity),20040131,1,9E+17,9E+17
405069002,Effect of substance addiction (observable entity),20040131,1,9E+17,9E+17
406220002,Detail of neglect (observable entity),20040131,1,9E+17,9E+17
406222005,Population health status (observable entity),20040131,1,9E+17,9E+17
405072009,Parent-infant attachment behavior (observable entity),20040131,1,9E+17,9E+17
405071002,Self-control behavior: depression (observable entity),20040131,1,9E+17,9E+17
405070001,Self-control behavior: suicide (observable entity),20040131,1,9E+17,9E+17
405054003,Acceptance behavior: health status (observable entity),20040131,1,9E+17,9E+17
406223000,Caregiver health status (observable entity),20040131,1,9E+17,9E+17
407601004,Forced expiratory volume in one second/Forced vital capacity ratio post steroids (observable entity),20040131,1,9E+17,9E+17
405079000,Health promotion behavior (observable entity),20040131,1,9E+17,9E+17
405048004,Sexual identity acceptance (observable entity),20040131,1,9E+17,9E+17
405047009,Will to live (observable entity),20040131,1,9E+17,9E+17
405078008,Compliance behavior (observable entity),20040131,1,9E+17,9E+17
405073004,Role performance behavior (observable entity),20040131,1,9E+17,9E+17
405074005,Social interaction skills (observable entity),20040131,1,9E+17,9E+17
405059008,Pain level: psychological effects (observable entity),20040131,1,9E+17,9E+17
405075006,Social involvement behavior (observable entity),20040131,1,9E+17,9E+17
405058000,Psychosocial adaptive behavior: life change (observable entity),20040131,1,9E+17,9E+17
405076007,Social support status (observable entity),20040131,1,9E+17,9E+17
405056001,Coping behavior (observable entity),20040131,1,9E+17,9E+17
405055002,Child adaptive behavior: hospitalization (observable entity),20040131,1,9E+17,9E+17
406219008,Urinary elimination status (observable entity),20040131,1,9E+17,9E+17
405024008,Neurological status: cranial function (observable entity),20040131,1,9E+17,9E+17
406221003,Health status (observable entity),20040131,1,9E+17,9E+17
405023002,Neurological status: consciousness (observable entity),20040131,1,9E+17,9E+17
405099006,Health belief: perceived ability to perform (observable entity),20040131,1,9E+17,9E+17
405000000,Ability to maintain bowel continence (observable entity),20040131,1,9E+17,9E+17
404999000,Blood loss status (observable entity),20040131,1,9E+17,9E+17
405001001,Bowel elimination status (observable entity),20040131,1,9E+17,9E+17
404996007,Airway patency status (observable entity),20040131,1,9E+17,9E+17
404995006,Blood coagulation status (observable entity),20040131,1,9E+17,9E+17
404994005,Pulmonary tissue perfusion status (observable entity),20040131,1,9E+17,9E+17
405098003,Health belief (observable entity),20040131,1,9E+17,9E+17
405004009,Kidney filtration status (observable entity),20040131,1,9E+17,9E+17
405799000,Time of arrival at hospital (observable entity),20040131,1,9E+17,9E+17
405096004,Diabetes self-management behavior (observable entity),20040131,1,9E+17,9E+17
405800001,Initial coronary reperfusion location (observable entity),20040131,1,9E+17,9E+17
405003003,Ability to collect and discharge urine (observable entity),20040131,1,9E+17,9E+17
405801002,Coronary reperfusion type (observable entity),20040131,1,9E+17,9E+17
405002008,Ability to maintain urinary continence (observable entity),20040131,1,9E+17,9E+17
405802009,Initial coronary reperfusion decision maker (observable entity),20040131,1,9E+17,9E+17
405803004,Cardiac arrest location (observable entity),20040131,1,9E+17,9E+17
405805006,Cardiac resuscitation outcome (observable entity),20040131,1,9E+17,9E+17
405097008,Seizure control behavior (observable entity),20040131,1,9E+17,9E+17
404993004,Peripheral tissue perfusion status (observable entity),20040131,1,9E+17,9E+17
404992009,Cerebral tissue perfusion status (observable entity),20040131,1,9E+17,9E+17
404991002,Cardiac tissue perfusion status (observable entity),20040131,1,9E+17,9E+17
404984000,Readiness for discharge to independent living (observable entity),20040131,1,9E+17,9E+17
405100003,Health belief: perceived control (observable entity),20040131,1,9E+17,9E+17
404985004,Readiness for discharge to supported living (observable entity),20040131,1,9E+17,9E+17
404986003,Cardiac pump effectiveness (observable entity),20040131,1,9E+17,9E+17
404990001,Abdominal tissue perfusion status (observable entity),20040131,1,9E+17,9E+17
404988002,Respiratory gas exchange status (observable entity),20040131,1,9E+17,9E+17
404987007,Circulation status (observable entity),20040131,1,9E+17,9E+17
405092002,Ostomy self-management behavior (observable entity),20040131,1,9E+17,9E+17
405020004,Neurological status (observable entity),20040131,1,9E+17,9E+17
405798008,Time of arrival of emergency services (observable entity),20040131,1,9E+17,9E+17
405091009,Personal autonomy behavior (observable entity),20040131,1,9E+17,9E+17
405010009,Asthma self-management behavior (observable entity),20040131,1,9E+17,9E+17
406218000,Urinary continence status (observable entity),20040131,1,9E+17,9E+17
405009004,Infection status (observable entity),20040131,1,9E+17,9E+17
405012001,Systemic allergic response status (observable entity),20040131,1,9E+17,9E+17
405013006,Infection status: newborn (observable entity),20040131,1,9E+17,9E+17
405011008,Localized allergic response status (observable entity),20040131,1,9E+17,9E+17
405797003,Time of arrival of first professional help (observable entity),20040131,1,9E+17,9E+17
405750004,Initial contact type (observable entity),20040131,1,9E+17,9E+17
405090005,Self-directed care behavior (observable entity),20040131,1,9E+17,9E+17
405094001,Cardiac disease self-management behavior (observable entity),20040131,1,9E+17,9E+17
405022007,Neurological status: central motor control (observable entity),20040131,1,9E+17,9E+17
405093007,Body mechanics behavior (observable entity),20040131,1,9E+17,9E+17
405095000,Nausea and vomiting control behavior (observable entity),20040131,1,9E+17,9E+17
405796007,Time of call for help (observable entity),20040131,1,9E+17,9E+17
405021000,Neurological status: autonomic (observable entity),20040131,1,9E+17,9E+17
405789005,Behavioral phenotype (observable entity),20040131,1,9E+17,9E+17
405008007,Blood transfusion reaction status (observable entity),20040131,1,9E+17,9E+17
405795006,Time of symptom onset (observable entity),20040131,1,9E+17,9E+17
412726003,Length of gestation at birth (observable entity),20040731,1,9E+17,9E+17
412823000,Percentage rapid progressive sperm (observable entity),20040731,1,9E+17,9E+17
413173009,Minutes from waking to first tobacco consumption (observable entity),20040731,1,9E+17,9E+17
413155006,Right ankle circumference (observable entity),20040731,1,9E+17,9E+17
413156007,Left ankle circumference (observable entity),20040731,1,9E+17,9E+17
413157003,Right calf circumference (observable entity),20040731,1,9E+17,9E+17
413158008,Left calf circumference (observable entity),20040731,1,9E+17,9E+17
413171006,Lower limb circumference (observable entity),20040731,1,9E+17,9E+17
412824006,Percentage non-progressive sperm (observable entity),20040731,1,9E+17,9E+17
412878006,Semen appearance (observable entity),20040731,1,9E+17,9E+17
412829001,Percentage slow progressive sperm (observable entity),20040731,1,9E+17,9E+17
412835001,Calculus appearance (observable entity),20040731,1,9E+17,9E+17
413326007,Health belief: sometimes feels at risk of crime (observable entity),20040731,1,9E+17,9E+17
413337008,Actual duration - external beam radiation therapy (observable entity),20040731,1,9E+17,9E+17
413209003,Site of narrowing of hiatus esophagus of diaphragm (observable entity),20040731,1,9E+17,9E+17
409645006,Lethal dose 50 (observable entity),20040731,1,9E+17,9E+17
408714007,Degree of blood vessel lumen cross sectional area reduction (observable entity),20040731,1,9E+17,9E+17
408715008,Degree of blood vessel lumen diameter reduction (observable entity),20040731,1,9E+17,9E+17
408716009,Stenotic lesion length (observable entity),20040731,1,9E+17,9E+17
408704003,Vascular stent volume (observable entity),20040731,1,9E+17,9E+17
408705002,Vascular stent cross sectional area (observable entity),20040731,1,9E+17,9E+17
408706001,Vascular stent diameter (observable entity),20040731,1,9E+17,9E+17
408717000,Stenotic lesion axial cross sectional area (observable entity),20040731,1,9E+17,9E+17
408676007,Patient preferred name (observable entity),20040731,1,9E+17,9E+17
409653003,Case fatality rate (observable entity),20040731,1,9E+17,9E+17
409652008,Population statistic (observable entity),20040731,1,9E+17,9E+17
409651001,Mortality rate (observable entity),20040731,1,9E+17,9E+17
408699006,Device observable (observable entity),20040731,1,9E+17,9E+17
408700007,Vascular stent observable (observable entity),20040731,1,9E+17,9E+17
408702004,Vascular stent apposition (observable entity),20040731,1,9E+17,9E+17
408703009,Vascular stent length (observable entity),20040731,1,9E+17,9E+17
408701006,Vascular stent patency (observable entity),20040731,1,9E+17,9E+17
409646007,Lethal concentration 50 (observable entity),20040731,1,9E+17,9E+17
408677003,Forename (observable entity),20040731,1,9E+17,9E+17
409644005,Lethal dose (observable entity),20040731,1,9E+17,9E+17
364687002,Urine observable (observable entity),20040731,1,9E+17,9E+17
364689004,Stool observable (observable entity),20040731,1,9E+17,9E+17
364692000,Sweat measure (observable entity),20040731,1,9E+17,9E+17
364693005,Vomit observable (observable entity),20040731,1,9E+17,9E+17
364695003,Sputum observable (observable entity),20040731,1,9E+17,9E+17
364685005,Semen observable (observable entity),20040731,1,9E+17,9E+17
409496000,Mode of transmission (observable entity),20040731,1,9E+17,9E+17
408727006,Stenotic lesion longitudinal cross sectional area (observable entity),20040731,1,9E+17,9E+17
409599009,Laboratory biosafety level (observable entity),20040731,1,9E+17,9E+17
409728006,International neuroblastoma pathology classification (observable entity),20040731,1,9E+17,9E+17
409720004,International neuroblastoma staging system stage (observable entity),20040731,1,9E+17,9E+17
409746000,Status of distant metastasis for primary extraosseous tumor (observable entity),20040731,1,9E+17,9E+17
409745001,Status of distant metastasis for primary osseous tumor (observable entity),20040731,1,9E+17,9E+17
409744002,"pT category, primary extraosseous tumor (observable entity)",20040731,1,9E+17,9E+17
409743008,"pT category, primary osseous tumor (observable entity)",20040731,1,9E+17,9E+17
409742003,Distance of neoplasm from closest surgical margin of soft tissue in excised specimen (observable entity),20040731,1,9E+17,9E+17
409741005,Distance of neoplasm from closest surgical margin of bone in excised specimen (observable entity),20040731,1,9E+17,9E+17
408655002,Status of intactness of mesorectal specimen (observable entity),20040731,1,9E+17,9E+17
409670006,Intrinsic incubation period (observable entity),20040731,1,9E+17,9E+17
409669005,Extrinsic incubation period (observable entity),20040731,1,9E+17,9E+17
408894003,Religiosity (observable entity),20040731,1,9E+17,9E+17
408864009,Vaccination status (observable entity),20040731,1,9E+17,9E+17
409086003,Estimated maternal blood loss (observable entity),20040731,1,9E+17,9E+17
409085004,Quantity of maternal blood loss (observable entity),20040731,1,9E+17,9E+17
409084000,Estimated blood loss (observable entity),20040731,1,9E+17,9E+17
409760003,Status of histological necrosis after induction chemotherapy (observable entity),20040731,1,9E+17,9E+17
409764007,Percentage of histological necrosis after induction chemotherapy (observable entity),20040731,1,9E+17,9E+17
409770001,Narrative comments on pathology specimen (observable entity),20040731,1,9E+17,9E+17
415178003,Process (observable entity),20050131,1,9E+17,9E+17
415180009,Prolate cornea (observable entity),20050131,1,9E+17,9E+17
414884008,Number of surgical fires (observable entity),20050131,1,9E+17,9E+17
414921003,Oblate cornea (observable entity),20050131,1,9E+17,9E+17
414807004,National surgical quality improvement program defined race (observable entity),20050131,1,9E+17,9E+17
413975003,Depth of vessel from surface (observable entity),20050131,1,9E+17,9E+17
413920005,Corneal shape (observable entity),20050131,1,9E+17,9E+17
415565009,Spectacle lens base curve (observable entity),20050131,1,9E+17,9E+17
415566005,Spectacle lens ocular curve (observable entity),20050131,1,9E+17,9E+17
415567001,Specular reflection (observable entity),20050131,1,9E+17,9E+17
413947000,Date treatment stopped (observable entity),20050131,1,9E+17,9E+17
413946009,Date treatment started (observable entity),20050131,1,9E+17,9E+17
413944007,Date chemotherapy stopped (observable entity),20050131,1,9E+17,9E+17
415504005,Sclerotic scatter (observable entity),20050131,1,9E+17,9E+17
413943001,Date chemotherapy completed (observable entity),20050131,1,9E+17,9E+17
414412005,"Hispanic, white (observable entity)",20050131,1,9E+17,9E+17
414409007,"Hispanic, black (observable entity)",20050131,1,9E+17,9E+17
414361006,Going to live abroad (observable entity),20050131,1,9E+17,9E+17
414513003,Instantaneous radius of curvature (observable entity),20050131,1,9E+17,9E+17
414482001,Indication for relapse (observable entity),20050131,1,9E+17,9E+17
413673008,Blood velocity (observable entity),20050131,1,9E+17,9E+17
414237002,Feature of entity (observable entity),20050131,1,9E+17,9E+17
414236006,Feature of anatomical entity (observable entity),20050131,1,9E+17,9E+17
414174009,Eye observable (observable entity),20050131,1,9E+17,9E+17
413530006,Anatomic structure potentially involved in evolution of disease (observable entity),20050131,1,9E+17,9E+17
414315006,Gated lymphocyte population (observable entity),20050131,1,9E+17,9E+17
414302002,Function of eye region structure (observable entity),20050131,1,9E+17,9E+17
415760001,Tuberculosis status (observable entity),20050131,1,9E+17,9E+17
415759006,Tuberculosis index case (observable entity),20050131,1,9E+17,9E+17
414656001,Mean corneal curvature (observable entity),20050131,1,9E+17,9E+17
413753009,Carbon monoxide reading at 4 weeks (observable entity),20050131,1,9E+17,9E+17
414755005,"Molecular, genetic AND/OR cellular observable (observable entity)",20050131,1,9E+17,9E+17
415814008,Vessel intimal cross-sectional diameter (observable entity),20050131,1,9E+17,9E+17
415815009,Vessel intimal diameter (observable entity),20050131,1,9E+17,9E+17
415817001,Vessel lumen cross-sectional diameter increase (observable entity),20050131,1,9E+17,9E+17
415816005,Vessel lumen cross-sectional area increase (observable entity),20050131,1,9E+17,9E+17
414599003,Length of vessel segment (observable entity),20050131,1,9E+17,9E+17
415823006,Vision observable (observable entity),20050131,1,9E+17,9E+17
416540001,Calcium deposit observable (observable entity),20050731,1,9E+17,9E+17
416603001,Lumbosacral angle (observable entity),20050731,1,9E+17,9E+17
416869002,Leukocyte feature (observable entity),20050731,1,9E+17,9E+17
416600003,Motion barrier (observable entity),20050731,1,9E+17,9E+17
416701009,Erythrocyte osmotic fragility (observable entity),20050731,1,9E+17,9E+17
416595007,Positive end expiratory pressure setting (observable entity),20050731,1,9E+17,9E+17
416765002,Erythrocyte diameter (observable entity),20050731,1,9E+17,9E+17
417030002,Translatory motion (observable entity),20050731,1,9E+17,9E+17
416799004,Anatomic motion barrier (observable entity),20050731,1,9E+17,9E+17
416452005,Lumbolumbar lordotic angle (observable entity),20050731,1,9E+17,9E+17
416437003,Preoccupied with substance misuse (observable entity),20050731,1,9E+17,9E+17
416388004,Myogenic tonus (observable entity),20050731,1,9E+17,9E+17
416767005,Depression anxiety stress scales stress score (observable entity),20050731,1,9E+17,9E+17
416766001,Quantity of hemoglobin in erythrocyte (observable entity),20050731,1,9E+17,9E+17
416580005,"Muscle resilience, function (observable entity)",20050731,1,9E+17,9E+17
416203008,Elastic motion barrier (observable entity),20050731,1,9E+17,9E+17
416366004,Innominate bone rotation (observable entity),20050731,1,9E+17,9E+17
416436007,"Habituation, function (observable entity)",20050731,1,9E+17,9E+17
416787006,Respiratory axis of the sacrum (observable entity),20050731,1,9E+17,9E+17
416428003,Pathologic motion barrier (observable entity),20050731,1,9E+17,9E+17
416251000,Feature of circulating blood (observable entity),20050731,1,9E+17,9E+17
416211003,Proximal tourniquet off (observable entity),20050731,1,9E+17,9E+17
416527006,Restrictive motion barrier (observable entity),20050731,1,9E+17,9E+17
416674008,Distance of aneurysm from renal pedicle (observable entity),20050731,1,9E+17,9E+17
416320009,Calcium volume (observable entity),20050731,1,9E+17,9E+17
416726000,Accessory joint motion (observable entity),20050731,1,9E+17,9E+17
416537001,Distal tourniquet on (observable entity),20050731,1,9E+17,9E+17
416131009,Erythrocyte feature (observable entity),20050731,1,9E+17,9E+17
416078007,Isokinetic muscle contraction (observable entity),20050731,1,9E+17,9E+17
416343000,Erythrocyte volume (observable entity),20050731,1,9E+17,9E+17
416926006,"Eccentric muscle contraction, function (observable entity)",20050731,1,9E+17,9E+17
416647007,Country of residence (observable entity),20050731,1,9E+17,9E+17
416835003,Abstinence history (observable entity),20050731,1,9E+17,9E+17
416342005,Procedure related observable (observable entity),20050731,1,9E+17,9E+17
416917008,"Cell production, function (observable entity)",20050731,1,9E+17,9E+17
416619008,Depression anxiety stress scales anxiety score (observable entity),20050731,1,9E+17,9E+17
416811008,Tidal volume setting (observable entity),20050731,1,9E+17,9E+17
416954004,Depression anxiety stress scales depression score (observable entity),20050731,1,9E+17,9E+17
416421009,"Reciprocal inhibition, function (observable entity)",20050731,1,9E+17,9E+17
416232006,Anterior innominate rotation (observable entity),20050731,1,9E+17,9E+17
416693005,Pelvic index (observable entity),20050731,1,9E+17,9E+17
416262000,Continuous use of drugs (observable entity),20050731,1,9E+17,9E+17
416628009,"Concentric muscle contraction, function (observable entity)",20050731,1,9E+17,9E+17
416853009,Posterior innominate rotation (observable entity),20050731,1,9E+17,9E+17
416125006,Concentration of hemoglobin in erythrocyte (observable entity),20050731,1,9E+17,9E+17
416684009,Platelet diameter (observable entity),20050731,1,9E+17,9E+17
417687007,Sacral spine observable (observable entity),20050731,1,9E+17,9E+17
417635008,Inherent motion (observable entity),20050731,1,9E+17,9E+17
417624003,Oculocephalogyric reflex (observable entity),20050731,1,9E+17,9E+17
417712000,Physiologic motion barrier (observable entity),20050731,1,9E+17,9E+17
417438001,Distal tourniquet off (observable entity),20050731,1,9E+17,9E+17
417553006,Platelet volume (observable entity),20050731,1,9E+17,9E+17
417557007,"Isolytic muscle contraction, function (observable entity)",20050731,1,9E+17,9E+17
417590007,Axis of sacral motion (observable entity),20050731,1,9E+17,9E+17
417595002,Cell feature (observable entity),20050731,1,9E+17,9E+17
417552001,Intersegmental vertebral motion (observable entity),20050731,1,9E+17,9E+17
417205008,Physiologic motion (observable entity),20050731,1,9E+17,9E+17
417251009,Vascular stent composition (observable entity),20050731,1,9E+17,9E+17
417252002,Episodic use of drugs (observable entity),20050731,1,9E+17,9E+17
417214003,Number of breaths (observable entity),20050731,1,9E+17,9E+17
417239007,Number of minutes (observable entity),20050731,1,9E+17,9E+17
417236000,Lumbosacral lordotic angle (observable entity),20050731,1,9E+17,9E+17
417112006,Proximal tourniquet on (observable entity),20050731,1,9E+17,9E+17
417108000,"Cell destruction, function (observable entity)",20050731,1,9E+17,9E+17
417071008,Inspiratory pressure setting (observable entity),20050731,1,9E+17,9E+17
417086002,Movement of sacral spine (observable entity),20050731,1,9E+17,9E+17
417413006,Platelet feature (observable entity),20050731,1,9E+17,9E+17
417408007,Minute volume setting (observable entity),20050731,1,9E+17,9E+17
417323003,Lacrimal drainage system observable (observable entity),20050731,1,9E+17,9E+17
417390006,"Post-isometric muscle relaxation, function (observable entity)",20050731,1,9E+17,9E+17
417296002,Pelvic structure observable (observable entity),20050731,1,9E+17,9E+17
418305009,Self-propelled locomotion activity (observable entity),20060131,1,9E+17,9E+17
418772006,Near reflex (observable entity),20060131,1,9E+17,9E+17
418594001,Crawling (observable entity),20060131,1,9E+17,9E+17
418633004,Medication compliance (observable entity),20060131,1,9E+17,9E+17
418755004,Interincisor distance (observable entity),20060131,1,9E+17,9E+17
418706008,Tissue observable (observable entity),20060131,1,9E+17,9E+17
418423000,Intermediate segment height (observable entity),20060131,1,9E+17,9E+17
418719007,Pseudoaccommodation (observable entity),20060131,1,9E+17,9E+17
419391003,Reason for procedure delay (observable entity),20060131,1,9E+17,9E+17
419309008,Reading segment height (observable entity),20060131,1,9E+17,9E+17
419821004,Topographic optical zone (observable entity),20060131,1,9E+17,9E+17
419776002,Number of positive Ranson's criteria (observable entity),20060131,1,9E+17,9E+17
419617009,Reason for procedure cancelation (observable entity),20060131,1,9E+17,9E+17
419651008,Reason for outcome variance (observable entity),20060131,1,9E+17,9E+17
420236003,Neck circumference (observable entity),20060131,1,9E+17,9E+17
418060005,Running (observable entity),20060131,1,9E+17,9E+17
419126006,Anesthesia preparation time (observable entity),20060131,1,9E+17,9E+17
420160007,Ocular tear film observable (observable entity),20060131,1,9E+17,9E+17
417949001,Corneal optical zone (observable entity),20060131,1,9E+17,9E+17
421698003,Ophthalmic ultrasonographic internal reflectivity of mass (observable entity),20060731,1,9E+17,9E+17
421770006,Corneal stroma observable (observable entity),20060731,1,9E+17,9E+17
421730004,Lacrimal gland observable (observable entity),20060731,1,9E+17,9E+17
422205000,Distance of malignant neoplasm from closest surgical margin of mesentery of colon in excised specimen (observable entity),20060731,1,9E+17,9E+17
422162007,Central corneal thickness (observable entity),20060731,1,9E+17,9E+17
422347003,Corneal graft appearance (observable entity),20060731,1,9E+17,9E+17
422291001,Number of bowel incontinence episodes (observable entity),20060731,1,9E+17,9E+17
422004007,Acoustic reflectivity of mass (observable entity),20060731,1,9E+17,9E+17
421917005,Murmur duration (observable entity),20060731,1,9E+17,9E+17
422149008,Optic disc size (observable entity),20060731,1,9E+17,9E+17
422058003,Number of urinary incontinence episodes (observable entity),20060731,1,9E+17,9E+17
420527001,Acoustic shadowing of mass (observable entity),20060731,1,9E+17,9E+17
420443006,Jerky pursuit movement (observable entity),20060731,1,9E+17,9E+17
420432003,Homans' sign location (observable entity),20060731,1,9E+17,9E+17
420425007,Anatomic location directly invaded focally by neoplasm (observable entity),20060731,1,9E+17,9E+17
420772006,Index of refraction (observable entity),20060731,1,9E+17,9E+17
420415002,Acoustic feature of mass (observable entity),20060731,1,9E+17,9E+17
420404007,Urinary catheterization status (observable entity),20060731,1,9E+17,9E+17
420257006,Internal acoustic reflectivity of mass (observable entity),20060731,1,9E+17,9E+17
420294002,Nerve fiber layer (observable entity),20060731,1,9E+17,9E+17
421222001,Ultrasonographic echogenicity (observable entity),20060731,1,9E+17,9E+17
421193006,Anatomic location directly invaded multifocally by neoplasm (observable entity),20060731,1,9E+17,9E+17
421261009,Eyelash observable (observable entity),20060731,1,9E+17,9E+17
421469009,Ultrasonographic observable (observable entity),20060731,1,9E+17,9E+17
421566000,Corneal incision observable (observable entity),20060731,1,9E+17,9E+17
421528003,Contact lens peripheral curve (observable entity),20060731,1,9E+17,9E+17
421507007,Corneal endothelium observable (observable entity),20060731,1,9E+17,9E+17
420962000,Intercanthal distance (observable entity),20060731,1,9E+17,9E+17
420849000,Date of last papanicolaou test (observable entity),20060731,1,9E+17,9E+17
420911003,Ophthalmic ultrasonography observable (observable entity),20060731,1,9E+17,9E+17
425012009,Sewage disposal (observable entity),20070131,1,9E+17,9E+17
423925001,Family planning observable (observable entity),20070131,1,9E+17,9E+17
425024002,Body weight without shoes (observable entity),20070131,1,9E+17,9E+17
423901009,Identification code (observable entity),20070131,1,9E+17,9E+17
425039001,Adequacy of play space (observable entity),20070131,1,9E+17,9E+17
424927000,Body weight with shoes (observable entity),20070131,1,9E+17,9E+17
425001009,Reason for unscheduled ambulance service (observable entity),20070131,1,9E+17,9E+17
424949006,Anatomic location of malignant melanoma with uninvolved deep margin in excised skin specimen (observable entity),20070131,1,9E+17,9E+17
424966008,Patient email address (observable entity),20070131,1,9E+17,9E+17
425271000,Cultural barrier status (observable entity),20070131,1,9E+17,9E+17
425133002,Location of malignant melanoma in specimen with involved deep margin (observable entity),20070131,1,9E+17,9E+17
425149000,Characteristics of animals in environment (observable entity),20070131,1,9E+17,9E+17
425094009,Depth of wound (observable entity),20070131,1,9E+17,9E+17
425170006,Depth of lesion (observable entity),20070131,1,9E+17,9E+17
425260001,Body position for height measurement (observable entity),20070131,1,9E+17,9E+17
424838004,Community health status: crime rate (observable entity),20070131,1,9E+17,9E+17
424391002,Hertel exophthalmometry measurement (observable entity),20070131,1,9E+17,9E+17
424060000,Depth of burn (observable entity),20070131,1,9E+17,9E+17
423991001,Postpartum health behavior (observable entity),20070131,1,9E+17,9E+17
424136002,Contraceptive use behavior (observable entity),20070131,1,9E+17,9E+17
424696000,Location of malignant melanoma in specimen with uninvolved lateral margin (observable entity),20070131,1,9E+17,9E+17
424724000,Body position for blood pressure measurement (observable entity),20070131,1,9E+17,9E+17
424812004,Reason for scheduled ambulance service (observable entity),20070131,1,9E+17,9E+17
424544008,Tear meniscus height (observable entity),20070131,1,9E+17,9E+17
424471005,Details of water supply (observable entity),20070131,1,9E+17,9E+17
424483007,Transportation details (observable entity),20070131,1,9E+17,9E+17
424649008,Details of environmental odor (observable entity),20070131,1,9E+17,9E+17
423968000,Episcleral venous pressure (observable entity),20070131,1,9E+17,9E+17
422630005,Adequacy of exercise space (observable entity),20070131,1,9E+17,9E+17
422629000,Temperature of home environment (observable entity),20070131,1,9E+17,9E+17
422746009,Stage of retinopathy in retinopathy of prematurity (observable entity),20070131,1,9E+17,9E+17
422686005,Mouth shape (observable entity),20070131,1,9E+17,9E+17
422693009,Language barrier (observable entity),20070131,1,9E+17,9E+17
422433003,Volume of drug additive (observable entity),20070131,1,9E+17,9E+17
422431001,Body position for procedure (observable entity),20070131,1,9E+17,9E+17
422392005,Order control (observable entity),20070131,1,9E+17,9E+17
422462002,Margin reflex distance (observable entity),20070131,1,9E+17,9E+17
422518009,Ability to obtain contraception (observable entity),20070131,1,9E+17,9E+17
422549004,Patient-related Identification code (observable entity),20070131,1,9E+17,9E+17
423406008,Inferior scleral show measurement (observable entity),20070131,1,9E+17,9E+17
423514004,Community resource details (observable entity),20070131,1,9E+17,9E+17
423264007,Lower eyelid margin reflex distance (observable entity),20070131,1,9E+17,9E+17
423340009,Family lifestyle disruption status (observable entity),20070131,1,9E+17,9E+17
423792003,Lagophthalmos measurement (observable entity),20070131,1,9E+17,9E+17
423745002,Details of environmental infestation (observable entity),20070131,1,9E+17,9E+17
423740007,Eastern Cooperative Oncology Group performance status (observable entity),20070131,1,9E+17,9E+17
423817004,Superior scleral show measurement (observable entity),20070131,1,9E+17,9E+17
423844009,Length of colon specimen (observable entity),20070131,1,9E+17,9E+17
423833001,Duration of eye contact (observable entity),20070131,1,9E+17,9E+17
423723003,Communication device observable (observable entity),20070131,1,9E+17,9E+17
423597007,Upper eyelid margin reflex distance (observable entity),20070131,1,9E+17,9E+17
423573003,Details of stairs in home (observable entity),20070131,1,9E+17,9E+17
423690003,General physical performance status (observable entity),20070131,1,9E+17,9E+17
423087008,Scleral show measurement (observable entity),20070131,1,9E+17,9E+17
422984006,Order status (observable entity),20070131,1,9E+17,9E+17
422796005,Location of melanoma in situ in specimen with uninvolved lateral margin (observable entity),20070131,1,9E+17,9E+17
423173005,Length of appendix specimen (observable entity),20070131,1,9E+17,9E+17
422821004,Details of laundry facilities (observable entity),20070131,1,9E+17,9E+17
423203003,Maiden name (observable entity),20070131,1,9E+17,9E+17
426141008,Drug diluent solution (observable entity),20070731,1,9E+17,9E+17
426146003,Single dose characteristic (observable entity),20070731,1,9E+17,9E+17
425610002,Surgical bone margin closest to malignant neoplasm (observable entity),20070731,1,9E+17,9E+17
425608004,Delivered oxygen concentration (observable entity),20070731,1,9E+17,9E+17
426203009,Carotid intima media thickness (observable entity),20070731,1,9E+17,9E+17
425621006,Expired desflurane concentration (observable entity),20070731,1,9E+17,9E+17
426175009,Hyoidmental distance (observable entity),20070731,1,9E+17,9E+17
425679006,Sternomental distance (observable entity),20070731,1,9E+17,9E+17
426034004,Distance of sarcoma from closest surgical margin of soft tissue in excised specimen (observable entity),20070731,1,9E+17,9E+17
426007002,Multiple dose characteristic (observable entity),20070731,1,9E+17,9E+17
425911000,Status of correlation between radiographic image and pathologic finding (observable entity),20070731,1,9E+17,9E+17
425952009,Inspired halothane concentration (observable entity),20070731,1,9E+17,9E+17
425795004,Multiple organ dysfunction score (observable entity),20070731,1,9E+17,9E+17
425976001,Acceptable pain level status (observable entity),20070731,1,9E+17,9E+17
425783004,Measure of head and neck region (observable entity),20070731,1,9E+17,9E+17
425724007,Inspired sevoflurane concentration (observable entity),20070731,1,9E+17,9E+17
425709003,Therapeutic substance unit size (observable entity),20070731,1,9E+17,9E+17
425762005,Therapeutic substance bar code (observable entity),20070731,1,9E+17,9E+17
425875003,End tidal enflurane concentration (observable entity),20070731,1,9E+17,9E+17
426998000,Drug dilution characteristic (observable entity),20070731,1,9E+17,9E+17
427034007,Expired halothane concentration (observable entity),20070731,1,9E+17,9E+17
426929000,Systemic inflammatory response syndrome score (observable entity),20070731,1,9E+17,9E+17
426941007,Therapeutic substance identifier (observable entity),20070731,1,9E+17,9E+17
426981000,Respired isoflurane concentration (observable entity),20070731,1,9E+17,9E+17
426988006,End tidal desflurane concentration (observable entity),20070731,1,9E+17,9E+17
426543000,Hourly urine volume (observable entity),20070731,1,9E+17,9E+17
426548009,Controlled substance control feature (observable entity),20070731,1,9E+17,9E+17
426504004,Inspired isoflurane concentration (observable entity),20070731,1,9E+17,9E+17
426524000,Expired enflurane concentration (observable entity),20070731,1,9E+17,9E+17
426888005,Respired sevoflurane concentration (observable entity),20070731,1,9E+17,9E+17
426748007,Inspired desflurane concentration (observable entity),20070731,1,9E+17,9E+17
427604003,Inspired enflurane concentration (observable entity),20070731,1,9E+17,9E+17
427598001,End tidal halothane concentration (observable entity),20070731,1,9E+17,9E+17
427597006,End tidal sevoflurane concentration (observable entity),20070731,1,9E+17,9E+17
426262001,Controlled substance dispensation control number (observable entity),20070731,1,9E+17,9E+17
426280005,Respired desflurane concentration (observable entity),20070731,1,9E+17,9E+17
426274002,Type of preoperative treatment (observable entity),20070731,1,9E+17,9E+17
427701001,Distance of sarcoma from closest bone margin (observable entity),20070731,1,9E+17,9E+17
427210008,Expired sevoflurane concentration (observable entity),20070731,1,9E+17,9E+17
427221004,Therapeutic substance unit characteristic (observable entity),20070731,1,9E+17,9E+17
427416004,Therapeutic substance expiration date (observable entity),20070731,1,9E+17,9E+17
427422008,Thyromental distance (observable entity),20070731,1,9E+17,9E+17
426377006,Respired halothane concentration (observable entity),20070731,1,9E+17,9E+17
427401002,Drug dilution volume (observable entity),20070731,1,9E+17,9E+17
427452000,End tidal isoflurane concentration (observable entity),20070731,1,9E+17,9E+17
427312003,Intima media thickness (observable entity),20070731,1,9E+17,9E+17
427309001,Surgical soft tissue margin closest to malignant neoplasm (observable entity),20070731,1,9E+17,9E+17
425421000,Expired isoflurane concentration (observable entity),20070731,1,9E+17,9E+17
425402008,Geriatric depression score (observable entity),20070731,1,9E+17,9E+17
425400000,Toxic exposure status (observable entity),20070731,1,9E+17,9E+17
425416003,Therapeutic substance lot identifier (observable entity),20070731,1,9E+17,9E+17
425547006,Respired enflurane concentration (observable entity),20070731,1,9E+17,9E+17
428330008,Preferred mode of communication (observable entity),20080131,1,9E+17,9E+17
428842005,Patient textphone number (observable entity),20080131,1,9E+17,9E+17
428843000,Patient work telephone number (observable entity),20080131,1,9E+17,9E+17
428550008,T wave alternans (observable entity),20080131,1,9E+17,9E+17
428556002,Total international prostate symptom score (observable entity),20080131,1,9E+17,9E+17
428630002,Maximum heart rate achieved during course of procedure (observable entity),20080131,1,9E+17,9E+17
428481002,Patient mobile telephone number (observable entity),20080131,1,9E+17,9E+17
428442002,Pierce suicide intent scale score (observable entity),20080131,1,9E+17,9E+17
428531008,Heart rate response (observable entity),20080131,1,9E+17,9E+17
428395000,Medical identification bracelet present (observable entity),20080131,1,9E+17,9E+17
429622005,ST Depression (observable entity),20080131,1,9E+17,9E+17
429524004,Patient facsimile number (observable entity),20080131,1,9E+17,9E+17
429736008,Date of last mammogram (observable entity),20080131,1,9E+17,9E+17
429684009,Reason for nonvaccination (observable entity),20080131,1,9E+17,9E+17
429697006,Patient home telephone number (observable entity),20080131,1,9E+17,9E+17
429745009,Diurnal variation of peak expiratory flow rate (observable entity),20080131,1,9E+17,9E+17
429770009,Date of last bowel movement (observable entity),20080131,1,9E+17,9E+17
429053008,Wells deep vein thrombosis clinical probability score (observable entity),20080131,1,9E+17,9E+17
429086007,Patient alias name (observable entity),20080131,1,9E+17,9E+17
428996008,Language preference (observable entity),20080131,1,9E+17,9E+17
428967007,Time of last bowel movement (observable entity),20080131,1,9E+17,9E+17
429153006,Speed of heart rate response (observable entity),20080131,1,9E+17,9E+17
429157007,Heart rate recovery time (observable entity),20080131,1,9E+17,9E+17
429162008,Extent of myocardial stress ischemia (observable entity),20080131,1,9E+17,9E+17
427810001,Speed of cardiovascular response (observable entity),20080131,1,9E+17,9E+17
427732000,Speed of blood pressure response (observable entity),20080131,1,9E+17,9E+17
427751006,Extent of cardiac perfusion defect (observable entity),20080131,1,9E+17,9E+17
437728003,Template version identifier (observable entity),20080131,1,9E+17,9E+17
430327009,Color of urine (observable entity),20080731,1,9E+17,9E+17
164955000,Electrocardiogram: Q-T interval normal (finding),20080731,1,9E+17,9E+17
433178008,City of residence (observable entity),20080731,1,9E+17,9E+17
433204000,Rate of sampling of peripheral oxygen saturation by device (observable entity),20080731,1,9E+17,9E+17
432678004,Indication for procedure (observable entity),20080731,1,9E+17,9E+17
432407003,County of residence (observable entity),20080731,1,9E+17,9E+17
432213005,Date of diagnosis (observable entity),20080731,1,9E+17,9E+17
439238004,Echocardiography test interpretation (observable entity),20090131,1,9E+17,9E+17
439228009,Degree of physical and psychological healing following burn (observable entity),20090131,1,9E+17,9E+17
439166003,Risk of elopement for cognitvely impaired subject (observable entity),20090131,1,9E+17,9E+17
439907006,Number of sick days off work in last month (observable entity),20090131,1,9E+17,9E+17
439914008,Compliance behavior to prescribed medication (observable entity),20090131,1,9E+17,9E+17
439923006,Interpretation of test for detection of virus (observable entity),20090131,1,9E+17,9E+17
439932008,Length of structure by imaging measurement (observable entity),20090131,1,9E+17,9E+17
440012000,Smoking cessation behavior (observable entity),20090131,1,9E+17,9E+17
440013005,Number of preterm births (observable entity),20090131,1,9E+17,9E+17
440020003,Date of positive pregnancy test (observable entity),20090131,1,9E+17,9E+17
440030007,Adequacy of cardiac output and alveolar gas exchange (observable entity),20090131,1,9E+17,9E+17
440031006,Adequacy of ventilation and alveolar gas exchange (observable entity),20090131,1,9E+17,9E+17
440035002,Dual energy X-ray photon absorptiometry scan T score (observable entity),20090131,1,9E+17,9E+17
440040005,Number of elopements for cognitively impaired subject (observable entity),20090131,1,9E+17,9E+17
439933003,Long axis length of structure by imaging measurement (observable entity),20090131,1,9E+17,9E+17
439934009,Depth of structure by imaging measurement (observable entity),20090131,1,9E+17,9E+17
439982003,Major axis length of structure by imaging measurement (observable entity),20090131,1,9E+17,9E+17
439983008,Minor axis length of structure by imaging measurement (observable entity),20090131,1,9E+17,9E+17
439984002,Diameter of structure by imaging measurement (observable entity),20090131,1,9E+17,9E+17
439985001,Area of body region by imaging measurement (observable entity),20090131,1,9E+17,9E+17
439428006,Short axis length of structure by imaging measurement (observable entity),20090131,1,9E+17,9E+17
439429003,Radius of structure by imaging measurement (observable entity),20090131,1,9E+17,9E+17
439635008,Observable related to donation of body structure (observable entity),20090131,1,9E+17,9E+17
439434004,Level of comfort of environment (observable entity),20090131,1,9E+17,9E+17
439066001,Healthy diet adherence behavior (observable entity),20090131,1,9E+17,9E+17
439393008,Cardiovascular stress test interpretation (observable entity),20090131,1,9E+17,9E+17
439391005,Holter monitor test interpretation (observable entity),20090131,1,9E+17,9E+17
439373000,Behavior to promote weight loss (observable entity),20090131,1,9E+17,9E+17
439374006,Drug abuse cessation behavior (observable entity),20090131,1,9E+17,9E+17
439415004,Behavior to maintain weight (observable entity),20090131,1,9E+17,9E+17
439401001,Diagnosis (observable entity),20090131,1,9E+17,9E+17
439408007,Level of confusion of sudden onset (observable entity),20090131,1,9E+17,9E+17
439590007,Cardiovascular stress test abnormal (finding),20090131,1,9E+17,9E+17
439369003,Neurologic status of peripheral nervous system (observable entity),20090131,1,9E+17,9E+17
439830001,Behavior to prevent infection (observable entity),20090131,1,9E+17,9E+17
439814009,International normalized ratio derived warfarin dose (observable entity),20090131,1,9E+17,9E+17
439812008,Number of hours worked per week (observable entity),20090131,1,9E+17,9E+17
439271000,Date of most recent screening for disease (observable entity),20090131,1,9E+17,9E+17
439272007,Date of procedure (observable entity),20090131,1,9E+17,9E+17
439729002,Behavior related to multiple sclerosis self management (observable entity),20090131,1,9E+17,9E+17
439356002,Length of ulna (observable entity),20090131,1,9E+17,9E+17
439772008,Date of last episode of disorder (observable entity),20090131,1,9E+17,9E+17
439771001,Date of event (observable entity),20090131,1,9E+17,9E+17
439749006,Volume of structure by imaging measurement (observable entity),20090131,1,9E+17,9E+17
439736001,Language for which interpreter is needed (observable entity),20090131,1,9E+17,9E+17
439748003,Diameter of circular structure by imaging measurement (observable entity),20090131,1,9E+17,9E+17
439747008,Circumference of circular structure by imaging measurement (observable entity),20090131,1,9E+17,9E+17
439746004,Area of structure by imaging measurement (observable entity),20090131,1,9E+17,9E+17
439744001,Ulcer observable (observable entity),20090131,1,9E+17,9E+17
439743007,Exudate observable (observable entity),20090131,1,9E+17,9E+17
441210008,Odor of exudate (observable entity),20090131,1,9E+17,9E+17
441199002,Stress echocardiography test interpretation (observable entity),20090131,1,9E+17,9E+17
441281002,Amount of exudate (observable entity),20090131,1,9E+17,9E+17
441280001,Color of exudate (observable entity),20090131,1,9E+17,9E+17
441273003,Private referral to (observable entity),20090131,1,9E+17,9E+17
441090001,Transthoracic echocardiography test interpretation (observable entity),20090131,1,9E+17,9E+17
441308009,New diagnosis (observable entity),20090131,1,9E+17,9E+17
441390007,Surface area of ulcer (observable entity),20090131,1,9E+17,9E+17
441389003,Viscosity of exudate (observable entity),20090131,1,9E+17,9E+17
441377000,Thallium stress test abnormal (finding),20090131,1,9E+17,9E+17
441316000,Private referral for (observable entity),20090131,1,9E+17,9E+17
441315001,Private referral by (observable entity),20090131,1,9E+17,9E+17
441312003,Eligibility to be a donor (observable entity),20090131,1,9E+17,9E+17
440433004,Perimeter of noncircular structure by imaging measurement (observable entity),20090131,1,9E+17,9E+17
440431002,History relating to Army service (observable entity),20090131,1,9E+17,9E+17
440425000,Number of births at term (observable entity),20090131,1,9E+17,9E+17
440423007,Level of severity of substance withdrawal symptoms (observable entity),20090131,1,9E+17,9E+17
440593000,Response of community to disaster (observable entity),20090131,1,9E+17,9E+17
440592005,Readiness to undergo procedure (observable entity),20090131,1,9E+17,9E+17
440537001,Number of ectopic pregnancies (observable entity),20090131,1,9E+17,9E+17
440384002,Safe wandering behavior of cognitively impaired subject (observable entity),20090131,1,9E+17,9E+17
440382003,Behavior to prevent hypothermia (observable entity),20090131,1,9E+17,9E+17
440381005,Behavior to prevent sun exposure (observable entity),20090131,1,9E+17,9E+17
440379008,Referral to (observable entity),20090131,1,9E+17,9E+17
440378000,Referral for (observable entity),20090131,1,9E+17,9E+17
440377005,Referral by (observable entity),20090131,1,9E+17,9E+17
440392006,Adequacy of tissue perfusion at cellular level (observable entity),20090131,1,9E+17,9E+17
440396009,Use of oral contraceptive status at conception (observable entity),20090131,1,9E+17,9E+17
440394007,Compliance behavior to prescribed diet (observable entity),20090131,1,9E+17,9E+17
440357003,Width of structure by imaging measurement (observable entity),20090131,1,9E+17,9E+17
440356007,Perpendicular axis length of structure by imaging measurement (observable entity),20090131,1,9E+17,9E+17
440349001,Behavior to promote weight gain (observable entity),20090131,1,9E+17,9E+17
440664005,Details of drug use behavior during pregnancy (observable entity),20090131,1,9E+17,9E+17
440665006,Compensatory behavior related to unilateral stroke deficit (observable entity),20090131,1,9E+17,9E+17
440652002,Alcohol abuse cessation behavior (observable entity),20090131,1,9E+17,9E+17
440634002,Ability to adapt after personal crisis (observable entity),20090131,1,9E+17,9E+17
440633008,Behavior to prevent hyperthermia (observable entity),20090131,1,9E+17,9E+17
434911002,Plasma glucose concentration (observable entity),20090131,1,9E+17,9E+17
434912009,Blood glucose concentration (observable entity),20090131,1,9E+17,9E+17
434913004,Glucose concentration in quality control reagent (observable entity),20090131,1,9E+17,9E+17
434910001,Interstitial fluid glucose concentration (observable entity),20090131,1,9E+17,9E+17
438950009,Environment observable (observable entity),20090131,1,9E+17,9E+17
442244004,Length of time homeless (observable entity),20090731,1,9E+17,9E+17
442229000,Amount of money spent per day on drug habit (observable entity),20090731,1,9E+17,9E+17
442194005,Swollen joint count for rheumatoid arthritis assessment (observable entity),20090731,1,9E+17,9E+17
275731005,Urodynamic studies abnormal (finding),20090731,1,9E+17,9E+17
275730006,Urodynamic studies normal (finding),20090731,1,9E+17,9E+17
441765008,Time of induction of anesthesia (observable entity),20090731,1,9E+17,9E+17
441744002,Fecal pH (observable entity),20090731,1,9E+17,9E+17
441927008,Time of patient arrival to location for anesthesia (observable entity),20090731,1,9E+17,9E+17
441968004,Time of patient arrival in healthcare facility (observable entity),20090731,1,9E+17,9E+17
441870009,Disease activity score using 28 joint count (observable entity),20090731,1,9E+17,9E+17
441857000,Forced vital capacity before bronchodilation (observable entity),20090731,1,9E+17,9E+17
274523007,Electromyogram abnormal (finding),20090731,1,9E+17,9E+17
274521009,Electroencephalogram abnormal (finding),20090731,1,9E+17,9E+17
442133001,Housing history (observable entity),20090731,1,9E+17,9E+17
11953005,Renal function (observable entity),20090731,1,9E+17,9E+17
442720002,Expired oxygen tension (observable entity),20090731,1,9E+17,9E+17
313170008,Colonoscopy normal (finding),20090731,1,9E+17,9E+17
313172000,Colonoscopy abnormal (finding),20090731,1,9E+17,9E+17
442687006,Swollen 28 joint count (observable entity),20090731,1,9E+17,9E+17
442751009,Inspired oxygen tension (observable entity),20090731,1,9E+17,9E+17
442736000,Tender 28 joint count (observable entity),20090731,1,9E+17,9E+17
442547005,Number of alcohol units consumed on heaviest drinking day (observable entity),20090731,1,9E+17,9E+17
415527002,Sigmoidoscopy normal (finding),20090731,1,9E+17,9E+17
442415003,Time of arrival of anesthesia care provider to anesthetizing location (observable entity),20090731,1,9E+17,9E+17
442308007,Duration of anticoagulant therapy (observable entity),20090731,1,9E+17,9E+17
442335003,Time of establishment of adequate anesthesia (observable entity),20090731,1,9E+17,9E+17
442364007,Influenza A virus subtype H1N1 vaccination status (observable entity),20090731,1,9E+17,9E+17
442492001,Duration of early morning joint stiffness (observable entity),20090731,1,9E+17,9E+17
442521001,Tender joint count for rheumatoid arthritis assessment (observable entity),20090731,1,9E+17,9E+17
441674002,Microorganism motility (observable entity),20090731,1,9E+17,9E+17
442465007,Respired oxygen tension (observable entity),20090731,1,9E+17,9E+17
165140000,Endoscopy normal (finding),20090731,1,9E+17,9E+17
165141001,Gastroscopy normal (finding),20090731,1,9E+17,9E+17
165145005,Bronchoscopy abnormal (finding),20090731,1,9E+17,9E+17
165144009,Gastroscopy abnormal (finding),20090731,1,9E+17,9E+17
165143003,Endoscopy abnormal (finding),20090731,1,9E+17,9E+17
165142008,Bronchoscopy normal (finding),20090731,1,9E+17,9E+17
164722000,Electromyogram normal (finding),20090731,1,9E+17,9E+17
164718005,Neurological diagnostic procedure - abnormal (finding),20090731,1,9E+17,9E+17
164717000,Electroencephalogram normal (finding),20090731,1,9E+17,9E+17
164716009,Neurological diagnostic procedure normal (finding),20090731,1,9E+17,9E+17
164852001,Ambulatory electrocardiogram abnormal (finding),20090731,1,9E+17,9E+17
164851008,Ambulatory electrocardiogram normal (finding),20090731,1,9E+17,9E+17
164816000,Postcoital test normal (finding),20090731,1,9E+17,9E+17
164800002,Cystometry abnormal (finding),20090731,1,9E+17,9E+17
164798009,Cystometry normal (finding),20090731,1,9E+17,9E+17
164779007,Special cardiovascular system test abnormal (finding),20090731,1,9E+17,9E+17
164778004,Special cardiovascular system test normal (finding),20090731,1,9E+17,9E+17
164759004,Tympanogram abnormal (finding),20090731,1,9E+17,9E+17
164758007,Tympanogram normal (finding),20090731,1,9E+17,9E+17
164815001,Postcoital test abnormal (finding),20090731,1,9E+17,9E+17
443772002,Clockface position of neoplasm (observable entity),20100131,1,9E+17,9E+17
444514002,Hospital falls risk assessment score for the elderly (observable entity),20100131,1,9E+17,9E+17
444246003,Falls risk assessment score for the elderly (observable entity),20100131,1,9E+17,9E+17
443443002,Age of caregiver (observable entity),20100131,1,9E+17,9E+17
444245004,Cardiovascular device observable (observable entity),20100131,1,9E+17,9E+17
443394008,Visual analog scale pain score (observable entity),20100131,1,9E+17,9E+17
444478008,Clockface position of neoplasm of nipple (observable entity),20100131,1,9E+17,9E+17
444479000,Rate of blood flow through cardiovascular device (observable entity),20100131,1,9E+17,9E+17
443657009,Tinetti balance and gait evaluation total score (observable entity),20100131,1,9E+17,9E+17
443941007,"Edition of American Joint Commission on Cancer, Cancer Staging Manual used for TNM staging (observable entity)",20100131,1,9E+17,9E+17
443412009,Degree of microsatellite instability (observable entity),20100131,1,9E+17,9E+17
443722004,Educational level of parent of subject (observable entity),20100131,1,9E+17,9E+17
444465008,Rate of leakage flow around cardiovascular device (observable entity),20100131,1,9E+17,9E+17
442864001,Date of discharge (observable entity),20100131,1,9E+17,9E+17
443223005,Brief pain inventory score (observable entity),20100131,1,9E+17,9E+17
444060007,Disease activity score in rheumatoid arthritis using C-reactive protein (observable entity),20100131,1,9E+17,9E+17
443225003,Ethnicity of caregiver (observable entity),20100131,1,9E+17,9E+17
443825005,Number of specimen blocks examined (observable entity),20100131,1,9E+17,9E+17
443431003,Assigned color zone for Broselow Luten pediatric weight estimation (observable entity),20100131,1,9E+17,9E+17
443748007,Number of malignant neoplasm foci (observable entity),20100131,1,9E+17,9E+17
444028004,Educational level of guardian of subject (observable entity),20100131,1,9E+17,9E+17
443618001,Tinetti gait score (observable entity),20100131,1,9E+17,9E+17
444323003,Modified Glasgow coma score (observable entity),20100131,1,9E+17,9E+17
443504004,Severity of alcohol dependence questionnaire score (observable entity),20100131,1,9E+17,9E+17
443845002,Rh>o<(D) immune globulin dose (observable entity),20100131,1,9E+17,9E+17
443846001,Detail of history of travel (observable entity),20100131,1,9E+17,9E+17
443848000,Apgar score at 15 minutes (observable entity),20100131,1,9E+17,9E+17
443849008,Apgar score at 20 minutes (observable entity),20100131,1,9E+17,9E+17
443125007,Activities specific balance confidence score (observable entity),20100131,1,9E+17,9E+17
443117005,Asthma control test score (observable entity),20100131,1,9E+17,9E+17
443881004,Adelaide pediatric coma score (observable entity),20100131,1,9E+17,9E+17
443481007,Tinetti falls efficacy score (observable entity),20100131,1,9E+17,9E+17
444276005,Arterial closing pressure (observable entity),20100131,1,9E+17,9E+17
444427001,Community falls risk assessment score for the elderly (observable entity),20100131,1,9E+17,9E+17
443315005,Number of alcohol units consumed on typical drinking day (observable entity),20100131,1,9E+17,9E+17
443158003,Number of mitotic figures per square millimeter (observable entity),20100131,1,9E+17,9E+17
444421000,Disease that is endemic in recent area visited (observable entity),20100131,1,9E+17,9E+17
443639008,Tinetti balance score (observable entity),20100131,1,9E+17,9E+17
443172007,Bristol stool form score (observable entity),20100131,1,9E+17,9E+17
444411008,Number of sentinel lymph nodes examined by microscopy in lymph node specimen (observable entity),20100131,1,9E+17,9E+17
444195007,Developmental age (observable entity),20100131,1,9E+17,9E+17
443280005,Alcohol use disorders identification test score (observable entity),20100131,1,9E+17,9E+17
444135009,Estimated fetal gestational age at delivery (observable entity),20100131,1,9E+17,9E+17
443914002,Deepest level of microscopic extension of neoplasm (observable entity),20100131,1,9E+17,9E+17
443428004,Braden Scale for Predicting Pressure Sore Risk score (observable entity),20100131,1,9E+17,9E+17
443787007,Site involved by extension of neoplasm (observable entity),20100131,1,9E+17,9E+17
443133008,Norton pressure ulcer risk score (observable entity),20100131,1,9E+17,9E+17
443911005,Ordinal level of hemoglobin A1c (observable entity),20100131,1,9E+17,9E+17
443097008,Lymph node station of involved lymph nodes (observable entity),20100131,1,9E+17,9E+17
141988003,Prostatic hypertrophy risk score (observable entity),20100131,1,9E+17,9E+17
444948009,Disabilities of the arm shoulder and hand outcome measure score (observable entity),20100731,1,9E+17,9E+17
444949001,Geriatric depression scale 4 item score (observable entity),20100731,1,9E+17,9E+17
444873005,Brighton pediatric early warning score (observable entity),20100731,1,9E+17,9E+17
444987009,Residual cancer burden class (observable entity),20100731,1,9E+17,9E+17
444982003,Geriatric depression scale short form score (observable entity),20100731,1,9E+17,9E+17
444810000,Alcohol withdrawal scale score (observable entity),20100731,1,9E+17,9E+17
444782009,Residual cancer burden index (observable entity),20100731,1,9E+17,9E+17
444837003,Marks and Mathews fear questionnaire level of avoidance score (observable entity),20100731,1,9E+17,9E+17
444696007,Status of specimen involvement by multifocal invasion (observable entity),20100731,1,9E+17,9E+17
444740005,Largest dimension of in situ neoplasm (observable entity),20100731,1,9E+17,9E+17
445520006,Visual infusion phlebitis score (observable entity),20100731,1,9E+17,9E+17
445494006,Length of appointment needed (observable entity),20100731,1,9E+17,9E+17
445502002,70-gene signature classification (observable entity),20100731,1,9E+17,9E+17
445504001,Addiction Research Foundation Clinical Institute Withdrawal Assessment for Alcohol score (observable entity),20100731,1,9E+17,9E+17
445565002,Total boost radiation dose delivered (observable entity),20100731,1,9E+17,9E+17
445541000,Dry body weight (observable entity),20100731,1,9E+17,9E+17
445549003,"Historical, clinical, risk management 20 assessing risk for violence scheme version 2 score (observable entity)",20100731,1,9E+17,9E+17
445551004,Modified early warning score (observable entity),20100731,1,9E+17,9E+17
445552006,Social phobia inventory score (observable entity),20100731,1,9E+17,9E+17
445416009,Adult early warning scoring system score (observable entity),20100731,1,9E+17,9E+17
445389005,Percentage of predicted vital capacity (observable entity),20100731,1,9E+17,9E+17
445397003,Duration of recurrence-free survival (observable entity),20100731,1,9E+17,9E+17
445461008,Total radiation dose delivered (observable entity),20100731,1,9E+17,9E+17
445455005,Generalized Anxiety Disorder 7 item score (observable entity),20100731,1,9E+17,9E+17
445466003,Forced expired volume in 1 second reversibility (observable entity),20100731,1,9E+17,9E+17
445647005,Area of residual neoplasm (observable entity),20100731,1,9E+17,9E+17
445648000,Quick disabilities of the arm shoulder and hand outcome measure score (observable entity),20100731,1,9E+17,9E+17
445655003,Largest dimension of residual neoplasm (observable entity),20100731,1,9E+17,9E+17
445128006,Marks and Mathews fear questionnaire global phobia rating (observable entity),20100731,1,9E+17,9E+17
445043005,Marks and Mathews fear questionnaire total associated anxiety and depression score (observable entity),20100731,1,9E+17,9E+17
445044004,Marks and Mathews fear questionnaire total phobia score (observable entity),20100731,1,9E+17,9E+17
445035000,Short falls efficacy scale - international score (observable entity),20100731,1,9E+17,9E+17
445028008,Status of estrogen receptors of neoplasm (observable entity),20100731,1,9E+17,9E+17
445029000,Status of progesterone receptors of neoplasm (observable entity),20100731,1,9E+17,9E+17
445032002,Reason procedure not performed (observable entity),20100731,1,9E+17,9E+17
445064009,Geriatric depression scale original long form score (observable entity),20100731,1,9E+17,9E+17
445073001,Filled tooth surfaces count (observable entity),20100731,1,9E+17,9E+17
445192002,Clinical chronic obstructive pulmonary disease questionnaire total score (observable entity),20100731,1,9E+17,9E+17
445320007,Survival time (observable entity),20100731,1,9E+17,9E+17
445358006,Decayed tooth surfaces count (observable entity),20100731,1,9E+17,9E+17
445233004,Percentage span of neoplasm consisting of stroma (observable entity),20100731,1,9E+17,9E+17
445234005,Percentage span of neoplasm consisting of epithelium (observable entity),20100731,1,9E+17,9E+17
445200009,Status of residual neoplasm (observable entity),20100731,1,9E+17,9E+17
445210000,Percentage of predicted forced vital capacity (observable entity),20100731,1,9E+17,9E+17
445277006,Number of Rh>o<(D) immune globulin vials recommended (observable entity),20100731,1,9E+17,9E+17
445953008,Manchester foot pain and disability index score (observable entity),20110131,1,9E+17,9E+17
445958004,Erection hardness score (observable entity),20110131,1,9E+17,9E+17
445962005,Range of ankle eversion (observable entity),20110131,1,9E+17,9E+17
445930007,International index of erectile function score (observable entity),20110131,1,9E+17,9E+17
445888007,Volitional questionnaire version 4.1 score (observable entity),20110131,1,9E+17,9E+17
446056006,Dallas pain questionnaire score (observable entity),20110131,1,9E+17,9E+17
446054009,Falls behavioral scale for older people score (observable entity),20110131,1,9E+17,9E+17
446053003,Beck depression inventory score (observable entity),20110131,1,9E+17,9E+17
446044005,Victorian Institute of Sport Assessment-Achilles questionnaire score (observable entity),20110131,1,9E+17,9E+17
446089006,Volume of lower limb (observable entity),20110131,1,9E+17,9E+17
446086004,Volume of upper limb (observable entity),20110131,1,9E+17,9E+17
446085000,12-item general health questionnaire score (observable entity),20110131,1,9E+17,9E+17
446082002,Range of ankle inversion (observable entity),20110131,1,9E+17,9E+17
446074002,Hemoglobin A1c target value using International Federation of Clinical Chemistry and Laboratory Medicine standardized method (observable entity),20110131,1,9E+17,9E+17
446042009,Repeatable battery for the assessment of neuropsychological status score (observable entity),20110131,1,9E+17,9E+17
446041002,Hand volumeter set reading (observable entity),20110131,1,9E+17,9E+17
446039003,Eating disorder examination questionnaire score (observable entity),20110131,1,9E+17,9E+17
446038006,Brief pain coping inventory score (observable entity),20110131,1,9E+17,9E+17
446037001,Behavioral assessment of the dysexecutive syndrome score (observable entity),20110131,1,9E+17,9E+17
445872007,Length of gestation at time of procedure (observable entity),20110131,1,9E+17,9E+17
446879006,Eating disorder inventory score (observable entity),20110131,1,9E+17,9E+17
446880009,Fatigue impact scale score (observable entity),20110131,1,9E+17,9E+17
446881008,Home falls and accidents screening tool score (observable entity),20110131,1,9E+17,9E+17
446625004,Frontal assessment battery score (observable entity),20110131,1,9E+17,9E+17
446623006,Childhood health assessment questionnaire score (observable entity),20110131,1,9E+17,9E+17
446627007,Semmes-Weinstein monofilament test score (observable entity),20110131,1,9E+17,9E+17
446963009,Comprehensive occupational therapy evaluation scale score (observable entity),20110131,1,9E+17,9E+17
446949003,Psychotic symptom rating scales total score (observable entity),20110131,1,9E+17,9E+17
446454000,Career interest test score (observable entity),20110131,1,9E+17,9E+17
446453006,Chessington occupational therapy neurological assessment battery score (observable entity),20110131,1,9E+17,9E+17
446452001,Clifton assessment procedures for the elderly score (observable entity),20110131,1,9E+17,9E+17
446974000,Body mass index centile (observable entity),20110131,1,9E+17,9E+17
446498000,Method of substance administration (observable entity),20110131,1,9E+17,9E+17
446910001,Mental test score (observable entity),20110131,1,9E+17,9E+17
446911002,Mayers' lifestyle questionnaire (2) interpretation (observable entity),20110131,1,9E+17,9E+17
446520003,Draw a person test score (observable entity),20110131,1,9E+17,9E+17
446519009,Stirling eating disorders scales total score (observable entity),20110131,1,9E+17,9E+17
446518001,Rivermead behavioral memory test score (observable entity),20110131,1,9E+17,9E+17
446517006,Penn State worry questionnaire score (observable entity),20110131,1,9E+17,9E+17
446515003,Health assessment questionnaire score (observable entity),20110131,1,9E+17,9E+17
446514004,European league against rheumatism response criteria score (observable entity),20110131,1,9E+17,9E+17
447548005,Occupation of husband (observable entity),20110131,1,9E+17,9E+17
447549002,Occupation of wife (observable entity),20110131,1,9E+17,9E+17
446824003,Health anxiety inventory short month score (observable entity),20110131,1,9E+17,9E+17
446831004,"Bulimic investigatory test, Edinburgh score (observable entity)",20110131,1,9E+17,9E+17
446826001,Eating disorder examination questionnaire global score (observable entity),20110131,1,9E+17,9E+17
446827005,Modified health assessment questionnaire score (observable entity),20110131,1,9E+17,9E+17
446794002,Eating attitudes test score (observable entity),20110131,1,9E+17,9E+17
446793008,Health anxiety inventory short week score (observable entity),20110131,1,9E+17,9E+17
447487007,Method of drug administration (observable entity),20110131,1,9E+17,9E+17
446768006,Joint protection knowledge assessment score (observable entity),20110131,1,9E+17,9E+17
446840000,Abbreviated mental test score (observable entity),20110131,1,9E+17,9E+17
447431004,Passive range of ankle eversion (observable entity),20110131,1,9E+17,9E+17
446661009,Visual analog scale score (observable entity),20110131,1,9E+17,9E+17
446660005,Chronic obstructive pulmonary disease assessment test score (observable entity),20110131,1,9E+17,9E+17
446658008,Average peak flow rate (observable entity),20110131,1,9E+17,9E+17
446663007,Pain self efficacy questionnaire score (observable entity),20110131,1,9E+17,9E+17
446664001,Modified checklist for autism in toddlers score (observable entity),20110131,1,9E+17,9E+17
446666004,Methods time measurement score (observable entity),20110131,1,9E+17,9E+17
447437000,Passive range of ankle inversion (observable entity),20110131,1,9E+17,9E+17
447583009,Active range of ankle eversion (observable entity),20110131,1,9E+17,9E+17
447438005,Active range of ankle inversion (observable entity),20110131,1,9E+17,9E+17
447280006,Work environment impact scale version 2.0 score (observable entity),20110131,1,9E+17,9E+17
447277005,Checklist for autism in toddlers score (observable entity),20110131,1,9E+17,9E+17
447264001,Valpar component work sample 17 pre-vocational readiness battery score (observable entity),20110131,1,9E+17,9E+17
447254005,Percentage predicted forced expiratory volume in 1 second after bronchodilation (observable entity),20110131,1,9E+17,9E+17
447273009,Westcotes individualized outcome measure score (observable entity),20110131,1,9E+17,9E+17
447272004,Binary individualized outcome measure score (observable entity),20110131,1,9E+17,9E+17
447267008,Anorexia nervosa stages of change questionnaire score (observable entity),20110131,1,9E+17,9E+17
447164006,Scleroderma assessment questionnaire score (observable entity),20110131,1,9E+17,9E+17
447161003,Barriers to employment and coping efficacy scale score (observable entity),20110131,1,9E+17,9E+17
447057006,Occupation of spouse (observable entity),20110131,1,9E+17,9E+17
446329001,Obligatory exercise questionnaire score (observable entity),20110131,1,9E+17,9E+17
446333008,Mayers' lifestyle questionnaire (1) interpretation (observable entity),20110131,1,9E+17,9E+17
446366007,Ages and stages questionnaire second edition score (observable entity),20110131,1,9E+17,9E+17
446363004,Adult comorbidity evaluation-27 score (observable entity),20110131,1,9E+17,9E+17
446357008,Stereognostic test score (observable entity),20110131,1,9E+17,9E+17
447316007,Mini-mental state examination score (observable entity),20110131,1,9E+17,9E+17
446996006,Dosage of radiation exposure (observable entity),20110131,1,9E+17,9E+17
447314005,Michigan hand outcomes questionnaire score (observable entity),20110131,1,9E+17,9E+17
448021003,Number of ventricular septal defects (observable entity),20110731,1,9E+17,9E+17
447987002,Number of aortic valve cusps (observable entity),20110731,1,9E+17,9E+17
448003001,Royal College of Physicians 3 questions score (observable entity),20110731,1,9E+17,9E+17
447754009,Number of procedure attempts (observable entity),20110731,1,9E+17,9E+17
447715008,Chronic respiratory disease questionnaire score (observable entity),20110731,1,9E+17,9E+17
448755007,Tobacco smokefree home (observable entity),20110731,1,9E+17,9E+17
448886007,Time from call for help to patient arrival at facility (observable entity),20110731,1,9E+17,9E+17
448885006,Time from arrival at facility to administration of parenteral treatment (observable entity),20110731,1,9E+17,9E+17
448878007,Time from onset of pain to call for help (observable entity),20110731,1,9E+17,9E+17
448906006,Time from onset of pain to administration of thrombolytic agent (observable entity),20110731,1,9E+17,9E+17
449302007,Readiness for transport (observable entity),20110731,1,9E+17,9E+17
449361003,Pattern of weight gain (observable entity),20110731,1,9E+17,9E+17
449331006,Date of last sexual intercourse (observable entity),20110731,1,9E+17,9E+17
450324005,Obsessive compulsive inventory score (observable entity),20120731,1,9E+17,9E+17
450326007,Panic disorder severity scale score (observable entity),20120731,1,9E+17,9E+17
450359005,Benign prostatic hyperplasia impact index score (observable entity),20120731,1,9E+17,9E+17
450360000,Coronary artery calcium score (observable entity),20120731,1,9E+17,9E+17
450755002,Medical Research Council Dyspnoea scale score (observable entity),20120731,1,9E+17,9E+17
450758000,Voice handicap index score (observable entity),20120731,1,9E+17,9E+17
450728006,Impact of event scale revised score (observable entity),20120731,1,9E+17,9E+17
450317009,Strengths and difficulties questionnaire score (observable entity),20120731,1,9E+17,9E+17
450320001,Edinburgh postnatal depression scale score (observable entity),20120731,1,9E+17,9E+17
450743008,National Institutes of Health stroke scale score (observable entity),20120731,1,9E+17,9E+17
450747009,Saint George's respiratory questionnaire score (observable entity),20120731,1,9E+17,9E+17
450735003,Housing dependency scale score (observable entity),20120731,1,9E+17,9E+17
450979009,Sensory modality assessment and rehabilitation technique score (observable entity),20120731,1,9E+17,9E+17
473333005,Chronic respiratory disease questionnaire mastery subscale score (observable entity),20130131,1,9E+17,9E+17
473332000,Chronic respiratory disease questionnaire fatigue subscale score (observable entity),20130131,1,9E+17,9E+17
473331007,Chronic respiratory disease questionnaire emotional function subscale score (observable entity),20130131,1,9E+17,9E+17
473330008,Chronic respiratory disease questionnaire dyspnea subscale score (observable entity),20130131,1,9E+17,9E+17
473329003,Chronic respiratory disease questionnaire observable (observable entity),20130131,1,9E+17,9E+17
473355002,Mobility inventory for agoraphobia when alone score (observable entity),20130131,1,9E+17,9E+17
473354003,Mobility inventory for agoraphobia when accompanied score (observable entity),20130131,1,9E+17,9E+17
473346000,Eating disorder examination questionnaire shape concern subscale score (observable entity),20130131,1,9E+17,9E+17
473345001,Eating disorder examination questionnaire eating concern subscale score (observable entity),20130131,1,9E+17,9E+17
473344002,Eating disorder examination questionnaire observable (observable entity),20130131,1,9E+17,9E+17
473347009,Eating disorder examination questionnaire weight concern subscale score (observable entity),20130131,1,9E+17,9E+17
473353009,Standing-start 180 degree turn test number of steps (observable entity),20130131,1,9E+17,9E+17
473348004,Eating disorder examination questionnaire restraint subscale score (observable entity),20130131,1,9E+17,9E+17
473296001,Psychotic symptom rating scales delusions subscale emotional characteristics score (observable entity),20130131,1,9E+17,9E+17
473295002,Psychotic symptom rating scales delusions subscale score (observable entity),20130131,1,9E+17,9E+17
473294003,Psychotic symptom rating scales delusions subscale cognitive interpretation score (observable entity),20130131,1,9E+17,9E+17
473293009,Psychotic symptom rating scales auditory hallucination subscale score (observable entity),20130131,1,9E+17,9E+17
473292004,Psychotic symptom rating scales auditory hallucination subscale emotional characteristics score (observable entity),20130131,1,9E+17,9E+17
473291006,Psychotic symptom rating scales auditory hallucination subscale physical characteristics score (observable entity),20130131,1,9E+17,9E+17
473290007,Psychotic symptom rating scales auditory hallucination subscale cognitive interpretation score (observable entity),20130131,1,9E+17,9E+17
473289003,Psychotic symptom rating scales observable (observable entity),20130131,1,9E+17,9E+17
699232007,Disabilities of the arm shoulder and hand outcome measurement sports/performing arts module score (observable entity),20140131,1,9E+17,9E+17
699250000,Fetal diagnosis (observable entity),20140131,1,9E+17,9E+17
699863002,Maxilla residual ridge observable (observable entity),20140131,1,9E+17,9E+17
699666008,Keratometry flat axis (observable entity),20140131,1,9E+17,9E+17
699664006,Keratometry flat power (observable entity),20140131,1,9E+17,9E+17
699663000,Keratometry steep axis (observable entity),20140131,1,9E+17,9E+17
699662005,Keratometry steep power (observable entity),20140131,1,9E+17,9E+17
698828003,Circulatory arrest time (observable entity),20140131,1,9E+17,9E+17
698824001,Expiratory tidal volume (observable entity),20140131,1,9E+17,9E+17
698823007,Inspiratory tidal volume (observable entity),20140131,1,9E+17,9E+17
698822002,Airway plateau pressure (observable entity),20140131,1,9E+17,9E+17
698821009,Mean inspiratory airway pressure (observable entity),20140131,1,9E+17,9E+17
698830001,Oxygen concentration at common gas outlet (observable entity),20140131,1,9E+17,9E+17
699092002,Spirometric lung age (observable entity),20140131,1,9E+17,9E+17
699089001,Social wellbeing (observable entity),20140131,1,9E+17,9E+17
699087004,Social phobia inventory avoidance subscore (observable entity),20140131,1,9E+17,9E+17
699086008,Social phobia inventory fear subscore (observable entity),20140131,1,9E+17,9E+17
699085007,Social phobia inventory physical symptoms subscore (observable entity),20140131,1,9E+17,9E+17
699047009,Duration of antiplatelet therapy (observable entity),20140131,1,9E+17,9E+17
699095000,Marks and Mathews fear questionnaire total social phobia score (observable entity),20140131,1,9E+17,9E+17
699097008,Marks and Mathews fear questionnaire total agoraphobia score (observable entity),20140131,1,9E+17,9E+17
699096004,Marks and Mathews fear questionnaire total blood injury phobia score (observable entity),20140131,1,9E+17,9E+17
699113009,Expiratory positive airway pressure (observable entity),20140131,1,9E+17,9E+17
699100003,"Historical, clinical, risk management 20 assessing risk for violence scheme version 2 clinical subscore (observable entity)",20140131,1,9E+17,9E+17
699099006,"Historical, clinical, risk management 20 assessing risk for violence scheme version 2 historical subscore (observable entity)",20140131,1,9E+17,9E+17
699098003,"Historical, clinical, risk management 20 assessing risk for violence scheme version 2 risk management subscore (observable entity)",20140131,1,9E+17,9E+17
702534005,Forced expiratory volume in one second/Forced expiratory volume in six seconds ratio (observable entity),20140731,1,9E+17,9E+17
703503000,Name (observable entity),20140731,1,9E+17,9E+17
703502005,Glomerular filtration of creatinine (observable entity),20140731,1,9E+17,9E+17
703065002,Specimen source (observable entity),20140731,1,9E+17,9E+17
703421000,Temperature (observable entity),20140731,1,9E+17,9E+17
703247007,Color (observable entity),20140731,1,9E+17,9E+17
703248002,Appearance (observable entity),20140731,1,9E+17,9E+17
703489001,Anogenital distance (observable entity),20140731,1,9E+17,9E+17
702748008,Number of occurrences observable (observable entity),20140731,1,9E+17,9E+17
700484007,Ability to self manage symptoms (observable entity),20140731,1,9E+17,9E+17
700501004,DoloTest profile (observable entity),20140731,1,9E+17,9E+17
700457006,Frequency of blood ketone self-monitoring (observable entity),20140731,1,9E+17,9E+17
700466005,DoloTest score (observable entity),20140731,1,9E+17,9E+17
700469003,Frequency of pain symptom (observable entity),20140731,1,9E+17,9E+17
700471003,Level of nausea (observable entity),20140731,1,9E+17,9E+17
446763002,Eating disorder examination global score (observable entity),20140731,1,9E+17,9E+17
1.221E+12,Age at smoking cessation (observable entity),20150131,1,9E+17,9E+17
6.51E+11,Peritoneal dialysis prescription compliance (observable entity),20150131,1,9E+17,9E+17
1.421E+12,Readiness to stop tobacco use (observable entity),20150131,1,9E+17,9E+17
1.431E+12,Tobacco cessation treatment history (observable entity),20150131,1,9E+17,9E+17
2.801E+12,Hours per day playing games on a screen (observable entity),20150131,1,9E+17,9E+17
2.811E+12,Hours per day watching television or videos (observable entity),20150131,1,9E+17,9E+17
3.51E+11,Prescription observable (observable entity),20150131,1,9E+17,9E+17
707285009,One leg stand test time (observable entity),20150131,1,9E+17,9E+17
708507001,Diastolic blood pressure of neonate at birth (observable entity),20150131,1,9E+17,9E+17
708509003,Maxillary incisor display (observable entity),20150131,1,9E+17,9E+17
708499008,Core body temperature of neonate at birth (observable entity),20150131,1,9E+17,9E+17
708502007,Systolic blood pressure of neonate at birth (observable entity),20150131,1,9E+17,9E+17
707738004,Lower limb length discrepancy (observable entity),20150131,1,9E+17,9E+17
704122005,Contraception method of partner (observable entity),20150131,1,9E+17,9E+17
704393002,Attitude towards care (observable entity),20150131,1,9E+17,9E+17
704394008,Attitude towards dietary regime (observable entity),20150131,1,9E+17,9E+17
704395009,Attitude towards exercise (observable entity),20150131,1,9E+17,9E+17
704396005,Attitude towards medication management (observable entity),20150131,1,9E+17,9E+17
704397001,Attitude towards treatment (observable entity),20150131,1,9E+17,9E+17
704207005,Frequency of angina (observable entity),20150131,1,9E+17,9E+17
705074003,Ability to see (observable entity),20150131,1,9E+17,9E+17
705048009,Ability to self monitor disease (observable entity),20150131,1,9E+17,9E+17
705096009,Deep symmetric anterior T wave inversion (finding),20150131,1,9E+17,9E+17
705035005,Lymphedema quality of life tool (leg) score (observable entity),20150131,1,9E+17,9E+17
705036006,Lymphedema quality of life tool (arm) score (observable entity),20150131,1,9E+17,9E+17
705037002,Hypomania checklist 32 item revised score (observable entity),20150131,1,9E+17,9E+17
705023006,Born in Democratic Republic of Congo (finding),20150131,1,9E+17,9E+17
706952004,Disabilities of the arm shoulder and hand outcome measure work module score (observable entity),20150131,1,9E+17,9E+17
710108006,Length of body of mandible (observable entity),20150731,1,9E+17,9E+17
710111007,Range of hallux dorsiflexion (observable entity),20150731,1,9E+17,9E+17
710001002,Tooth number (observable entity),20150731,1,9E+17,9E+17
710004005,Retruded to maximum intercuspation (observable entity),20150731,1,9E+17,9E+17
710764000,Edentulous maxillomandibular relationship (observable entity),20150731,1,9E+17,9E+17
710793000,Cant of occlusal plane (observable entity),20150731,1,9E+17,9E+17
710801003,Width of periodontal ligament (observable entity),20150731,1,9E+17,9E+17
710800002,Width of molar tooth (observable entity),20150731,1,9E+17,9E+17
710799001,Width of canine tooth (observable entity),20150731,1,9E+17,9E+17
708675002,Gonial angle (observable entity),20150731,1,9E+17,9E+17
708685001,Mandibular plane angle (observable entity),20150731,1,9E+17,9E+17
709463006,Root number (observable entity),20150731,1,9E+17,9E+17
709007004,Compliance behavior to therapeutic regimen (observable entity),20150731,1,9E+17,9E+17
709015001,Compliance behavior to medical regimen (observable entity),20150731,1,9E+17,9E+17
709016000,Compliance behavior to fluid volume regime (observable entity),20150731,1,9E+17,9E+17
709017009,Compliance behavior to safety precaution (observable entity),20150731,1,9E+17,9E+17
708896007,Deauville five point scale score (observable entity),20150731,1,9E+17,9E+17
3.411E+12,Total number of postpartum care visits (observable entity),20150731,1,9E+17,9E+17
3.401E+12,Total number of prenatal care visits (observable entity),20150731,1,9E+17,9E+17
2.781E+12,"Video, television or computer screen time (observable entity)",20150731,1,9E+17,9E+17
3.941E+12,Birth abdominal circumference (observable entity),20150731,1,9E+17,9E+17
3.931E+12,Birth chest circumference (observable entity),20150731,1,9E+17,9E+17
3.921E+12,Patient written birth plan location (observable entity),20150731,1,9E+17,9E+17
4.061E+12,Date of last foot examination (observable entity),20150731,1,9E+17,9E+17
711464005,Lower anterior face height (observable entity),20150731,1,9E+17,9E+17
711468008,Tooth crown to root ratio (observable entity),20150731,1,9E+17,9E+17
711462009,Posterior face height (observable entity),20150731,1,9E+17,9E+17
711459006,Lower face height (observable entity),20150731,1,9E+17,9E+17
712495001,Health of partner (observable entity),20150731,1,9E+17,9E+17
711562006,Body position for feeding (observable entity),20150731,1,9E+17,9E+17
711559008,Domestic violence screening interpretation (observable entity),20150731,1,9E+17,9E+17
711585007,Length of ramus of mandible (observable entity),20150731,1,9E+17,9E+17
711583000,Upper anterior face height (observable entity),20150731,1,9E+17,9E+17
711582005,Anterior face height (observable entity),20150731,1,9E+17,9E+17
711558000,Angle between lower incisor tooth and mandibular plane (observable entity),20150731,1,9E+17,9E+17
713556009,Form of natal cleft (observable entity),20160131,1,9E+17,9E+17
713521005,Concentration of sperm (observable entity),20160131,1,9E+17,9E+17
713596006,Carer Support Needs Assessment Tool score (observable entity),20160131,1,9E+17,9E+17
713408000,Mini-Cog brief cognitive screening test score (observable entity),20160131,1,9E+17,9E+17
713931006,Ability to acculturate (observable entity),20160131,1,9E+17,9E+17
713660004,Ability to complete a sentence in one breath (observable entity),20160131,1,9E+17,9E+17
712814005,Date of last seizure (observable entity),20160131,1,9E+17,9E+17
713052001,Measure Yourself Medical Outcome Profile score (observable entity),20160131,1,9E+17,9E+17
2.71E+11,Medical reason for exclusion from performance measure (observable entity),20160131,1,9E+17,9E+17
2.81E+11,Patient reason for exclusion from performance measure (observable entity),20160131,1,9E+17,9E+17
2.91E+11,System reason for exclusion from performance measure (observable entity),20160131,1,9E+17,9E+17
4.91E+11,Clinical performance measure (observable entity),20160131,1,9E+17,9E+17
714151003,Environmental tobacco smoke exposure (observable entity),20160131,1,9E+17,9E+17
713981002,Ability to abstain from drinking (observable entity),20160131,1,9E+17,9E+17
713985006,Ability to adhere to rules and boundaries (observable entity),20160131,1,9E+17,9E+17
713986007,Ability to adjust to work situation (observable entity),20160131,1,9E+17,9E+17
713987003,Ability to agree with care plan (observable entity),20160131,1,9E+17,9E+17
714474007,Aachen Aphasia Test score (observable entity),20160131,1,9E+17,9E+17
714524007,Maxillary vestibule depth (observable entity),20160131,1,9E+17,9E+17
714525008,Mandibular vestibule depth (observable entity),20160131,1,9E+17,9E+17
714360001,Alzheimer's Disease Assessment Scale score (observable entity),20160131,1,9E+17,9E+17
717270009,Rutter A Scale score (observable entity),20160731,1,9E+17,9E+17
717229007,Communication Assessment Profile score (observable entity),20160731,1,9E+17,9E+17
717227009,Beck Hopelessness Scale score (observable entity),20160731,1,9E+17,9E+17
717288001,Zung self rating depression scale score (observable entity),20160731,1,9E+17,9E+17
3.161E+12,Suicide risk (observable entity),20160731,1,9E+17,9E+17
716822001,Renfrew Word Finding Vocabulary Test score (observable entity),20160731,1,9E+17,9E+17
716824000,Mount Wilga High Level Language Test score (observable entity),20160731,1,9E+17,9E+17
716834009,Fullerton Language Test for Adolescents score (observable entity),20160731,1,9E+17,9E+17
716837002,Repertory Grid score (observable entity),20160731,1,9E+17,9E+17
716841003,Frenchay Dysarthria Assessment score (observable entity),20160731,1,9E+17,9E+17
716817001,Phonological assessment of child speech score (observable entity),20160731,1,9E+17,9E+17
716798001,Porch Index of Communicative Ability score (observable entity),20160731,1,9E+17,9E+17
716800008,Face Arm Speech Test score (observable entity),20160731,1,9E+17,9E+17
716802000,Discourse abilities profile score (observable entity),20160731,1,9E+17,9E+17
716804004,Pre-speech Assessment Scale score (observable entity),20160731,1,9E+17,9E+17
716806002,Fundamental speech skills test score (observable entity),20160731,1,9E+17,9E+17
716811000,Assessment Protocol of Pragmatic Linguistic Skills score (observable entity),20160731,1,9E+17,9E+17
716814008,Measurement of Cognitive Linguistic Ability score (observable entity),20160731,1,9E+17,9E+17
716845007,Bankson Language Test score (observable entity),20160731,1,9E+17,9E+17
716848009,Amsterdam-Nijmegen Everyday Language Test score (observable entity),20160731,1,9E+17,9E+17
716874003,Assessment of Intelligibility of Dysarthric Speech score (observable entity),20160731,1,9E+17,9E+17
716879008,Beck Anxiety Inventory score (observable entity),20160731,1,9E+17,9E+17
716882003,Consensus Auditory-Perceptual Evaluation of Voice score (observable entity),20160731,1,9E+17,9E+17
716883008,Behavioral Inattention Test score (observable entity),20160731,1,9E+17,9E+17
716847004,Multilevel Informal Language Inventory score (observable entity),20160731,1,9E+17,9E+17
716851002,Carrow Elicited Language Inventory score (observable entity),20160731,1,9E+17,9E+17
716853004,Wechsler Objective Language Dimensions test score (observable entity),20160731,1,9E+17,9E+17
716854005,Yale Swallow Protocol score (observable entity),20160731,1,9E+17,9E+17
717000003,Stocker Probe Technique score (observable entity),20160731,1,9E+17,9E+17
717015002,Developmental Dimensional and Diagnostic Interview score (observable entity),20160731,1,9E+17,9E+17
717037009,South Tyneside Assessment of Syntactic Structures score (observable entity),20160731,1,9E+17,9E+17
717038004,Test of Language Competence score (observable entity),20160731,1,9E+17,9E+17
717039007,Test of Word Knowledge score (observable entity),20160731,1,9E+17,9E+17
717034002,Diagnostic Interview for Children and Adolescents score (observable entity),20160731,1,9E+17,9E+17
717017005,Children's Communication Checklist Second Edition score (observable entity),20160731,1,9E+17,9E+17
718321009,Stuttering Severity Instrument for Children and Adults score (observable entity),20160731,1,9E+17,9E+17
718334005,Aston Index score (observable entity),20160731,1,9E+17,9E+17
718298009,Renfrew Bus Story score (observable entity),20160731,1,9E+17,9E+17
718300009,Bracken Basic Concept Scale: Expressive score (observable entity),20160731,1,9E+17,9E+17
718316006,Brief Assessment Schedule Depression Cards score (observable entity),20160731,1,9E+17,9E+17
718340003,Test of Word Finding in Discourse score (observable entity),20160731,1,9E+17,9E+17
718343001,Test of Syntactic Abilities score (observable entity),20160731,1,9E+17,9E+17
718377006,Pragmatics Profile score (observable entity),20160731,1,9E+17,9E+17
718379009,Acceptance of Illness Scale score (observable entity),20160731,1,9E+17,9E+17
718384003,Bayley Scales of Infant Development score (observable entity),20160731,1,9E+17,9E+17
718386001,Denver Development Screening Test score (observable entity),20160731,1,9E+17,9E+17
718387005,Symbol Digit Modalities Test score (observable entity),20160731,1,9E+17,9E+17
718389008,Schonell Reading Test score (observable entity),20160731,1,9E+17,9E+17
718357004,Reynell-Zinkin Scales: Developmental Scales for Young Visually Handicapped Children score (observable entity),20160731,1,9E+17,9E+17
718358009,Callier-Azusa Scale score (observable entity),20160731,1,9E+17,9E+17
718364002,Peter and the Cat Narrative Assessment score (observable entity),20160731,1,9E+17,9E+17
718366000,Beck Depression Inventory II score (observable entity),20160731,1,9E+17,9E+17
718367009,Miller Assessment for Preschoolers score (observable entity),20160731,1,9E+17,9E+17
718202004,Gesell Developmental Observation Revised score (observable entity),20160731,1,9E+17,9E+17
718205002,Test of Auditory Perceptual Skills Revised score (observable entity),20160731,1,9E+17,9E+17
718206001,Oxford Hip Score using revised scoring system (observable entity),20160731,1,9E+17,9E+17
718209008,Renfrew Action Picture Test Revised Edition score (observable entity),20160731,1,9E+17,9E+17
718168008,Buffalo III Voice Profile score (observable entity),20160731,1,9E+17,9E+17
718169000,Mill Hill Vocabulary Scale score (observable entity),20160731,1,9E+17,9E+17
718233002,Wessex Revised Portage Language Checklist score (observable entity),20160731,1,9E+17,9E+17
718236005,Denver Developmental Screening Test Second Edition score (observable entity),20160731,1,9E+17,9E+17
719073006,Modified Wisconsin Card Sorting Test score (observable entity),20160731,1,9E+17,9E+17
718507006,Edinburgh Functional Communication Profile score (observable entity),20160731,1,9E+17,9E+17
718503005,South Tyneside Assessment of Phonology score second edition score (observable entity),20160731,1,9E+17,9E+17
718429007,Clinical Outcomes in Routine Evaluation Outcome Measure observable (observable entity),20160731,1,9E+17,9E+17
718431003,Child Group Session Rating Scale score (observable entity),20160731,1,9E+17,9E+17
718434006,SCORE Index of Family Function and Change 15 Dimension 1 Strengths and Adaptability average score (observable entity),20160731,1,9E+17,9E+17
718437004,Young Person's Clinical Outcomes in Routine Evaluation clinical score (observable entity),20160731,1,9E+17,9E+17
718441000,Group Session Rating Scale score (observable entity),20160731,1,9E+17,9E+17
718426000,Warwick Edinburgh Mental Well Being Scale score (observable entity),20160731,1,9E+17,9E+17
718424002,28 item General Health Questionnaire score (observable entity),20160731,1,9E+17,9E+17
718409006,Test of Minimal Articulation Competence score (observable entity),20160731,1,9E+17,9E+17
718416007,Behavioral Screening Questionnaire score (observable entity),20160731,1,9E+17,9E+17
718167003,Crichton Vocabulary Scale score (observable entity),20160731,1,9E+17,9E+17
718487006,Clinical Outcomes in Routine Evaluation Learning Disabilities risk score (observable entity),20160731,1,9E+17,9E+17
718490000,Clinical Outcomes in Routine Evaluation Outcome Measure Functioning score (observable entity),20160731,1,9E+17,9E+17
718492008,Clinical Outcomes in Routine Evaluation Outcome Measure Well being score (observable entity),20160731,1,9E+17,9E+17
718482000,Strengths and Difficulties Questionnaire self-rated for 11-17 year olds hyperactivity score (observable entity),20160731,1,9E+17,9E+17
718455008,SCORE Index of Family Function and Change 15 total score (observable entity),20160731,1,9E+17,9E+17
718456009,SCORE Index of Family Function and Change 15 Dimension 2 Overwhelmed by Difficulties average score (observable entity),20160731,1,9E+17,9E+17
718457000,Clinical Outcomes in Routine Evaluation Learning Disabilities total score (observable entity),20160731,1,9E+17,9E+17
718458005,Child Outcome Rating Scale total score (observable entity),20160731,1,9E+17,9E+17
718459002,Me and My School Questionnaire behavioral difficulties score (observable entity),20160731,1,9E+17,9E+17
718461006,Young Child Outcome Rating Scale score (observable entity),20160731,1,9E+17,9E+17
718464003,Number of previous sudden infant death syndrome deaths (observable entity),20160731,1,9E+17,9E+17
718466001,Short Warwick Edinburgh Mental Well-being Scale score (observable entity),20160731,1,9E+17,9E+17
718470009,Cormack and Lehane System score (observable entity),20160731,1,9E+17,9E+17
718477007,Strengths and Difficulties Questionnaire self-rated for 11-17 year olds impact score (observable entity),20160731,1,9E+17,9E+17
718166007,Bangor Dyslexia Test score (observable entity),20160731,1,9E+17,9E+17
718165006,Checklist of Communication Competencies score (observable entity),20160731,1,9E+17,9E+17
718164005,Therapy Outcome Measure carer wellbeing score (observable entity),20160731,1,9E+17,9E+17
717786001,Brief Depression Rating Scale score (observable entity),20160731,1,9E+17,9E+17
717834003,Vocal Profile Analysis Scheme score (observable entity),20160731,1,9E+17,9E+17
717639006,Strengths and Difficulties Questionnaire self-rated for 11-17 year old score (observable entity),20160731,1,9E+17,9E+17
718087004,QRISK2 cardiovascular disease 10 year risk score (observable entity),20160731,1,9E+17,9E+17
718090005,Bedside Evaluation Screening Test Second Edition score (observable entity),20160731,1,9E+17,9E+17
718051006,Surface of gingiva (observable entity),20160731,1,9E+17,9E+17
718143006,Strengths and Difficulties Questionnaire self-rated for 11-17 year olds conduct problems score (observable entity),20160731,1,9E+17,9E+17
718145004,Strengths and Difficulties Questionnaire self-rated for 11-17 year olds emotional symptoms score (observable entity),20160731,1,9E+17,9E+17
718146003,Strengths and Difficulties Questionnaire self-rated for 11-17 year olds peer problems score (observable entity),20160731,1,9E+17,9E+17
718147007,Strengths and Difficulties Questionnaire self-rated for 11-17 year olds prosocial score (observable entity),20160731,1,9E+17,9E+17
718149005,Goodenough Draw-a-man Test score (observable entity),20160731,1,9E+17,9E+17
718153007,National Adult Reading Test score (observable entity),20160731,1,9E+17,9E+17
718163004,Therapy Outcome Measure participation score (observable entity),20160731,1,9E+17,9E+17
718050007,Morphology of gingiva (observable entity),20160731,1,9E+17,9E+17
718137009,Modified Strengths and Difficulties Questionnaire 8 Impact score (observable entity),20160731,1,9E+17,9E+17
718133008,Strengths and Difficulties Questionnaire for parents or teachers of 4-17 year olds score (observable entity),20160731,1,9E+17,9E+17
718134002,Strengths and Difficulties Questionnaire self-rated for 11-17 year old total difficulties score (observable entity),20160731,1,9E+17,9E+17
718139007,Strengths and Difficulties Questionnaire for parents or educators of 2-4 year olds score (observable entity),20160731,1,9E+17,9E+17
718045001,Therapy Outcome Measure impairment score (observable entity),20160731,1,9E+17,9E+17
718034004,26 item Eating Attitudes Test score (observable entity),20160731,1,9E+17,9E+17
718038001,Therapy Outcome Measure wellbeing score (observable entity),20160731,1,9E+17,9E+17
718040006,Therapy Outcome Measure activity score (observable entity),20160731,1,9E+17,9E+17
718025009,Wrist joint circumference (observable entity),20160731,1,9E+17,9E+17
716796002,Illinois Test of Psycholinguistic Abilities score (observable entity),20160731,1,9E+17,9E+17
716794004,Minnesota Test for Differential Diagnosis of Aphasia score (observable entity),20160731,1,9E+17,9E+17
715922008,Wiig Criterion Referenced Inventory of Language score (observable entity),20160731,1,9E+17,9E+17
715831007,Elbow joint circumference (observable entity),20160731,1,9E+17,9E+17
715832000,Knee joint circumference (observable entity),20160731,1,9E+17,9E+17
715813006,Perceptions of Stuttering Inventory score (observable entity),20160731,1,9E+17,9E+17
715815004,St. Mark's incontinence score (observable entity),20160731,1,9E+17,9E+17
715889001,Assessment of Comprehension and Expression 6-11 score (observable entity),20160731,1,9E+17,9E+17
716795003,Functional Independence Measure score (observable entity),20160731,1,9E+17,9E+17
715196001,Person name suffix (observable entity),20160731,1,9E+17,9E+17
715392006,30 item General Health Questionnaire score (observable entity),20160731,1,9E+17,9E+17
715393001,20 item General Health Questionnaire score (observable entity),20160731,1,9E+17,9E+17
716705008,Phonological Awareness Profile score (observable entity),20160731,1,9E+17,9E+17
716702006,Rutter Behaviour Questionnaire score (observable entity),20160731,1,9E+17,9E+17
716728009,Modified Hoehn and Yahr Scale score (observable entity),20160731,1,9E+17,9E+17
716757008,Referring organization (observable entity),20160731,1,9E+17,9E+17
716551007,Revised Edinburgh Functional Communication Profile score (observable entity),20160731,1,9E+17,9E+17
716553005,Anomalous Sentences Repetition Test score (observable entity),20160731,1,9E+17,9E+17
716555003,Metaphon Screening Assessment score (observable entity),20160731,1,9E+17,9E+17
716557006,Language Assessment Remediation and Screening Procedure score (observable entity),20160731,1,9E+17,9E+17
716560004,Multilingual Aphasia Examination score (observable entity),20160731,1,9E+17,9E+17
716561000,Peabody Picture Vocabulary Test score (observable entity),20160731,1,9E+17,9E+17
716563002,Cambridge Apraxia Battery score (observable entity),20160731,1,9E+17,9E+17
716550008,Apraxia Battery for Adults score (observable entity),20160731,1,9E+17,9E+17
716564008,Shortened Minnesota Test for Differential Diagnosis of Aphasia score (observable entity),20160731,1,9E+17,9E+17
716566005,Test of Word Finding Third Edition score (observable entity),20160731,1,9E+17,9E+17
716568006,California Verbal Learning Test Children's Version score (observable entity),20160731,1,9E+17,9E+17
716570002,Bracken Basic Concept Scale score (observable entity),20160731,1,9E+17,9E+17
716571003,Illinois Test of Psycholinguistic Abilities Third Edition score (observable entity),20160731,1,9E+17,9E+17
716572005,Boston Diagnostic Aphasia Examination score (observable entity),20160731,1,9E+17,9E+17
716573000,Wepman Auditory Discrimination Test Second Edition score (observable entity),20160731,1,9E+17,9E+17
716574006,Northwestern Syntax Screening Test score (observable entity),20160731,1,9E+17,9E+17
716575007,Verbal Rating Scale score (observable entity),20160731,1,9E+17,9E+17
716534000,Voice Impact Profile score (observable entity),20160731,1,9E+17,9E+17
716535004,Auditory Comprehension Test for Sentences score (observable entity),20160731,1,9E+17,9E+17
716540007,Heel height of footwear (observable entity),20160731,1,9E+17,9E+17
716544003,Aphasia Screening Test score (observable entity),20160731,1,9E+17,9E+17
716611002,Revised Token Test score (observable entity),20160731,1,9E+17,9E+17
716612009,Wisconsin Card Sorting Test score (observable entity),20160731,1,9E+17,9E+17
716613004,Outcome Rating Scale total score (observable entity),20160731,1,9E+17,9E+17
716614005,Boston Naming Test score (observable entity),20160731,1,9E+17,9E+17
716615006,Frenchay Aphasia Screening Test score (observable entity),20160731,1,9E+17,9E+17
716616007,Stuttering Prediction Instrument for Young Children score (observable entity),20160731,1,9E+17,9E+17
716617003,Western Aphasia Battery Revised score (observable entity),20160731,1,9E+17,9E+17
716618008,Therapy Outcome Measure score (observable entity),20160731,1,9E+17,9E+17
716619000,Ages and Stages Questionnaires Third Edition score (observable entity),20160731,1,9E+17,9E+17
716620006,Behavior Assessment Battery score (observable entity),20160731,1,9E+17,9E+17
716621005,Renfrew Action Picture Test score (observable entity),20160731,1,9E+17,9E+17
716622003,Merrill-Palmer-Revised Scales of Development score (observable entity),20160731,1,9E+17,9E+17
716610001,Revised Kendrick Battery for detection of dementia in the elderly score (observable entity),20160731,1,9E+17,9E+17
716607008,Behavior Problem Checklist score (observable entity),20160731,1,9E+17,9E+17
716587000,Eysenck Personality Inventory score (observable entity),20160731,1,9E+17,9E+17
716589002,Attributional Style Questionnaire score (observable entity),20160731,1,9E+17,9E+17
716596000,Reynell Developmental Language Scales score (observable entity),20160731,1,9E+17,9E+17
716599007,Centor criteria score (observable entity),20160731,1,9E+17,9E+17
716600005,American Association on Mental Retardation Adaptive Behavior Scale score (observable entity),20160731,1,9E+17,9E+17
716602002,New Reynell Developmental Language Scales score (observable entity),20160731,1,9E+17,9E+17
716604001,Preschool Behavior Checklist score (observable entity),20160731,1,9E+17,9E+17
716605000,Vineland Adaptive Behavior Scales Second Edition score (observable entity),20160731,1,9E+17,9E+17
716609006,Pain Catastrophizing Scale score (observable entity),20160731,1,9E+17,9E+17
716158006,Token Test score (observable entity),20160731,1,9E+17,9E+17
716175000,Arizona Battery for Communication Disorders of Dementia score (observable entity),20160731,1,9E+17,9E+17
716138005,Hoehn and Yahr Scale score (observable entity),20160731,1,9E+17,9E+17
716057004,Middle name (observable entity),20160731,1,9E+17,9E+17
71420008,Central venous pressure (observable entity),20170131,1,9E+17,9E+17
720372000,Health status of spouse (observable entity),20170131,1,9E+17,9E+17
4.1671E+13,Abnormal finding on auditory function study (finding),20170131,1,9E+17,9E+17
720433000,Patient Health Questionnaire Nine Item score (observable entity),20170131,1,9E+17,9E+17
720594007,SCORE Index of Family Function and Change 15 Dimension 3 Disrupted Communication total score (observable entity),20170131,1,9E+17,9E+17
720484004,Screening Test for Developmental Apraxia of Speech Second Edition score (observable entity),20170131,1,9E+17,9E+17
720485003,Modified Mini-Mental State Examination score (observable entity),20170131,1,9E+17,9E+17
720483005,Story Completion Test score (observable entity),20170131,1,9E+17,9E+17
720482000,Session Rating Scale score (observable entity),20170131,1,9E+17,9E+17
720481007,Schonell Graded Spelling Test score (observable entity),20170131,1,9E+17,9E+17
720477007,Pyramids and Palm Trees Test score (observable entity),20170131,1,9E+17,9E+17
720541003,Symbolic Play Test Second Edition score (observable entity),20170131,1,9E+17,9E+17
720546008,Boone Voice Program for Children score (observable entity),20170131,1,9E+17,9E+17
720550001,Children's Health Locus of Control Scale score (observable entity),20170131,1,9E+17,9E+17
720552009,Reading Comprehension Battery for Aphasia Second Edition score (observable entity),20170131,1,9E+17,9E+17
720557003,Receptive Expressive Emergent Language Test Third Edition score (observable entity),20170131,1,9E+17,9E+17
720559000,SCORE Index of Family Function and Change 15 observable (observable entity),20170131,1,9E+17,9E+17
720549001,Bracken Basic Concept Scale Third Edition: Receptive score (observable entity),20170131,1,9E+17,9E+17
722248002,Patient hospital visit number (observable entity),20170131,1,9E+17,9E+17
722250005,Multiple birth order (observable entity),20170131,1,9E+17,9E+17
721955008,SCORE Index of Family Function and Change 15 Dimension 3 Disrupted Communication average score (observable entity),20170131,1,9E+17,9E+17
37476000,Jugular venous pressure (observable entity),20170131,1,9E+17,9E+17
718861000,Neurological Disorders Depression Inventory in Epilepsy score (observable entity),20170131,1,9E+17,9E+17
718865009,Mothers' Object Relations Scale - Short Form - Warmth Subscale score (observable entity),20170131,1,9E+17,9E+17
718866005,Mothers' Object Relations Scale - Short Form - Invasiveness Subscale score (observable entity),20170131,1,9E+17,9E+17
718915001,Comprehensive Assessment of At-Risk Mental States non-bizarre ideas level of distress score (observable entity),20170131,1,9E+17,9E+17
718917009,Comprehensive Assessment of At-Risk Mental States perceptual abnormalities global rating scale score (observable entity),20170131,1,9E+17,9E+17
718918004,Comprehensive Assessment of At-risk Mental States disorganised speech global rating scale score (observable entity),20170131,1,9E+17,9E+17
718907004,DIALOG patient rated outcome measure quality of life score (observable entity),20170131,1,9E+17,9E+17
718906008,DIALOG patient rated outcome measure treatment satisfaction score (observable entity),20170131,1,9E+17,9E+17
718884007,Comprehensive Assessment of At-risk Mental States unusual thought content frequency and duration score (observable entity),20170131,1,9E+17,9E+17
718885008,Comprehensive Assessment of At-risk Mental States non-bizarre ideas frequency and duration score (observable entity),20170131,1,9E+17,9E+17
718886009,Comprehensive Assessment of At-risk Mental States perceptual abnormalities level of distress score (observable entity),20170131,1,9E+17,9E+17
718887000,Comprehensive Assessment of At-risk Mental States unusual thought content level of distress score (observable entity),20170131,1,9E+17,9E+17
718888005,Comprehensive Assessment of At-risk Mental States unusual thought content global rating scale score (observable entity),20170131,1,9E+17,9E+17
718889002,Comprehensive Assessment of At-Risk Mental States disorganised speech frequency and duration score (observable entity),20170131,1,9E+17,9E+17
718891005,Comprehensive Assessment of At-risk Mental States perceptual abnormalities frequency and duration score (observable entity),20170131,1,9E+17,9E+17
718892003,Comprehensive Assessment of At-risk Mental States non-bizarre ideas global rating scale score (observable entity),20170131,1,9E+17,9E+17
718894002,Comprehensive Assessment of At-risk Mental States disorganised speech level of distress score (observable entity),20170131,1,9E+17,9E+17
718708004,Rutter B Behavioural Scale score (observable entity),20170131,1,9E+17,9E+17
718693006,Rivermead Behavioral Memory Test adult version score (observable entity),20170131,1,9E+17,9E+17
718694000,Rivermead Behavioral Memory Test for Children score (observable entity),20170131,1,9E+17,9E+17
718697007,Lysholm Knee Scoring Scale score (observable entity),20170131,1,9E+17,9E+17
718762000,Child Session Rating Scale score (observable entity),20170131,1,9E+17,9E+17
719149000,California Verbal Learning Test Second Edition score (observable entity),20170131,1,9E+17,9E+17
719154009,Holborn Reading Scale score (observable entity),20170131,1,9E+17,9E+17
719109008,Phonological Evaluation and Transcription of Audio-Visual Language score (observable entity),20170131,1,9E+17,9E+17
719114007,Test of Pragmatic Language Skills Second Edition score (observable entity),20170131,1,9E+17,9E+17
719115008,Test for Reception of Grammar Version 2 score (observable entity),20170131,1,9E+17,9E+17
719116009,Test for Auditory Comprehension of Language Fourth Edition score (observable entity),20170131,1,9E+17,9E+17
719117000,Test of Language Development Fourth Edition score (observable entity),20170131,1,9E+17,9E+17
719120008,Phonological Awareness Test Second Edition score (observable entity),20170131,1,9E+17,9E+17
719123005,Make-a-Picture Story Test score (observable entity),20170131,1,9E+17,9E+17
719181009,Number of chronic care management minutes (observable entity),20170131,1,9E+17,9E+17
718991006,Token Test for Children Second Edition score (observable entity),20170131,1,9E+17,9E+17
719006004,Position of male external urethral orifice (observable entity),20170131,1,9E+17,9E+17
718970003,McGill Pain Questionnaire score (observable entity),20170131,1,9E+17,9E+17
718985009,Preschool Language Scale score (observable entity),20170131,1,9E+17,9E+17
718986005,Preschool Language Scale Fifth Edition score (observable entity),20170131,1,9E+17,9E+17
718672008,Revised Children's Anxiety and Depression Scale Parent Version total anxiety and depression score (observable entity),20170131,1,9E+17,9E+17
719061006,Diurnal variation of pain (observable entity),20170131,1,9E+17,9E+17
719084004,Clinical Evaluation of Language Fundamentals Fifth Edition score (observable entity),20170131,1,9E+17,9E+17
719085003,Psycholinguistic Assessments of Language Processing in Aphasia score (observable entity),20170131,1,9E+17,9E+17
719051004,Quantity of postpartum maternal blood loss (observable entity),20170131,1,9E+17,9E+17
718671001,Revised Children's Anxiety and Depression Scale Parent Version total anxiety score (observable entity),20170131,1,9E+17,9E+17
718669001,Revised Children's Anxiety and Depression Scale Parent Version separation anxiety score (observable entity),20170131,1,9E+17,9E+17
118433006,Pulmonary artery wedge pressure (observable entity),20170131,1,9E+17,9E+17
717319002,Rutter B2 Behaviour Scale score (observable entity),20170131,1,9E+17,9E+17
718583008,Clinical Outcomes in Routine Evaluation 10 clinical score (observable entity),20170131,1,9E+17,9E+17
718584002,Morse Falls Risk Assessment score (observable entity),20170131,1,9E+17,9E+17
718546008,Cystoscopy normal (finding),20170131,1,9E+17,9E+17
718547004,Cystoscopy abnormal (finding),20170131,1,9E+17,9E+17
718562002,Me and My School Questionnaire score (observable entity),20170131,1,9E+17,9E+17
718652003,DIALOG patient rated outcome measure score (observable entity),20170131,1,9E+17,9E+17
718654002,Revised Children's Anxiety and Depression Scale observable (observable entity),20170131,1,9E+17,9E+17
718655001,Revised Children's Anxiety and Depression Scale depression score (observable entity),20170131,1,9E+17,9E+17
718656000,Revised Children's Anxiety and Depression Scale generalized anxiety score (observable entity),20170131,1,9E+17,9E+17
718657009,Revised Children's Anxiety and Depression Scale obsessions compulsion score (observable entity),20170131,1,9E+17,9E+17
718658004,Revised Children's Anxiety and Depression Scale panic score (observable entity),20170131,1,9E+17,9E+17
718659007,Revised Children's Anxiety and Depression Scale separation anxiety score (observable entity),20170131,1,9E+17,9E+17
718660002,Revised Children's Anxiety and Depression Scale social phobia score (observable entity),20170131,1,9E+17,9E+17
718661003,Revised Children's Anxiety and Depression Scale total anxiety score (observable entity),20170131,1,9E+17,9E+17
718662005,Revised Children's Anxiety and Depression Scale total anxiety and depression score (observable entity),20170131,1,9E+17,9E+17
718663000,Revised Children's Anxiety and Depression Scale Parent Version observable (observable entity),20170131,1,9E+17,9E+17
718665007,Revised Children's Anxiety and Depression Scale Parent Version depression score (observable entity),20170131,1,9E+17,9E+17
718666008,Revised Children's Anxiety and Depression Scale Parent Version generalized anxiety score (observable entity),20170131,1,9E+17,9E+17
718667004,Revised Children's Anxiety and Depression Scale Parent Version obsession compulsion score (observable entity),20170131,1,9E+17,9E+17
718668009,Revised Children's Anxiety and Depression Scale Parent Version panic score (observable entity),20170131,1,9E+17,9E+17
718613005,Clinical Outcomes in Routine Evaluation Outcome Measure Problems symptom score (observable entity),20170131,1,9E+17,9E+17
718616002,Preschool Language Scale Fourth Edition score (observable entity),20170131,1,9E+17,9E+17
718617006,Clinical Institute Withdrawal Assessment for Benzodiazepines scale score (observable entity),20170131,1,9E+17,9E+17
718618001,Listening Skills Checklist score (observable entity),20170131,1,9E+17,9E+17
718670000,Revised Children's Anxiety and Depression Scale Parent Version social phobia score (observable entity),20170131,1,9E+17,9E+17
718515009,Bristol Language Assessment Scales score (observable entity),20170131,1,9E+17,9E+17
7.241E+12,Date of vaccination (observable entity),20170131,1,9E+17,9E+17
719873005,Fibrosis-4 index score (observable entity),20170131,1,9E+17,9E+17
719876002,Parenting Daily Hassles Scale score (observable entity),20170131,1,9E+17,9E+17
719879009,Social Satisfaction Questionnaire score (observable entity),20170131,1,9E+17,9E+17
719929005,Goldman-Fristoe Test for Articulation Second Edition score (observable entity),20170131,1,9E+17,9E+17
719931001,Goldman-Fristoe Test for Articulation Third Edition score (observable entity),20170131,1,9E+17,9E+17
719934009,Hearing Handicap Inventory for the Elderly score (observable entity),20170131,1,9E+17,9E+17
719936006,Test of Auditory Processing Skills Third Edition score (observable entity),20170131,1,9E+17,9E+17
719937002,Test for Auditory Comprehension of Language Third Edition score (observable entity),20170131,1,9E+17,9E+17
719941003,New Salford Sentence Reading Test score (observable entity),20170131,1,9E+17,9E+17
719942005,Test of Pretend Play score (observable entity),20170131,1,9E+17,9E+17
165077006,Intracardiac pressure (observable entity),20170131,1,9E+17,9E+17
720211004,Kessler Psychological Distress Scale K10 score (observable entity),20170131,1,9E+17,9E+17
720212006,Macmillan Readers Level Test score (observable entity),20170131,1,9E+17,9E+17
720206001,Edinburgh Articulation Test score (observable entity),20170131,1,9E+17,9E+17
720196002,SCORE Index of Family Function and Change 15 Dimension 2 Overwhelmed by Difficulties total score (observable entity),20170131,1,9E+17,9E+17
720197006,SCORE Index of Family Function and Change 15 average total score (observable entity),20170131,1,9E+17,9E+17
720200007,SCORE Index of Family Function and Change 15 Dimension 1 Strengths and Adaptability total score (observable entity),20170131,1,9E+17,9E+17
719992006,Receptive Expressive Emergent Language Test second edition score (observable entity),20170131,1,9E+17,9E+17
719333006,Fitness for activity (observable entity),20170131,1,9E+17,9E+17
719337007,Children's Test of Nonword Repetition score (observable entity),20170131,1,9E+17,9E+17
719339005,Dizziness Handicap Inventory score (observable entity),20170131,1,9E+17,9E+17
719344003,Elderly Assessment System score (observable entity),20170131,1,9E+17,9E+17
719319006,Postoperative recovery status (observable entity),20170131,1,9E+17,9E+17
719308008,Special examination status (observable entity),20170131,1,9E+17,9E+17
252076005,Venous pressure (observable entity),20170131,1,9E+17,9E+17
252077001,Venous mean pressure (observable entity),20170131,1,9E+17,9E+17
252080000,Ambulatory post-hyperemic venous pressure (observable entity),20170131,1,9E+17,9E+17
248835004,Temperature of breast (observable entity),20170131,1,9E+17,9E+17
250124002,Temperature of joint (observable entity),20170131,1,9E+17,9E+17
250766006,Jugular bulb pressure (observable entity),20170131,1,9E+17,9E+17
251068006,Atrial pressure (observable entity),20170131,1,9E+17,9E+17
251069003,Ventricular pressure (observable entity),20170131,1,9E+17,9E+17
723186007,Prosthetic device status (observable entity),20170131,1,9E+17,9E+17
723245007,Number of chronic obstructive pulmonary disease exacerbations in past year (observable entity),20170131,1,9E+17,9E+17
9.78253E+17,Small bowel enteroscopy normal (finding),20170131,1,9E+17,9E+17
431598003,Core body temperature measured in esophagus (observable entity),20170131,1,9E+17,9E+17
276775004,Mean right atrial pressure (observable entity),20170131,1,9E+17,9E+17
276776003,Right atrial pressure - a wave (observable entity),20170131,1,9E+17,9E+17
276773006,Right ventricular diastolic pressure (observable entity),20170131,1,9E+17,9E+17
276772001,Right ventricular systolic pressure (observable entity),20170131,1,9E+17,9E+17
276769008,Left ventricular pressure (observable entity),20170131,1,9E+17,9E+17
722471002,Size of blood pressure cuff (observable entity),20170131,1,9E+17,9E+17
276755008,Right atrial pressure (observable entity),20170131,1,9E+17,9E+17
276756009,Right ventricular pressure (observable entity),20170131,1,9E+17,9E+17
276762004,Direct left atrial pressure (observable entity),20170131,1,9E+17,9E+17
276763009,Mean wedge pressure (observable entity),20170131,1,9E+17,9E+17
276764003,Wedge pressure - a wave (observable entity),20170131,1,9E+17,9E+17
276765002,Wedge pressure - x trough (observable entity),20170131,1,9E+17,9E+17
276766001,Wedge pressure - v wave (observable entity),20170131,1,9E+17,9E+17
276767005,Wedge pressure - y trough (observable entity),20170131,1,9E+17,9E+17
276760007,Left atrial pressure (observable entity),20170131,1,9E+17,9E+17
276777007,Right atrial pressure - x trough (observable entity),20170131,1,9E+17,9E+17
276778002,Right atrial pressure - v wave (observable entity),20170131,1,9E+17,9E+17
276779005,Right atrial pressure - y trough (observable entity),20170131,1,9E+17,9E+17
276780008,Left ventricular systolic pressure (observable entity),20170131,1,9E+17,9E+17
276783005,Mean direct left atrial pressure (observable entity),20170131,1,9E+17,9E+17
276784004,Direct left atrial pressure - a wave (observable entity),20170131,1,9E+17,9E+17
276785003,Direct left atrial pressure - x trough (observable entity),20170131,1,9E+17,9E+17
276786002,Direct left atrial pressure - v wave (observable entity),20170131,1,9E+17,9E+17
276788001,Direct left atrial pressure - y trough (observable entity),20170131,1,9E+17,9E+17
364525003,Temperature of toe joint (observable entity),20170131,1,9E+17,9E+17
364246006,Core body temperature measured vaginally (observable entity),20170131,1,9E+17,9E+17
363997004,Temperature of pinna (observable entity),20170131,1,9E+17,9E+17
364495009,Temperature of finger joint (observable entity),20170131,1,9E+17,9E+17
364491000,Temperature of thumb joint (observable entity),20170131,1,9E+17,9E+17
364506001,Temperature of knee joint (observable entity),20170131,1,9E+17,9E+17
364511004,Temperature of ankle joint (observable entity),20170131,1,9E+17,9E+17
364518005,Temperature of foot (observable entity),20170131,1,9E+17,9E+17
364521007,Temperature of foot joint (observable entity),20170131,1,9E+17,9E+17
364482004,Temperature of wrist joint (observable entity),20170131,1,9E+17,9E+17
364476002,Temperature of shoulder joint (observable entity),20170131,1,9E+17,9E+17
364429006,Temperature of lumbar spine (observable entity),20170131,1,9E+17,9E+17
364424001,Temperature of thoracic spine (observable entity),20170131,1,9E+17,9E+17
364419004,Temperature of cervical spine (observable entity),20170131,1,9E+17,9E+17
366874008,Number of asthma exacerbations in past year (observable entity),20170131,1,9E+17,9E+17
725081001,Children's Revised Impact of Events Scale 8 score (observable entity),20170731,1,9E+17,9E+17
723617007,Ages and Stages Questionnaires Social-Emotional second edition score (observable entity),20170731,1,9E+17,9E+17
723472002,Number of moisture lesions (observable entity),20170731,1,9E+17,9E+17
724237005,Gait speed (observable entity),20170731,1,9E+17,9E+17
724061007,Device status (observable entity),20170731,1,9E+17,9E+17
1.601E+12,Passport number (observable entity),20170731,1,9E+17,9E+17
733653003,Sciatic nerve stretch response (observable entity),20170731,1,9E+17,9E+17
733462007,Opiate tolerance (observable entity),20170731,1,9E+17,9E+17
733851004,Breast consistency (observable entity),20170731,1,9E+17,9E+17
761872001,Christo Inventory for Substance-misuse Services total score (observable entity),20180131,1,9E+17,9E+17
761871008,International Consultation on Incontinence Questionnaire-Urinary Incontinence-Short Form score (observable entity),20180131,1,9E+17,9E+17
761866001,Palliative care Outcome Scale symptom list for end-stage renal disease score (observable entity),20180131,1,9E+17,9E+17
761880008,Hamilton Rating Scale for Depression score (observable entity),20180131,1,9E+17,9E+17
761955007,New Zealand Priority Criteria for Major Joint Replacement score (observable entity),20180131,1,9E+17,9E+17
1.30061E+14,Multiple marker screen positive for increased neural tube defects (finding),20180131,1,9E+17,9E+17
8.61E+11,Interdialytic time (observable entity),20180131,1,9E+17,9E+17
736015003,Observable related to oxygenation status (observable entity),20180131,1,9E+17,9E+17
735204006,Born in Serbia (finding),20180131,1,9E+17,9E+17
734919008,Brief Parental Self-efficacy Scale score (observable entity),20180131,1,9E+17,9E+17
734949005,Number of prescriptions for reliever inhaler per year (observable entity),20180131,1,9E+17,9E+17
734948002,Number of times reliever inhaler used per week (observable entity),20180131,1,9E+17,9E+17
736537001,Confusion Assessment Method short version score (observable entity),20180131,1,9E+17,9E+17
736535009,EuroQol visual analogue score (observable entity),20180131,1,9E+17,9E+17
736534008,EuroQol five dimension five level index value (observable entity),20180131,1,9E+17,9E+17
736628009,Epigastric sounds (observable entity),20180131,1,9E+17,9E+17
736415005,Posture of tongue (observable entity),20180131,1,9E+17,9E+17
736991005,Planned contraception method (observable entity),20180131,1,9E+17,9E+17
736956002,Osteoporotic fracture probability score using fracture risk assessment tool (observable entity),20180131,1,9E+17,9E+17
736957006,Hip fracture probability score using fracture risk assessment tool (observable entity),20180131,1,9E+17,9E+17
736705000,Dentofacial function (observable entity),20180131,1,9E+17,9E+17
736731003,Pacifier use (observable entity),20180131,1,9E+17,9E+17
736729007,Lip habits (observable entity),20180131,1,9E+17,9E+17
736803003,Distance between cuspid teeth (observable entity),20180131,1,9E+17,9E+17
736802008,Length of ramus on left side of mandible (observable entity),20180131,1,9E+17,9E+17
736801001,Length of ramus on right side of mandible (observable entity),20180131,1,9E+17,9E+17
736817007,Age of sexual partner (observable entity),20180131,1,9E+17,9E+17
736797002,Expectation of weight management program (observable entity),20180131,1,9E+17,9E+17
736796006,Reason for no contraception (observable entity),20180131,1,9E+17,9E+17
736784004,Distance between molar teeth (observable entity),20180131,1,9E+17,9E+17
738070007,Estimated date of delivery from antenatal ultrasound scan (observable entity),20180131,1,9E+17,9E+17
734008008,Spacing of teeth (observable entity),20180131,1,9E+17,9E+17
769046008,Height of alveolar bone surrounding tooth (observable entity),20180731,1,9E+17,9E+17
769045007,Height of alveolar bone surrounding teeth (observable entity),20180731,1,9E+17,9E+17
769210005,Strength of cough (observable entity),20180731,1,9E+17,9E+17
764906002,Salford Rheumatoid Arthritis Foot Evaluation Instrument Part B: Patient Preference Scale - Foot and Ankle Symptoms domain total score (observable entity),20180731,1,9E+17,9E+17
764905003,Salford Rheumatoid Arthritis Foot Evaluation Instrument Part B: Patient Preference Scale - Personal adaptation domain total score (observable entity),20180731,1,9E+17,9E+17
764904004,Salford Rheumatoid Arthritis Foot Evaluation Instrument Part B: Patient Preference Scale - Impact on social life domain total score (observable entity),20180731,1,9E+17,9E+17
764903005,Salford Rheumatoid Arthritis Foot Evaluation Instrument Part B: Patient Preference Scale - Experiences with footwear domain total score (observable entity),20180731,1,9E+17,9E+17
764902000,Salford Rheumatoid Arthritis Foot Evaluation Instrument Part B: Patient Preference Scale - Impact on everyday functioning domain total score (observable entity),20180731,1,9E+17,9E+17
764901007,Salford Rheumatoid Arthritis Foot Evaluation Instrument Part A: Fixed Scale - Impairment total score (observable entity),20180731,1,9E+17,9E+17
764900008,Salford Rheumatoid Arthritis Foot Evaluation Instrument Part B: Patient Preference Scale - Visual impact domain total score (observable entity),20180731,1,9E+17,9E+17
764899003,Salford Rheumatoid Arthritis Foot Evaluation Instrument Part B: Patient Preference Scale - External factors that affect foot symptoms domain total score (observable entity),20180731,1,9E+17,9E+17
764898006,Salford Rheumatoid Arthritis Foot Evaluation Instrument Part B: Patient Preference Scale - Effect on family life domain total score (observable entity),20180731,1,9E+17,9E+17
764897001,Salford Rheumatoid Arthritis Foot Evaluation Instrument Part B: Patient Preference Scale - Impact on career domain total score (observable entity),20180731,1,9E+17,9E+17
764896005,Salford Rheumatoid Arthritis Foot Evaluation Instrument Part B: Patient Preference Scale - Personal feelings domain total score (observable entity),20180731,1,9E+17,9E+17
764895009,Salford Rheumatoid Arthritis Foot Evaluation Instrument Part A: Fixed Scale - Disability total score (observable entity),20180731,1,9E+17,9E+17
764894008,Salford Rheumatoid Arthritis Foot Evaluation Instrument Part A: Fixed Scale - Footwear total score (observable entity),20180731,1,9E+17,9E+17
764566006,Gastric aspirate observable (observable entity),20180731,1,9E+17,9E+17
763265004,Montgomery-Asberg Depression Rating Scale score (observable entity),20180731,1,9E+17,9E+17
763263006,"Depth, Extent, Phase and Associated etiology Score (observable entity)",20180731,1,9E+17,9E+17
763262001,Canadian Cardiovascular Society grading of angina pectoris grade (observable entity),20180731,1,9E+17,9E+17
763261008,Manchester Scale for grading hallux valgus score (observable entity),20180731,1,9E+17,9E+17
763260009,Patient Global Impression of Improvement score (observable entity),20180731,1,9E+17,9E+17
763259004,Disease Activity Score (observable entity),20180731,1,9E+17,9E+17
763258007,"Site, Ischemia, Neuropathy, Bacterial Infection and Depth classification total score (observable entity)",20180731,1,9E+17,9E+17
763257002,"Cutting down, Annoyance by criticism, Guilty feeling and Eye-openers Questionnaire total score (observable entity)",20180731,1,9E+17,9E+17
763256006,Alcohol Use Disorders Identification Test - Consumption score (observable entity),20180731,1,9E+17,9E+17
763255005,"Perfusion, Extent, Depth, Infection and Sensation scoring system score (observable entity)",20180731,1,9E+17,9E+17
763254009,Epworth Sleepiness Scale score (observable entity),20180731,1,9E+17,9E+17
763297004,"Size (area, depth), Sepsis, Arteriopathy, Denervation system score (observable entity)",20180731,1,9E+17,9E+17
763295007,Manchester-Oxford Foot Questionnaire (foot) Summary Index score (observable entity),20180731,1,9E+17,9E+17
763244005,QRISK cardiovascular disease 10 year risk calculator score (observable entity),20180731,1,9E+17,9E+17
763299001,Manchester-Oxford Foot Questionnaire (foot and ankle) Summary Index score (observable entity),20180731,1,9E+17,9E+17
763382004,Patient satisfaction score (observable entity),20180731,1,9E+17,9E+17
763077003,Asthma Control Questionnaire score (observable entity),20180731,1,9E+17,9E+17
763075006,Cardiovascular Limitations and Symptoms Profile ankle swelling score (observable entity),20180731,1,9E+17,9E+17
763074005,Cardiovascular Limitations and Symptoms Profile shortness of breath score (observable entity),20180731,1,9E+17,9E+17
763073004,Cardiovascular Limitations and Symptoms Profile angina score (observable entity),20180731,1,9E+17,9E+17
762994006,New York Heart Association Classification class (observable entity),20180731,1,9E+17,9E+17
762991003,Fagerstrom Test for Nicotine Dependence total score (observable entity),20180731,1,9E+17,9E+17
762989006,Insomnia Severity Index score (observable entity),20180731,1,9E+17,9E+17
763005005,University of Texas Wound Classification System stage (observable entity),20180731,1,9E+17,9E+17
763004009,University of Texas Wound Classification System grade (observable entity),20180731,1,9E+17,9E+17
763081003,Bristol Foot Score (observable entity),20180731,1,9E+17,9E+17
763185005,Dermatology Life Quality Index score (observable entity),20180731,1,9E+17,9E+17
763106009,Five-Shot questionnaire score (observable entity),20180731,1,9E+17,9E+17
763122005,Leeds Foot Impact Scale score (observable entity),20180731,1,9E+17,9E+17
763116001,Foot Function Index total score (observable entity),20180731,1,9E+17,9E+17
763699005,Clinical Opiate Withdrawal Scale score (observable entity),20180731,1,9E+17,9E+17
763697007,Maelor Score Pressure Ulcer Risk Assessment total score (observable entity),20180731,1,9E+17,9E+17
763695004,Mini Asthma Quality of Life Questionnaire score (observable entity),20180731,1,9E+17,9E+17
765150007,Pocock death from cardiovascular disease risk score (observable entity),20180731,1,9E+17,9E+17
765147009,Diabetes Treatment Satisfaction Questionnaire status version score (observable entity),20180731,1,9E+17,9E+17
312369005,Doppler studies normal (finding),20180731,1,9E+17,9E+17
4.41361E+14,Unintentional weight gain (finding),20180731,1,9E+17,9E+17
780823005,Number of dependant children (observable entity),20190131,1,9E+17,9E+17
780834008,Target serum total cholesterol level (observable entity),20190131,1,9E+17,9E+17
781144001,Acute Physiology and Chronic Health Evaluation III score (observable entity),20190131,1,9E+17,9E+17
781140005,Acute Physiology and Chronic Health Evaluation II score (observable entity),20190131,1,9E+17,9E+17
782487009,Assessment score (observable entity),20190131,1,9E+17,9E+17
771398004,Stability of lumbar spine joint (observable entity),20190131,1,9E+17,9E+17
771399007,Stability of intercarpal joint (observable entity),20190131,1,9E+17,9E+17
771406006,Stability of midtarsal joint (observable entity),20190131,1,9E+17,9E+17
771414000,Stability of lateral collateral ligament (observable entity),20190131,1,9E+17,9E+17
771393008,Stability of patellofemoral joint (observable entity),20190131,1,9E+17,9E+17
771415004,Stability of medial collateral ligament (observable entity),20190131,1,9E+17,9E+17
771311009,Tooth furcation involvement index for assessment of periodontal disease (observable entity),20190131,1,9E+17,9E+17
772087009,Stool buoyancy (observable entity),20190131,1,9E+17,9E+17
771563003,Index for level of dental plaque on tooth (observable entity),20190131,1,9E+17,9E+17
770614002,Norris Amyotrophic Lateral Sclerosis Scale score (observable entity),20190131,1,9E+17,9E+17
770585004,Liver transient elastography fibrosis score (observable entity),20190131,1,9E+17,9E+17
770657007,Standardized Assessment of Concussion total score (observable entity),20190131,1,9E+17,9E+17
770634001,Abbey Pain Scale score (observable entity),20190131,1,9E+17,9E+17
770539002,Trauma Screening Questionnaire score (observable entity),20190131,1,9E+17,9E+17
770577008,Munich Alcoholism Test score (observable entity),20190131,1,9E+17,9E+17
770552007,Goal Attainment Scaling-Light score (observable entity),20190131,1,9E+17,9E+17
774089008,Alcohol Use Disorders Identification Test for Primary Care score (observable entity),20190131,1,9E+17,9E+17
774092007,Alcohol Dependence Scale total score (observable entity),20190131,1,9E+17,9E+17
774099003,Apnea Hypopnea Index (observable entity),20190131,1,9E+17,9E+17
774198008,Affect Balance Scale score (observable entity),20190131,1,9E+17,9E+17
772815008,Non-Alcoholic Fatty Liver Disease fibrosis score (observable entity),20190131,1,9E+17,9E+17
772209000,Ability to balance when standing with both feet apart (observable entity),20190131,1,9E+17,9E+17
772228007,Ability to balance when standing with both feet in tandem stance (observable entity),20190131,1,9E+17,9E+17
772229004,Ability to balance when standing with both feet together (observable entity),20190131,1,9E+17,9E+17
772230009,Ability to balance when standing with both feet in semi tandem stance (observable entity),20190131,1,9E+17,9E+17
773669000,Paced Auditory Serial Addition Test score (observable entity),20190131,1,9E+17,9E+17
786985009,Hand joint range of movement (observable entity),20190731,1,9E+17,9E+17
787475007,Post Anesthetic Recovery score (observable entity),20190731,1,9E+17,9E+17
786071002,Active range of joint movement (observable entity),20190731,1,9E+17,9E+17
784402004,Self reported nutrition adherence score (observable entity),20190731,1,9E+17,9E+17
784547001,Tenure of accommodation (observable entity),20190731,1,9E+17,9E+17
787907007,Length discrepancy between two limbs (observable entity),20200131,1,9E+17,9E+17
787908002,Length discrepancy between upper limbs (observable entity),20200131,1,9E+17,9E+17
363808001,Measured body weight (observable entity),20200131,1,9E+17,9E+17
816172003,Measured gestational weight loss (observable entity),20200131,1,9E+17,9E+17
816164000,Weight change intent (observable entity),20200131,1,9E+17,9E+17
816161008,Measured gestational weight gain (observable entity),20200131,1,9E+17,9E+17
816160009,Measured weight loss (observable entity),20200131,1,9E+17,9E+17
816159004,Measured weight gain (observable entity),20200131,1,9E+17,9E+17
816953004,Date urine test due (observable entity),20200131,1,9E+17,9E+17
789539003,Date immunization due (observable entity),20200131,1,9E+17,9E+17
789279006,Clavien-Dindo complication grade (observable entity),20200131,1,9E+17,9E+17
816083005,Extracellular fluid volume (observable entity),20200131,1,9E+17,9E+17
789734006,Timed unsupported steady stand time (observable entity),20200131,1,9E+17,9E+17
1.12711E+15,"Pulpal involvement, ulceration, fistula and abscess index score (observable entity)",20200731,1,9E+17,9E+17
1.24046E+15,Measurement of severe acute respiratory syndrome coronavirus 2 antibody (observable entity),20200731,1,9E+17,9E+17
1.24047E+15,Measurement of severe acute respiratory syndrome coronavirus 2 antigen (observable entity),20200731,1,9E+17,9E+17
4.91581E+14,Post-traumatic stress disorder checklist for Diagnostic and Statistical Manual of Mental Disorders - Fifth Edition total symptom severity score (observable entity),20200731,1,9E+17,9E+17
1.361E+12,Depth of wound undermining (observable entity),20200731,1,9E+17,9E+17
5.13881E+14,Current medication as reported by patient (observable entity),20200731,1,9E+17,9E+17
249043002,Fetal heart rate (observable entity),20200731,1,9E+17,9E+17
1.45041E+14,London Measure of Unplanned Pregnancy score (observable entity),20200731,1,9E+17,9E+17
860932002,Minimum alveolar concentration of inhaled anesthetic (observable entity),20200731,1,9E+17,9E+17
860938003,End tidal minimum alveolar concentration of inhaled anesthetic (observable entity),20200731,1,9E+17,9E+17
860939006,Age adjusted minimum alveolar concentration of inhaled anesthetic (observable entity),20200731,1,9E+17,9E+17
860940008,Age adjusted end tidal minimum alveolar concentration of inhaled anesthetic (observable entity),20200731,1,9E+17,9E+17
865985007,Planned stop date for anticoagulation therapy (observable entity),20200731,1,9E+17,9E+17
865984006,Frequency of blood glucose self-monitoring (observable entity),20200731,1,9E+17,9E+17
865933005,Mood Disorder Questionnaire score (observable entity),20200731,1,9E+17,9E+17
866040002,Antidiabetic drug therapy observation (observable entity),20200731,1,9E+17,9E+17
863930006,Creatinine clearance decreased (finding),20200731,1,9E+17,9E+17
865876006,Clinical Outcomes in Routine Evaluation Outcome Measure Global Distress total score (observable entity),20200731,1,9E+17,9E+17
865877002,Clinical Outcomes in Routine Evaluation Outcome Measure Risk/Harm score (observable entity),20200731,1,9E+17,9E+17
840415004,Date fecal test due (observable entity),20200731,1,9E+17,9E+17
840416003,Date blood test due (observable entity),20200731,1,9E+17,9E+17
840417007,Date laboratory test due (observable entity),20200731,1,9E+17,9E+17
840414000,Date semen analysis due (observable entity),20200731,1,9E+17,9E+17
840413006,Date bone density scan due (observable entity),20200731,1,9E+17,9E+17
840410009,Presence of carbon monoxide detector (observable entity),20200731,1,9E+17,9E+17
840644009,Date of last oral examination (observable entity),20200731,1,9E+17,9E+17
840643003,Date of last examination (observable entity),20200731,1,9E+17,9E+17
871552002,Detection of severe acute respiratory syndrome coronavirus 2 antibody (observable entity),20200731,1,9E+17,9E+17
871553007,Detection of severe acute respiratory syndrome coronavirus 2 antigen (observable entity),20200731,1,9E+17,9E+17
871555000,Detection of ribonucleic acid of severe acute respiratory syndrome coronavirus 2 (observable entity),20200731,1,9E+17,9E+17
871556004,Detection of ribonucleic acid of severe acute respiratory syndrome coronavirus 2 in nasopharyngeal swab (observable entity),20200731,1,9E+17,9E+17
871557008,Detection of ribonucleic acid of severe acute respiratory syndrome coronavirus 2 in oropharyngeal swab (observable entity),20200731,1,9E+17,9E+17
871558003,Detection of ribonucleic acid of severe acute respiratory syndrome coronavirus 2 in sputum (observable entity),20200731,1,9E+17,9E+17
871559006,Detection of ribonucleic acid of severe acute respiratory syndrome coronavirus 2 in bronchoalveolar lavage fluid (observable entity),20200731,1,9E+17,9E+17
871560001,Detection of ribonucleic acid of severe acute respiratory syndrome coronavirus 2 using polymerase chain reaction (observable entity),20200731,1,9E+17,9E+17
871562009,Detection of severe acute respiratory syndrome coronavirus 2 (observable entity),20200731,1,9E+17,9E+17
870593000,Body height growth rate (observable entity),20200731,1,9E+17,9E+17
870594006,Timed six meter walk time (observable entity),20200731,1,9E+17,9E+17
870598009,Timed six meter walk gait speed (observable entity),20200731,1,9E+17,9E+17
870601004,Target body mass index for age z-score (observable entity),20200731,1,9E+17,9E+17
870605008,Target weight for length z-score (observable entity),20200731,1,9E+17,9E+17
870604007,Target mid upper arm circumference z-score (observable entity),20200731,1,9E+17,9E+17
870552008,Health literacy (observable entity),20200731,1,9E+17,9E+17
833316001,Volume of body spaces using radionuclide dilution technique (observable entity),20200731,1,9E+17,9E+17
9.011E+12,Physical activity barrier (observable entity),20210131,1,9E+17,9E+17
9.001E+12,Name of medication injected (observable entity),20210131,1,9E+17,9E+17
8.991E+12,Platelet aggregation inhibitor therapy contraindication (observable entity),20210131,1,9E+17,9E+17
1.9401E+13,Postpartum Depression Screening Scale score (observable entity),20210131,1,9E+17,9E+17
8.521E+12,Suicide plan (observable entity),20210131,1,9E+17,9E+17
1003998008,Arm demispan (observable entity),20210131,1,9E+17,9E+17
1003999000,Arm halfspan (observable entity),20210131,1,9E+17,9E+17
1003996007,Tibia length (observable entity),20210131,1,9E+17,9E+17
780838006,Target serum non high density lipoprotein cholesterol level (observable entity),20210131,1,9E+17,9E+17
780837001,Target serum low density lipoprotein cholesterol level (observable entity),20210131,1,9E+17,9E+17
780836005,Target serum high density lipoprotein cholesterol level (observable entity),20210131,1,9E+17,9E+17
780835009,Target serum triglyceride level (observable entity),20210131,1,9E+17,9E+17
390896004,Target cholesterol level (observable entity),20210131,1,9E+17,9E+17
408591000,Hemoglobin A1c target (observable entity),20210131,1,9E+17,9E+17
443245006,Estimated weight using Broselow Luten pediatric weight estimation (observable entity),20210131,1,9E+17,9E+17
27113001,Body weight (observable entity),20210131,1,9E+17,9E+17
878870000,Peak expiratory flow rate after exercise (observable entity),20210131,1,9E+17,9E+17
878869001,Forced expired volume in six seconds (observable entity),20210131,1,9E+17,9E+17
876783001,Clinical trial arm (observable entity),20210131,1,9E+17,9E+17
4.56701E+14,Length of arm span (observable entity),20210131,1,9E+17,9E+17
1.10444E+15,Alert Confusion Voice Pain Unresponsive scale score (observable entity),20210131,1,9E+17,9E+17
868242008,Target weight gain per day (observable entity),20210131,1,9E+17,9E+17
1119388009,Reduction of alpha activity in left cerebral hemisphere (finding),20210131,1,9E+17,9E+17
1055210001,Target parameter (observable entity),20210131,1,9E+17,9E+17
1078215008,Target body weight (observable entity),20210131,1,9E+17,9E+17
1119389001,Reduction of alpha activity in right cerebral hemisphere (finding),20210131,1,9E+17,9E+17
1153593003,Weight for age z-score (observable entity),20210731,1,9E+17,9E+17
1153594009,Head circumference for age z-score (observable entity),20210731,1,9E+17,9E+17
1153591001,Length for age percentile (observable entity),20210731,1,9E+17,9E+17
1153592008,Weight for age percentile (observable entity),20210731,1,9E+17,9E+17
1153598007,Weight for length z score (observable entity),20210731,1,9E+17,9E+17
1155696002,Readiness to change nutrition behavior stage (observable entity),20210731,1,9E+17,9E+17
1155700005,Self reported readiness to change nutrition behavior score (observable entity),20210731,1,9E+17,9E+17
1155777007,Anatomic location directly invaded by primary malignant neoplasm of stomach (observable entity),20210731,1,9E+17,9E+17
1155778002,Presence of direct invasion by primary malignant neoplasm of stomach to lymphatic vessel and/or small blood vessel (observable entity),20210731,1,9E+17,9E+17
1155779005,Presence of direct invasion by primary malignant neoplasm of stomach to nerve (observable entity),20210731,1,9E+17,9E+17
1153622008,Outdoor competitive activity (qualifier value),20210731,1,9E+17,9E+17
1153599004,Weight for length percentile (observable entity),20210731,1,9E+17,9E+17
1153600001,Weight for height z-score (observable entity),20210731,1,9E+17,9E+17
1153601002,Weight for height percentile (observable entity),20210731,1,9E+17,9E+17
1153602009,Body mass index for age percentile (observable entity),20210731,1,9E+17,9E+17
1153604005,Body height for age z-score (observable entity),20210731,1,9E+17,9E+17
1153605006,Body height for age percentile (observable entity),20210731,1,9E+17,9E+17
1153606007,Mid parental height (observable entity),20210731,1,9E+17,9E+17
1153637007,Body height (observable entity),20210731,1,9E+17,9E+17
1153590000,Length for age z score (observable entity),20210731,1,9E+17,9E+17
1155780008,Anatomic location directly invaded by primary malignant neoplasm of small intestine (observable entity),20210731,1,9E+17,9E+17
396984004,Histologic feature of neoplasm (observable entity),20210731,1,9E+17,9E+17
1155781007,Presence of direct invasion by primary malignant neoplasm of small intestine to lymphatic vessel and/or small blood vessel (observable entity),20210731,1,9E+17,9E+17
1155869002,Presence of direct invasion by primary malignant neoplasm of larynx to nerve (observable entity),20210731,1,9E+17,9E+17
1155946001,Presence of direct invasion by primary malignant neoplasm of urethra to lymphatic vessel and/or small blood vessel (observable entity),20210731,1,9E+17,9E+17
1155945002,Anatomic location directly invaded by primary malignant neoplasm of urethra (observable entity),20210731,1,9E+17,9E+17
1155939005,Anatomic location directly invaded by primary malignant neoplasm of ureter (observable entity),20210731,1,9E+17,9E+17
1155938002,Presence of direct invasion by primary malignant neoplasm of ureter to lymphatic vessel and/or small blood vessel (observable entity),20210731,1,9E+17,9E+17
1155937007,Presence of direct invasion by primary malignant neoplasm of renal pelvis to lymphatic vessel and/or small blood vessel (observable entity),20210731,1,9E+17,9E+17
1155970002,Emotion function (observable entity),20210731,1,9E+17,9E+17
1155924009,Presence of direct invasion by primary malignant neoplasm of soft tissue to lymphatic vessel and/or small blood vessel (observable entity),20210731,1,9E+17,9E+17
1155925005,Anatomic location directly invaded by primary malignant neoplasm of lung (observable entity),20210731,1,9E+17,9E+17
1155936003,Anatomic location directly invaded by primary malignant neoplasm of renal pelvis (observable entity),20210731,1,9E+17,9E+17
1155932001,Anatomic location directly invaded by primary malignant neoplasm of kidney (observable entity),20210731,1,9E+17,9E+17
1155931008,Presence of direct invasion by primary malignant neoplasm of kidney to lymphatic vessel and/or small blood vessel (observable entity),20210731,1,9E+17,9E+17
1155930009,Anatomic location directly invaded by primary malignant neoplasm of urinary bladder (observable entity),20210731,1,9E+17,9E+17
1155929004,Presence of direct invasion by primary malignant neoplasm of urinary bladder to lymphatic vessel and/or small blood vessel (observable entity),20210731,1,9E+17,9E+17
1155928007,Presence of direct invasion by primary malignant neoplasm of thymus to lymphatic vessel and/or small blood vessel (observable entity),20210731,1,9E+17,9E+17
1155927002,Anatomic location directly invaded by primary malignant neoplasm of thymus (observable entity),20210731,1,9E+17,9E+17
1155926006,Anatomic location directly invaded by primary malignant neoplasm of mesothelium (observable entity),20210731,1,9E+17,9E+17
1155899006,Presence of direct invasion by primary malignant neoplasm of bone to lymphatic vessel and/or small blood vessel (observable entity),20210731,1,9E+17,9E+17
1155898003,Anatomic location directly invaded by primary malignant neoplasm of bone (observable entity),20210731,1,9E+17,9E+17
1155833005,Presence of direct invasion by primary malignant neoplasm of gallbladder to lymphatic vessel and/or small blood vessel (observable entity),20210731,1,9E+17,9E+17
1155832000,Anatomic location directly invaded by primary malignant neoplasm of gallbladder (observable entity),20210731,1,9E+17,9E+17
1155831007,Presence of direct invasion by primary malignant neoplasm of gallbladder to nerve (observable entity),20210731,1,9E+17,9E+17
1155830008,Presence of direct invasion by primary malignant neoplasm of extrahepatic bile duct to nerve (observable entity),20210731,1,9E+17,9E+17
1155829003,Anatomic location directly invaded by primary malignant neoplasm of extrahepatic bile duct (observable entity),20210731,1,9E+17,9E+17
1155861004,Anatomic location directly invaded by primary malignant neoplasm of intrahepatic bile duct (observable entity),20210731,1,9E+17,9E+17
1155860003,Anatomic location directly invaded by primary malignant neoplasm of liver (observable entity),20210731,1,9E+17,9E+17
1155858000,Presence of direct invasion by primary malignant neoplasm of esophagus to lymphatic vessel and/or small blood vessel (observable entity),20210731,1,9E+17,9E+17
1155857005,Presence of direct invasion by primary malignant neoplasm of esophagus to nerve (observable entity),20210731,1,9E+17,9E+17
1155828006,Presence of direct invasion by primary malignant neoplasm of distal hepatic bile duct to lymphatic vessel and/or small blood vessel (observable entity),20210731,1,9E+17,9E+17
1155827001,Presence of direct invasion by primary malignant neoplasm of thyroid to lymphatic vessel and/or small blood vessel (observable entity),20210731,1,9E+17,9E+17
1155805005,Presence of direct invasion by primary malignant neoplasm of uterus to lymphatic vessel and/or small blood vessel (observable entity),20210731,1,9E+17,9E+17
1155804009,Anatomic location directly invaded by primary malignant neoplasm of uterus (observable entity),20210731,1,9E+17,9E+17
1155803003,Presence of direct invasion by primary malignant neoplasm of cervix uteri to lymphatic vessel and/or small blood vessel (observable entity),20210731,1,9E+17,9E+17
1155802008,Anatomic location directly invaded by primary malignant neoplasm of cervix uteri (observable entity),20210731,1,9E+17,9E+17
1155801001,Anatomic location directly invaded by primary malignant neoplasm of vagina (observable entity),20210731,1,9E+17,9E+17
1155800000,Presence of direct invasion by primary malignant neoplasm of vagina to lymphatic vessel and/or small blood vessel (observable entity),20210731,1,9E+17,9E+17
1155799004,Presence of direct invasion by primary malignant neoplasm of vulva to lymphatic vessel and/or small blood vessel (observable entity),20210731,1,9E+17,9E+17
1155798007,Anatomic location directly invaded by primary malignant neoplasm of vulva (observable entity),20210731,1,9E+17,9E+17
1155797002,Presence of direct invasion by primary malignant neoplasm of colon to nerve (observable entity),20210731,1,9E+17,9E+17
1155796006,Presence of direct invasion by primary malignant neoplasm of colon to lymphatic vessel and/or small blood vessel (observable entity),20210731,1,9E+17,9E+17
1155795005,Presence of direct invasion by primary malignant neoplasm of appendix to lymphatic vessel and/or small blood vessel (observable entity),20210731,1,9E+17,9E+17
1155794009,Presence of direct invasion by primary malignant neoplasm of appendix to nerve (observable entity),20210731,1,9E+17,9E+17
1155793003,Anatomic location directly invaded by primary malignant neoplasm of appendix (observable entity),20210731,1,9E+17,9E+17
1155792008,Presence of direct invasion by primary malignant neoplasm of anus to nerve (observable entity),20210731,1,9E+17,9E+17
1155791001,Presence of direct invasion by primary malignant neoplasm of anus to lymphatic vessel and/or small blood vessel (observable entity),20210731,1,9E+17,9E+17
1155790000,Anatomic location directly invaded by primary malignant neoplasm of anus (observable entity),20210731,1,9E+17,9E+17
1155809004,Presence of direct invasion by primary malignant neoplasm of endometrium to lymphatic vessel and/or small blood vessel (observable entity),20210731,1,9E+17,9E+17
1155826005,Presence of direct invasion by primary malignant neoplasm of thyroid to nerve (observable entity),20210731,1,9E+17,9E+17
1155825009,Presence of direct invasion by primary malignant neoplasm of pancreas to nerve (observable entity),20210731,1,9E+17,9E+17
1155824008,Anatomic location directly invaded by primary malignant neoplasm of pancreas (observable entity),20210731,1,9E+17,9E+17
1155823002,Presence of direct invasion by primary malignant neoplasm of pancreas to lymphatic vessel and/or small blood vessel (observable entity),20210731,1,9E+17,9E+17
1155822007,Presence of direct invasion by primary malignant neoplasm of ileum to nerve (observable entity),20210731,1,9E+17,9E+17
1155821000,Anatomic location directly invaded by primary malignant neoplasm of ileum (observable entity),20210731,1,9E+17,9E+17
1155820004,Presence of direct invasion by primary malignant neoplasm of jejunum to lymphatic vessel and/or small blood vessel (observable entity),20210731,1,9E+17,9E+17
1155819005,Presence of direct invasion by primary malignant neoplasm of jejunum to nerve (observable entity),20210731,1,9E+17,9E+17
1155818002,Anatomic location directly invaded by primary malignant neoplasm of jejunum (observable entity),20210731,1,9E+17,9E+17
1155817007,Presence of direct invasion by primary malignant neoplasm of ampulla of Vater to nerve (observable entity),20210731,1,9E+17,9E+17
1155816003,Presence of direct invasion by primary malignant neoplasm of ampulla of Vater to lymphatic vessel and/or small blood vessel (observable entity),20210731,1,9E+17,9E+17
1155815004,Anatomic location directly invaded by primary malignant neoplasm of ampulla of Vater (observable entity),20210731,1,9E+17,9E+17
1155814000,Presence of direct invasion by primary malignant neoplasm of duodenum to lymphatic vessel and/or small blood vessel (observable entity),20210731,1,9E+17,9E+17
1155813006,Presence of direct invasion by primary malignant neoplasm of duodenum to nerve (observable entity),20210731,1,9E+17,9E+17
1155812001,Anatomic location directly invaded by primary malignant neoplasm of duodenum (observable entity),20210731,1,9E+17,9E+17
1155810009,Anatomic location directly invaded by primary malignant neoplasm of adrenal gland (observable entity),20210731,1,9E+17,9E+17
1155808007,Anatomic location directly invaded by primary malignant neoplasm of endometrium (observable entity),20210731,1,9E+17,9E+17
1155863001,Presence of direct invasion by primary malignant neoplasm of liver to nerve (observable entity),20210731,1,9E+17,9E+17
1155886008,Anatomic location directly invaded by primary malignant neoplasm of nose (observable entity),20210731,1,9E+17,9E+17
1155884006,Presence of direct invasion by primary malignant neoplasm of nasal sinus to nerve (observable entity),20210731,1,9E+17,9E+17
1155883000,Presence of direct invasion by primary malignant neoplasm of nasal sinus to lymphatic vessel and/or small blood vessel (observable entity),20210731,1,9E+17,9E+17
1155882005,Anatomic location directly invaded by primary malignant neoplasm of nasal sinus (observable entity),20210731,1,9E+17,9E+17
1155881003,Presence of direct invasion by primary malignant neoplasm of minor salivary gland to lymphatic vessel and/or small blood vessel (observable entity),20210731,1,9E+17,9E+17
1155897008,Anatomic location directly invaded by primary malignant neoplasm of eye (observable entity),20210731,1,9E+17,9E+17
1155896004,Anatomic location directly invaded by primary malignant neoplasm of testis (observable entity),20210731,1,9E+17,9E+17
1155895000,Presence of direct invasion by primary malignant neoplasm of testis to lymphatic vessel and/or small blood vessel (observable entity),20210731,1,9E+17,9E+17
1155894001,Presence of direct invasion by primary malignant neoplasm of penis to lymphatic vessel and/or small blood vessel (observable entity),20210731,1,9E+17,9E+17
1155893007,Presence of direct invasion by primary malignant neoplasm of penis to nerve (observable entity),20210731,1,9E+17,9E+17
1155892002,Anatomic location directly invaded by primary malignant neoplasm of penis (observable entity),20210731,1,9E+17,9E+17
1155891009,Presence of direct invasion by primary malignant neoplasm of pharynx to nerve (observable entity),20210731,1,9E+17,9E+17
1155890005,Presence of direct invasion by primary malignant neoplasm of pharynx to lymphatic vessel and/or small blood vessel (observable entity),20210731,1,9E+17,9E+17
1155889001,Anatomic location directly invaded by primary malignant neoplasm of pharynx (observable entity),20210731,1,9E+17,9E+17
1155888009,Presence of direct invasion by primary malignant neoplasm of nose to nerve (observable entity),20210731,1,9E+17,9E+17
1155887004,Presence of direct invasion by primary malignant neoplasm of nose to lymphatic vessel and/or small blood vessel (observable entity),20210731,1,9E+17,9E+17
1155782000,Anatomic location directly invaded by primary malignant neoplasm of esophagus (observable entity),20210731,1,9E+17,9E+17
1155868005,Presence of direct invasion by primary malignant neoplasm of larynx to lymphatic vessel and/or small blood vessel (observable entity),20210731,1,9E+17,9E+17
1155867000,Anatomic location directly invaded by primary malignant neoplasm of larynx (observable entity),20210731,1,9E+17,9E+17
1155865008,Presence of direct invasion by primary malignant neoplasm of intrahepatic bile duct to nerve (observable entity),20210731,1,9E+17,9E+17
1155864007,Presence of direct invasion by primary malignant neoplasm of intrahepatic bile duct to lymphatic vessel and/or small blood vessel (observable entity),20210731,1,9E+17,9E+17
1155870001,Anatomic location directly invaded by primary malignant neoplasm of oral mucosa (observable entity),20210731,1,9E+17,9E+17
1155871002,Presence of direct invasion by primary malignant neoplasm of oral mucosa to nerve (observable entity),20210731,1,9E+17,9E+17
1155880002,Presence of direct invasion by primary malignant neoplasm of minor salivary gland to nerve (observable entity),20210731,1,9E+17,9E+17
1155879000,Anatomic location directly invaded by primary malignant neoplasm of minor salivary gland (observable entity),20210731,1,9E+17,9E+17
1155878008,Presence of direct invasion by primary malignant neoplasm of major salivary gland to lymphatic vessel and/or small blood vessel (observable entity),20210731,1,9E+17,9E+17
1155877003,Presence of direct invasion by primary malignant neoplasm of major salivary gland to nerve (observable entity),20210731,1,9E+17,9E+17
1155876007,Anatomic location directly invaded by primary malignant neoplasm of major salivary gland (observable entity),20210731,1,9E+17,9E+17
1155875006,Presence of direct invasion by primary malignant neoplasm of oral soft tissue to lymphatic vessel and/or small blood vessel (observable entity),20210731,1,9E+17,9E+17
1155874005,Presence of direct invasion by primary malignant neoplasm of oral soft tissue to nerve (observable entity),20210731,1,9E+17,9E+17
1155873004,Anatomic location directly invaded by primary malignant neoplasm of oral soft tissue (observable entity),20210731,1,9E+17,9E+17
1155872009,Presence of direct invasion by primary malignant neoplasm of oral mucosa to lymphatic vessel and/or small blood vessel (observable entity),20210731,1,9E+17,9E+17
2.62E+15,Specimen collection procedure (observable entity),20210731,1,9E+17,9E+17
1149283006,Tissue specimen observable (observable entity),20210731,1,9E+17,9E+17
1148960009,Communication function (observable entity),20210731,1,9E+17,9E+17
1149051005,Ability to perform health maintenance (observable entity),20210731,1,9E+17,9E+17
1149050006,Histologic grade of primary malignant neoplasm of penis (observable entity),20210731,1,9E+17,9E+17
1149048003,Histologic grade of malignant neuroendocrine neoplasm of thyroid (observable entity),20210731,1,9E+17,9E+17
1149047008,Histologic grade of malignant neuroendocrine neoplasm of stomach (observable entity),20210731,1,9E+17,9E+17
1149046004,Histologic grade of malignant neuroendocrine neoplasm of ampulla of Vater (observable entity),20210731,1,9E+17,9E+17
1149045000,Histologic grade of malignant neuroendocrine neoplasm of small intestine (observable entity),20210731,1,9E+17,9E+17
1149044001,Histologic grade of malignant neuroendocrine neoplasm of pancreas (observable entity),20210731,1,9E+17,9E+17
1149043007,Histologic grade of primary malignant neoplasm of pancreas (observable entity),20210731,1,9E+17,9E+17
1149042002,Histologic grade of primary malignant neoplasm of lung (observable entity),20210731,1,9E+17,9E+17
1149041009,Histologic grade of primary malignant neoplasm of liver (observable entity),20210731,1,9E+17,9E+17
1149040005,Histologic grade of primary malignant neoplasm of pharynx (observable entity),20210731,1,9E+17,9E+17
1149039008,Histologic grade of primary malignant neoplasm of nasal sinus (observable entity),20210731,1,9E+17,9E+17
1149101003,Recumbent body height (observable entity),20210731,1,9E+17,9E+17
1149037005,Histologic grade of primary malignant neoplasm of oral mucosa (observable entity),20210731,1,9E+17,9E+17
1149010008,Histologic type of primary malignant neoplasm of fallopian tube (observable entity),20210731,1,9E+17,9E+17
1149009003,Histologic type of primary malignant neoplasm of female genital tract (observable entity),20210731,1,9E+17,9E+17
1149008006,Histologic type of primary malignant neoplasm of pharynx (observable entity),20210731,1,9E+17,9E+17
1149007001,Histologic type of primary malignant neoplasm of nasal sinus (observable entity),20210731,1,9E+17,9E+17
1149006005,Histologic type of primary malignant neoplasm of nasal structure (observable entity),20210731,1,9E+17,9E+17
1149004008,Histologic type of primary malignant neoplasm of minor salivary gland (observable entity),20210731,1,9E+17,9E+17
1149003002,Histologic type of primary malignant neoplasm of major salivary gland (observable entity),20210731,1,9E+17,9E+17
1149002007,Histologic type of primary malignant neoplasm of oral soft tissue (observable entity),20210731,1,9E+17,9E+17
1148995007,Histologic type of primary malignant neoplasm of cervix uteri (observable entity),20210731,1,9E+17,9E+17
1148994006,Histologic type of primary malignant neoplasm of extrahepatic bile duct (observable entity),20210731,1,9E+17,9E+17
1148993000,Histologic type of primary malignant neoplasm of intrahepatic bile duct (observable entity),20210731,1,9E+17,9E+17
1148992005,Histologic type of primary malignant neoplasm of distal hepatic bile duct (observable entity),20210731,1,9E+17,9E+17
1148991003,Histologic type of primary malignant neoplasm of anus (observable entity),20210731,1,9E+17,9E+17
1149012000,Histologic type of primary malignant neoplasm of eye (observable entity),20210731,1,9E+17,9E+17
1149038000,Histologic grade of primary malignant neoplasm of nasal structure (observable entity),20210731,1,9E+17,9E+17
1149013005,Histologic type of primary malignant neoplasm of soft tissue (observable entity),20210731,1,9E+17,9E+17
1149015003,Histologic type of primary malignant neoplasm of renal pelvis (observable entity),20210731,1,9E+17,9E+17
1149036001,Histologic grade of primary malignant neoplasm of oral soft tissue (observable entity),20210731,1,9E+17,9E+17
1149035002,Histologic grade of primary malignant neoplasm of larynx (observable entity),20210731,1,9E+17,9E+17
1149034003,Histologic grade of primary malignant neoplasm of gallbladder (observable entity),20210731,1,9E+17,9E+17
1149033009,Histologic grade of primary malignant neoplasm of esophagus (observable entity),20210731,1,9E+17,9E+17
1149032004,Histologic grade of malignant neuroendocrine neoplasm of appendix (observable entity),20210731,1,9E+17,9E+17
1149031006,Histologic grade of primary malignant neoplasm of cervix uteri (observable entity),20210731,1,9E+17,9E+17
1149029002,Histologic grade of primary malignant neoplasm of extrahepatic bile duct (observable entity),20210731,1,9E+17,9E+17
1149027000,Histologic grade of primary malignant neoplasm of intrahepatic bile duct (observable entity),20210731,1,9E+17,9E+17
1149026009,Histologic grade of primary malignant neoplasm of appendix (observable entity),20210731,1,9E+17,9E+17
1149024007,Histologic grade of primary malignant neoplasm of anus (observable entity),20210731,1,9E+17,9E+17
1149022006,Histologic grade of primary malignant neoplasm of adrenal gland (observable entity),20210731,1,9E+17,9E+17
1149021004,Histologic type of primary malignant neoplasm of vulva (observable entity),20210731,1,9E+17,9E+17
1149020003,Histologic type of primary malignant neoplasm of vagina (observable entity),20210731,1,9E+17,9E+17
1149019009,Histologic type of primary malignant neoplasm of male urethra (observable entity),20210731,1,9E+17,9E+17
1149018001,Histologic type of primary malignant neoplasm of female urethra (observable entity),20210731,1,9E+17,9E+17
1149017006,Histologic type of primary malignant neoplasm of urethra (observable entity),20210731,1,9E+17,9E+17
1149016002,Histologic type of primary malignant neoplasm of ureter (observable entity),20210731,1,9E+17,9E+17
1149014004,Histologic type of primary malignant neoplasm of thymus (observable entity),20210731,1,9E+17,9E+17
1149299000,Subjective Global Nutritional Assessment for children score (observable entity),20210731,1,9E+17,9E+17
2.9E+15,Presence of ductal carcinoma in situ in epidermis of nipple (observable entity),20210731,1,9E+17,9E+17
2.96E+15,Presence of direct invasion by metastatic carcinoma of lymph node in excised specimen to perilymphatic tissue (observable entity),20210731,1,9E+17,9E+17
3.01E+15,Nottingham mitotic count in primary malignant neoplasm of breast (observable entity),20210731,1,9E+17,9E+17
3.1E+15,Number of paraffin embedded tissue blocks examined from excised specimen (observable entity),20210731,1,9E+17,9E+17
3.28E+15,Anatomic location directly invaded by primary malignant neoplasm of breast (observable entity),20210731,1,9E+17,9E+17
3.4E+15,Architectural pattern of ductal carcinoma in situ in breast (observable entity),20210731,1,9E+17,9E+17
2.89E+15,Nuclear grade of ductal carcinoma in situ of breast (observable entity),20210731,1,9E+17,9E+17
4.37E+15,Length of excised tissue specimen (observable entity),20210731,1,9E+17,9E+17
4.52E+15,Nottingham nuclear pleomorphism score of primary malignant neoplasm of breast (observable entity),20210731,1,9E+17,9E+17
5.31E+15,Histologic type of neoplasm of skin (observable entity),20210731,1,9E+17,9E+17
5.73E+15,Histologic type of malignant melanoma of skin (observable entity),20210731,1,9E+17,9E+17
5.98E+15,Distance of melanoma in situ of skin from closest peripheral margin in excised skin specimen (observable entity),20210731,1,9E+17,9E+17
3.72E+15,Nottingham glandular differentiation score of primary malignant neoplasm of breast (observable entity),20210731,1,9E+17,9E+17
2.82E+15,Nottingham mitotic rate score of primary malignant neoplasm of breast (observable entity),20210731,1,9E+17,9E+17
2.67E+15,Presence of direct invasion by primary malignant neoplasm of breast to lymphatic vessel and/or small vessel in skin of breast (observable entity),20210731,1,9E+17,9E+17
1.85E+15,Histologic grade of primary malignant neoplasm (observable entity),20210731,1,9E+17,9E+17
1.87E+15,Histologic grade of primary malignant neoplasm of colon (observable entity),20210731,1,9E+17,9E+17
2.1E+15,Histologic type of malignant neoplasm (observable entity),20210731,1,9E+17,9E+17
2.52E+15,Anatomic location directly invaded macroscopically by primary malignant neoplasm of breast (observable entity),20210731,1,9E+17,9E+17
1.81249E+15,Histologic grade of primary malignant neoplasm of prostate by International Society of Urological Pathology technique (observable entity),20210731,1,9E+17,9E+17
1.66E+15,Histologic type of primary malignant neoplasm of breast (observable entity),20210731,1,9E+17,9E+17
106243009,Breslow depth staging for melanoma of skin (observable entity),20210731,1,9E+17,9E+17
364108009,Lymph node observable (observable entity),20210731,1,9E+17,9E+17
1.52583E+15,Percentage of primary malignant neoplasm of prostate in resected prostate specimen (observable entity),20210731,1,9E+17,9E+17
1.536E+15,Anatomic location directly invaded by primary malignant neoplasm of prostate (observable entity),20210731,1,9E+17,9E+17
405922009,Weight of kidney (observable entity),20210731,1,9E+17,9E+17
1.54658E+15,Gleason pattern of primary malignant neoplasm of prostate at surgical margin of prostatectomy specimen (observable entity),20210731,1,9E+17,9E+17
1.5466E+15,Length of excised prostate specimen (observable entity),20210731,1,9E+17,9E+17
1.54661E+15,Weight of excised prostate specimen (observable entity),20210731,1,9E+17,9E+17
103419001,Clark melanoma level of invasion of excised malignant melanoma of skin (observable entity),20210731,1,9E+17,9E+17
1.54662E+15,Presence of direct invasion by primary malignant neoplasm of lung to lymphatic vessel and/or small blood vessel (observable entity),20210731,1,9E+17,9E+17
364109001,Length of lymph node in excised specimen (observable entity),20210731,1,9E+17,9E+17
1.13668E+15,Anatomic location of excised primary malignant neoplasm (observable entity),20210731,1,9E+17,9E+17
1.22E+15,Anatomic location directly invaded by primary malignant neoplasm of colon (observable entity),20210731,1,9E+17,9E+17
1149388004,Urinary system function (observable entity),20210731,1,9E+17,9E+17
1149434005,Histologic grade of primary malignant neoplasm of colon using World Health Organization classification of tumors system fifth edition method (observable entity),20210731,1,9E+17,9E+17
4.30001E+14,Length of excised colon specimen (observable entity),20210731,1,9E+17,9E+17
1157167001,Histologic grade of dysplasia at proximal surgical margin (observable entity),20210731,1,9E+17,9E+17
1156896009,Thoracoabdominal circumference of fetus (observable entity),20210731,1,9E+17,9E+17
1156895008,Diameter of amniotic sac (observable entity),20210731,1,9E+17,9E+17
1156894007,Date of pregnancy detection (observable entity),20210731,1,9E+17,9E+17
1156893001,Occipitofrontal diameter of fetal head (observable entity),20210731,1,9E+17,9E+17
248333004,Standing height (observable entity),20210731,1,9E+17,9E+17
1157210001,Communicating feelings (observable entity),20210731,1,9E+17,9E+17
371512006,Presence of direct invasion by primary malignant neoplasm to lymphatic vessel and/or small blood vessel (observable entity),20210731,1,9E+17,9E+17
371513001,Presence of direct invasion by primary malignant neoplasm to nerve (observable entity),20210731,1,9E+17,9E+17
895467003,Histologic grade of primary malignant neoplasm of breast by Nottingham technique (observable entity),20210731,1,9E+17,9E+17
397440000,Anatomic location of excised lymph node containing metastatic neoplasm (observable entity),20210731,1,9E+17,9E+17
268369000,Special urinary test normal (finding),20210731,1,9E+17,9E+17
268370004,Special urinary test abnormal (finding),20210731,1,9E+17,9E+17
371441004,Histologic type of proliferative mass (observable entity),20210731,1,9E+17,9E+17
371469007,Histologic grade of neoplasm (observable entity),20210731,1,9E+17,9E+17
371480007,Anatomic location of neoplasm (observable entity),20210731,1,9E+17,9E+17
371487005,Presence of direct invasion by neoplasm (observable entity),20210731,1,9E+17,9E+17
372278000,Gleason score (observable entity),20210731,1,9E+17,9E+17
372309006,Number of regional lymph nodes examined by microscopy in excised specimen (observable entity),20210731,1,9E+17,9E+17
1157294009,Weight of organ (observable entity),20210731,1,9E+17,9E+17
444025001,Number of lymph nodes examined by microscopy in excised specimen (observable entity),20210731,1,9E+17,9E+17
1157244008,Compliance behavior with law (observable entity),20210731,1,9E+17,9E+17
1157309008,Percentile of fetal growth (observable entity),20210731,1,9E+17,9E+17
1157308000,Corrected fetal gestational age in weeks and days (observable entity),20210731,1,9E+17,9E+17
1156287001,Compliance behavior to rehabilitation regime (observable entity),20210731,1,9E+17,9E+17
1156281000,Compliance behavior to fluid regime (observable entity),20210731,1,9E+17,9E+17
1156280004,Compliance behavior to exercise regime (observable entity),20210731,1,9E+17,9E+17
1156253006,Proton density fat fraction of liver (observable entity),20210731,1,9E+17,9E+17
1156071007,Catheter observable (observable entity),20210731,1,9E+17,9E+17
385421009,Anatomic location of metastatic spread of malignant neoplasm (observable entity),20210731,1,9E+17,9E+17
1156226007,Gleason score by composite method (observable entity),20210731,1,9E+17,9E+17
1156225006,Gleason score by largest nodule method (observable entity),20210731,1,9E+17,9E+17
1156224005,Gleason score by highest grade nodule method (observable entity),20210731,1,9E+17,9E+17
7.98721E+14,Histologic type of primary malignant neoplasm of colon (observable entity),20210731,1,9E+17,9E+17
1156187007,Anatomic location directly invaded by primary malignant neoplasm of male urethra (observable entity),20210731,1,9E+17,9E+17
1156188002,Anatomic location directly invaded by primary malignant neoplasm of female urethra (observable entity),20210731,1,9E+17,9E+17
5.12001E+14,Histologic type of primary malignant neoplasm (observable entity),20210731,1,9E+17,9E+17
399742000,Histologic type of carcinoma of upper aerodigestive tract (observable entity),20210731,1,9E+17,9E+17
399604000,Histologic type of carcinoma of minor salivary gland (observable entity),20210731,1,9E+17,9E+17
399635006,Anatomic location of excised lymph node (observable entity),20210731,1,9E+17,9E+17
399687005,Anatomic location of primary malignant neoplasm (observable entity),20210731,1,9E+17,9E+17
167183007,Creatinine clearance-glomerular filtration abnormal (finding),20210731,1,9E+17,9E+17
167182002,Creatinine clearance-glomerular filtration normal (finding),20210731,1,9E+17,9E+17
1156601009,Treatment parameter (observable entity),20210731,1,9E+17,9E+17
1156738004,Fetal gestational age in weeks and days (observable entity),20210731,1,9E+17,9E+17
1156600005,Device setting parameter (observable entity),20210731,1,9E+17,9E+17
384813000,Anatomic location directly invaded by neoplasm (observable entity),20210731,1,9E+17,9E+17
384962004,Anatomic location directly invaded by primary malignant neoplasm (observable entity),20210731,1,9E+17,9E+17
385009003,Presence of direct invasion by primary malignant neoplasm of prostate to periprostatic tissue (observable entity),20210731,1,9E+17,9E+17
1156597009,Parameter (observable entity),20210731,1,9E+17,9E+17
1156478007,Graf classification (observable entity),20210731,1,9E+17,9E+17
396642005,Presence of direct invasion by metastatic neoplasm of lymph node to perilymphatic tissue (observable entity),20210731,1,9E+17,9E+17
396659000,Histologic grade of urothelial carcinoma by World Health Organization and International Society of Urological Pathology technique (observable entity),20210731,1,9E+17,9E+17
1144649008,Six minute walk test distance (observable entity),20210731,1,9E+17,9E+17
1137435002,Access to transportation (observable entity),20210731,1,9E+17,9E+17
9.11754E+17,Histologic type of primary malignant neoplasm of larynx (observable entity),20210731,1,9E+17,9E+17
9.11754E+17,Histologic type of primary malignant neoplasm of omentum (observable entity),20210731,1,9E+17,9E+17
9.11754E+17,Histologic type of primary malignant neoplasm of maxilla (observable entity),20210731,1,9E+17,9E+17
9.11754E+17,Histologic type of primary malignant neoplasm of oral mucosa (observable entity),20210731,1,9E+17,9E+17
9.11754E+17,Histologic type of primary malignant neoplasm of ovary (observable entity),20210731,1,9E+17,9E+17
9.11754E+17,Histologic type of primary malignant neoplasm of penis (observable entity),20210731,1,9E+17,9E+17
9.11754E+17,Histologic type of primary malignant neoplasm of peritoneum (observable entity),20210731,1,9E+17,9E+17
9.11754E+17,Histologic type of primary malignant neoplasm of testis (observable entity),20210731,1,9E+17,9E+17
9.11754E+17,Histologic type of primary malignant neoplasm of uterus (observable entity),20210731,1,9E+17,9E+17
9.11754E+17,Histologic type of primary malignant neoplasm of kidney (observable entity),20210731,1,9E+17,9E+17
9.11754E+17,Histologic type of primary malignant neoplasm of brain (observable entity),20210731,1,9E+17,9E+17
9.11754E+17,Histologic type of primary malignant neoplasm of appendix (observable entity),20210731,1,9E+17,9E+17
9.11754E+17,Histologic type of primary malignant neoplasm of ampulla of Vater (observable entity),20210731,1,9E+17,9E+17
772227002,Height of gingival recession (observable entity),20210731,1,9E+17,9E+17
9.11751E+17,Histologic type of primary malignant neoplasm of lung (observable entity),20210731,1,9E+17,9E+17
9.11753E+17,Histologic type of primary malignant neoplasm of urinary bladder (observable entity),20210731,1,9E+17,9E+17
9.11753E+17,Histologic type of primary malignant neoplasm of bone (observable entity),20210731,1,9E+17,9E+17
9.11753E+17,Histologic type of primary malignant neoplasm of esophagus (observable entity),20210731,1,9E+17,9E+17
9.11753E+17,Histologic type of primary malignant neoplasm of stomach (observable entity),20210731,1,9E+17,9E+17
9.11754E+17,Histologic type of primary malignant neoplasm of small intestine (observable entity),20210731,1,9E+17,9E+17
9.11754E+17,Histologic type of primary malignant neoplasm of pancreas (observable entity),20210731,1,9E+17,9E+17
9.11754E+17,Histologic type of primary malignant neoplasm of prostate (observable entity),20210731,1,9E+17,9E+17
9.11754E+17,Histologic type of primary malignant neoplasm of gallbladder (observable entity),20210731,1,9E+17,9E+17
9.11754E+17,Histologic type of primary malignant neoplasm of liver (observable entity),20210731,1,9E+17,9E+17
9.11754E+17,Histologic type of primary malignant neoplasm of adrenal gland (observable entity),20210731,1,9E+17,9E+17
9.11754E+17,Histologic type of primary malignant neoplasm of thyroid (observable entity),20210731,1,9E+17,9E+17
1141765004,Knowledge level of fetal development (observable entity),20210731,1,9E+17,9E+17
395531003,Neoplasm observable (observable entity),20210731,1,9E+17,9E+17
1137718000,Freshwater fishing (qualifier value),20210731,1,9E+17,9E+17
1137717005,Fishing (qualifier value),20210731,1,9E+17,9E+17
396414002,Number of regional lymph nodes containing metastatic neoplasm identified by microscopy in excised specimen (observable entity),20210731,1,9E+17,9E+17
396413008,Number of regional lymph nodes containing metastatic neoplasm identified macroscopically in excised specimen (observable entity),20210731,1,9E+17,9E+17
1145228009,Impulse control (observable entity),20210731,1,9E+17,9E+17
1145214003,Histologic feature of proliferative mass (observable entity),20210731,1,9E+17,9E+17
1145211006,Proliferative mass observable (observable entity),20210731,1,9E+17,9E+17
1148842005,Compliance behavior to social norm (observable entity),20210731,1,9E+17,9E+17
1148798001,Compliance behavior to treatment (observable entity),20210731,1,9E+17,9E+17
786458005,Self reported usual body weight (observable entity),20210731,1,9E+17,9E+17
396785008,Histologic type of metastatic neoplasm (observable entity),20210731,1,9E+17,9E+17
1144798005,Verbal Rating Scale pain intensity score (observable entity),20210731,1,9E+17,9E+17
1144665009,5-item World Health Organization Well-being Index value (observable entity),20210731,1,9E+17,9E+17
1144655003,EuroQol five dimension three level index value (observable entity),20210731,1,9E+17,9E+17
784399000,Self reported body weight (observable entity),20210731,1,9E+17,9E+17
1162949004,Ability to decontaminate water (observable entity),20210930,1,9E+17,9E+17
1162944009,Awareness of public health water alert (observable entity),20210930,1,9E+17,9E+17
1162942008,Access to potable water (observable entity),20210930,1,9E+17,9E+17
1162952007,Availability of food shopping facility (observable entity),20210930,1,9E+17,9E+17
1162953002,Ability to identify safe food (observable entity),20210930,1,9E+17,9E+17
1162941001,Access to toileting facilities (observable entity),20210930,1,9E+17,9E+17
1163310004,Self reported likelihood of performing food and/or nutrition behavior score (observable entity),20210930,1,9E+17,9E+17
1163309009,Self reported perceived susceptibility to food and/or nutrition health problem score (observable entity),20210930,1,9E+17,9E+17
1163308001,Self reported perceived severity of risk to health score (observable entity),20210930,1,9E+17,9E+17
1163307006,Self reported perceived benefit of food and/or nutrition behavior change score (observable entity),20210930,1,9E+17,9E+17
1163306002,Self reported perceived barrier to food and/or nutrition behavior score (observable entity),20210930,1,9E+17,9E+17
276361009,Waist circumference (observable entity),20210930,1,9E+17,9E+17
1172399009,Numeric rating scale score (observable entity),20210930,1,9E+17,9E+17
1167365001,Dual energy X-ray photon absorptiometry lumbar spine scan T score (observable entity),20210930,1,9E+17,9E+17
1167364002,Dual energy X-ray photon absorptiometry lumbar spine scan Z score (observable entity),20210930,1,9E+17,9E+17
1167358009,Dual energy X-ray photon absorptiometry forearm scan T score (observable entity),20210930,1,9E+17,9E+17
1167357004,Dual energy X-ray photon absorptiometry forearm scan Z score (observable entity),20210930,1,9E+17,9E+17
1167355007,Dual energy X-ray photon absorptiometry heel scan T score (observable entity),20210930,1,9E+17,9E+17
1163593000,Dual energy X-ray photon absorptiometry heel scan Z score (observable entity),20210930,1,9E+17,9E+17
1163278003,Self reported perceived control over food and/or nutrition behavior score (observable entity),20210930,1,9E+17,9E+17
1163277008,Self reported food and/or nutrition self efficacy score (observable entity),20210930,1,9E+17,9E+17
1162545001,Mid upper right arm circumference (observable entity),20210930,1,9E+17,9E+17
1162533005,Measured interdialytic weight gain (observable entity),20210930,1,9E+17,9E+17
1162534004,Measured interdialytic weight loss (observable entity),20210930,1,9E+17,9E+17
1162535003,Waist circumference at midpoint between lowest rib and iliac crest (observable entity),20210930,1,9E+17,9E+17
1162536002,Waist circumference at narrowest point (observable entity),20210930,1,9E+17,9E+17
1162540006,Mid upper left arm circumference (observable entity),20210930,1,9E+17,9E+17
1162541005,Mid upper arm circumference z score (observable entity),20210930,1,9E+17,9E+17
1162543008,Mid arm muscle circumference percentile (observable entity),20210930,1,9E+17,9E+17
1162544002,Body mass index prime ratio (observable entity),20210930,1,9E+17,9E+17
1162586008,Irradiated volume of organ at risk (observable entity),20210930,1,9E+17,9E+17
1162253005,Diameter of fetal abdomen (observable entity),20210930,1,9E+17,9E+17
1162388008,Dosing body weight (observable entity),20210930,1,9E+17,9E+17
1162389000,Self reported pre-pregnancy body weight (observable entity),20210930,1,9E+17,9E+17
1162392001,Pre-amputation measured body height (observable entity),20210930,1,9E+17,9E+17
1162421003,Pre-dialysis body weight (observable entity),20210930,1,9E+17,9E+17
1162420002,Post-dialysis body weight (observable entity),20210930,1,9E+17,9E+17
1162419008,Self reported body height (observable entity),20210930,1,9E+17,9E+17
1162417005,Pre-amputation estimated body height (observable entity),20210930,1,9E+17,9E+17
1162413009,Post-amputation estimated body weight (observable entity),20210930,1,9E+17,9E+17
1162414003,Pre-amputation estimated body weight (observable entity),20210930,1,9E+17,9E+17
1162415002,Post-amputation measured body weight (observable entity),20210930,1,9E+17,9E+17
1162416001,Pre-amputation measured body weight (observable entity),20210930,1,9E+17,9E+17
1162418000,Estimated body height (observable entity),20210930,1,9E+17,9E+17
1172965002,Method of parenteral nutrition feeding administration (observable entity),20210930,1,9E+17,9E+17
1172968000,Method of administration for tube feeding of patient (observable entity),20210930,1,9E+17,9E+17
1172963009,Body position for tube feeding of patient (observable entity),20210930,1,9E+17,9E+17
1172687009,Clothing observable (observable entity),20210930,1,9E+17,9E+17
1157134000,Qualitative distribution of primary malignant neoplasm of ampulla of Vater in ampullectomy specimen (observable entity),20211031,1,9E+17,9E+17
1157135004,Qualitative distribution of primary malignant mesothelioma in excised tissue specimen (observable entity),20211031,1,9E+17,9E+17
372439002,Presence of neoplasm at proximal surgical margin in excised tissue specimen (observable entity),20211031,1,9E+17,9E+17
372440000,Presence of neoplasm at distal surgical margin in excised tissue specimen (observable entity),20211031,1,9E+17,9E+17
1179437007,Availability of breastfeeding accommodation and facilities (observable entity),20211031,1,9E+17,9E+17
371488000,Presence of neoplasm at excised surgical margin (observable entity),20211031,1,9E+17,9E+17
1179436003,Readiness to consume increased variety of food (observable entity),20211031,1,9E+17,9E+17
1179438002,Awareness of program offering food and nutrition services (observable entity),20211031,1,9E+17,9E+17
1157133006,Qualitative distribution of primary malignant neoplasm of small intestine in resected small intestine specimen (observable entity),20211031,1,9E+17,9E+17
396469004,Presence of neoplasm at surgical margin of extrahepatic bile duct in excised specimen of extrahepatic bile duct (observable entity),20211031,1,9E+17,9E+17
396464009,Presence of neoplasm at surgical parenchymal margin in excised tissue specimen (observable entity),20211031,1,9E+17,9E+17
396324006,Surgical margin involved by neoplasm in excised tissue specimen (observable entity),20211031,1,9E+17,9E+17
1179646007,Anterior posterior diameter of fetal abdomen (observable entity),20211031,1,9E+17,9E+17
1157093005,Site of excised primary malignant neoplasm of esophagus relative to esophagogastric junction in esophageal resection specimen (observable entity),20211031,1,9E+17,9E+17
1156554004,Presence of primary malignant neoplasm of pancreas at distal surgical margin in pancreaticoduodenectomy specimen (observable entity),20211031,1,9E+17,9E+17
1157131008,Qualitative distribution of primary malignant neoplasm of liver in excised liver specimen (observable entity),20211031,1,9E+17,9E+17
1156351006,Presence of primary malignant neoplasm of appendix at mesenteric surgical margin in appendectomy specimen (observable entity),20211031,1,9E+17,9E+17
1156354003,Presence of primary malignant neoplasm of appendix at proximal surgical margin in appendectomy specimen (observable entity),20211031,1,9E+17,9E+17
1156355002,Presence of primary malignant neoplasm of appendix at radial surgical margin in appendectomy specimen (observable entity),20211031,1,9E+17,9E+17
1156357005,Presence of primary malignant neoplasm of appendix at mesenteric surgical margin in appendectomy and right colectomy specimen (observable entity),20211031,1,9E+17,9E+17
1156364007,Presence of primary malignant neoplasm of appendix at radial surgical margin in appendectomy and right colectomy specimen (observable entity),20211031,1,9E+17,9E+17
1156365008,Presence of primary malignant neoplasm of appendix at proximal surgical margin in appendectomy and right colectomy specimen (observable entity),20211031,1,9E+17,9E+17
1156371002,Presence of primary malignant neoplasm of appendix at distal surgical margin in appendectomy and right colectomy specimen (observable entity),20211031,1,9E+17,9E+17
1156374005,Presence of primary malignant neoplasm of colon at distal surgical margin in colectomy specimen (observable entity),20211031,1,9E+17,9E+17
384618006,Presence of neoplasm at circumferential surgical margin in excised tissue specimen (observable entity),20211031,1,9E+17,9E+17
1156421004,Presence of primary malignant neoplasm of appendix at surgical margin in appendectomy specimen (observable entity),20211031,1,9E+17,9E+17
384960007,Surgical margin involved by malignant neoplasm in excised tissue specimen (observable entity),20211031,1,9E+17,9E+17
1156129008,Surgical margin involved by primary malignant neoplasm of major salivary gland in excised tissue specimen (observable entity),20211031,1,9E+17,9E+17
1156130003,Surgical margin involved by primary malignant neoplasm of minor salivary gland in excised tissue specimen (observable entity),20211031,1,9E+17,9E+17
1156131004,Surgical margin involved by primary malignant neoplasm of nasal sinus in excised tissue specimen (observable entity),20211031,1,9E+17,9E+17
1156132006,Surgical margin involved by primary malignant neoplasm of nose in excised tissue specimen (observable entity),20211031,1,9E+17,9E+17
1156133001,Surgical margin involved by primary malignant neoplasm of oral soft tissue in excised tissue specimen (observable entity),20211031,1,9E+17,9E+17
1156134007,Surgical margin involved by primary malignant neoplasm of penis in excised tissue specimen (observable entity),20211031,1,9E+17,9E+17
1.03E+15,Site of excised primary malignant neoplasm of rectosigmoid colon relative to peritoneal reflection (observable entity),20211031,1,9E+17,9E+17
7.60001E+14,Presence of neoplasm at surgical margin in excised colorectal surgical specimen (observable entity),20211031,1,9E+17,9E+17
396809007,Surgical margin closest to malignant neoplasm in excised specimen (observable entity),20211031,1,9E+17,9E+17
384996006,Gleason pattern (observable entity),20211031,1,9E+17,9E+17
1156128000,Surgical margin involved by primary malignant neoplasm of ureter in ureterectomy specimen (observable entity),20211031,1,9E+17,9E+17
1156509000,Presence of primary malignant neoplasm of small intestine at distal surgical margin in small bowel resection specimen (observable entity),20211031,1,9E+17,9E+17
1156514001,Presence of primary malignant neoplasm of small intestine at distal surgical margin in pancreaticoduodenectomy specimen (observable entity),20211031,1,9E+17,9E+17
1156553005,Presence of primary malignant neoplasm of pancreas at distal surgical margin in partial pancreatectomy specimen (observable entity),20211031,1,9E+17,9E+17
1156127005,Surgical margin involved by primary malignant neoplasm of urethra in excised tissue specimen (observable entity),20211031,1,9E+17,9E+17
1156125002,Surgical margin involved by primary malignant neoplasm of kidney in excised kidney specimen (observable entity),20211031,1,9E+17,9E+17
1.09578E+15,Presence of carcinoma in situ at surgical margin in excised tissue specimen (observable entity),20211031,1,9E+17,9E+17
1.09572E+15,Presence of adenoma at surgical margin in excised tissue specimen (observable entity),20211031,1,9E+17,9E+17
1010721005,Presence of neoplasm at distal surgical margin in excised specimen of colon (observable entity),20211031,1,9E+17,9E+17
1155981004,Surgical margin involved by primary malignant neoplasm of liver in excised liver specimen (observable entity),20211031,1,9E+17,9E+17
1155982006,Surgical margin involved by primary malignant neoplasm of adrenal gland in excised adrenal gland specimen (observable entity),20211031,1,9E+17,9E+17
6.05E+15,Presence of neoplasm of skin at peripheral surgical margin in excised specimen of skin (observable entity),20211031,1,9E+17,9E+17
1.54663E+15,Presence of direct invasion by primary malignant neoplasm of prostate to nerve (observable entity),20211031,1,9E+17,9E+17
1.54639E+15,Surgical margin involved by primary malignant neoplasm of prostate in prostatectomy specimen (observable entity),20211031,1,9E+17,9E+17
405913008,Surgical margin involved by sarcoma in excised tissue specimen (observable entity),20211031,1,9E+17,9E+17
6.07E+15,Surgical margin closest to carcinoma in excised specimen of colon (observable entity),20211031,1,9E+17,9E+17
1156126001,Surgical margin involved by primary malignant neoplasm of renal pelvis in nephroureterectomy specimen (observable entity),20211031,1,9E+17,9E+17
1155983001,Surgical margin involved by primary malignant neoplasm of appendix in appendectomy specimen (observable entity),20211031,1,9E+17,9E+17
1155985008,Surgical margin involved by primary malignant neoplasm of colon in colectomy specimen (observable entity),20211031,1,9E+17,9E+17
1156085002,Surgical margin involved by primary malignant neoplasm of cervix uteri in hysterectomy specimen (observable entity),20211031,1,9E+17,9E+17
1156086001,Surgical margin involved by primary malignant neoplasm of uterus in hysterectomy specimen (observable entity),20211031,1,9E+17,9E+17
1156087005,Surgical margin involved by primary malignant neoplasm of endometrium in hysterectomy specimen (observable entity),20211031,1,9E+17,9E+17
1156088000,Surgical margin involved by primary malignant neoplasm of vagina in vaginectomy specimen (observable entity),20211031,1,9E+17,9E+17
1156089008,Surgical margin involved by primary malignant neoplasm of vulva in excised tissue specimen (observable entity),20211031,1,9E+17,9E+17
1156109007,Surgical margin involved by primary malignant neoplasm of distal hepatic bile duct in segmental resection of bile ducts specimen (observable entity),20211031,1,9E+17,9E+17
1156110002,Surgical margin involved by primary malignant neoplasm of extrahepatic bile duct in pancreaticoduodenectomy specimen (observable entity),20211031,1,9E+17,9E+17
1156112005,Surgical margin involved by primary malignant neoplasm of gall bladder in cholecystectomy specimen (observable entity),20211031,1,9E+17,9E+17
1156113000,Surgical margin involved by primary malignant neoplasm of intrahepatic bile duct in excised liver specimen (observable entity),20211031,1,9E+17,9E+17
1156114006,Surgical margin involved by primary malignant neoplasm of extrahepatic bile duct in segmental resection of bile duct specimen (observable entity),20211031,1,9E+17,9E+17
1156115007,Surgical margin involved by primary malignant neoplasm of extrahepatic bile duct in excised liver specimen (observable entity),20211031,1,9E+17,9E+17
1156116008,Surgical margin involved by primary malignant neoplasm of esophagus in esophageal resection specimen (observable entity),20211031,1,9E+17,9E+17
1156118009,Surgical margin involved by primary malignant neoplasm of colon in transanal disk excision specimen (observable entity),20211031,1,9E+17,9E+17
1156119001,Surgical margin involved by primary malignant neoplasm of anus in anal resection specimen (observable entity),20211031,1,9E+17,9E+17
1156120007,Surgical margin involved by primary malignant neoplasm of larynx in laryngectomy specimen (observable entity),20211031,1,9E+17,9E+17
1156121006,Surgical margin involved by primary malignant neoplasm of testis in orchidectomy specimen (observable entity),20211031,1,9E+17,9E+17
1156122004,Surgical margin involved by primary malignant neoplasm of lung in resected lung specimen (observable entity),20211031,1,9E+17,9E+17
1156123009,Surgical margin involved by primary malignant neoplasm of urinary bladder in excised tissue specimen (observable entity),20211031,1,9E+17,9E+17
1156124003,Surgical margin involved by primary malignant neoplasm of eye in excised tissue specimen (observable entity),20211031,1,9E+17,9E+17
1156083009,Surgical margin involved by primary malignant neoplasm of thyroid in thyroidectomy specimen (observable entity),20211031,1,9E+17,9E+17
1155984007,Surgical margin involved by primary malignant neoplasm of appendix in appendectomy and right colectomy specimen (observable entity),20211031,1,9E+17,9E+17
1156082004,Surgical margin involved by primary malignant neoplasm of pancreas in excisional biopsy specimen (observable entity),20211031,1,9E+17,9E+17
1156080007,Surgical margin involved by primary malignant neoplasm of pancreas in resection of body of pancreas (observable entity),20211031,1,9E+17,9E+17
1155986009,Surgical margin involved by primary malignant neoplasm of stomach in gastrectomy specimen (observable entity),20211031,1,9E+17,9E+17
1155987000,Surgical margin involved by primary malignant neoplasm of small intestine in pancreaticoduodenectomy specimen (observable entity),20211031,1,9E+17,9E+17
1155988005,Surgical margin involved by primary malignant neoplasm of small intestine in small bowel resection specimen (observable entity),20211031,1,9E+17,9E+17
1156076002,Surgical margin involved by primary malignant neoplasm of ampulla of Vater in ampullectomy specimen (observable entity),20211031,1,9E+17,9E+17
1156077006,Surgical margin involved by primary malignant neoplasm of ampulla of Vater in pancreaticoduodenectomy specimen (observable entity),20211031,1,9E+17,9E+17
1156078001,Surgical margin involved by primary malignant neoplasm of small intestine in ileal resection specimen (observable entity),20211031,1,9E+17,9E+17
1156079009,Surgical margin involved by primary malignant neoplasm of pancreas in pancreaticoduodenectomy specimen (observable entity),20211031,1,9E+17,9E+17
1156081006,Surgical margin involved by primary malignant neoplasm of pancreas in resection of tail of pancreas (observable entity),20211031,1,9E+17,9E+17
1156560004,Presence of primary malignant neoplasm of stomach at distal surgical margin in gastrectomy specimen (observable entity),20211031,1,9E+17,9E+17
1184597001,Transverse diameter of fetal abdomen (observable entity),20211031,1,9E+17,9E+17
396631001,Surgical margin observable (observable entity),20211031,1,9E+17,9E+17
1157111009,Qualitative distribution of primary malignant neoplasm of lung in resected lung specimen (observable entity),20211031,1,9E+17,9E+17
1157115000,Qualitative distribution of primary malignant neoplasm of kidney in excised kidney specimen (observable entity),20211031,1,9E+17,9E+17
1157117008,Qualitative distribution of primary malignant neoplasm of testis in orchidectomy specimen (observable entity),20211031,1,9E+17,9E+17
1157119006,Qualitative distribution of primary malignant neoplasm of penis in excised tissue specimen (observable entity),20211031,1,9E+17,9E+17
1157123003,Qualitative distribution of primary malignant neoplasm of pharynx in excised tissue specimen (observable entity),20211031,1,9E+17,9E+17
1157124009,Qualitative distribution of primary malignant neoplasm of nose in excised tissue specimen (observable entity),20211031,1,9E+17,9E+17
1157125005,Qualitative distribution of primary malignant neoplasm of major salivary gland in excised tissue specimen (observable entity),20211031,1,9E+17,9E+17
1157126006,Qualitative distribution of primary malignant neoplasm of oral cavity in excised tissue specimen (observable entity),20211031,1,9E+17,9E+17
1157127002,Qualitative distribution of primary malignant neoplasm of larynx in excised tissue specimen (observable entity),20211031,1,9E+17,9E+17
1157128007,Qualitative distribution of primary malignant neoplasm of breast in excised breast specimen (observable entity),20211031,1,9E+17,9E+17
1157129004,Qualitative distribution of primary malignant neoplasm of stomach in gastrectomy specimen (observable entity),20211031,1,9E+17,9E+17
1157130009,Qualitative distribution of primary malignant neoplasm of thyroid in thyroidectomy specimen (observable entity),20211031,1,9E+17,9E+17
1156612009,Presence of primary malignant neoplasm of anus at distal surgical margin in anal resection specimen (observable entity),20211031,1,9E+17,9E+17
1156613004,Presence of primary malignant neoplasm of anus at circumferential surgical margin in anal resection specimen (observable entity),20211031,1,9E+17,9E+17
1156616007,Presence of primary malignant neoplasm of esophagus at distal surgical margin in esophageal resection specimen (observable entity),20211031,1,9E+17,9E+17
1156625001,Presence of neoplasm at surgical margin in appendectomy specimen (observable entity),20211031,1,9E+17,9E+17
1156626000,Presence of neoplasm at distal surgical margin in appendectomy specimen (observable entity),20211031,1,9E+17,9E+17
1156627009,Presence of primary malignant neoplasm of appendix at distal surgical margin in appendectomy specimen (observable entity),20211031,1,9E+17,9E+17
1156632005,Presence of neoplasm of colon at surgical margin in transanal disk excision specimen (observable entity),20211031,1,9E+17,9E+17
1156633000,Presence of neoplasm of colon at mucosal surgical margin in transanal disk excision specimen (observable entity),20211031,1,9E+17,9E+17
1156577004,Presence of primary malignant neoplasm of ampulla of Vater at distal surgical margin in pancreaticoduodenectomy specimen (observable entity),20211031,1,9E+17,9E+17
1156578009,Presence of primary malignant neoplasm of extrahepatic bile duct at distal surgical margin in segmental resection of bile duct specimen (observable entity),20211031,1,9E+17,9E+17
1156579001,Presence of primary malignant neoplasm of extrahepatic bile duct at distal surgical margin in pancreaticoduodenectomy specimen (observable entity),20211031,1,9E+17,9E+17
396691004,Surgical margin involved by carcinoma in situ in excised tissue specimen (observable entity),20211031,1,9E+17,9E+17
399663008,Surgical margin closest to ductal carcinoma in situ in excised breast specimen (observable entity),20211031,1,9E+17,9E+17
399531007,Surgical margin involved by malignant mesothelioma in excised tissue specimen (observable entity),20211031,1,9E+17,9E+17
399377002,Surgical margin involved by ductal carcinoma in situ in excised breast specimen (observable entity),20211031,1,9E+17,9E+17
1157132001,Qualitative distribution of primary malignant neoplasm of intrahepatic bile duct in excised liver specimen (observable entity),20211031,1,9E+17,9E+17
396776008,Presence of primary malignant neoplasm of prostate at surgical margin of spermatic cord in excised specimen of prostate (observable entity),20211031,1,9E+17,9E+17
1179210008,Ability to build and utilize social network (observable entity),20211031,1,9E+17,9E+17
1179181005,Characteristic of perception (observable entity),20211031,1,9E+17,9E+17
422616000,Presence of neoplasm at proximal surgical margin in appendectomy specimen (observable entity),20211031,1,9E+17,9E+17
1178982008,Presence of direct invasion by primary malignant neoplasm of prostate to lymphatic vessel and/or small blood vessel (observable entity),20211031,1,9E+17,9E+17
1163261007,Qualitative distribution of primary malignant neoplasm (observable entity),20211031,1,9E+17,9E+17
1179033001,Presence of surfactant in fetal lung measured in amniotic fluid using bubble stability technique (observable entity),20211031,1,9E+17,9E+17
423105004,Presence of neoplasm at proximal surgical margin of colectomy specimen (observable entity),20211031,1,9E+17,9E+17
424082007,Radial location of melanoma in situ in peripheral surgical margin of excised skin specimen (observable entity),20211031,1,9E+17,9E+17
1179269001,Histologic grade of primary malignant neoplasm of small intestine (observable entity),20211031,1,9E+17,9E+17
396199003,Neoplasm focality (observable entity),20211031,1,9E+17,9E+17
422973004,Radial location of malignant melanoma in peripheral surgical margin of excised specimen of skin (observable entity),20211031,1,9E+17,9E+17
1.70001E+14,Surgical margin closest to malignant neoplasm in excised specimen of breast (observable entity),20211031,1,9E+17,9E+17
1186606009,Patient request observable (observable entity),20211130,1,9E+17,9E+17
1187057000,Substance use behavior (observable entity),20211130,1,9E+17,9E+17
1.13811E+14,Pediatric early warning score (observable entity),20211130,1,9E+17,9E+17
1187491009,Sequential Organ Failure Assessment score (observable entity),20220131,1,9E+17,9E+17
1193838006,Legal guardian status (observable entity),20220131,1,9E+17,9E+17
1193609005,Time specimen collected from subject (observable entity),20220131,1,9E+17,9E+17
3.98E+15,Radial location of primary malignant neoplasm in excised breast specimen (observable entity),20220228,1,9E+17,9E+17
1197367003,Language preference for written health-related material (observable entity),20220228,1,9E+17,9E+17
1201788001,Volume fraction of nitric oxide in exhaled air (observable entity),20220228,1,9E+17,9E+17
1202026006,Number of exercise repetitions completed (observable entity),20220228,1,9E+17,9E+17
1201746005,Internal gross tumor volume (observable entity),20220228,1,9E+17,9E+17
1201745009,Internal target volume (observable entity),20220228,1,9E+17,9E+17
7.88481E+14,Presence of macroscopic perforation of colon by primary malignant neoplasm of colon (observable entity),20220228,1,9E+17,9E+17
1197010003,Rate of speech (observable entity),20220228,1,9E+17,9E+17
736785003,Partial pressure of carbon dioxide in umbilical cord venous blood (observable entity),20220331,1,9E+17,9E+17
736730002,Partial pressure of carbon dioxide in umbilical cord arterial blood (observable entity),20220331,1,9E+17,9E+17
1193634005,Born in Cabo Verde (finding),20220331,1,9E+17,9E+17
1217333002,Integrity of mucous membrane (observable entity),20220430,1,9E+17,9E+17
1217331000,Integrity of oral mucous membrane (observable entity),20220430,1,9E+17,9E+17
1208522006,Type of supervision for specimen collection (observable entity),20220430,1,9E+17,9E+17
3.4051E+13,Citizenship status (observable entity),20220430,1,9E+17,9E+17
3.3821E+13,Gender identity (observable entity),20220531,1,9E+17,9E+17
1222698008,Target body mass index (observable entity),20220531,1,9E+17,9E+17
1222611003,Base of gait (observable entity),20220531,1,9E+17,9E+17
1222610002,Angle of gait (observable entity),20220531,1,9E+17,9E+17
1220613005,Perceived proximity to green space (observable entity),20220531,1,9E+17,9E+17
1220612000,Access to physical activity facility (observable entity),20220531,1,9E+17,9E+17
1220611007,Perceived safety of neighborhood (observable entity),20220531,1,9E+17,9E+17
1220610008,Perceived walkability of neighborhood (observable entity),20220531,1,9E+17,9E+17
1231384003,Knowledge level of complementary therapy (observable entity),20220630,1,9E+17,9E+17
1230348002,World Health Organization performance status score (observable entity),20220630,1,9E+17,9E+17
1230136007,Method for determining body fat percentage (observable entity),20220630,1,9E+17,9E+17
1230278008,Self reported peak adult body height (observable entity),20220731,1,9E+17,9E+17
1230277003,Self reported peak body weight (observable entity),20220731,1,9E+17,9E+17
233568002,Intraoperative blood salvage (procedure),20020131,1,9E+17,9E+17
233555005,Random blood donation (procedure),20020131,1,9E+17,9E+17
121241001,Malaria thin smear (procedure),20020131,1,9E+17,9E+17
121257001,Platelet mean diameter determination (procedure),20020131,1,9E+17,9E+17
121240000,Malaria thick smear (procedure),20020131,1,9E+17,9E+17
121097007,Tilt tube reptilase induced coagulation method (procedure),20020131,1,9E+17,9E+17
121100002,"Reticulocyte count, hematocrit adjusted (procedure)",20020131,1,9E+17,9E+17
122436009,Thrombin-antithrombin III complex assay (procedure),20020131,1,9E+17,9E+17
122437000,Kaolin-induced partial thromboplastin time (procedure),20020131,1,9E+17,9E+17
122438005,Cervical mucus analysis (procedure),20020131,1,9E+17,9E+17
127791007,Laboratory test related to hemostasis (procedure),20020131,1,9E+17,9E+17
127793005,Alpha-2 antiplasmin functional assay (procedure),20020131,1,9E+17,9E+17
116147009,Cytologic test (procedure),20020131,1,9E+17,9E+17
115609009,Percentage measurement of cell type to blood cells (procedure),20020131,1,9E+17,9E+17
113035006,Thromboplastin generation test (procedure),20020131,1,9E+17,9E+17
113036007,Blood group typing O (procedure),20020131,1,9E+17,9E+17
113039000,Osmotic fragility (procedure),20020131,1,9E+17,9E+17
113040003,T cell depletion of bone marrow for transplantation (procedure),20020131,1,9E+17,9E+17
120648008,"Hemolysin detection, warm (procedure)",20020131,1,9E+17,9E+17
120647003,"Hemolysin detection, cold (procedure)",20020131,1,9E+17,9E+17
116786000,Leukocyte count corrected for nucleated erythrocytes (procedure),20020131,1,9E+17,9E+17
116836000,Prekallikrein screen (procedure),20020131,1,9E+17,9E+17
117039004,Alkaline denaturation method for fetal hemoglobin determination (procedure),20020131,1,9E+17,9E+17
117022001,MacNeal's tetrachrome blood stain method (procedure),20020131,1,9E+17,9E+17
116708001,Polymorphonuclear leukocyte count (procedure),20020131,1,9E+17,9E+17
116709009,Bone marrow myeloid-erythroid ratio determination (procedure),20020131,1,9E+17,9E+17
116710004,Mononuclear cell count (procedure),20020131,1,9E+17,9E+17
116713002,"Cell count, semen (procedure)",20020131,1,9E+17,9E+17
117722009,Measurement of circulating antiplatelet antibody (procedure),20020131,1,9E+17,9E+17
117726007,Evaluation of spermatozoa morphology (procedure),20020131,1,9E+17,9E+17
117611001,Semen liquefaction time measurement (procedure),20020131,1,9E+17,9E+17
117612008,Sputum smear examination (procedure),20020131,1,9E+17,9E+17
118131001,Examination of specimen for hemolysis (procedure),20020131,1,9E+17,9E+17
118133003,Spermatozoa morphology differential count (procedure),20020131,1,9E+17,9E+17
118134009,TdT positive blast count (procedure),20020131,1,9E+17,9E+17
117355001,"Blood cell count, manual (procedure)",20020131,1,9E+17,9E+17
117303002,Holzer stain method (procedure),20020131,1,9E+17,9E+17
117306005,Lawson-Van Gieson stain method (procedure),20020131,1,9E+17,9E+17
117309003,Mallory Heidenhain stain method (procedure),20020131,1,9E+17,9E+17
117317006,Mayer mucicarmine stain method (procedure),20020131,1,9E+17,9E+17
117322006,Movat pentachrome stain method (procedure),20020131,1,9E+17,9E+17
117327000,Reticulin stain method (procedure),20020131,1,9E+17,9E+17
117330007,Schmorl stain method (procedure),20020131,1,9E+17,9E+17
117331006,Sevier-Munger stain method (procedure),20020131,1,9E+17,9E+17
117249008,"Platelet count, Rees-Ecker method (procedure)",20020131,1,9E+17,9E+17
117171008,Peripheral blood buffy coat smear interpretation (procedure),20020131,1,9E+17,9E+17
117356000,"Blood cell count, automated (procedure)",20020131,1,9E+17,9E+17
117232001,Fontana Masson silver stain method (procedure),20020131,1,9E+17,9E+17
117243009,Phosphotungstic acid-hematoxylin stain method (procedure),20020131,1,9E+17,9E+17
117246001,"Osmotic fragility test, red blood cell dilution method (procedure)",20020131,1,9E+17,9E+17
117218003,Mallory bleach stain method (procedure),20020131,1,9E+17,9E+17
117221001,Butyrate esterase stain method (procedure),20020131,1,9E+17,9E+17
117361003,Indirect mixed antiglobulin reaction test (procedure),20020131,1,9E+17,9E+17
171245007,Urine screening (procedure),20020131,1,9E+17,9E+17
182795002,Fibrinogen degradation product screening (procedure),20020131,1,9E+17,9E+17
168115006,Amniotic fetal cell study (procedure),20020131,1,9E+17,9E+17
168445004,Cell chromosome examination (procedure),20020131,1,9E+17,9E+17
168440009,Cytology examination - general (procedure),20020131,1,9E+17,9E+17
167335004,Urine microscopy for casts (procedure),20020131,1,9E+17,9E+17
167907006,Bone marrow examination (procedure),20020131,1,9E+17,9E+17
167849002,Vomit occult blood (procedure),20020131,1,9E+17,9E+17
167759007,Semen examination - general (procedure),20020131,1,9E+17,9E+17
167804000,Sperm total count procedure (procedure),20020131,1,9E+17,9E+17
167805004,Total count of normal and motile sperm (procedure),20020131,1,9E+17,9E+17
167806003,Total count of motile sperm (procedure),20020131,1,9E+17,9E+17
167813003,Determination of density of morphologically normal and motile sperm (procedure),20020131,1,9E+17,9E+17
167814009,Measurement of density of motile sperm (procedure),20020131,1,9E+17,9E+17
167815005,Tray agglutination test (procedure),20020131,1,9E+17,9E+17
167791008,Measurement of percentage of normal sperm (procedure),20020131,1,9E+17,9E+17
167770000,Semen volume measurement (procedure),20020131,1,9E+17,9E+17
167782009,Sperm concentration measurement (procedure),20020131,1,9E+17,9E+17
165875002,Lupus circulating anticoagulant index measurement (procedure),20020131,1,9E+17,9E+17
165599007,Kaolin cephalin clotting time procedure (procedure),20020131,1,9E+17,9E+17
165600005,Dilute Russell viper venom ratio measurement (procedure),20020131,1,9E+17,9E+17
165602002,Protein C function estimate (procedure),20020131,1,9E+17,9E+17
165603007,Protein S function estimate (procedure),20020131,1,9E+17,9E+17
165604001,Plasma activated protein C resistance (procedure),20020131,1,9E+17,9E+17
165605000,Plasma protein C antigen level (procedure),20020131,1,9E+17,9E+17
165670009,Red cell hemoglobin A2 estimation test (procedure),20020131,1,9E+17,9E+17
165696006,Red cell volume measurement (procedure),20020131,1,9E+17,9E+17
165705008,Plasma intrinsic inhibitor screening test (procedure),20020131,1,9E+17,9E+17
165706009,Plasma extrinsic inhibitor screening test (procedure),20020131,1,9E+17,9E+17
165586009,Plasma free protein S measurement (procedure),20020131,1,9E+17,9E+17
165498002,Red blood cell enzyme test (procedure),20020131,1,9E+17,9E+17
165511009,Differential white blood cell count procedure (procedure),20020131,1,9E+17,9E+17
165549008,Promyelocyte count procedure (procedure),20020131,1,9E+17,9E+17
165550008,Myelocyte count procedure (procedure),20020131,1,9E+17,9E+17
165551007,Metamyelocyte count procedure (procedure),20020131,1,9E+17,9E+17
165552000,Myeloblast count procedure (procedure),20020131,1,9E+17,9E+17
165566005,Whole blood clotting time procedure (procedure),20020131,1,9E+17,9E+17
165584007,Plasma total protein S measurement (procedure),20020131,1,9E+17,9E+17
165745004,Rhesus blood grouping (procedure),20020131,1,9E+17,9E+17
165750005,"Blood group typing, minor blood group (procedure)",20020131,1,9E+17,9E+17
165752002,Kidd blood group (procedure),20020131,1,9E+17,9E+17
165753007,Kell blood group (procedure),20020131,1,9E+17,9E+17
165754001,Lewis blood group (procedure),20020131,1,9E+17,9E+17
165756004,Lutheran blood group typing (procedure),20020131,1,9E+17,9E+17
165767003,Rhesus antibody titer measurement (procedure),20020131,1,9E+17,9E+17
165771000,Coombs test - anti-human globulin (procedure),20020131,1,9E+17,9E+17
363783003,Rh blood group typing (procedure),20020131,1,9E+17,9E+17
359828005,"Cytopathology, review of slides and report, fluids, washings or brushings, by physician (procedure)",20020131,1,9E+17,9E+17
359825008,"Cytopathology, review of bronchioalveolar lavage specimen (procedure)",20020131,1,9E+17,9E+17
359849006,Thyroxine/thyroxine binding globulin ratio (procedure),20020131,1,9E+17,9E+17
310540006,Eosinophil percent differential count (procedure),20020131,1,9E+17,9E+17
312404004,Antenatal blood tests (procedure),20020131,1,9E+17,9E+17
312461009,Heterozygous SS genotype determination (procedure),20020131,1,9E+17,9E+17
312460005,Homozygous SS genotype determination (procedure),20020131,1,9E+17,9E+17
312459000,Hemoglobin S genotype determination (procedure),20020131,1,9E+17,9E+17
315188003,Saturation of iron binding capacity (procedure),20020131,1,9E+17,9E+17
300590001,Red blood cell enzyme activity measurement (procedure),20020131,1,9E+17,9E+17
313233005,Red cell hemoglobin S estimation (procedure),20020131,1,9E+17,9E+17
313597007,Factor VIII von Willebrand factor ratio measurement (procedure),20020131,1,9E+17,9E+17
313596003,Factor IX related antigen measurement (procedure),20020131,1,9E+17,9E+17
302792004,Sperm count (procedure),20020131,1,9E+17,9E+17
302763003,Hemoglobin variant test (procedure),20020131,1,9E+17,9E+17
313478005,Promyelocyte percent differential count (procedure),20020131,1,9E+17,9E+17
313995005,Hemoglobin A measurement (procedure),20020131,1,9E+17,9E+17
314072006,Hematology screening test (procedure),20020131,1,9E+17,9E+17
314090007,Sickle cell disease screening test (procedure),20020131,1,9E+17,9E+17
314089003,Thrombophilia screening test (procedure),20020131,1,9E+17,9E+17
314088006,Clotting screening test (procedure),20020131,1,9E+17,9E+17
313696009,Myelocyte percent differential count (procedure),20020131,1,9E+17,9E+17
302560003,Determination of percentage differential white blood cells (procedure),20020131,1,9E+17,9E+17
313639004,Reticulocyte percent count (procedure),20020131,1,9E+17,9E+17
252052002,Evaluation of sperm viability (procedure),20020131,1,9E+17,9E+17
252054001,Sperm agglutination (procedure),20020131,1,9E+17,9E+17
252055000,Sperm immature germ cell count (procedure),20020131,1,9E+17,9E+17
252056004,Examination of sperm migration (swimup) (procedure),20020131,1,9E+17,9E+17
252057008,Semen measurement (procedure),20020131,1,9E+17,9E+17
252051009,Sperm examination - number of other cells (procedure),20020131,1,9E+17,9E+17
252048002,Determination of motile sperm percentage (procedure),20020131,1,9E+17,9E+17
252047007,Sperm measurement (procedure),20020131,1,9E+17,9E+17
252286002,Factor VIIIc inhibitor screening (procedure),20020131,1,9E+17,9E+17
252294009,Red blood cell test (procedure),20020131,1,9E+17,9E+17
252299004,Pyruvate kinase deficiency spot test (procedure),20020131,1,9E+17,9E+17
252300007,Schumm's test (procedure),20020131,1,9E+17,9E+17
252301006,Urinary hemosiderin detection (procedure),20020131,1,9E+17,9E+17
252302004,Acidified glycerol lysis test (procedure),20020131,1,9E+17,9E+17
252303009,Direct antiglobulin test using drug-sensitized red cells (procedure),20020131,1,9E+17,9E+17
252304003,Indirect antiglobulin test using drug-sensitized cells (procedure),20020131,1,9E+17,9E+17
252305002,White blood cell test (procedure),20020131,1,9E+17,9E+17
252306001,White blood cell cytochemistry (procedure),20020131,1,9E+17,9E+17
252281007,Extrinsic coagulation pathway screening (procedure),20020131,1,9E+17,9E+17
252279005,Correction study (procedure),20020131,1,9E+17,9E+17
252275004,Hematology test (procedure),20020131,1,9E+17,9E+17
252276003,Blood cell analysis (procedure),20020131,1,9E+17,9E+17
252278002,Coagulation pathway screening (procedure),20020131,1,9E+17,9E+17
252280008,Intrinsic coagulation pathway screening (procedure),20020131,1,9E+17,9E+17
252307005,White blood cell immunology (procedure),20020131,1,9E+17,9E+17
252309008,Lymphocyte surface immunoglobulin identification (procedure),20020131,1,9E+17,9E+17
252308000,Lymphocyte cytoplasmic immunoglobulin identification (procedure),20020131,1,9E+17,9E+17
252310003,White blood cell membrane marker identification (procedure),20020131,1,9E+17,9E+17
252311004,Non-cytochemical white blood cell test (procedure),20020131,1,9E+17,9E+17
252312006,Horse erythrocyte antigen test (procedure),20020131,1,9E+17,9E+17
252313001,White blood cell cytogenetic investigation (procedure),20020131,1,9E+17,9E+17
252314007,Blood transfusion test (procedure),20020131,1,9E+17,9E+17
252315008,Blood group antibody screening (procedure),20020131,1,9E+17,9E+17
252316009,Group and save (procedure),20020131,1,9E+17,9E+17
252317000,Antibody quantitation (procedure),20020131,1,9E+17,9E+17
251656001,Postcoital cervical mucus sperm count procedure (procedure),20020131,1,9E+17,9E+17
252928006,Sperm examination (procedure),20020131,1,9E+17,9E+17
252929003,Sperm microscopy (procedure),20020131,1,9E+17,9E+17
252930008,Sperm immobilization test (procedure),20020131,1,9E+17,9E+17
252416005,Histopathology test (procedure),20020131,1,9E+17,9E+17
250402006,Blood group antibody titer measurement (procedure),20020131,1,9E+17,9E+17
250403001,Blood group antibody concentration measurement (procedure),20020131,1,9E+17,9E+17
250404007,Blood compatibility test (procedure),20020131,1,9E+17,9E+17
250407000,Determination of anti-D suitability (procedure),20020131,1,9E+17,9E+17
250501001,Evaluation of semen fertility (procedure),20020131,1,9E+17,9E+17
250502008,Examination of semen constituents (procedure),20020131,1,9E+17,9E+17
250379004,Rh system antigen type determination (procedure),20020131,1,9E+17,9E+17
250257006,Modified red blood cell osmotic fragility test (procedure),20020131,1,9E+17,9E+17
250260004,Evaluation of rate of hemolysis (procedure),20020131,1,9E+17,9E+17
250261000,Determination of amount of hemolysis (procedure),20020131,1,9E+17,9E+17
250273000,Evaluation of white blood cell age (procedure),20020131,1,9E+17,9E+17
250221001,Detection of hemoglobin (procedure),20020131,1,9E+17,9E+17
250222008,Globin chain ratio measurement (procedure),20020131,1,9E+17,9E+17
250231008,Packed cell volume measurement (procedure),20020131,1,9E+17,9E+17
250330007,Intrinsic coagulation pathway factor measurement (procedure),20020131,1,9E+17,9E+17
250337005,Contact factor measurement (procedure),20020131,1,9E+17,9E+17
250340005,Extrinsic coagulation pathway factor measurement (procedure),20020131,1,9E+17,9E+17
250360002,Anticoagulant control test (procedure),20020131,1,9E+17,9E+17
250361003,Heparin control test (procedure),20020131,1,9E+17,9E+17
250363000,Anti factor Xa measurement (procedure),20020131,1,9E+17,9E+17
250366008,Warfarin control test (procedure),20020131,1,9E+17,9E+17
250367004,British corrected ratio measurement (procedure),20020131,1,9E+17,9E+17
250368009,Thrombotest (procedure),20020131,1,9E+17,9E+17
250369001,Blood coagulation pathway antibody activity measurement (procedure),20020131,1,9E+17,9E+17
250370000,Lupus antibody activity measurement (procedure),20020131,1,9E+17,9E+17
250372008,Factor VIIIc inhibitor activity measurement (procedure),20020131,1,9E+17,9E+17
250378007,ABO antigen type determination (procedure),20020131,1,9E+17,9E+17
250326009,Platelet aggregation ratio measurement (procedure),20020131,1,9E+17,9E+17
250320003,Platelet release reaction test (procedure),20020131,1,9E+17,9E+17
250298004,Reversed neutrophil/lymphocyte ratio measurement (procedure),20020131,1,9E+17,9E+17
250300004,White blood cell enzyme activity measurement (procedure),20020131,1,9E+17,9E+17
250305009,White blood cell membrane antigen determination (procedure),20020131,1,9E+17,9E+17
250307001,White blood cell cytochemical reaction determination (procedure),20020131,1,9E+17,9E+17
250308006,Immunoglobulin chain concentration measurement (procedure),20020131,1,9E+17,9E+17
250313005,Platelet distribution width measurement (procedure),20020131,1,9E+17,9E+17
250314004,Platelet hematocrit measurement (procedure),20020131,1,9E+17,9E+17
250318001,Evaluation of platelet metabolism (procedure),20020131,1,9E+17,9E+17
250208008,Blood hematinic activity measurement (procedure),20020131,1,9E+17,9E+17
275304009,Ferning - cervical test (procedure),20020131,1,9E+17,9E+17
278035005,Contact factor screening test (procedure),20020131,1,9E+17,9E+17
277453009,Intrinsic coagulation factor assay (procedure),20020131,1,9E+17,9E+17
277755001,Anti-sperm antibody test (procedure),20020131,1,9E+17,9E+17
271339000,Galactose-1-phosphate uridyl transferase test (procedure),20020131,1,9E+17,9E+17
271357004,Evaluation of bone marrow myeloid cells (procedure),20020131,1,9E+17,9E+17
271358009,Evaluation of bone marrow: foreign cells (procedure),20020131,1,9E+17,9E+17
271359001,Evaluation of bone marrow megakaryocytes (procedure),20020131,1,9E+17,9E+17
271276000,Semen pH measurement (procedure),20020131,1,9E+17,9E+17
271041005,Smear cell percent differential count (procedure),20020131,1,9E+17,9E+17
271026005,Hemoglobin level estimation (procedure),20020131,1,9E+17,9E+17
271033005,Plasma volume measurement (procedure),20020131,1,9E+17,9E+17
271035003,Neutrophil percent differential count (procedure),20020131,1,9E+17,9E+17
271036002,Lymphocyte percent differential count (procedure),20020131,1,9E+17,9E+17
271037006,Monocyte percent differential count (procedure),20020131,1,9E+17,9E+17
271038001,Basophil percent differential count (procedure),20020131,1,9E+17,9E+17
271039009,Metamyelocyte percent differential count (procedure),20020131,1,9E+17,9E+17
271040006,Blast cell percent differential count (procedure),20020131,1,9E+17,9E+17
271215008,Plasma free/total protein S ratio measurement (procedure),20020131,1,9E+17,9E+17
269820002,Serum iron tests (procedure),20020131,1,9E+17,9E+17
269822005,Hemoglobin A2 measurement (procedure),20020131,1,9E+17,9E+17
269826008,ABO blood grouping (procedure),20020131,1,9E+17,9E+17
269831005,Infectious mononucleosis test (procedure),20020131,1,9E+17,9E+17
269819008,Factor VIII assay (procedure),20020131,1,9E+17,9E+17
269907001,Sperm count - number/cc (procedure),20020131,1,9E+17,9E+17
269910008,Evaluation of bone marrow erythropoiesis (procedure),20020131,1,9E+17,9E+17
270922003,Unclassified cells (procedure),20020131,1,9E+17,9E+17
270925001,Percentage cell count (procedure),20020131,1,9E+17,9E+17
270029009,Determination of total normal and motile sperm (procedure),20020131,1,9E+17,9E+17
43292009,"Compatibility test, crossmatch, complete standard technique, includes typing and antibody screening of red blood cells (procedure)",20020131,1,9E+17,9E+17
43782000,Organ or system related test (procedure),20020131,1,9E+17,9E+17
43600003,Tubeless gastric analysis and measurement (procedure),20020131,1,9E+17,9E+17
42862001,Sperm evaluation by hamster penetration test (procedure),20020131,1,9E+17,9E+17
43222004,Test kit method (procedure),20020131,1,9E+17,9E+17
43789009,Complete blood count without differential (procedure),20020131,1,9E+17,9E+17
44608003,Blood group typing (procedure),20020131,1,9E+17,9E+17
44190001,White blood cell morphology (procedure),20020131,1,9E+17,9E+17
41206009,"Antibody elution, alcohol (procedure)",20020131,1,9E+17,9E+17
41487004,"Fibrin split products, protamine sulfate assay (procedure)",20020131,1,9E+17,9E+17
41068000,"Fibrin split products, hemagglutination inhibition microtiter assay (procedure)",20020131,1,9E+17,9E+17
42396003,White blood cell estimate (procedure),20020131,1,9E+17,9E+17
42313005,Plasma recalcification time (procedure),20020131,1,9E+17,9E+17
42307001,"Antibody elution, heat (procedure)",20020131,1,9E+17,9E+17
42525009,"Partial thromboplastin time, activated (procedure)",20020131,1,9E+17,9E+17
41874004,Paracoagulation test (procedure),20020131,1,9E+17,9E+17
41902000,Major crossmatch (procedure),20020131,1,9E+17,9E+17
41824001,Qualitative measurement of urobilin in urine (procedure),20020131,1,9E+17,9E+17
41833004,Activated protein C resistance assay (procedure),20020131,1,9E+17,9E+17
42106004,Capillary fragility test (procedure),20020131,1,9E+17,9E+17
47412009,Preparation of packed red blood cells (procedure),20020131,1,9E+17,9E+17
47815000,Lymphocyte storage (procedure),20020131,1,9E+17,9E+17
47615003,"Urinalysis, acetone or ketone bodies measurement (procedure)",20020131,1,9E+17,9E+17
47043008,"Osmotic fragility, incubated (procedure)",20020131,1,9E+17,9E+17
48716005,"Lymphocyte storage, liquid nitrogen (procedure)",20020131,1,9E+17,9E+17
48627002,"Protein C, assay (procedure)",20020131,1,9E+17,9E+17
48684007,Pharmacokinetic study (procedure),20020131,1,9E+17,9E+17
48157005,"Compatibility test, crossmatch, screening for compatible unit, antiglobulin technique (procedure)",20020131,1,9E+17,9E+17
45400006,"Reagent red blood cell, freeze, liquid nitrogen (procedure)",20020131,1,9E+17,9E+17
45745006,"Alkaline phosphatase stain method, blood or bone marrow (procedure)",20020131,1,9E+17,9E+17
45295008,Urine dilution test (procedure),20020131,1,9E+17,9E+17
46035008,"Special hematology procedure, explain by report (procedure)",20020131,1,9E+17,9E+17
35382002,Frozen blood thawing and processing (procedure),20020131,1,9E+17,9E+17
35435005,"Antibody absorption, red blood cell, cold with autoabsorption (procedure)",20020131,1,9E+17,9E+17
36056007,Factor XIII inhibitor assay (procedure),20020131,1,9E+17,9E+17
35880001,"Antibody elution, ether (procedure)",20020131,1,9E+17,9E+17
33468001,Hematology procedure (procedure),20020131,1,9E+17,9E+17
33353001,Food analysis (procedure),20020131,1,9E+17,9E+17
34035008,Partial thromboplastin time substituted test (procedure),20020131,1,9E+17,9E+17
33923000,"Routine stain, blood or bone marrow (procedure)",20020131,1,9E+17,9E+17
39613004,"Non-specific esterase stain method, blood or bone marrow (procedure)",20020131,1,9E+17,9E+17
38677001,"Protein C, antigenic assay (procedure)",20020131,1,9E+17,9E+17
38759002,Saliva secretor studies (procedure),20020131,1,9E+17,9E+17
39762009,"Calcium, urine, qualitative (procedure)",20020131,1,9E+17,9E+17
40166005,Blood group typing Rho(D) (procedure),20020131,1,9E+17,9E+17
37254006,Mean corpuscular hemoglobin concentration determination (procedure),20020131,1,9E+17,9E+17
37954002,Lupus erythematosus cell preparation (procedure),20020131,1,9E+17,9E+17
59985005,Bone marrow staining and interpretation (procedure),20020131,1,9E+17,9E+17
59254005,Water analysis (procedure),20020131,1,9E+17,9E+17
59524001,Blood bank procedure (procedure),20020131,1,9E+17,9E+17
59424003,Preparation of enzyme treated pooled reagent red blood cells (procedure),20020131,1,9E+17,9E+17
59500009,"Leukocyte poor blood preparation, nylon filter (procedure)",20020131,1,9E+17,9E+17
60752001,"Parasite detection, blood (procedure)",20020131,1,9E+17,9E+17
60864000,Autopsy review for conference (procedure),20020131,1,9E+17,9E+17
60923009,Cell count of synovial fluid (procedure),20020131,1,9E+17,9E+17
60218003,"Urinalysis, protein, qualitative (procedure)",20020131,1,9E+17,9E+17
57932006,"Peroxidase stain method, blood or bone marrow (procedure)",20020131,1,9E+17,9E+17
56960002,"Coagulation time, HAREM test (procedure)",20020131,1,9E+17,9E+17
57399005,Plasminogen assay (procedure),20020131,1,9E+17,9E+17
57425007,"Leukocyte poor blood preparation, invert-spin (procedure)",20020131,1,9E+17,9E+17
57347008,Clotting test with substitution (procedure),20020131,1,9E+17,9E+17
57242004,"Cytopathology, screening of smear, routine, genital source, by cytotechnologist (procedure)",20020131,1,9E+17,9E+17
58543006,Plasminogen activator inhibitor assay (procedure),20020131,1,9E+17,9E+17
58059003,Washing red blood cells for transfusion (procedure),20020131,1,9E+17,9E+17
58448000,"Lyophilized coagulation concentrate, reconstitution (procedure)",20020131,1,9E+17,9E+17
63351009,von Willebrand factor multimer assay (procedure),20020131,1,9E+17,9E+17
63300003,Lupus anticoagulant assay (procedure),20020131,1,9E+17,9E+17
63400002,"Blood donor accounting, clerical (procedure)",20020131,1,9E+17,9E+17
64108007,Blood unit processing (procedure),20020131,1,9E+17,9E+17
64836000,Blood in gastric contents measurement (procedure),20020131,1,9E+17,9E+17
64676008,Platelet aggregation with thrombin test (procedure),20020131,1,9E+17,9E+17
64528004,Platelet aggregation with drug test (procedure),20020131,1,9E+17,9E+17
61805007,"Hemolysin detection, cold, biphasic (procedure)",20020131,1,9E+17,9E+17
61943006,Red blood cell antibody detection with albumin (procedure),20020131,1,9E+17,9E+17
61338009,"Alpha naphthyl acetate stain method, blood or bone marrow (procedure)",20020131,1,9E+17,9E+17
61431004,"Hemolysin detection, ABO (procedure)",20020131,1,9E+17,9E+17
62968005,Seminal fluid detection by acid phosphatase method (procedure),20020131,1,9E+17,9E+17
62594005,"Reagent red blood cell, freeze, glycerol (procedure)",20020131,1,9E+17,9E+17
62381009,Water load test (procedure),20020131,1,9E+17,9E+17
62454005,"Fibrin split products, immunoelectrophoresis (procedure)",20020131,1,9E+17,9E+17
51587007,"Bleeding time, template (procedure)",20020131,1,9E+17,9E+17
51422001,Platelet aggregation with epinephrine test (procedure),20020131,1,9E+17,9E+17
51481005,"Antibody identification, red blood cell (procedure)",20020131,1,9E+17,9E+17
52744009,Cytochemical test (procedure),20020131,1,9E+17,9E+17
52067000,"Thromboplastin generation test, Biggs-Douglas (procedure)",20020131,1,9E+17,9E+17
52036002,Partial thromboplastin time inhibition test (procedure),20020131,1,9E+17,9E+17
51949007,Preparation and centrifugation of packed red blood cells (procedure),20020131,1,9E+17,9E+17
52391000,Hemolysin detection (procedure),20020131,1,9E+17,9E+17
49790006,Blood group typing A (procedure),20020131,1,9E+17,9E+17
49151003,Clotting factor II assay (procedure),20020131,1,9E+17,9E+17
50631004,"Clot retraction, quantitative (procedure)",20020131,1,9E+17,9E+17
55548003,"Prothrombin consumption time, substituted (procedure)",20020131,1,9E+17,9E+17
55511007,"Rapid urine screening test, enzyme tube test (procedure)",20020131,1,9E+17,9E+17
55165001,"Antibody identification, red blood cell antibody panel, cold (procedure)",20020131,1,9E+17,9E+17
55304007,Red blood cell histogram evaluation (procedure),20020131,1,9E+17,9E+17
56584004,"Semen analysis, motility and count (procedure)",20020131,1,9E+17,9E+17
56503007,"Antibody identification, platelet antibody (procedure)",20020131,1,9E+17,9E+17
56880000,"Ferric chloride test, urine (procedure)",20020131,1,9E+17,9E+17
56027003,Thromboelastography (procedure),20020131,1,9E+17,9E+17
56326001,Thromboplastin generation test with substitution (procedure),20020131,1,9E+17,9E+17
56274004,Cryoprecipitate thawing and pooling (procedure),20020131,1,9E+17,9E+17
53643002,"Blood coagulation panel, disseminated intravascular coagulation (procedure)",20020131,1,9E+17,9E+17
53531008,"Antibody identification, red blood cell, albumin and anti-human globulin (procedure)",20020131,1,9E+17,9E+17
53853004,"Urinalysis, reagent strip without microscopy (procedure)",20020131,1,9E+17,9E+17
53029006,"Bleeding time, quantitative (procedure)",20020131,1,9E+17,9E+17
53044007,Tissue thromboplastin inhibitor assay (procedure),20020131,1,9E+17,9E+17
54706004,Mean corpuscular hemoglobin determination (procedure),20020131,1,9E+17,9E+17
54207009,Factor VIII-related Willebrand factor assay (procedure),20020131,1,9E+17,9E+17
10821005,"Gastric fluid analysis, food, forensic (procedure)",20020131,1,9E+17,9E+17
11078007,Fletcher factor assay (procedure),20020131,1,9E+17,9E+17
10956008,"Clot retraction, inhibition by drug (procedure)",20020131,1,9E+17,9E+17
11017006,Thromboxane B2 assay (procedure),20020131,1,9E+17,9E+17
10967009,"Eosinophil count, nasal (procedure)",20020131,1,9E+17,9E+17
10223001,"Fat stain, urine (procedure)",20020131,1,9E+17,9E+17
11743002,"Semen analysis, post vasectomy (procedure)",20020131,1,9E+17,9E+17
11921001,"Heinz body determination, induced (procedure)",20020131,1,9E+17,9E+17
11184008,"Urinalysis, blood, qualitative (procedure)",20020131,1,9E+17,9E+17
11415005,"Antibody identification, red blood cell antibody panel, standard technique (procedure)",20020131,1,9E+17,9E+17
8796000,"Cytopathology procedure requiring centrifugation, nongenital source (procedure)",20020131,1,9E+17,9E+17
8478005,"Gastric fluid analysis, pH titration (procedure)",20020131,1,9E+17,9E+17
8574009,Platelet estimate (procedure),20020131,1,9E+17,9E+17
9777005,"Bile pigment measurement, urine (procedure)",20020131,1,9E+17,9E+17
10110004,Platelet adhesiveness test (procedure),20020131,1,9E+17,9E+17
9213003,"Gastric fluid analysis, free acid measurement (procedure)",20020131,1,9E+17,9E+17
9381008,"Antibody identification, red blood cell, saline and anti-human globulin (procedure)",20020131,1,9E+17,9E+17
9336009,"Chemical test, qualitative and quantitative (procedure)",20020131,1,9E+17,9E+17
14768001,Peripheral blood smear interpretation (procedure),20020131,1,9E+17,9E+17
15947002,"Periodic acid Schiff stain method, blood or bone marrow (procedure)",20020131,1,9E+17,9E+17
16132001,"Bleeding time, Ivy (procedure)",20020131,1,9E+17,9E+17
15220000,Laboratory test (procedure),20020131,1,9E+17,9E+17
15719007,Fine needle aspirate with routine interpretation and report (procedure),20020131,1,9E+17,9E+17
12845003,Malaria smear (procedure),20020131,1,9E+17,9E+17
13072001,"Antibody identification, red blood cell, albumin (procedure)",20020131,1,9E+17,9E+17
12234009,"Red blood cells antibody detection, warm with titration (procedure)",20020131,1,9E+17,9E+17
13728005,Gastric analysis (procedure),20020131,1,9E+17,9E+17
13956007,Urine concentration test (procedure),20020131,1,9E+17,9E+17
13405005,Plasma clot lysis time (procedure),20020131,1,9E+17,9E+17
13374006,"Hemolysin detection, cold, quantitative (procedure)",20020131,1,9E+17,9E+17
2448007,Cell count of synovial fluid with differential count (procedure),20020131,1,9E+17,9E+17
2373006,Buffy coat smear evaluation (procedure),20020131,1,9E+17,9E+17
2278000,"Urinalysis, automated (procedure)",20020131,1,9E+17,9E+17
2279008,"Antibody detection, red blood cell, enzyme, 1 stage technique, including anti-human globulin (procedure)",20020131,1,9E+17,9E+17
3955006,Antibody elution from red blood cells (procedure),20020131,1,9E+17,9E+17
3717006,Dilute Russell viper venom time (procedure),20020131,1,9E+17,9E+17
3770000,Ward urine dip stick testing (procedure),20020131,1,9E+17,9E+17
3116009,Blood coagulation panel (procedure),20020131,1,9E+17,9E+17
879007,"Special blood coagulation test, explain by report (procedure)",20020131,1,9E+17,9E+17
352003,Preparation of antibody sensitized pooled reagent red blood cells (procedure),20020131,1,9E+17,9E+17
1788001,"Blood unit collection for directed donation, donor (procedure)",20020131,1,9E+17,9E+17
1358008,"Anti-human globulin test, enzyme technique, titer (procedure)",20020131,1,9E+17,9E+17
6986008,"Precipitin test for blood group, species identification (procedure)",20020131,1,9E+17,9E+17
6126006,Fitzgerald factor assay (procedure),20020131,1,9E+17,9E+17
6225001,"Antibody detection, red blood cell, enzyme, 2 stage technique, including anti-human globulin (procedure)",20020131,1,9E+17,9E+17
6434009,Seminal fluid detection (procedure),20020131,1,9E+17,9E+17
6388003,"Terminal deoxynucleotidyl transferase stain method, blood or bone marrow (procedure)",20020131,1,9E+17,9E+17
6491004,"Protein S, free assay (procedure)",20020131,1,9E+17,9E+17
6289009,White blood cell histogram evaluation (procedure),20020131,1,9E+17,9E+17
8008000,"Naphthol-AS-D-chloracetate esterase stain method, blood or bone marrow (procedure)",20020131,1,9E+17,9E+17
4699005,"Alpha naphthyl butyrate stain method, blood or bone marrow (procedure)",20020131,1,9E+17,9E+17
4815000,"Antibody identification, red blood cell antibody panel, enzyme, 2 stage technique including anti-human globulin (procedure)",20020131,1,9E+17,9E+17
4007002,"Anti-human globulin test, indirect, titer, non-gamma (procedure)",20020131,1,9E+17,9E+17
5025004,"Semen analysis, presence and motility of sperm (procedure)",20020131,1,9E+17,9E+17
5357009,Leukocyte poor blood preparation (procedure),20020131,1,9E+17,9E+17
27107005,"Osmotic fragility, immediate (procedure)",20020131,1,9E+17,9E+17
27198009,"Blood group typing, RH genotyping, complete (procedure)",20020131,1,9E+17,9E+17
26488000,"Plasminogen assay, antigenic (procedure)",20020131,1,9E+17,9E+17
26589006,"Antibody identification, leukocyte antibody (procedure)",20020131,1,9E+17,9E+17
26604007,Complete blood count (procedure),20020131,1,9E+17,9E+17
26769008,"Bleeding time, Duke (procedure)",20020131,1,9E+17,9E+17
28040002,General health panel (procedure),20020131,1,9E+17,9E+17
28317006,Hematocrit determination (procedure),20020131,1,9E+17,9E+17
27848005,"Platelet concentrate, preparation (procedure)",20020131,1,9E+17,9E+17
25340006,Neutrophil band count (procedure),20020131,1,9E+17,9E+17
25179006,Whole blood unit collection (procedure),20020131,1,9E+17,9E+17
24593002,Plasmin assay (procedure),20020131,1,9E+17,9E+17
24643008,"Circulating inhibitor assay, factor IX (procedure)",20020131,1,9E+17,9E+17
24519004,Free radical assay technique measurement (procedure),20020131,1,9E+17,9E+17
26234007,Platelet aggregation with collagen test (procedure),20020131,1,9E+17,9E+17
26086007,Bone marrow laboratory procedure (procedure),20020131,1,9E+17,9E+17
26047008,Aspirin tolerance test (procedure),20020131,1,9E+17,9E+17
26245005,Fresh frozen plasma thawing (procedure),20020131,1,9E+17,9E+17
26300008,"Protein C, functional assay (procedure)",20020131,1,9E+17,9E+17
25450006,"Stain, acid phosphatase, blood or bone marrow (procedure)",20020131,1,9E+17,9E+17
25464006,"Thromboplastin generation test, Hicks-Pitney modification (procedure)",20020131,1,9E+17,9E+17
31359006,"Special blood bank procedure, explain by report (procedure)",20020131,1,9E+17,9E+17
31385005,"Cytopathology screening of smear, routine, nongenital source, by cytotechnologist (procedure)",20020131,1,9E+17,9E+17
29466004,Blood group typing A>2< (procedure),20020131,1,9E+17,9E+17
30481007,Pyruvate kinase measurement (procedure),20020131,1,9E+17,9E+17
29711001,Coagulation panel for thrombosis (procedure),20020131,1,9E+17,9E+17
29651008,Complete semen analysis (procedure),20020131,1,9E+17,9E+17
29779009,"Reagent red blood cell, preparation A, B or O pool (procedure)",20020131,1,9E+17,9E+17
29861003,"Circulating inhibitor assay, factor II (procedure)",20020131,1,9E+17,9E+17
18921005,"Packed red blood cell preparation, sedimentation (procedure)",20020131,1,9E+17,9E+17
18980008,Red blood cell antibody detection with saline (procedure),20020131,1,9E+17,9E+17
19271007,"Fibrin split products, ethanol gel assay (procedure)",20020131,1,9E+17,9E+17
18499008,"Radionuclide study, protein kinetics (procedure)",20020131,1,9E+17,9E+17
18312004,Fresh frozen plasma preparation (procedure),20020131,1,9E+17,9E+17
18360001,"Red blood cell antibody detection, cold with titration (procedure)",20020131,1,9E+17,9E+17
19957009,White blood cell enzyme determination (procedure),20020131,1,9E+17,9E+17
20099001,"Blood typing, ABO, Rho(D) and red blood cell antibody screening (procedure)",20020131,1,9E+17,9E+17
19566001,Sperm evaluation by cervical mucus penetration test (procedure),20020131,1,9E+17,9E+17
19739004,Platelet aggregation test (procedure),20020131,1,9E+17,9E+17
16939009,"Compatibility test, crossmatch, screening for compatible unit, saline and/or high protein (procedure)",20020131,1,9E+17,9E+17
16742006,Indirect Coombs test (procedure),20020131,1,9E+17,9E+17
16254007,Lipid panel (procedure),20020131,1,9E+17,9E+17
16690007,Prothrombin consumption time (procedure),20020131,1,9E+17,9E+17
16493001,Platelet aggregation with adenosine diphosphate test (procedure),20020131,1,9E+17,9E+17
23244001,Fetal hemoglobin determination (procedure),20020131,1,9E+17,9E+17
22370005,"Blood donor rejection, clerical (procedure)",20020131,1,9E+17,9E+17
24247004,Euglobulin lysis time (procedure),20020131,1,9E+17,9E+17
23779000,"Crystal identification, urine (procedure)",20020131,1,9E+17,9E+17
21221007,Blood group typing B (procedure),20020131,1,9E+17,9E+17
20469004,"Protein S, antigenic assay (procedure)",20020131,1,9E+17,9E+17
20501000,"Urinalysis, specific gravity measurement (procedure)",20020131,1,9E+17,9E+17
20688004,"Antibody detection, red blood cell, saline, high protein and anti-human globulin technique (procedure)",20020131,1,9E+17,9E+17
20592001,"Eosinophil count, stool (procedure)",20020131,1,9E+17,9E+17
77820007,Red blood cell indices determination (procedure),20020131,1,9E+17,9E+17
77020008,Direct Coombs test (procedure),20020131,1,9E+17,9E+17
90533000,Platelet factor 3 release test (procedure),20020131,1,9E+17,9E+17
78882004,Clotting factor IX assay (procedure),20020131,1,9E+17,9E+17
89857002,"Semen analysis, count only (procedure)",20020131,1,9E+17,9E+17
89961007,"Fibrinolysin assay, screening (procedure)",20020131,1,9E+17,9E+17
91049002,Heparin-protamine titration assay (procedure),20020131,1,9E+17,9E+17
91315004,ABO typing (procedure),20020131,1,9E+17,9E+17
90689002,"Iron stain method, blood or bone marrow (procedure)",20020131,1,9E+17,9E+17
90777005,"Compatibility test, crossmatch, minor, includes recipient and donor typing and antibody screening (procedure)",20020131,1,9E+17,9E+17
90798005,Minor crossmatch (procedure),20020131,1,9E+17,9E+17
75510007,"Anti-human globulin test, enzyme technique, qualitative (procedure)",20020131,1,9E+17,9E+17
75212000,"Indican measurement, urine (procedure)",20020131,1,9E+17,9E+17
75195008,Crystal identification of synovial fluid (procedure),20020131,1,9E+17,9E+17
75126003,Mechanical fragility red blood cell (procedure),20020131,1,9E+17,9E+17
75672003,Platelet mean volume determination (procedure),20020131,1,9E+17,9E+17
75710009,"Pyruvate kinase measurement, erythrocytes (procedure)",20020131,1,9E+17,9E+17
83058000,"Stain, Sudan Black B, blood or bone marrow (procedure)",20020131,1,9E+17,9E+17
86908003,"Protein S, functional assay (procedure)",20020131,1,9E+17,9E+17
86459005,"Compatibility test, crossmatch, enzyme technique (procedure)",20020131,1,9E+17,9E+17
86446002,Ward urine dip stick testing for acetone (procedure),20020131,1,9E+17,9E+17
86528005,Reactive lymphocyte count (procedure),20020131,1,9E+17,9E+17
87532009,Serotonin release assay for platelet antibody (procedure),20020131,1,9E+17,9E+17
87267008,"Anti-human globulin test, drug sensitization and identification (procedure)",20020131,1,9E+17,9E+17
82655008,"Red blood cell antibody detection, warm (procedure)",20020131,1,9E+17,9E+17
85011005,"Antibody absorption, red blood cell, differential (procedure)",20020131,1,9E+17,9E+17
86236002,Circulating anticoagulant assay (procedure),20020131,1,9E+17,9E+17
80275000,Thawing of reagent red blood cells (procedure),20020131,1,9E+17,9E+17
80329005,Platelet function test (procedure),20020131,1,9E+17,9E+17
88708002,"Chemical test, quantitative (procedure)",20020131,1,9E+17,9E+17
88778001,Separation of blood unit into aliquots (procedure),20020131,1,9E+17,9E+17
79469008,Heparin assay (procedure),20020131,1,9E+17,9E+17
89754000,Red blood cell antibody detection (procedure),20020131,1,9E+17,9E+17
79623001,"Antibody detection, platelet antibody (procedure)",20020131,1,9E+17,9E+17
89226006,Fibrinogen inhibitor assay (procedure),20020131,1,9E+17,9E+17
89517007,"Clotting factor XIII assay, screen (procedure)",20020131,1,9E+17,9E+17
88040009,Clotting factor XI assay (procedure),20020131,1,9E+17,9E+17
87960001,Streptokinase titer (procedure),20020131,1,9E+17,9E+17
81876003,"Fibrin split products, agglutination assay (procedure)",20020131,1,9E+17,9E+17
88291001,Obstetric panel (procedure),20020131,1,9E+17,9E+17
88498005,"Compatibility test, crossmatch, screening for compatible unit, enzyme technique (procedure)",20020131,1,9E+17,9E+17
81228005,ABO and Rho(D) typing (procedure),20020131,1,9E+17,9E+17
88242007,"Cytopathology procedure, preparation, screening and interpretation, nongenital source (procedure)",20020131,1,9E+17,9E+17
88211002,"Red blood cell antibody detection, cold (procedure)",20020131,1,9E+17,9E+17
70152007,"Non-specific esterase stain method with NaF inhibition, blood or bone marrow (procedure)",20020131,1,9E+17,9E+17
66842004,Red cell distribution width determination (procedure),20020131,1,9E+17,9E+17
69874005,"Coagulation time, activated (procedure)",20020131,1,9E+17,9E+17
71100000,Factor VIII R: Ag assay (procedure),20020131,1,9E+17,9E+17
71130008,Thrombin titer (procedure),20020131,1,9E+17,9E+17
104119003,"White blood cell count, automated, pleural fluid (procedure)",20020131,1,9E+17,9E+17
104120009,"Neutrophil count, automated, pleural fluid (procedure)",20020131,1,9E+17,9E+17
71517003,"Circulating inhibitor assay, factor VIII (procedure)",20020131,1,9E+17,9E+17
104117001,"Cell count, pleural fluid (procedure)",20020131,1,9E+17,9E+17
104118006,"Red blood cell count, automated, pleural fluid (procedure)",20020131,1,9E+17,9E+17
104132008,Erythrocyte mean corpuscular diameter determination (procedure),20020131,1,9E+17,9E+17
104133003,Erythrocyte mean corpuscular volume determination (procedure),20020131,1,9E+17,9E+17
104134009,"Hemoglobin distribution, width determination (procedure)",20020131,1,9E+17,9E+17
104137002,Bone marrow processing to eliminate cells (procedure),20020131,1,9E+17,9E+17
104138007,"Tartrate resistant acid phosphatase stain method, blood or bone marrow (procedure)",20020131,1,9E+17,9E+17
104139004,"Hematocrit, spun microhematocrit method (procedure)",20020131,1,9E+17,9E+17
104124000,"White blood cell count, automated, semen (procedure)",20020131,1,9E+17,9E+17
104125004,"Red blood cell count, automated, synovial fluid (procedure)",20020131,1,9E+17,9E+17
104126003,"White blood cell count, automated, synovial fluid (procedure)",20020131,1,9E+17,9E+17
104127007,"Neutrophil count, automated, synovial fluid (procedure)",20020131,1,9E+17,9E+17
104128002,"White blood cells differential count, peripheral blood buffy coat smear (procedure)",20020131,1,9E+17,9E+17
71607003,"Coagulation time, capillary (procedure)",20020131,1,9E+17,9E+17
104096007,"Segmented neutrophil count, blood (procedure)",20020131,1,9E+17,9E+17
104088002,Blood Product Unit Description (procedure),20020131,1,9E+17,9E+17
104097003,"Hypersegmented neutrophil count, blood (procedure)",20020131,1,9E+17,9E+17
104107006,"Platelet count, blood, automated (procedure)",20020131,1,9E+17,9E+17
104101007,"Prolymphocyte count, blood (procedure)",20020131,1,9E+17,9E+17
104102000,"Blast count, blood (procedure)",20020131,1,9E+17,9E+17
104103005,"Myeloblast count, blood (procedure)",20020131,1,9E+17,9E+17
104105003,"Lymphocytes and monocytes, count, blood (procedure)",20020131,1,9E+17,9E+17
104106002,"Platelet count, blood, manual (procedure)",20020131,1,9E+17,9E+17
104161009,"Cytopathology, review of slides and report, cerebrospinal fluid (procedure)",20020131,1,9E+17,9E+17
104163007,"Cytopathology procedure, preparation of smear and interpretation, non-genital source (procedure)",20020131,1,9E+17,9E+17
104150001,Sucrose hemolysis test (procedure),20020131,1,9E+17,9E+17
104149001,"Acidified serum lysis test, red blood cells (procedure)",20020131,1,9E+17,9E+17
104144006,Determination of hemoglobin subtype (procedure),20020131,1,9E+17,9E+17
104148009,"Apt test (hemoglobin), stool (procedure)",20020131,1,9E+17,9E+17
104152009,"Reticulocyte count, manual (procedure)",20020131,1,9E+17,9E+17
104151002,"Complement lysis sensitivity test, red blood cell (procedure)",20020131,1,9E+17,9E+17
70494000,"Fibrin split products, staphylococcal clumping (procedure)",20020131,1,9E+17,9E+17
104990004,Triglyceride and ester in high density lipoprotein measurement (procedure),20020131,1,9E+17,9E+17
104991000,Triglyceride and ester in intermediate density lipoprotein measurement (procedure),20020131,1,9E+17,9E+17
104992007,Triglyceride and ester in low density lipoprotein measurement (procedure),20020131,1,9E+17,9E+17
104993002,Triglyceride and ester in very low density lipoprotein measurement (procedure),20020131,1,9E+17,9E+17
105362001,"Urinalysis, automated, without microscopy (procedure)",20020131,1,9E+17,9E+17
104955007,Terminal deoxyribonucleotidyl transferase measurement (procedure),20020131,1,9E+17,9E+17
70648006,D-dimer assay (procedure),20020131,1,9E+17,9E+17
104084000,Measurement of volume of whole blood transfused (procedure),20020131,1,9E+17,9E+17
67738001,Clotting factor XIII assay (procedure),20020131,1,9E+17,9E+17
108256005,Hematology staining procedure (procedure),20020131,1,9E+17,9E+17
67776007,Monocyte count (procedure),20020131,1,9E+17,9E+17
68184000,"Autopsy review, consultation and report (procedure)",20020131,1,9E+17,9E+17
67241009,Fibrin-fibrinogen split products assay (procedure),20020131,1,9E+17,9E+17
67637001,Alpha-2 antiplasmin assay (procedure),20020131,1,9E+17,9E+17
68938006,Blood bank inventory control (procedure),20020131,1,9E+17,9E+17
68923005,Autocontrol procedure for crossmatch (procedure),20020131,1,9E+17,9E+17
68902004,Clotting factor XII assay (procedure),20020131,1,9E+17,9E+17
69145003,"Antibody identification, red blood cell, saline (procedure)",20020131,1,9E+17,9E+17
74216007,Heinz body determination (procedure),20020131,1,9E+17,9E+17
65667006,"Hemosiderin measurement, urine (procedure)",20020131,1,9E+17,9E+17
73623007,Platelet morphology (procedure),20020131,1,9E+17,9E+17
103771005,Peripheral vein renin stimulation panel (procedure),20020131,1,9E+17,9E+17
103940009,I blood group typing (procedure),20020131,1,9E+17,9E+17
103939007,"Blood typing, red blood cell antigens from Ii collection (International Society of Blood Transfusion 207) (procedure)",20020131,1,9E+17,9E+17
103802005,Kallikrein assay (procedure),20020131,1,9E+17,9E+17
103800002,Coagulation factor assay (procedure),20020131,1,9E+17,9E+17
103799001,Prothrombin fragment 1.2 assay (procedure),20020131,1,9E+17,9E+17
103938004,"Blood typing, red blood cell antigens from Cost collection (International Society of Blood Transfusion 205) (procedure)",20020131,1,9E+17,9E+17
72530004,"Coagulation time, Bart test (procedure)",20020131,1,9E+17,9E+17
103943006,"Blood typing, red blood cell antigens from GLOBO collection (International Society of Blood Transfusion 209) (procedure)",20020131,1,9E+17,9E+17
103770006,Renal vein renin stimulation panel (procedure),20020131,1,9E+17,9E+17
103941008,Little i blood group typing (procedure),20020131,1,9E+17,9E+17
103766003,Evocative or suppression testing panel (procedure),20020131,1,9E+17,9E+17
103942001,"Blood typing, red blood cell antigens from Er collection (International Society of Blood Transfusion 208) (procedure)",20020131,1,9E+17,9E+17
103815001,Fibrinogen fragments assay (procedure),20020131,1,9E+17,9E+17
103816000,Fibrin fragments assay (procedure),20020131,1,9E+17,9E+17
103817009,Fibrin monomer assay (procedure),20020131,1,9E+17,9E+17
103818004,Fibrinopeptide assay (procedure),20020131,1,9E+17,9E+17
103819007,Fibrinopeptides A assay (procedure),20020131,1,9E+17,9E+17
103934002,"Blood typing, red blood cell antigens from Gerbich system (International Society of Blood Transfusion 020) (procedure)",20020131,1,9E+17,9E+17
103814002,"Fibrin-fibrinogen split products assay, quantitative (procedure)",20020131,1,9E+17,9E+17
103813008,"Fibrin-fibrinogen split products assay, semi-quantitative (procedure)",20020131,1,9E+17,9E+17
103812003,Soluble fibrin assay (procedure),20020131,1,9E+17,9E+17
103823004,Fibrinopeptide B-beta (15-42) assay (procedure),20020131,1,9E+17,9E+17
72406003,Bleeding time (procedure),20020131,1,9E+17,9E+17
103824005,Fibrinopeptide B-beta (43-47) assay (procedure),20020131,1,9E+17,9E+17
103822009,Fibrinopeptide B-beta (1-42) assay (procedure),20020131,1,9E+17,9E+17
103820001,Fibrinopeptides B assay (procedure),20020131,1,9E+17,9E+17
103821002,Fibrinopeptide B-beta (1-14) assay (procedure),20020131,1,9E+17,9E+17
103810006,Activated protein C inhibitor assay (procedure),20020131,1,9E+17,9E+17
103808009,Factor XII inhibitor assay (procedure),20020131,1,9E+17,9E+17
103805007,Factor VII inhibitor assay (procedure),20020131,1,9E+17,9E+17
103936000,"Blood typing, red blood cell antigens from Knops system (International Society of Blood Transfusion 022) (procedure)",20020131,1,9E+17,9E+17
103937009,"Blood typing, red blood cell antigens from Indian system (International Society of Blood Transfusion 023) (procedure)",20020131,1,9E+17,9E+17
103803000,"Lupus anticoagulant assay, platelet neutralization method (procedure)",20020131,1,9E+17,9E+17
103804006,Factor V inhibitor assay (procedure),20020131,1,9E+17,9E+17
103944000,P^k^ blood group typing (procedure),20020131,1,9E+17,9E+17
103807004,Factor XI inhibitor assay (procedure),20020131,1,9E+17,9E+17
103935001,"Blood typing, red blood cell antigens from Cromer system (International Society of Blood Transfusion 021) (procedure)",20020131,1,9E+17,9E+17
103806008,Factor X inhibitor assay (procedure),20020131,1,9E+17,9E+17
103956004,"Red cell antigen phenotyping, blood product unit (procedure)",20020131,1,9E+17,9E+17
103955000,P2 blood group typing (procedure),20020131,1,9E+17,9E+17
103957008,"Red cell antigen phenotyping, patient red cells (procedure)",20020131,1,9E+17,9E+17
103954001,P1 blood group typing (procedure),20020131,1,9E+17,9E+17
103958003,"Antibody screen, serum (procedure)",20020131,1,9E+17,9E+17
103962009,"Antibody screen, rest absorption (procedure)",20020131,1,9E+17,9E+17
103963004,"Antibody screen, warm absorption (procedure)",20020131,1,9E+17,9E+17
103959006,"Antibody screen, cold absorption (procedure)",20020131,1,9E+17,9E+17
103960001,"Antibody screen, eluate (procedure)",20020131,1,9E+17,9E+17
103961002,"Antibody screen, prewarmed (procedure)",20020131,1,9E+17,9E+17
103946003,"Blood typing, red blood cell antigens from 210 collection (International Society of Blood Transfusion 210) (procedure)",20020131,1,9E+17,9E+17
103948002,Bg^a^ blood group typing (procedure),20020131,1,9E+17,9E+17
103947007,"Blood typing, red blood cell antigens, not in systems or collections classified by International Society of Blood Transfusion 1995 (procedure)",20020131,1,9E+17,9E+17
103945004,P blood group typing (procedure),20020131,1,9E+17,9E+17
103953007,M1 blood group typing (procedure),20020131,1,9E+17,9E+17
103952002,Little p blood group typing (procedure),20020131,1,9E+17,9E+17
103951009,I int phenotype determination (procedure),20020131,1,9E+17,9E+17
103950005,i-2 blood group phenotype determination (procedure),20020131,1,9E+17,9E+17
103949005,i-1 blood group phenotype determination (procedure),20020131,1,9E+17,9E+17
103825006,"D-dimer assay, semi-quantitative (procedure)",20020131,1,9E+17,9E+17
103884008,G blood group typing (procedure),20020131,1,9E+17,9E+17
103885009,V blood group typing (procedure),20020131,1,9E+17,9E+17
103886005,"Blood typing, red blood cell antigens from MNS system (International Society of Blood Transfusion 002) (procedure)",20020131,1,9E+17,9E+17
103887001,M blood group typing (procedure),20020131,1,9E+17,9E+17
103888006,N blood group typing (procedure),20020131,1,9E+17,9E+17
103883002,Little f blood group typing (procedure),20020131,1,9E+17,9E+17
103882007,E^w^ blood group typing (procedure),20020131,1,9E+17,9E+17
103902006,Kp^a^ blood group typing (procedure),20020131,1,9E+17,9E+17
103878005,D blood group typing (procedure),20020131,1,9E+17,9E+17
103903001,Kp^b^ blood group typing (procedure),20020131,1,9E+17,9E+17
103876009,C blood group typing (procedure),20020131,1,9E+17,9E+17
103877000,Little c blood group typing (procedure),20020131,1,9E+17,9E+17
72137008,Determination of bone marrow iron stores (procedure),20020131,1,9E+17,9E+17
103879002,Weak D blood group typing (procedure),20020131,1,9E+17,9E+17
103880004,E blood group typing (procedure),20020131,1,9E+17,9E+17
103881000,Little e blood group typing (procedure),20020131,1,9E+17,9E+17
103901004,Js^b^ blood group typing (procedure),20020131,1,9E+17,9E+17
103895002,"Blood typing, red blood cell antigens from Lutheran system (International Society of Blood Transfusion 005) (procedure)",20020131,1,9E+17,9E+17
103893009,M^g^ blood group typing (procedure),20020131,1,9E+17,9E+17
103894003,"Blood typing, red blood cell antigens from P system (International Society of Blood Transfusion 003) (procedure)",20020131,1,9E+17,9E+17
103896001,Lu^a^ blood group typing (procedure),20020131,1,9E+17,9E+17
103897005,Lu^b^ blood group typing (procedure),20020131,1,9E+17,9E+17
103898000,Au^a^ blood group typing (procedure),20020131,1,9E+17,9E+17
103899008,"Blood typing, red blood cell antigens from Kell system (International Society of Blood Transfusion 006) (procedure)",20020131,1,9E+17,9E+17
103900003,Js^a^ blood group typing (procedure),20020131,1,9E+17,9E+17
103889003,S blood group typing (procedure),20020131,1,9E+17,9E+17
103890007,Little s blood group typing (procedure),20020131,1,9E+17,9E+17
103891006,U blood group typing (procedure),20020131,1,9E+17,9E+17
103904007,K blood group typing (procedure),20020131,1,9E+17,9E+17
103892004,Mi^a^ blood group typing (procedure),20020131,1,9E+17,9E+17
103905008,Little k blood group typing (procedure),20020131,1,9E+17,9E+17
103848001,"Platelet antibody, immunoglobulin G measurement (procedure)",20020131,1,9E+17,9E+17
103850009,"Platelet associated antibody, immunoglobulin M measurement (procedure)",20020131,1,9E+17,9E+17
103851008,Heparin associated thrombocytopenia assay (procedure),20020131,1,9E+17,9E+17
103852001,Russell viper venom time (procedure),20020131,1,9E+17,9E+17
103928009,"Blood typing, red blood cell antigens from Colton system (International Society of Blood Transfusion 015) (procedure)",20020131,1,9E+17,9E+17
103847006,Platelet factor 4 assay (procedure),20020131,1,9E+17,9E+17
103925007,"Blood typing, red blood cell antigens from Scianna system (International Society of Blood Transfusion 013) (procedure)",20020131,1,9E+17,9E+17
103853006,Reptilase time (procedure),20020131,1,9E+17,9E+17
103924006,Xg^a^ blood group typing (procedure),20020131,1,9E+17,9E+17
103926008,"Blood typing, red blood cell antigens from Dombrock system (International Society of Blood Transfusion 014) (procedure)",20020131,1,9E+17,9E+17
103927004,Do^a^ blood group typing (procedure),20020131,1,9E+17,9E+17
103846002,Platelet factor 3 assay (procedure),20020131,1,9E+17,9E+17
103929001,"Blood typing, red blood cell antigens from Landsteiner-Weiner system (International Society of Blood Transfusion 016) (procedure)",20020131,1,9E+17,9E+17
103833007,Plasminogen activator inhibitor type 2 antigen assay (procedure),20020131,1,9E+17,9E+17
103834001,Tissue plasminogen activator-plasminogen activator inhibitor assay (procedure),20020131,1,9E+17,9E+17
103835000,Tissue plasminogen activator assay (procedure),20020131,1,9E+17,9E+17
103836004,Tissue plasminogen activator activity assay (procedure),20020131,1,9E+17,9E+17
103933008,"Blood typing, red blood cell antigens from Kx system (International Society of Blood Transfusion 019) (procedure)",20020131,1,9E+17,9E+17
103832002,Plasminogen activator inhibitor type 2 assay (procedure),20020131,1,9E+17,9E+17
103831009,Plasminogen activator inhibitor type 1 antigen assay (procedure),20020131,1,9E+17,9E+17
103826007,"D-dimer assay, quantitative (procedure)",20020131,1,9E+17,9E+17
103828008,Urokinase type plasminogen activator assay (procedure),20020131,1,9E+17,9E+17
103829000,Plasminogen activator inhibitor antigen assay (procedure),20020131,1,9E+17,9E+17
103830005,Plasminogen activator inhibitor type 1 assay (procedure),20020131,1,9E+17,9E+17
103932003,"Blood typing, red blood cell antigens from Hh system (International Society of Blood Transfusion 018) (procedure)",20020131,1,9E+17,9E+17
103931005,"Blood typing, red blood cell antigens from Chido/Rodgers system (International Society of Blood Transfusion 017) (procedure)",20020131,1,9E+17,9E+17
103930006,LW blood group typing (obsolete notation) (procedure),20020131,1,9E+17,9E+17
103842000,Platelet aggregation with norepinephrine test (procedure),20020131,1,9E+17,9E+17
103843005,Platelet aggregation with ristocetin test (procedure),20020131,1,9E+17,9E+17
103844004,Platelet aggregation with arachidonate test (procedure),20020131,1,9E+17,9E+17
103845003,Platelet aggregation with serotonin test (procedure),20020131,1,9E+17,9E+17
103841007,Platelet aggregation with calcium ionophore test (procedure),20020131,1,9E+17,9E+17
103837008,Tissue plasminogen activator antigen assay (procedure),20020131,1,9E+17,9E+17
103840008,Heparin neutralization assay (procedure),20020131,1,9E+17,9E+17
103854000,Thromboglobulin measurement (procedure),20020131,1,9E+17,9E+17
103910007,"Blood typing, red blood cell antigens from Duffy system (International Society of Blood Transfusion 008) (procedure)",20020131,1,9E+17,9E+17
103871004,Bombay blood group typing (procedure),20020131,1,9E+17,9E+17
103909002,Le^ab^ blood group typing (procedure),20020131,1,9E+17,9E+17
103872006,"Blood group typing, RH phenotyping (procedure)",20020131,1,9E+17,9E+17
103873001,Ce blood group typing (procedure),20020131,1,9E+17,9E+17
72316005,"Platelet concentrate, pooling (procedure)",20020131,1,9E+17,9E+17
103911006,Fy^a^ blood group typing (procedure),20020131,1,9E+17,9E+17
103869004,"B variant blood group, typing (procedure)",20020131,1,9E+17,9E+17
103870003,H blood group typing (procedure),20020131,1,9E+17,9E+17
103907000,Le^a^ blood group typing (procedure),20020131,1,9E+17,9E+17
103906009,"Blood typing, red blood cell antigens from Lewis system (International Society of Blood Transfusion 007) (procedure)",20020131,1,9E+17,9E+17
103875008,C^x^ blood group typing (procedure),20020131,1,9E+17,9E+17
103874007,C^w^ blood group typing (procedure),20020131,1,9E+17,9E+17
103908005,Le^b^ blood group typing (procedure),20020131,1,9E+17,9E+17
103868007,Blood group typing AB (procedure),20020131,1,9E+17,9E+17
103922005,Yt^b^ blood group typing (procedure),20020131,1,9E+17,9E+17
103921003,Yt^a^ blood group typing (procedure),20020131,1,9E+17,9E+17
72336006,Spot test (procedure),20020131,1,9E+17,9E+17
103860000,Blood group typing A variant (procedure),20020131,1,9E+17,9E+17
103861001,Blood group typing A>m< (procedure),20020131,1,9E+17,9E+17
103862008,Blood group typing A>x< (procedure),20020131,1,9E+17,9E+17
103859005,Reverse ABO group typing (procedure),20020131,1,9E+17,9E+17
103855004,Thrombomodulin measurement (procedure),20020131,1,9E+17,9E+17
103857007,Heparin cofactor II assay (procedure),20020131,1,9E+17,9E+17
103858002,Low molecular weight kininogen assay (procedure),20020131,1,9E+17,9E+17
103923000,"Blood typing, red blood cell antigens from Xg system (International Society of Blood Transfusion 012) (procedure)",20020131,1,9E+17,9E+17
103863003,Blood group typing A>1< (procedure),20020131,1,9E+17,9E+17
103916001,Jk3 blood group typing (procedure),20020131,1,9E+17,9E+17
103915002,Jk^b^ blood group typing (procedure),20020131,1,9E+17,9E+17
103867002,Blood group typing A>3<B (procedure),20020131,1,9E+17,9E+17
103914003,Jk^a^ blood group typing (procedure),20020131,1,9E+17,9E+17
103913009,"Blood typing, red blood cell antigens from Kidd system (International Society of Blood Transfusion 009) (procedure)",20020131,1,9E+17,9E+17
103912004,Fy^b^ blood group typing (procedure),20020131,1,9E+17,9E+17
103917005,"Blood typing, red blood cell antigens from Diego system (International Society of Blood Transfusion 010) (procedure)",20020131,1,9E+17,9E+17
103866006,Blood group typing A>2<B (procedure),20020131,1,9E+17,9E+17
103864009,Blood group typing A>3< (procedure),20020131,1,9E+17,9E+17
103865005,Blood group typing A>1<B (procedure),20020131,1,9E+17,9E+17
103920002,"Blood typing, red blood cell antigens from Yt system (International Society of Blood Transfusion 011) (procedure)",20020131,1,9E+17,9E+17
103919008,Di^b^ blood group typing (procedure),20020131,1,9E+17,9E+17
103918000,Di^a^ blood group typing (procedure),20020131,1,9E+17,9E+17
104059003,PP>1<P^k^ blood group antibody identification (procedure),20020131,1,9E+17,9E+17
104058006,P2 blood group antibody identification (procedure),20020131,1,9E+17,9E+17
71687000,"Platelet rich plasma, preparation (procedure)",20020131,1,9E+17,9E+17
104060008,"Direct antiglobulin test, complement-specific reagent (procedure)",20020131,1,9E+17,9E+17
104056005,LW blood group antibody identification (procedure),20020131,1,9E+17,9E+17
104057001,M1 blood group antibody identification (procedure),20020131,1,9E+17,9E+17
104062000,"Direct antiglobulin test, polyspecific reagent (procedure)",20020131,1,9E+17,9E+17
104061007,"Direct antiglobulin test, immunoglobulin G-specific reagent (procedure)",20020131,1,9E+17,9E+17
104055009,i-2 blood group antibody identification (procedure),20020131,1,9E+17,9E+17
104049004,Identification of antibody to red blood cell antigens from 210 collection (International Society of Blood Transfusion 210) (procedure),20020131,1,9E+17,9E+17
104048007,P^k^ blood group antibody identification (procedure),20020131,1,9E+17,9E+17
104047002,P blood group antibody identification (procedure),20020131,1,9E+17,9E+17
104044009,Little i blood group antibody identification (procedure),20020131,1,9E+17,9E+17
104043003,I blood group antibody identification (procedure),20020131,1,9E+17,9E+17
104042008,Identification of antibody to red blood cell antigens from Ii collection (International Society of Blood Transfusion 207) (procedure),20020131,1,9E+17,9E+17
104041001,Identification of antibody to red blood cell antigens from Cost collection (International Society of Blood Transfusion 205) (procedure),20020131,1,9E+17,9E+17
104046006,Identification of antibody to red blood cell antigens from GLOBO collection (International Society of Blood Transfusion 209) (procedure),20020131,1,9E+17,9E+17
104045005,Identification of antibody to red blood cell antigens from Er collection (International Society of Blood Transfusion 208) (procedure),20020131,1,9E+17,9E+17
104054008,i-1 blood group antibody identification (procedure),20020131,1,9E+17,9E+17
104053002,Le^x^ blood group antibody identification (procedure),20020131,1,9E+17,9E+17
104051000,Bg^a^ blood group antibody identification (procedure),20020131,1,9E+17,9E+17
104050004,"Identification of antibody to red blood cell antigens, not in systems or collections classified by International Society of Blood Transfusion 1995 (procedure)",20020131,1,9E+17,9E+17
104052007,Iint blood group antibody identification (procedure),20020131,1,9E+17,9E+17
104081008,Reservation of blood product (procedure),20020131,1,9E+17,9E+17
104082001,Measurement of duration of transfusion (procedure),20020131,1,9E+17,9E+17
104079006,Determination of disposition of blood product (procedure),20020131,1,9E+17,9E+17
104080009,Determination of blood product release time (procedure),20020131,1,9E+17,9E+17
73529003,Cryoprecipitate preparation (procedure),20020131,1,9E+17,9E+17
104067006,Computer crossmatch (procedure),20020131,1,9E+17,9E+17
73392001,"Urinalysis, bacteriuria screen (procedure)",20020131,1,9E+17,9E+17
104068001,Fetal cell screen (procedure),20020131,1,9E+17,9E+17
104066002,"Blood compatibility test, crossmatch by antiglobulin technique (procedure)",20020131,1,9E+17,9E+17
104065003,"Blood compatibility test, crossmatch by incubation technique (procedure)",20020131,1,9E+17,9E+17
104077008,"Blood product reservation, release, transfusion or disposition (navigational concept)",20020131,1,9E+17,9E+17
104078003,Measurement of volume of blood product dispensed (procedure),20020131,1,9E+17,9E+17
71643009,Frozen blood preparation (procedure),20020131,1,9E+17,9E+17
104074001,Processing of reagent red blood cells (procedure),20020131,1,9E+17,9E+17
103989004,Little c blood group antibody identification (procedure),20020131,1,9E+17,9E+17
103988007,E blood group antibody identification (procedure),20020131,1,9E+17,9E+17
103987002,C blood group antibody identification (procedure),20020131,1,9E+17,9E+17
103991007,Little f blood group antibody identification (procedure),20020131,1,9E+17,9E+17
103990008,Little e blood group antibody identification (procedure),20020131,1,9E+17,9E+17
103985005,Identification of antibody to red blood cell antigens from Rh system (International Society of Blood Transfusion 004) (procedure),20020131,1,9E+17,9E+17
104002003,Au^a^ blood group antibody identification (procedure),20020131,1,9E+17,9E+17
104001005,Lu3 (Lu^ab^) blood group antibody identification (procedure),20020131,1,9E+17,9E+17
104000006,Lu^b^ blood group antibody identification (procedure),20020131,1,9E+17,9E+17
104003008,Identification of antibody to red blood cell antigens from Kell system (International Society of Blood Transfusion 006) (procedure),20020131,1,9E+17,9E+17
104004002,K blood group antibody identification (procedure),20020131,1,9E+17,9E+17
104007009,Kp^b^ blood group antibody identification (procedure),20020131,1,9E+17,9E+17
104006000,Kp^a^ blood group antibody identification (procedure),20020131,1,9E+17,9E+17
104005001,Little k blood group antibody identification (procedure),20020131,1,9E+17,9E+17
103993005,C^w^ blood group antibody identification (procedure),20020131,1,9E+17,9E+17
103992000,Ce blood group antibody identification (procedure),20020131,1,9E+17,9E+17
103994004,C^x^ blood group antibody identification (procedure),20020131,1,9E+17,9E+17
103995003,V blood group antibody identification (procedure),20020131,1,9E+17,9E+17
103999009,Lu^a^ blood group antibody identification (procedure),20020131,1,9E+17,9E+17
103998001,Identification of antibody to red blood cell antigens from Lutheran system (International Society of Blood Transfusion 005) (procedure),20020131,1,9E+17,9E+17
103996002,E^w^ blood group antibody identification (procedure),20020131,1,9E+17,9E+17
103997006,G blood group antibody identification (procedure),20020131,1,9E+17,9E+17
103984009,P1 blood group antibody identification (procedure),20020131,1,9E+17,9E+17
103983003,Identification of antibody to red blood cell antigens from P system (International Society of Blood Transfusion 003) (procedure),20020131,1,9E+17,9E+17
103966007,Pretreatment of serum for use in blood bank procedure (procedure),20020131,1,9E+17,9E+17
103965006,Pretreatment of red blood cells for use in blood bank procedure (procedure),20020131,1,9E+17,9E+17
103977001,N blood group antibody identification (procedure),20020131,1,9E+17,9E+17
103976005,M blood group antibody identification (procedure),20020131,1,9E+17,9E+17
103975009,Identification of antibody to red blood cell antigens from MNS system (International Society Blood Transfusion 002) (procedure),20020131,1,9E+17,9E+17
103974008,A>1< blood group antibody identification (procedure),20020131,1,9E+17,9E+17
103973002,"A,B blood group antibody identification (procedure)",20020131,1,9E+17,9E+17
103982008,M^g^ blood group antibody identification (procedure),20020131,1,9E+17,9E+17
103981001,Mi^a^ blood group antibody identification (procedure),20020131,1,9E+17,9E+17
103980000,U blood group antibody identification (procedure),20020131,1,9E+17,9E+17
103979003,Little s blood group antibody identification (procedure),20020131,1,9E+17,9E+17
103978006,S blood group antibody identification (procedure),20020131,1,9E+17,9E+17
103969000,Erythrocyte antibody concentration measurement (procedure),20020131,1,9E+17,9E+17
103972007,B blood group antibody identification (procedure),20020131,1,9E+17,9E+17
103970004,Identification of antibody to red blood cell antigens from ABO system (International Society of Blood Transfusion 001) (procedure),20020131,1,9E+17,9E+17
104023009,Yt^a^ blood group antibody identification (procedure),20020131,1,9E+17,9E+17
104022004,Identification of antibody to red blood cell antigens from Yt system (International Society of Blood Transfusion 011) (procedure),20020131,1,9E+17,9E+17
104024003,Yt^b^ blood group antibody identification (procedure),20020131,1,9E+17,9E+17
104028000,Identification of antibody to red blood cell antigens from Dombrock system (International Society of Blood Transfusion 014) (procedure),20020131,1,9E+17,9E+17
104027005,Identification of antibody to red blood cell antigens from Scianna system (International Society of Blood Transfusion 013) (procedure),20020131,1,9E+17,9E+17
104026001,Xg^a^ blood group antibody identification (procedure),20020131,1,9E+17,9E+17
104025002,Identification of antibody to red blood cell antigens from Xg system (International Society of Blood Transfusion 012) (procedure),20020131,1,9E+17,9E+17
104021006,Di^b^ blood group antibody identification (procedure),20020131,1,9E+17,9E+17
104034007,H blood group antibody identification (procedure),20020131,1,9E+17,9E+17
104038005,Identification of antibody to red blood cell antigens from Cromer system (International Society of Blood Transfusion 021) (procedure),20020131,1,9E+17,9E+17
104037000,Identification of antibody to red blood cell antigens from Gerbich system (International Society of Blood Transfusion 020) (procedure),20020131,1,9E+17,9E+17
104036009,Identification of antibody to red blood cell antigens from Kx system (International Society of Blood Transfusion 019) (procedure),20020131,1,9E+17,9E+17
104035008,Bombay blood group antibody identification (procedure),20020131,1,9E+17,9E+17
104030003,Identification of antibody to red blood cell antigens from Colton system (International Society of Blood Transfusion 015) (procedure),20020131,1,9E+17,9E+17
104029008,Do^a^ blood group antibody identification (procedure),20020131,1,9E+17,9E+17
104031004,Identification of antibody to red blood cell antigens from Landsteiner-Weiner system (International Society of Blood Transfusion 016) (procedure),20020131,1,9E+17,9E+17
104033001,Identification of antibody to red blood cell antigens from Hh system (International Society of Blood Transfusion 018) (procedure),20020131,1,9E+17,9E+17
104032006,Identification of antibody to red blood cell antigens from Chido/Rodgers system (International Society of Blood Transfusion 017) (procedure),20020131,1,9E+17,9E+17
104012005,Le^b^ blood group antibody identification (procedure),20020131,1,9E+17,9E+17
104011003,Le^a^ blood group antibody identification (procedure),20020131,1,9E+17,9E+17
104014006,Fy^a^ blood group antibody identification (procedure),20020131,1,9E+17,9E+17
104013000,Identification of antibody to red blood cell antigens from Duffy system (International Society of Blood Transfusion 008) (procedure),20020131,1,9E+17,9E+17
104040000,Identification of antibody to red blood cell antigens from Indian system (International Society of Blood Transfusion 023) (procedure),20020131,1,9E+17,9E+17
104008004,Js^a^ blood group antibody identification (procedure),20020131,1,9E+17,9E+17
104009007,Js^b^ blood group antibody identification (procedure),20020131,1,9E+17,9E+17
104010002,Identification of antibody to red blood cell antigens from Lewis system (International Society of Blood Transfusion 007) (procedure),20020131,1,9E+17,9E+17
71752009,"Antibody identification, red blood cell antibody panel, enzyme, 1 stage technique including anti-human globulin (procedure)",20020131,1,9E+17,9E+17
72931008,"Fibrin split products, precipitation (procedure)",20020131,1,9E+17,9E+17
104018009,Jk^b^ blood group antibody identification (procedure),20020131,1,9E+17,9E+17
104019001,Identification of antibody to red blood cell antigens from Diego system (International Society of Blood Transfusion 010) (procedure),20020131,1,9E+17,9E+17
71819008,"Coagulation time, Lee White (procedure)",20020131,1,9E+17,9E+17
104020007,Di^a^ blood group antibody identification (procedure),20020131,1,9E+17,9E+17
104016008,Identification of antibody to red blood cell antigens from Kidd system (International Society of Blood Transfusion 009) (procedure),20020131,1,9E+17,9E+17
104017004,Jk^a^ blood group antibody identification (procedure),20020131,1,9E+17,9E+17
104039002,Identification of antibody to red blood cell antigens from Knops system (International Society of Blood Transfusion 022) (procedure),20020131,1,9E+17,9E+17
104015007,Fy^b^ blood group antibody identification (procedure),20020131,1,9E+17,9E+17
372071003,Microscopy for malarial parasites (procedure),20020731,1,9E+17,9E+17
372295008,Cytologic examination of anus (procedure),20020731,1,9E+17,9E+17
372266004,Cytologic examination of extrahepatic bile duct (procedure),20020731,1,9E+17,9E+17
372268003,Cytologic examination of adrenal gland (procedure),20020731,1,9E+17,9E+17
395216006,Advanced coagulation studies (procedure),20030131,1,9E+17,9E+17
394884003,Plasma factor VIII inhibitor human and porcine screen (procedure),20030131,1,9E+17,9E+17
394883009,Collagen/epinephrine platelet function test (procedure),20030131,1,9E+17,9E+17
394949001,Kaolin clotting time (procedure),20030131,1,9E+17,9E+17
395209005,Activated protein C ratio (factor V Leiden deficient plasma) (procedure),20030131,1,9E+17,9E+17
395156001,Heinz body screen (procedure),20030131,1,9E+17,9E+17
395015001,Percentage hypochromic cells (procedure),20030131,1,9E+17,9E+17
395068007,Kaolin clotting time Rosner index (procedure),20030131,1,9E+17,9E+17
386521001,Bedside laboratory testing (procedure),20030131,1,9E+17,9E+17
391380004,Activated protein C V deficient assay (procedure),20030131,1,9E+17,9E+17
391393009,Plasmodium falciparum slide test (procedure),20030131,1,9E+17,9E+17
391426006,Bone marrow aspirate examination (procedure),20030131,1,9E+17,9E+17
391371004,Bone marrow trephine examination (procedure),20030131,1,9E+17,9E+17
391436003,Dilute Russell viper venom test correction (procedure),20030131,1,9E+17,9E+17
391532003,Plasmodium vivax slide test (procedure),20030131,1,9E+17,9E+17
391576005,Activated partial thromboplastin time ratio using actin FSL reagent (procedure),20030131,1,9E+17,9E+17
391575009,Total T lymphocyte count (procedure),20030131,1,9E+17,9E+17
391572007,Lupus erythematosus latex test (procedure),20030131,1,9E+17,9E+17
391558003,Total white blood cell count (procedure),20030131,1,9E+17,9E+17
391585005,Activated partial thromboplastin time ratio using actin FS reagent (procedure),20030131,1,9E+17,9E+17
391085004,Activated partial thromboplastin time ratio (procedure),20030131,1,9E+17,9E+17
391087007,Partial thromboplastin time ratio (procedure),20030131,1,9E+17,9E+17
401040003,Measurement of hemoglobin C (procedure),20030731,1,9E+17,9E+17
401297005,Hemolysis screening test (procedure),20030731,1,9E+17,9E+17
401296001,Percentage reticulated platelet count (procedure),20030731,1,9E+17,9E+17
401310009,Activated partial thromboplastin time 80:20 mix (procedure),20030731,1,9E+17,9E+17
401327001,Red blood cell malaria parasitemia count (procedure),20030731,1,9E+17,9E+17
401094008,Natural killer cell level (procedure),20030731,1,9E+17,9E+17
401106000,Semen examination for unclassified cells (procedure),20030731,1,9E+17,9E+17
401133001,Lymphocyte subset measurement (procedure),20030731,1,9E+17,9E+17
397617007,Von Willebrand factor activity measurement (procedure),20030731,1,9E+17,9E+17
407712009,Factor XI inhibitor screening test (procedure),20040131,1,9E+17,9E+17
407711002,Factor VII inhibitor screening test (procedure),20040131,1,9E+17,9E+17
408209009,Percentage abnormal sperm count (procedure),20040131,1,9E+17,9E+17
407728004,Hemoglobin D Iran level (procedure),20040131,1,9E+17,9E+17
408255006,Factor V(306) Cambridge mutation test (procedure),20040131,1,9E+17,9E+17
408189000,Hemoglobin Lepore level (procedure),20040131,1,9E+17,9E+17
408237002,Factor V Leiden test (procedure),20040131,1,9E+17,9E+17
408592007,Plasma plasminogen activity (procedure),20040131,1,9E+17,9E+17
407706004,Hemoglobin J level (procedure),20040131,1,9E+17,9E+17
407710001,Factor IX inhibitor screening test (procedure),20040131,1,9E+17,9E+17
407705000,Hemoglobin G level (procedure),20040131,1,9E+17,9E+17
407663004,Percentage plasma cell count (procedure),20040131,1,9E+17,9E+17
407724002,Adenosine diphosphate 5 umol test (procedure),20040131,1,9E+17,9E+17
408190009,Hemoglobin O level (procedure),20040131,1,9E+17,9E+17
408198002,Platelet neutralization procedure correction (procedure),20040131,1,9E+17,9E+17
407722003,Adenosine diphosphate 1 umol test (procedure),20040131,1,9E+17,9E+17
408193006,Ristocetin 1.5 umol test (procedure),20040131,1,9E+17,9E+17
408194000,Ristocetin 0.5 umol test (procedure),20040131,1,9E+17,9E+17
407723008,Adenosine diphosphate 3 umol test (procedure),20040131,1,9E+17,9E+17
408195004,Thick film for malarial parasites (procedure),20040131,1,9E+17,9E+17
408191008,Hemoglobin Sawara level (procedure),20040131,1,9E+17,9E+17
408256007,Porcine inhibitor activity (procedure),20040131,1,9E+17,9E+17
408240002,Fetal cell test (procedure),20040131,1,9E+17,9E+17
407725001,Collagen 2 umol test (procedure),20040131,1,9E+17,9E+17
407726000,Collagen 5 umol test (procedure),20040131,1,9E+17,9E+17
408230000,Heparin induced thrombocytopenia screening test (procedure),20040131,1,9E+17,9E+17
408242005,Soluble transferrin receptor test (procedure),20040131,1,9E+17,9E+17
407695003,Cord blood grouping (procedure),20040131,1,9E+17,9E+17
407699009,Hemoglobin D level (procedure),20040131,1,9E+17,9E+17
407700005,Hemoglobin E level (procedure),20040131,1,9E+17,9E+17
408221008,Absolute atypical mononuclear cell count (procedure),20040131,1,9E+17,9E+17
408222001,Percentage atypical mononuclear cell count (procedure),20040131,1,9E+17,9E+17
11900001,Semen analysis (procedure),20040131,1,9E+17,9E+17
408274003,Exner kaolin clotting time test (procedure),20040131,1,9E+17,9E+17
408277005,Activated partial thromboplastin time inhibitor screening test (procedure),20040131,1,9E+17,9E+17
408278000,von Willebrand factor collagen binding assay (procedure),20040131,1,9E+17,9E+17
391290009,Fluid sample alpha fetoprotein level (procedure),20040131,1,9E+17,9E+17
391355004,Fluid sample calcium level (procedure),20040131,1,9E+17,9E+17
59388001,"Cell count, body fluid (procedure)",20040131,1,9E+17,9E+17
396550006,Blood test (procedure),20040131,1,9E+17,9E+17
85396007,Synovial fluid analysis (procedure),20040131,1,9E+17,9E+17
405836003,Neurofibromatosis type 2 mutation carrier detection test (procedure),20040131,1,9E+17,9E+17
405837007,Multiple endocrine neoplasia type 2A mutation carrier detection test (procedure),20040131,1,9E+17,9E+17
405838002,Multiple endocrine neoplasia type 2B mutation carrier detection test (procedure),20040131,1,9E+17,9E+17
405839005,Familial medullary thyroid carcinoma mutation carrier detection test (procedure),20040131,1,9E+17,9E+17
405835004,Von Hippel-Lindau disease mutation carrier detection test (procedure),20040131,1,9E+17,9E+17
405823003,BRCA1 mutation carrier detection test (procedure),20040131,1,9E+17,9E+17
405824009,Genetic test (procedure),20040131,1,9E+17,9E+17
405832001,Neurofibromatosis type 1 mutation carrier detection test (procedure),20040131,1,9E+17,9E+17
405825005,Molecular genetic test (procedure),20040131,1,9E+17,9E+17
405826006,BRCA2 mutation carrier detection test (procedure),20040131,1,9E+17,9E+17
412894004,Menopausal profile (procedure),20040731,1,9E+17,9E+17
413010002,Blood acid esterase measurement (procedure),20040731,1,9E+17,9E+17
413021006,Factor VIII inhibitor screening test (procedure),20040731,1,9E+17,9E+17
413024003,Urine pigment analysis (procedure),20040731,1,9E+17,9E+17
413008004,Blood alpha-galactosidase measurement (procedure),20040731,1,9E+17,9E+17
412935002,Cerebrospinal fluid alpha-fetoprotein measurement (procedure),20040731,1,9E+17,9E+17
412931006,24hr urine arginine output measurement (procedure),20040731,1,9E+17,9E+17
412929002,24hr urine lysine output measurement (procedure),20040731,1,9E+17,9E+17
413004002,Blood alpha-N-Acetylgalactosaminidase measurement (procedure),20040731,1,9E+17,9E+17
413002003,Blood arylsulfatase measurement (procedure),20040731,1,9E+17,9E+17
412990009,Hematology test battery (procedure),20040731,1,9E+17,9E+17
412995004,Blood beta-galactosidase measurement (procedure),20040731,1,9E+17,9E+17
412994000,Blood beta-galactocerebrosidase measurement (procedure),20040731,1,9E+17,9E+17
412993006,Blood beta-glucosidase measurement (procedure),20040731,1,9E+17,9E+17
412992001,Blood beta-glucuronidase measurement (procedure),20040731,1,9E+17,9E+17
412841008,Blood coproporphyrin measurement (procedure),20040731,1,9E+17,9E+17
413042008,Immature reticulocyte fraction (procedure),20040731,1,9E+17,9E+17
413029008,Monospecific reagent reaction detection (procedure),20040731,1,9E+17,9E+17
103839006,Low molecular weight heparin assay (procedure),20040731,1,9E+17,9E+17
103827003,Alpha-2 antiplasmin antigen assay (procedure),20040731,1,9E+17,9E+17
45995003,Reticulocyte count (procedure),20040731,1,9E+17,9E+17
409682002,Serial platelet counts (procedure),20040731,1,9E+17,9E+17
409681009,Serial hematocrit determinations (procedure),20040731,1,9E+17,9E+17
409087007,Large unstained cell count (procedure),20040731,1,9E+17,9E+17
409075000,Semen viscosity measurement (procedure),20040731,1,9E+17,9E+17
409074001,Hemoglobin H inclusion test (procedure),20040731,1,9E+17,9E+17
409080009,Collagen adenosine diphosphate platelet function test (procedure),20040731,1,9E+17,9E+17
409078003,Activated partial thromboplastin time - reference (procedure),20040731,1,9E+17,9E+17
27171005,Urinalysis (procedure),20040731,1,9E+17,9E+17
409091002,24 hour urine measurement (procedure),20040731,1,9E+17,9E+17
415518003,Semen leukocyte test (procedure),20050131,1,9E+17,9E+17
415258002,Red cell mean osmotic fragility (procedure),20050131,1,9E+17,9E+17
104153004,"Reticulocyte count, flow cytometry (procedure)",20050131,1,9E+17,9E+17
416107004,Cervical cytology test (procedure),20050731,1,9E+17,9E+17
416583007,Erythrocyte color index measurement (procedure),20050731,1,9E+17,9E+17
416838001,Erythrocyte sedimentation rate measurement (procedure),20050731,1,9E+17,9E+17
427273003,Dispensing of blood product (procedure),20070731,1,9E+17,9E+17
165598004,Thrombophilia screening (procedure),20080131,1,9E+17,9E+17
412859006,Dialysis fluid examination (procedure),20080731,1,9E+17,9E+17
430854000,Touch preparation of specimen (procedure),20080731,1,9E+17,9E+17
390981004,Seminal fructose level (procedure),20080731,1,9E+17,9E+17
439253007,Microscopic examination of vulvar smear (procedure),20090131,1,9E+17,9E+17
440623000,Microscopic examination of cervical Papanicolaou smear (procedure),20090131,1,9E+17,9E+17
440616001,Microscopic examination of anal Papanicolaou smear (procedure),20090131,1,9E+17,9E+17
440615002,Microscopic examination of vaginal Papanicolaou smear (procedure),20090131,1,9E+17,9E+17
437742006,Huntington disease gene mutation carrier detection test (procedure),20090131,1,9E+17,9E+17
441689006,Measurement of total hemoglobin concentration (procedure),20090731,1,9E+17,9E+17
441777003,Measurement of calcium in dialysis fluid specimen (procedure),20090731,1,9E+17,9E+17
441778008,Measurement of aluminum in 24 hour urine specimen (procedure),20090731,1,9E+17,9E+17
441948005,Measurement of protein and glucose in urine specimen using reagent test strip (procedure),20090731,1,9E+17,9E+17
271510004,Hemoglobin S measurement (procedure),20090731,1,9E+17,9E+17
441921009,Determination of hemoglobin subtype using electrophoresis (procedure),20090731,1,9E+17,9E+17
442138005,Microscopy for organism in urine specimen (procedure),20090731,1,9E+17,9E+17
430509005,Examination of fluid specimen (procedure),20090731,1,9E+17,9E+17
442673006,Measurement of total hemoglobin concentration using dipstick (procedure),20090731,1,9E+17,9E+17
412907001,Blood spot propionylcarnitine measurement (procedure),20090731,1,9E+17,9E+17
412908006,Blood spot butyrylcarnitine measurement (procedure),20090731,1,9E+17,9E+17
412909003,Blood spot isovalerylcarnitine measurement (procedure),20090731,1,9E+17,9E+17
412911007,Blood spot hexanoylcarnitine measurement (procedure),20090731,1,9E+17,9E+17
412913005,Blood spot octanoylcarnitine measurement (procedure),20090731,1,9E+17,9E+17
412917006,Blood spot palmitoylcarnitine measurement (procedure),20090731,1,9E+17,9E+17
413668002,Blood catecholamine measurement (procedure),20090731,1,9E+17,9E+17
30669001,"Melanin measurement, urine, qualitative (procedure)",20090731,1,9E+17,9E+17
442468009,Urinalysis with reflex to microscopy (procedure),20090731,1,9E+17,9E+17
259696002,Hemoglobin Constant Spring measurement (procedure),20090731,1,9E+17,9E+17
259694004,Hemoglobin H measurement (procedure),20090731,1,9E+17,9E+17
259693005,Hemoglobin Barts measurement (procedure),20090731,1,9E+17,9E+17
105366003,"Urinalysis, pyuria screen (procedure)",20090731,1,9E+17,9E+17
171248009,Urine screening for blood (procedure),20090731,1,9E+17,9E+17
127801007,Body fluid analysis (procedure),20090731,1,9E+17,9E+17
250224009,Abnormal hemoglobin measurement (procedure),20090731,1,9E+17,9E+17
104798003,Lysozyme measurement (procedure),20090731,1,9E+17,9E+17
268556000,Urine screening for glucose (procedure),20090731,1,9E+17,9E+17
104069009,Hemolytic disease of newborn screen (procedure),20090731,1,9E+17,9E+17
441550005,Urinalysis with reflex to microscopy and culture (procedure),20090731,1,9E+17,9E+17
55605003,Measurement of platelet antibody (procedure),20100131,1,9E+17,9E+17
444226008,Detection of mutation in low density lipoprotein receptor gene (procedure),20100131,1,9E+17,9E+17
444225007,Detection of G20210A mutation in gene of coagulation factor II (procedure),20100131,1,9E+17,9E+17
444090000,Measurement of immunoglobulin G and M classes of antibody to viral capsid antigen of Epstein Barr virus in serum or plasma specimen (procedure),20100131,1,9E+17,9E+17
444260001,Screen for 20 common genetic mutations of cystic fibrosis using amplification refractory mutation system polymerase chain reaction assay technique (procedure),20100131,1,9E+17,9E+17
443345008,Testing for factor V Leiden by screening method (procedure),20100131,1,9E+17,9E+17
444078002,Detection of Arg3527Gln mutation in apolipoprotein B-100 gene (procedure),20100131,1,9E+17,9E+17
444149000,Detection of Arg506Gln mutation in gene of coagulation factor V gene and detection of G20210A mutation in gene of coagulation factor II (procedure),20100131,1,9E+17,9E+17
444032005,Detection of mutation in apolipoprotein B-100 gene (procedure),20100131,1,9E+17,9E+17
443528002,Quantitation of BCR-ABL t(9;22) translocation (procedure),20100131,1,9E+17,9E+17
443982007,Targeted analysis for gene mutation (procedure),20100131,1,9E+17,9E+17
443530000,Screen for 29 common genetic mutations of cystic fibrosis using amplification refractory mutation system polymerase chain reaction assay technique (procedure),20100131,1,9E+17,9E+17
443889002,Factor VIII mutation carrier detection test (procedure),20100131,1,9E+17,9E+17
444157002,Detection of BCR-ABL t(9;22) translocation (procedure),20100131,1,9E+17,9E+17
443751000,Measurement of platelet aggregation using high dose ristocetin (procedure),20100131,1,9E+17,9E+17
443752007,Measurement of platelet aggregation using low dose ristocetin (procedure),20100131,1,9E+17,9E+17
443981000,Testing for known gene mutation in family member (procedure),20100131,1,9E+17,9E+17
444281001,Detection of ordinal level of hemoglobin F in blood specimen (procedure),20100131,1,9E+17,9E+17
444122000,Quantitative measurement of mass rate of excretion of glucose in 24 hour urine specimen (procedure),20100131,1,9E+17,9E+17
443779006,Quantitative measurement of mass concentration ratio of excretion of histamine to excretion of creatinine in 24 hour urine specimen (procedure),20100131,1,9E+17,9E+17
444309000,Determination of karyotype from blood specimen (procedure),20100131,1,9E+17,9E+17
444306007,Measurement of immunoglobulin G and M classes of antibody to Ehrlichia chaffeensis in serum or plasma specimen (procedure),20100131,1,9E+17,9E+17
104100008,"Promyelocyte count, blood (procedure)",20100131,1,9E+17,9E+17
88308000,Blood cell count (procedure),20100131,1,9E+17,9E+17
104099000,"Myelocyte count, blood (procedure)",20100131,1,9E+17,9E+17
103759004,"Metamyelocyte count, blood (procedure)",20100131,1,9E+17,9E+17
117904002,Measurement of drug-induced platelet antibody (procedure),20100131,1,9E+17,9E+17
118139004,Mesothelial cell count (procedure),20100131,1,9E+17,9E+17
118140002,Macrophage count (procedure),20100131,1,9E+17,9E+17
270924002,Plasma cell count (procedure),20100131,1,9E+17,9E+17
117318001,Neutral red stain method (procedure),20100731,1,9E+17,9E+17
117316002,Mucicarmine stain method (procedure),20100731,1,9E+17,9E+17
117313005,Methyl green pyronin stain method (procedure),20100731,1,9E+17,9E+17
117312000,Methyl green stain method (procedure),20100731,1,9E+17,9E+17
117308006,Luxol fast blue with Periodic acid-Schiff stain method (procedure),20100731,1,9E+17,9E+17
117307001,Luxol fast blue with cresyl violet stain method (procedure),20100731,1,9E+17,9E+17
117319009,Night blue stain method (procedure),20100731,1,9E+17,9E+17
117222008,Carmine stain method (procedure),20100731,1,9E+17,9E+17
117320003,Oil red O stain method (procedure),20100731,1,9E+17,9E+17
117321004,Orcein stain method (procedure),20100731,1,9E+17,9E+17
117326009,Quinacrine fluorescent stain method (procedure),20100731,1,9E+17,9E+17
117325008,Prussian blue stain method (procedure),20100731,1,9E+17,9E+17
445202001,Quantitative measurement of time of activated coagulation in blood specimen using silica activator (procedure),20100731,1,9E+17,9E+17
168450005,Forensic examination (procedure),20110131,1,9E+17,9E+17
446325007,Total lymphocyte count (procedure),20110131,1,9E+17,9E+17
21268002,"Cytopathology procedure, forensic (procedure)",20110131,1,9E+17,9E+17
448469006,Synovial fluid mucin clot test (procedure),20110731,1,9E+17,9E+17
609291004,Microscopic examination of bacterial smear of blood specimen (procedure),20130731,1,9E+17,9E+17
609315006,Microscopic cytologic examination of specimen from urethra (procedure),20130731,1,9E+17,9E+17
609309006,Microscopic cytologic examination of specimen from perivesical tissue (procedure),20130731,1,9E+17,9E+17
609310001,Microscopic cytologic examination of semen specimen (procedure),20130731,1,9E+17,9E+17
609311002,Microscopic cytologic examination of specimen from seminal vesicle (procedure),20130731,1,9E+17,9E+17
609312009,Microscopic cytologic examination of specimen from prostate (procedure),20130731,1,9E+17,9E+17
609313004,Microscopic cytologic examination cerebrospinal fluid specimen (procedure),20130731,1,9E+17,9E+17
609316007,Microscopic cytologic examination of urine specimen (procedure),20130731,1,9E+17,9E+17
609314005,Microscopic cytologic examination of sputum specimen (procedure),20130731,1,9E+17,9E+17
609308003,Microscopic cytologic examination of specimen from nervous system (procedure),20130731,1,9E+17,9E+17
609307008,Microscopic cytologic examination of specimen from female genital tract (procedure),20130731,1,9E+17,9E+17
609306004,Microscopic cytologic examination of specimen from bladder (procedure),20130731,1,9E+17,9E+17
609297000,Microscopic cytologic examination of smear of specimen from lower gastrointestinal tract prepared using Papanicolaou technique (procedure),20130731,1,9E+17,9E+17
609299002,Microscopic cytologic examination of smear of blood specimen prepared using Papanicolaou technique (procedure),20130731,1,9E+17,9E+17
609300005,Microscopic cytologic examination of smear of stool specimen prepared using Papanicolaou technique (procedure),20130731,1,9E+17,9E+17
609115003,Microscopic examination of cell block of specimen from lower gastrointestinal tract (procedure),20130731,1,9E+17,9E+17
608836008,Microscopic examination of joint fluid specimen (procedure),20130731,1,9E+17,9E+17
609059009,Microscopic cytologic examination of smear of cerebrospinal fluid specimen prepared using Papanicolaou technique (procedure),20130731,1,9E+17,9E+17
609062007,Microscopic cytologic examination of smear of specimen from bone marrow prepared using Papanicolaou technique (procedure),20130731,1,9E+17,9E+17
609053005,Microscopic cytologic examination of smear of urine specimen prepared using Papanicolaou technique (procedure),20130731,1,9E+17,9E+17
609063002,Microscopic examination of specimen from retroperitoneum prepared using Papanicolaou technique (procedure),20130731,1,9E+17,9E+17
609068006,Microscopic cytologic examination of smear of sputum specimen prepared using Papanicolaou technique (procedure),20130731,1,9E+17,9E+17
609048000,Microscopic cytologic examination of smear of specimen from perivesical tissue prepared using Papanicolaou technique (procedure),20130731,1,9E+17,9E+17
609028007,Microscopic cytologic examination of smear of specimen from ureter prepared using Papanicolaou technique (procedure),20130731,1,9E+17,9E+17
609027002,Microscopic cytologic examination of smear of specimen from upper gastrointestinal tract prepared using Papanicolaou technique (procedure),20130731,1,9E+17,9E+17
609026006,Microscopic cytologic examination of smear of specimen from spleen prepared using Papanicolaou technique (procedure),20130731,1,9E+17,9E+17
609025005,Microscopic cytologic examination of smear of specimen from prostate prepared using Papanicolaou technique (procedure),20130731,1,9E+17,9E+17
609024009,Microscopic cytologic examination of smear of specimen from pancreas prepared using Papanicolaou technique (procedure),20130731,1,9E+17,9E+17
609023003,Microscopic cytologic examination of smear of specimen from nervous system prepared using Papanicolaou technique (procedure),20130731,1,9E+17,9E+17
609029004,Microscopic cytologic examination of smear of specimen from urethra prepared using Papanicolaou technique (procedure),20130731,1,9E+17,9E+17
609030009,Microscopic cytologic examination of smear of specimen from kidney prepared using Papanicolaou technique (procedure),20130731,1,9E+17,9E+17
609031008,Microscopic cytologic examination of smear of specimen from liver prepared using Papanicolaou technique (procedure),20130731,1,9E+17,9E+17
609041006,Microscopic cytologic examination of smear of specimen from integument prepared using Papanicolaou technique (procedure),20130731,1,9E+17,9E+17
609040007,Microscopic cytologic examination of smear of specimen from female genital tract prepared using Papanicolaou technique (procedure),20130731,1,9E+17,9E+17
609039005,Microscopic cytologic examination of smear of specimen from endocrine gland prepared using Papanicolaou technique (procedure),20130731,1,9E+17,9E+17
609038002,Microscopic cytologic examination of smear of specimen from bladder prepared using Papanicolaou technique (procedure),20130731,1,9E+17,9E+17
609037007,Microscopic cytologic examination of smear of specimen from peritoneum prepared using Papanicolaou technique (procedure),20130731,1,9E+17,9E+17
609036003,Microscopic cytologic examination of smear of specimen from biliary tract prepared using Papanicolaou technique (procedure),20130731,1,9E+17,9E+17
609034000,Microscopic cytologic examination of smear of specimen from seminal vesicle prepared using Papanicolaou technique (procedure),20130731,1,9E+17,9E+17
609033006,Microscopic cytologic examination of smear of specimen from musculoskeletal system prepared using Papanicolaou technique (procedure),20130731,1,9E+17,9E+17
609032001,Microscopic cytologic examination of smear of specimen from lymph node prepared using Papanicolaou technique (procedure),20130731,1,9E+17,9E+17
609118001,Microscopic examination of cell block of specimen from pancreas (procedure),20130731,1,9E+17,9E+17
609116002,Microscopic examination of cell block of specimen from lymph node (procedure),20130731,1,9E+17,9E+17
609114004,Microscopic examination of cell block of specimen from kidney (procedure),20130731,1,9E+17,9E+17
609111007,Microscopic examination of cell block of specimen from liver (procedure),20130731,1,9E+17,9E+17
609120003,Microscopic examination of cell block of sputum specimen (procedure),20130731,1,9E+17,9E+17
609123001,Microscopic examination of cell block of urine specimen (procedure),20130731,1,9E+17,9E+17
609081004,Microscopic cytologic examination of smear of semen specimen prepared using Papanicolaou technique (procedure),20130731,1,9E+17,9E+17
609101000,Microscopic cytologic examination of smear of lymph fluid specimen prepared using Papanicolaou technique (procedure),20130731,1,9E+17,9E+17
609100004,Microscopic cytologic examination of smear of joint fluid specimen prepared using Papanicolaou technique (procedure),20130731,1,9E+17,9E+17
609099007,Microscopic cytologic examination of smear of specimen from surgical wound prepared using Papanicolaou technique (procedure),20130731,1,9E+17,9E+17
608955007,Microscopic examination of bacterial smear of sputum specimen (procedure),20130731,1,9E+17,9E+17
608928003,Microscopic examination of lymph fluid specimen (procedure),20130731,1,9E+17,9E+17
608954006,Microscopic examination of bacterial smear of cerebrospinal fluid specimen (procedure),20130731,1,9E+17,9E+17
608952005,Microscopic examination of bacterial smear of seminal fluid specimen (procedure),20130731,1,9E+17,9E+17
608950002,Microscopic examination of bacterial smear of lymph fluid specimen (procedure),20130731,1,9E+17,9E+17
608947000,Microscopic examination of bacterial smear of joint fluid specimen (procedure),20130731,1,9E+17,9E+17
608996005,Microscopic examination of bacterial smear of vomitus specimen (procedure),20130731,1,9E+17,9E+17
711359007,Measurement of ionized calcium in blood specimen (procedure),20150731,1,9E+17,9E+17
714797009,Histologic test (procedure),20160131,1,9E+17,9E+17
714683008,Measurement of hemoglobin F by Kleihauer-Betke method (procedure),20160131,1,9E+17,9E+17
714696009,Quantitative measurement of hemoglobin F in maternal blood specimen using flow cytometry technique (procedure),20160131,1,9E+17,9E+17
767002,White blood cell count (procedure),20180131,1,9E+17,9E+17
15356000,Factor VIII R: R Co assay (procedure),20180131,1,9E+17,9E+17
14089001,Red blood cell count (procedure),20180131,1,9E+17,9E+17
786971004,Rho(D) immune globulin screening (procedure),20190731,1,9E+17,9E+17
165426009,Nucleated red blood cell count procedure (procedure),20190731,1,9E+17,9E+17
118144006,Screening test for red cell enzyme deficiency (procedure),20200731,1,9E+17,9E+17
42351005,Basophil count (procedure),20210731,1,9E+17,9E+17
61928009,Platelet count (procedure),20210731,1,9E+17,9E+17
30630007,Neutrophil count (procedure),20210731,1,9E+17,9E+17
74765001,Lymphocyte count (procedure),20210731,1,9E+17,9E+17
71960002,Eosinophil count (procedure),20210731,1,9E+17,9E+17
